Computational design and studies of neuro-active peptides and the effects of calcium on nicotinic acetylcholine receptors in relation to neurodegenerative disorders by Suresh, A
                         
i 
 
                                         
 
Computational Design and Studies of 
Neuro-Active Peptides and the Effects of 
Calcium on Nicotinic Acetylcholine 
Receptors in Relation to 
Neurodegenerative Disorders 
 
 
A thesis submitted in fulfillment of the 
requirements for the degree of Doctor of Philosophy 
 
 
 
Abishek Suresh 
B.Tech Bioinformatics, MSc Biotechnology. 
 
 
 
 
School of Applied Sciences 
College of Science, Engineering and Health 
RMIT University 
June 2017
 i 
 
 
 
Declaration of Candidature 
 
 
I certify that except where due acknowledgement has been made, the work is 
that of the author alone; the work has not been submitted previously, in whole 
or in part, to qualify for any other academic award; the content of the 
thesis/project is the result of work which has been carried out since the official 
commencement date of the approved research program; any editorial work, paid 
or unpaid, carried out by a third party is acknowledged; and, ethics procedures 
and guidelines have been followed.  
 
 
  
                                                                              Abishek Suresh 
                                                                                                                      June 7, 2017. 
 
 
 
 
 
 
 
                         
ii 
 
Acknowledgements  
 
I would firstly like to thank God for giving me this opportunity to begin my PhD at RMIT, 
Melbourne. It is His Grace that has brought me through this journey to completing this 
course.  
 
I wish to say a big thank you to my supervisor Dr. Andrew Hung for giving me the 
opportunity to take up this project. His guidance, ideas and support through the years has 
helped increase my research potential and has made this whole experience an enjoyable one.  
 
I wish to sincerely thank you to Professor Dr. David Adams, for his feedback on the direction 
of my research, especially with the experimental end of things. I would like to thank David’s 
team members Dr. Victoria Seymour and Dr Han Shen Tae for discussing and experimentally 
testing out the mutants I have proposed in this thesis. I am thankful to Dr. Norelle Daly, for 
preparing the toxin mutants in the first place that were of importance to this study. Thank you 
to Dr. Shiva Nag for all the feedback on my research when we met at conferences. I would 
also like to thank and Dr. Riley Yu for his invaluable suggestions and comments towards 
refining my manuscript and thesis chapter. 
On a more personal note, I wish to thank my parents and my family for all the love, 
understanding, never-ending support, prayers and advice they have given me through these 
years of my studies. The innumerable number of phone calls has definitely made me feel at 
ease when times got tough. This wouldn’t be complete if I didn’t say thanks to my dear wife 
Joyce, who is with me through everything and was so supportive and understanding during 
the completion of this thesis.  
                         
iii 
 
A special thanks to my family away from family, Adrian, Indrawan, Amanda, Natalia and 
Carina, Robert, Patrick, Ko Rudy and ci Suzanne for all the countless prayers, advice, and 
encouragement when I needed it the most, (not to mention the after midnight phone calls and 
texts!). Thank you guys for watching over me! My love goes out to everyone at BIC, 
especially the 180 Degrees. Thank you for giving me an opportunity to minister together with 
you guys for God and opening another amazing chapter in my life. You guys are amazing! 
I would say a big thank you to Kelly, Jan, Ben, Tim, Emily, Celine, Bogdan and Daniel at the 
school of Applied sciences, shared more than just their office/building space with me and 
always brought me back to reality in the midst of all the research. Thanks guys, you have all 
definitely been a great motivation to help me keep going.  
Thanks to all my classmates and friends from school, Raghav, Sreela, Elizabeth and Kesavan 
for keeping me posted with all the happenings back home! I had a good time with you at UK, 
Kesavan.  
My sincere thanks also goes out to the Victorian Government and the Australia India Institute 
for the Victoria India Doctoral scholarship that supported my stay here. Also to VLSCI and 
VPAC for all the computational resources without which this project would not be possible 
 
 
 
 
                         
iv 
 
 
List of Publications 
 
Molecular Simulation Study of the Unbinding of α-Conotoxin [ϒ4E]GID at 
the α7 and α4β2 Neuronal Nicotinic Acetylcholine Receptors 
Abishek Suresh, Andrew Hung. 
Journal of Molecular Graphics and Modelling 70, 109-121. 2016 Sep 21.  
 
 
 
 
 
 
 
 
 
 
 
 
 
                         
v 
 
List of Conference Presentations  
 
 
1. Abishek Suresh, A. Hung, David Adams.  
“Computational Identification of Structural and interaction properties of 
α-conotoxin GID and analogues at the α7 and α4β2 nicotinic acetylcholine 
receptors” .  
Nicotinic Receptors conference 2014, Cambridge, UK.  
 
 
2. Abishek Suresh, A. Hung, David Adams.  
“Computational study of conotoxin GID interaction with α7 and α4β2 
nicotinic receptor subtypes”.  
IUPAB Conference 2014, Brisbane, Australia.  
 
 
3. Abishek Suresh, A. Hung, David Adams.  
“Understanding differences in GID-conotoxin analogue interactions with 
α7 and α4β2 neuronal nicotinic receptors by umbrella sampling”  
Gage Conference, 2015, Canberra, Australia. 
 
 
 
 
 
                         
vi 
 
List of Abbreviations 
 
nAChR Nicotinic Acetylcholine Receptor 
     VGCC Voltage Gated Calcium channel 
    AChBp Acetylcholine Binding protein 
     LBD Ligand Binding Domain 
     ECD Extracellular Domain 
      TMD Transmembrane domain 
      CD Circular Dichroism 
     DNA Deoxyribonucleic acid 
      GROMACS GROningen Machine for Chemical Simulation 
  Ca2+ Representation of a Calcium ion 
   MD Molecular dynamics  
      NMR Nuclear Magnetic Resonance  
    NPT Constants number of particles, pressure and temperature  
NVT Constant number of particles, volume and temperature 
PBC Periodic boundary condition 
     PDB Protein Data Bank 
     RMSD Root Mean Square Deviation 
   VMD Visual Molecular Dynamics 
     VPAC Victorian Partnership for Advanced Computing  
  VLSCI Victorian Life Sciences Computation 
   WHAM Weighted Histogram Analysis Method 
    α-CgTxs α-Conotoxins     
 
 
 
                         
vii 
 
Table of Contents 
 
Declaration of Candidature ..................................................................................................... i 
Acknowledgements .................................................................................................................. ii 
List of Papers Published ......................................................................................................... iv 
Conference Presentations ........................................................................................................ v 
List of Abbreviations .............................................................................................................. vi 
Table of Contents ................................................................................................................... vii 
List of Tables ........................................................................................................................... xi 
List of Figures ......................................................................................................................... xii 
Abstract ..................................................................................................................................... 1 
1. Introduction – Nicotinic Acetylcholine Receptors and Conotoxins ............................. 4 
1.1. Introduction - Protein Structure................................................................................... 5 
1.2 Identification and isolation of acetylcholine receptors .................................................. 13 
1.3 Assembly and structure of neuronal nicotinic receptors ................................................ 15 
1.4 Ligand binding site and channel gating.......................................................................... 19 
1.5 Diversity of nAChR subtypes in the brain ..................................................................... 26 
1.6 Nicotinic Receptors in relation to addiction and disease ............................................... 27 
1.6.1 Addiction and smoking ............................................................................................ 28 
1.6.2 Alzheimer’s disease ................................................................................................. 29 
1.6.3 Parkinson’s disease .................................................................................................. 30 
1.6.4 Schizophrenia .......................................................................................................... 31 
1.6.5 Neuropathic pain ...................................................................................................... 32 
1.7 Nicotinic receptor antagonists ........................................................................................ 33 
1.7.1 Dihydro-β-erythroidine (DhβE) ............................................................................... 34 
1.7.2 MLA ........................................................................................................................ 35 
1.7.3 α-Lobeline (Lobeline) .............................................................................................. 35 
1.7.4 N-Alkylpyridinium halides ...................................................................................... 36 
1.8 Conotoxins ..................................................................................................................... 36 
1.8.1 Classification and structure of conotoxins ............................................................... 37 
1.8.2 α-Conotoxin [ϒ4E]-GID ......................................................................................... 43 
1.9 Computational studies of nAChr-conotoxin interactions ............................................... 45 
1.10 The roles of calcium (Ca2+) in nAChR and its relationship to disease ........................ 52 
                         
viii 
 
1.11 Aims of this thesis ........................................................................................................ 55 
 
 Computational Methods for Protein study .................................................................. 58 2.
2.1 Homology modelling...................................................................................................... 59 
2.1.1 Background and theory ............................................................................................ 59 
2.1.2 Methodologies and procedures ................................................................................ 66 
2.2 Molecular modelling ...................................................................................................... 68 
2.3 Molecular dynamics simulations .................................................................................... 70 
2.3.1 Background and theory ............................................................................................ 70 
2.3.2 FoldX ....................................................................................................................... 83 
2.3.3 Methodologies and procedures ................................................................................ 84 
2.4 Advanced molecular dynamics techniques: Umbrella sampling ................................... 86 
2.4.1 Background and theory ............................................................................................ 87 
 
 Equilibrium Molecular Dynamics Simulations of [γ4E]-GID Interactions with α7 3.
and α4β2 Nicotinic Receptors ............................................................................................... 90 
3.1 Introduction .................................................................................................................... 91 
3.2 Methods .......................................................................................................................... 95 
3.2.1 Homology models.................................................................................................... 95 
3.2.2 Molecular dynamics simulations ........................................................................... 105 
3.2.3 Analysis methods ................................................................................................... 108 
3.2.4 Position Scan – Mutation Analysis ........................................................................ 109 
3.3 Results and Discussion ................................................................................................. 110 
3.3.1 Secondary structure of [γ4E]-GID at α7 and α4β2 ................................................ 110 
3.3.2 Flexibility and conformational clusters of [γ4E]-GID at α7 and α4β2.................. 116 
3.3.3 [γ4E]-GID per-residue contacts with α7 and α4β2 ................................................ 131 
3.3.4 Proposed α4β2 selectivity-enhancing mutations based on conotoxin-nAChR 
contact analysis ............................................................................................................... 139 
3.4. Mutational free energy analysis .................................................................................. 151 
3.5 Conclusions .................................................................................................................. 165 
 
 
 
                         
ix 
 
 Unbinding pathways of α-conotoxin [ϒ4E]-GID at the α7 and α4β2 subtype 4.
receptors................................................................................................................................ 170 
4.1. Introduction ................................................................................................................. 171 
4.2. Methods ....................................................................................................................... 174 
4.2.1 Homology models.................................................................................................. 174 
4.2.2. Molecular dynamics simulations .......................................................................... 175 
4.2.3. Umbrella sampling ............................................................................................... 176 
4.3. Results and Discussion ................................................................................................ 179 
4.3.1. Potentials of mean force profiles at all interfaces studied .................................... 179 
4.3.2. Maximum-ΔGwell PMF profiles ............................................................................ 183 
4.3.3 Maximum- ΔGwell unbinding pathways ................................................................. 185 
4.3.4. Residues involved in [ϒ4E]-GID interaction with α7α7: maximum ΔGwell pathway 
(‘Tox-1’) ......................................................................................................................... 189 
4.3.5. Residues involved in [ϒ4E]-GID interaction with rat and human α4β2: maximum 
ΔGwell pathways (‘Tox-2’) .............................................................................................. 191 
4.3.6. Loop C structural behaviour at maximum-ΔGwell pathways ................................ 196 
4.3.7. Minimum-deformation pathways: selection based on toxin and receptor-loop C 
structural changes ........................................................................................................... 201 
4.3.8 Minimum-deformation PMF profiles and unbinding pathways ............................ 204 
4.3.9. Residues involved in [ϒ4E]-GID interaction with α7α7: minimum-deformation 
pathway (‘Tox 5’) ........................................................................................................... 208 
4.3.10. Residues involved in [ϒ4E]-GID interaction with rat α4β2: minimum-
deformation pathway (‘Tox-1’) ...................................................................................... 211 
4.3.11. Residues involved in [ϒ4E]-GID interaction with rat and human α4α4: sole 
pathways in the present study (‘Tox-3’) ......................................................................... 214 
4.4. Conclusions ................................................................................................................. 218 
 
 The effect of calcium ions on nAChr- a wrong key to an open receptor channel ... 224 5.
5.1. Introduction ................................................................................................................. 225 
5.1.1. Overview of Ca2+-related pathophysiology and nAChRs .................................... 226 
5.1.2. Previous simulation and modeling studies of Ca2+ interactions with nAChR ...... 229 
5.1.3. Aims of this chapter .............................................................................................. 231 
5.2 Methods ........................................................................................................................ 232 
5.2.1 Homology models.................................................................................................. 232 
5.2.2. Simulation systems ............................................................................................... 233 
                         
x 
 
5.2.3. Helix structure and flexibility analysis ................................................................. 236 
5.2.4. Ca2+ ion permeation umbrella sampling simulations ........................................... 236 
5.3. Results and Discussion ................................................................................................ 240 
5.3.1. Effects of Ca2+ on overall extracellular domain structure .................................... 240 
5.3.2. Identification of extracellular domain Ca2+ binding sites ..................................... 243 
5.3.3. Effects of Ca2+ on the transmembrane helices ...................................................... 247 
5.3.4. Effects of Ca2+ on the interfacial M1-M2 and M2-M3 loop regions .................... 257 
5.3.5. Effects of Ca2+ on bilayer density ......................................................................... 261 
5.3.6. Effects of Ca2+ on channel pore-dimensions ........................................................ 262 
5.3.7. Ca2+ permeation through the Ca2+-free and Ca2+-affected pores .......................... 266 
5.4. Conclusions ................................................................................................................. 277 
 
 Preliminary Studies of [γ4E]-GID-α7 Interactions in an Elevated [Ca2+] 6.
Environment ......................................................................................................................... 281 
6.1. Introduction ................................................................................................................. 282 
6.2 Methods ........................................................................................................................ 283 
6.3. Results and Discussions .............................................................................................. 284 
6.3.1. Changes in [γ4E]-GID structure ........................................................................... 284 
6.3.2 Changes in the hα7 receptor binding pocket ......................................................... 287 
6.4 Conclusions .................................................................................................................. 292 
 
 Conclusions and Future Directions ............................................................................. 293 7.
7.1. Conotoxin-nAChR Interactions .................................................................................. 294 
7.2. Importance of the Unbinding Pathway of the α-Conotoxin [γ4E]-GID ...................... 296 
7.3. Possible Effects of Ca2+ Ion Concentration on nAChRs and in Neurodegenerative 
Diseases .............................................................................................................................. 297 
7.4. Possible Effects of Ca2+ Ion Concentration on [γ4E]-GID at the human-α7 receptor 299 
7.5. Closing Thoughts and Future Directions .................................................................... 300 
References ............................................................................................................................. 301 
Appendix ............................................................................................................................... 331 
 
 
 
                         
xi 
 
List of Tables 
 
 
Table 1.1: The name, sequence and receptor subunit selectivity for some of the commonly 
known α-conotoxins are shown. Cysteine positions are highlighted. The toxins are arranged 
based on their Cysteine framework……………………….......……………………………...40 
Table 3.1: The population of the clusters exhibited at the human α7 (A) and α4β2 (B,C)  
receptor pockets are shown…………………………………………………………............123 
Table 3.2: Mutational free energy values for ImI-α7 complex predicted by FoldX and from 
literature. Uncertainties are given as standard errors of the mean over the 5 nominally 
identical interfaces of α7………………......………………………………………..…........154  
Table 3.3: FoldX-predicted mutational free energy (ΔΔG) for [γ4E]-GID residues (columns) 
mutated to each of the 20 natural amino acids (rows), for [γ4E]-GID bound to hα7 at the 
canonical binding site. Negative values are indicated in shades of red, positive values in 
shades of blue…………..….................................................................................….…..156 
Table 3.4: FoldX-predicted mutational free energy (ΔΔG) for [γ4E]-GID residues (columns) 
mutated to each of the 20 natural amino acids (rows), for [γ4E]-GID bound to hα4β2 at the 
canonical α4(+)β2(-) binding site. Negative values are indicated in shades of red, positive 
values in shades of blue…………………………………...…………………………….…..159 
Table 3.5: Difference in FoldX-predicted mutational free energy (Δ(ΔΔG)) between hα4β2 
and hα7 for [γ4E]-GID residues (columns) mutated to each of the 20 natural amino acids 
(rows). Negative values suggest selectivity for hα4β2 and are indicated in shades of red. 
Positive values suggest predicted selectivity for hα47 and are indicated in shades of 
blue……………………………................................................................………………..162  
 
 
 
 
 
 
 
                         
xii 
 
List of Figures 
 
Figure 1.1:  shows a general structure of an amino-acid, where the Cα holds together the 
NH2 (left) and the COOH ends (right) along with the unique side-chain, R. The amino acid in 
the Zwitterion configuration is also shown. ............................................................................... 6 
Figure 1.2: Shows the formation of a peptide bond during the process of protein synthesis. .. 7 
Figure 1.3: Shows the primary structural representation of a protein represented by the 
sequence of amino-acids. The secondary structures are represented by ribbons and Alpha-
helices. The tertiary structure is represented by coils and strands, while the quaternary 
structure is represented by five monomeric subunits, holding the α-conotoxin [ϒ4E]-GID at 
the respective binding pockets formed at the interface of adjacent subunits. ............................ 9 
Figure 1.4: Shows the Ramachandran plot that marks the allowed regions for the secondary 
structure of a protein. The marked yellow and green regions represent the residues with the 
most desired phi-psi angles. ..................................................................................................... 10 
Figure 1.5: Shows the β-hairpin structure; a) where the hydrogen bonding (shown as black 
dotted lines) on the protein backbone is shown; b) Cartoon representation of β-hairpin. ....... 12 
Figure 1.6: Basic structure of nicotinic acetylcholine receptors (nAChRs). A: the basic linear 
sequence of all nAChR subunits appears as a large extracellular domain, four transmembrane 
domains, and a cytoplasmic domain of variable size that resides between TM3 and TM4. (B): 
the EM structure of the Torpedo nAChR is from Unwin, and images were generated using the 
UCSF-chimera program with coordinates obtained from the Protein Data Bank ID 
1OED.pdb. The agonist-binding site is contained in a pocket between the α and the adjacent 
non-α subunit defined on its outer face by the Cys-Cys pair. Also, the extension of the C-loop 
around ligand is evident. D: similar to B, the receptor surface is added to show the relative 
positioning of each subunit (as labelled). Adapted from (25). ................................................... 18 
Figure 1.7: Upon binding of agonist and capping of the ligand-binding domain, rotational 
motion in the β-strands is transmitted through the subunit to residues that are near the TM 
domain-membrane interface. The rotational motion leads to important interactions that result 
in the rotation of TM4 ∼15° to move the hydrophobic gating residues (Val and Leu) away 
from the pore and the polar residues (Ser) towards the channel, resulting in channel-opening. 
[Model shown is based on the original study of Unwin (33) taken from electron microscopy 
studies of channel gating from theTorpedo nAChR (PDB ID: 2BG9) and from high-
resolution studies of the AChBPs. The different loops of the subunit have also been 
highlighted. Reference:(25)........................................................................................................ 20 
Figure 1.8: The location of the aromatic box residues on the hα7 receptor are shown along 
with the residues Glu 211 and Asp 219 beside them. Y140 that corresponds to  Here GID can 
also be seen in the binding pocket. .......................................................................................... 22 
                         
xiii 
 
Figure 1.9: Shows the sequence alignment of the human-α7(hα7), Human Acetylcholine 
receptor, human-α4, rat- α4, human-β2 and rat-β2 subunits. The aromatic-box residues, 
namely hα7(+)Y115, W171,Y210,Y217 and hα7(-)W77 have been boxed. The residues after 
hα7-L230 indicate the beginning of the transmembrane domain. The residues highlighted in 
yellow are the gating residues that align with Acetylcholine residues S248, L251, S252, V255 
and V259. ................................................................................................................................. 24 
Figure 1.10: Examples of non-peptide nicotinic receptor antagonists (104). ............................ 34 
Figure 1.11: The structure and sequence of the α-conotoxin GID. The disulphide bonded 
cysteine residues are represented as yellow dynamic-bonds format, and numbered from I-IV 
accordingly. Residues forming Loop I and Loop II of the conotoxin are also highlighted in 
red and blue respectively. ........................................................................................................ 43 
Figure 2.1: Comparative Protein Modelling by Modeller: The target sequence to be modelled 
is aligned on the template 3D structure. Next, Spatial features of the template structure such 
as Cα - Cα distances, hydrogen bonds, and main-chain and side-chain dihedral angles, are 
applied to the target. The 3D model that is finally obtained by satisfies the obtained restraints 
as close as possible................................................................................................................... 64 
Figure 2.2: Shows the ClustalW sequence alignment results that used the query sequence of 
the human α7 extracellular domain and the template sequence at the PDB ID 2BR8. ........... 67 
Figure 2.3: Shows the ClustalW sequence alignment results that used the query sequences of 
the human α4 and β2 extracellular domain and the template sequence at the PDB ID 2BR8. 67 
Figure 2.4: Shows the ClustalW sequence alignment results that used the query sequences of 
the rat α4 and β2 extracellular domain and the template sequence at the PDB ID 2BR8. ...... 68 
Figure 2.5: Shows a 2-dimensional representation of a unit-cell. The grey box represents the 
actual system, while the boxes in white represent mirror images of the system. .................... 77 
Figure 2.6: shows the protein in focus (α7 nicotinic receptor) in a solvent-filled (red dots) 
triclinic simulation box. ........................................................................................................... 78 
Figure 2.7: shows the biased distribution of a system along the reaction coordinate in the 
form of umbrella sampling windows (red). The free-energy is derived (Blue) from the biased 
potential.................................................................................................................................... 89 
Figure 3.1: Molecular models of the extracellular domain of (A) the human α7 receptor 
bound with five [γ4E]-GID conotoxins at the binding pockets located at the interface between 
adjacent subunits; and (B) the rat α4β2 neuronal nicotinic receptor with [γ4E]-GID found at 
three binding pockets located at the interface between the α4 subunit and the adjacent β2 
subunit and the α4-α4 subunit interface. The models were generated using Modeller9(343), 
while the template used was the crystal structure of Acetylcholine-binding protein (ACHBP) 
from Aplysia californica in complex with α-conotoxin PnIA variant (PDB ID: 2BR8). ........ 95 
                         
xiv 
 
Figure 3.2: Shows the coil regions on the AChBP structure that corresponded to gaps in the 
alignment with the hα7/hα4β2 receptor pocket. ...................................................................... 97 
Figure 3.3: 10 homology models of the hα7 receptor are superimposed (panels A and B) to 
show the similarity between the structures. The [γ4E]-GID structures were also superimposed 
(Panel C), where differences were noted only in the orientation of the N-terminal. ............... 98 
Figure 3.4: The alignment of tryptophan residues (at the binding pocket) between 2 selected 
homology models of the hα7 receptor for which a difference in Trp rotamer conformation is 
present (A). The orientation of the aromatic residues between α9 (red sidechains) and α7 
(blue side chains) showed slight differences in the orientation of hα7 Tyr corresponding to 
α9-Y95(B). ............................................................................................................................. 100 
Figure 3.5: The alignment of tryptophan residues (at the binding pocket) between 2 selected 
homology models of the α4β2 receptor for which a difference in Trp rotamer conformation is 
present (A). The orientation of the aromatic residues between α9 (red sidechain) and α4 (blue 
sidechain) showed slight differences in the orientation of rα4-Y98 compared to α9-Y95. ... 101 
Figure 3.6: The hα7 homology models (out of 100 models) that showed the minimum 
(shown as secondary structures) and the maximum (Blue) DOPE scores respectively are 
superimposed. Differences were seen in the loop regions and orientation of the tryptophan 
residues. ................................................................................................................................. 102 
Figure 3.7: The experimental structures of the α1 and α9 were superimposed with the top 
scoring models of the α7 and α4. Tyrosine residues have also been highlighted. ................. 104 
Figure 3.8: Shows the density of the water molecules using various frames of the 
equilibration simulation to understand the distribution of the water molecules across the 
simulation box containing both the human α7 (Panel A) and α4β2 (Panel B) receptors....... 107 
Figure 3.9: STRIDE secondary structure plots of each [γ4E]-GID residue (y-axes) with 
respect to simulation time (x-axes) for the hα7 interfaces (A-E); the α4β2 (D-E) and α4α4 (F) 
interfaces of hα4β2; and the α4β2 (G-H) and α4α4 (I) interfaces of rα4β2. (In each panel, 
results from all six independent are combined and the segments demarcated and labelled as 
Sim-1, etc., as indicated on the x-axes.) ................................................................................ 112 
Figure 3.10: Shows the superimposition of the initial binding modes [γ4E]-GID structures at 
the hα7 binding pockets 1 and 5 in panel (A) and the structures from all respective binding 
pockets in panel B. A clear difference in the orientation of the IRDE-tail residues is seen. . 113 
Figure 3.11: Shows the superimposition of [γ4E]-GID structures at the rα4β2 pockets 1 and 2 
(Panel A) and also a comparison of the [γ4E]-GID structures at the 2-α4/β2 receptor pockets 
and the α4/α4 pocket (Panel B). Panel A shows a slight difference in the conformation at the 
IRDE tail. However, [γ4E]-GID at the α4/α4 binding pocket showed a striking difference in 
the orientation of the IRDE-tail. ............................................................................................ 114 
                         
xv 
 
Figure 3.12: Shows the superimposition of [γ4E]-GID structures at the hα4β2 pockets 1 and 
2 (Panel A) and also a comparison of the [γ4E]-GID structures at the 2-α4/β2 receptor 
pockets and the α4/α4 pocket (Panel B). ............................................................................... 116 
Figure 3.13: Average Root Mean Square Fluctuation of each toxin residue at the human α7 
(A) rα4β2 (B) and hα4β2 (C) receptors respectively along the course of the 60ns simulation 
respectively. The RMSF of the toxin residues is seen to vary marginally between the receptor 
subtypes.................................................................................................................................. 119 
Figure 3.14: The average RMSD of [γ4E]-GID and the respective receptor subunit pockets 
during 6 simulations is shown. The stability of the system can be seen from these graphs. . 120 
Figure 3.15: Conformational cluster identification number with respect to simulation time for 
[γ4E]-GID at human α7 (A), human α4β2 (B) and rat α4β2 (C). The N-terminal tail was 
found to be more distant from the remaining toxin body, in comparison to [γ4E]-GID at the 
α7 receptor. Also, [γ4E]-GID at the α7 receptor pocket showed less fluctuation in structure 
along the time-frame, and accommodates itself with the binding pocket easily in comparison 
to that at the α4β2 receptor subtypes. The clusters that showed a significantly high presence 
in the simulation are highlighted in this figure, and numbered accordingly. (In each panel, 
results from all six independent are combined and the segments demarcated and labelled as 
Sim-1, etc., as indicated on the x-axes.) ................................................................................ 122 
Figure 3.16: Superimposition of the major [γ4E]-GID structures, identified by 
conformational cluster analysis to populate the majority of the respective trajectories. Clearly 
shown is that the IRDE tail of the [γ4E]-GID structures at the hα7 receptor (A) are more close 
to the toxin body compared to that at the rat (B) and human (C) α4β2 and α4α4 interfaces. 124 
Figure 3.17: Shows the superimposition of [γ4E]-GID structures at the hα4β2 pockets 1 and 
2 (Panel A) and also a comparison of the [γ4E]-GID structures at the 2-α4/β2 receptor 
pockets and the α4/α4 pocket (Panel B). ............................................................................... 129 
Figure 3.18: Shows the average number of contacts exhibited by [γ4E]-GID at the hα7(panel 
A), rα4β2 (panel B) and the hα4β2 receptors (panel C). ....................................................... 129 
Figure 3.19: shows the average number of contacts exhibited at the hα7/α4β2 receptor 
pockets (A) and α4α4 receptor subtype pockets (B). Panels C and D also show the contact 
surface area exposed by [γ4E]-GID at the hα7/α4β2 receptor pockets (C) and α4α4 receptor 
subtype pockets (D). The error-bars represent the standard deviation obtained from the data at 
5-hα7 and 2-α4/β2 receptor binding pockets respectively. .................................................... 131 
Figure 3.20: Differences in the number of contacts over the combined 60ns simulation 
between [γ4E]-GID at the human α7-receptor and the respective human (A) or rat (B) α4β2 
and α4α4 receptor binding pockets; and differences in the contact-surface area displayed by 
each [γ4E]-GID residue at the human α7 and the respective human (C) or rat (D) α4β2 and 
α4α4 receptor binding pockets. .............................................................................................. 135 
                         
xvi 
 
Figure 3.21: Average number of contacts that individual [γ4E]-GID residues form with the 
Cys-Cys pair residues at the hα7 (A), rα4β2 (B), rα4α4 (C), hα4β2 (D) and hα4α4 (E) 
binding pockets respectively. ................................................................................................. 136 
Figure 3.22: Representations of the interaction of the hα7 (A), rα4β2 (B) and hα4β2 (C) 
receptor residues that maintain close proximity and possibly interacting with the toxin residue 
Arg2. The orange ribbon represents the whole toxin chain, while the other representations 
symbolise the interacting residues. ........................................................................................ 142 
Figure 3.23: Residues on the rat α4(+)α4(-)  receptor binding pocket (A) and the residues on 
the human α4(+)α4(-)  receptor binding pocket (B) than make the most number of contacts 
with [γ4E]-GID-R2 respectively. ........................................................................................... 143 
Figure 3.24: Representation of the [γ4E]-GID interaction at the hα7(A), rα4β2(B) and 
hα4β2(C) receptor residues that maintain close proximity and interacting with [γ4E]-GID-S7. 
At the rα4β2 and hα4β2 receptor, Gln65 of the β2 subunit is represented differently in VDW 
from other residues to show that although the residue was in close proximity, it did not 
interact with Ser7. .................................................................................................................. 146 
Figure 3.25: Residues on the rat α4(+)α4(-)  receptor binding pocket (A) and the residues on 
the human α4(+)α4(-)  receptor binding pocket (B) than make the most number of contacts 
with [γ4E]-GID-S7 respectively. ........................................................................................... 147 
Figure 3.26: Residues that are in close contact with [γ4E]-GID-V13 at the human α7 
receptors (A), rat α4β2 receptor (B) and human α4β2 receptor (C) respectively. ................. 150 
Figure 3.27: Highlights the residues on the rat α4(+)α4(-)  receptor binding pocket (A) and 
the residues on the human α4(+)α4(-)  receptor binding pocket (B) than make the most 
number of contacts with [γ4E]-GID-V13 respectively. ......................................................... 151 
Figure 3.28: Correlation between FoldX-predicted and experimentally-estimated mutational 
free energy (ΔΔG, kcal/mol) for the ImI-α7 complex. Outlier ImI mutants are circled in red. 
Linear regression equation is inset. ........................................................................................ 155 
Figure 3.29: shows the correlation between pIC50 values from Millard’s study(333) and those 
obtained from FoldX at the Human α7 and α4β2 receptors respectively. ............................. 157 
Figure 3.30: Shows graphical representations of [γ4E]-GID residues whose mutants are 
predicted to enhance selectivity for hα4β2. [E4R]-GID is predicted to only weakly increase 
affinity at hα7 (A), but substantially increases affinity at hα4β2 due to close interaction with 
β2-D196 (B). [R12F]-GID is predicted to improve selectivity for hα4β2 by reducing 
electrostatic repulsion with β2-K188 (C), while no basic residues are in the vicinity of [γ4E]-
GID-R12 at hα7. .................................................................................................................... 163 
Figure 3.31: Electrophysiology measurements of relative inhibition of nAChR current for 
hα7 and hα4β2 by [γ4E]-GID variants (unpublished; data provided courtesy of Prof. Dr. 
                         
xvii 
 
David J. Adams and Dr. Han Shen Tae, RMIT University). The Standard Error of mean error 
bars are also shown respectively. ........................................................................................... 167 
Figure 4.1: The average predicted ΔG value obtained from the plateau region of potentials of 
mean force (PMF) profiles, calculated using WHAM on trajectories of varying length (from 
100ps to 1000 ps). .................................................................................................................. 181 
Figure 4.2: Potential of mean force (PMF) profiles of [ϒ4E]-GID unbinding from the 
canonical agonist binding site (distance ~0Å) at the hα7 (A), rα4β2 (B) and hα4β2 (C) 
receptor pockets respectively. Note that ‘Tox-3 of the α4β2 receptors correspond to α4α4 
interfaces. ............................................................................................................................... 182 
Figure 4.3: Maximum- ΔGwell PMF profiles of [γ4E]GID unbinding from the canonical 
orthosteric site  at the hα7, hα4β2 and rα4β2 receptor pockets. ............................................ 184 
Figure 4.4: Combined umbrella sampling windows illustrating the unbinding pathways of 
[ϒ4E]-GID out of the hα7 (different perspectives shown in (A) and (B)) and rat α4β2 (C and 
D) receptor binding pockets respectively. Centre-of-mass distances between the principal 
subunit and the toxin are indicated in (A) and (C). [ϒ4E]-GID is seen to make contact with 
the residues of the adjacent receptor subunit as it makes its path away from the respective 
binding pocket. In comparison to the hα7 nAChR [ϒ4E]-GID does not make as many 
contacts with the residues of the adjacent receptor subunit as it makes its way away from the 
extracellular domain of the β2 subunit. The Cys loop has also been highlighted to appreciate 
any changes in secondary structure as the toxin separates from the binding pocket ............. 186 
Figure 4.5: Shows concatenated umbrella sampling windows illustrating the unbinding 
pathways of [ϒ4E]-GID from the rat α4α4 (different perspectives shown in (A) and (B)) and 
human α4α4 (C and D) receptor binding pockets respectively. The X (blue), Y (green) and Z 
(red) axes are indicated by thick coloured arrows at the bottom left corner of each panel. .. 188 
Figure 4.6: Plots of number of inter-atomic contacts between receptor residues of the 
principal (A) and complementary (B) subunits of the hα7 receptor binding pocket-1 with 
[γ4E]- GID, at a number of selected centre-of-mass separation distances (colour coded as 
indicated in the legends). Also shown are the number of inter-atomic contacts between each 
[ϒ4E]-GID residue and the principal (C) and complementary (D) subunits of hα7. ............ 191 
Figure 4.7: Plots of number of inter-atomic contacts between receptor residues of the 
principal (A) and complementary (B) subunits of the rα4β2 receptor binding pocket-2 with 
[γ4E]-GID, at a number of selected centre-of-mass separation distances (colour coded as 
indicated in the legends). Also shown are the number of inter-atomic contacts between each 
[ϒ4E]-GID residue and the principal (C) and complementary (D) subunits of rα4β2. ......... 193 
Figure 4.8: Plots of number of inter-atomic contacts between receptor residues of the 
principal (A) and complementary (B) subunits of the hα4β2 receptor binding pocket with 
[γ4E]-GID, at a number of selected centre-of-mass separation distances (colour coded as 
                         
xviii 
 
indicated in the legends). Also shown are the number of inter-atomic contacts between each 
[ϒ4E]-GID residue and the principal (C) and complementary (D) subunits of hα4β2. ........ 194 
Figure 4.9: Shows the presence of R221 at the principal face of the α4β2 receptor pocket that 
protrudes within the binding pocket (Panel C) and behaves as a hindrance to [ϒ4E]-GID 
binding properly at the receptor pocket. However, at the α7 receptor binding pocket, R208 on 
the α7 (+) face poses no hindrance to [ϒ4E]-GID binding.................................................... 196 
Figure 4.10: Distance between the Cys residues at the ‘tip’ of loop C and a selected position 
at the complementary subunit for hα7, hα4β2 and rα4α4 interfaces with respect to toxin-
receptor COM separation. A gradual closure of the binding pocket at the hα7 receptor is 
observed, much more clearly than at either of the other interfaces. ...................................... 197 
Figure 4.11: Loop C distances at the start (toxin still bound at canonical agonist binding site; 
blue) and end (after toxin fully removed from canonical binding site; red) of the respective 
umbrella sampling trajectories at the hα7, rα4β2 and the rα4β2 receptors. The loop C 
distances are compared to that of the AChBP structure in the apo state (left-most bars; blue) 
and with ImI bound to the canonical binding pocket (left-most bars; red). ........................... 200 
Figure 4.12: Shows the fluctuation in RMSD of [ϒ4E]-GID as it unbinds from the Human 
α7 (A), Rat α4β2 (B) and Human α4β2 (C) receptors respectively. ...................................... 202 
Figure 4.13: Shows the changes in RMSD of the C-loop at the Human α7 (A), Rat α4β2 (B) 
and Human α4β2 (C) receptor binding pockets respectively. Toxins that showed the lowest 
RMSD during the unbinding process showed a comparatively larger C-loop RMSD. ......... 203 
Figure 4.14: Minimum- ΔGwell PMF profiles of [γ4E]GID unbinding from the canonical 
orthosteric site  at the hα7, hα4β2 and rα4β2 receptor pockets. ............................................ 204 
Figure 4.15: Combined umbrella sampling windows illustrating the unbinding pathways of 
[ϒ4E]-GID out of the hα7 (different perspectives shown in (A) and (B)) and rat α4β2 (C and 
D) receptor binding pockets respectively. In comparison to the hα7 nAChR in Fig.4.4 [ϒ4E]-
GID does not make as many contacts with the residues of the adjacent receptor subunit as it 
makes its way away from the extracellular domain of the α7(-) subunit. The X (blue), Y 
(green) and Z (red) axes are indicated by thick coloured arrows at the bottom left corner of 
each panel. The Cys loop has also been highlighted to appreciate any changes in secondary 
structure as the toxin separates from the binding pocket. ...................................................... 206 
Figure 4.16: Plots of number of inter-atomic contacts between receptor residues of the 
principal (A) and complementary (B) subunits of the hα7 receptor binding pocket-5 with 
[γ4E]- GID, at a number of selected centre-of-mass separation distances (colour coded as 
indicated in the legends). Also shown are the number of inter-atomic contacts between each 
[ϒ4E]-GID residue and the principal (C) and complementary (D) subunits of hα7. ............ 208 
Figure 4.17: Plots of number of inter-atomic contacts between receptor residues of the 
principal (A) and complementary (B) subunits of the rα4β2 receptor binding pocket-1 with 
                         
xix 
 
[γ4E]-GID, at a number of selected centre-of-mass separation distances (colour coded as 
indicated in the legends). Also shown are the number of inter-atomic contacts between each 
[ϒ4E]-GID residue and the principal (C) and complementary (D) subunits of rα4β2. ......... 211 
Figure 4.18: Plots of number of inter-atomic contacts between receptor residues of the 
principal (A) and complementary (B) subunits of the rα4α4 receptor binding pocket with 
[γ4E]-GID, at a number of selected centre-of-mass separation distances (colour coded as 
indicated in the legends). Also shown are the number of inter-atomic contacts between each 
[ϒ4E]-GID residue and the principal (C) and complementary (D) subunits of rα4α4. ......... 216 
Figure 4.19: Plots of number of inter-atomic contacts between receptor residues of the 
principal (A) and complementary (B) subunits of the hα4α4 receptor binding pocket with 
[γ4E]-GID, at a number of selected centre-of-mass separation distances (colour coded as 
indicated in the legends). Also shown are the number of inter-atomic contacts between each 
[ϒ4E]-GID residue and the principal (C) and complementary (D) subunits of hα4α4. ........ 217 
Figure 5.1: A schematic sketch of the synapse indicating the fundamental mechanisms 
involved in synaptic neurotransmission. (adapted from (440))]. .............................................. 227 
Figure 5.2: Shows that the thickness of the lipid bilayer (across the X-Y and Z axes) is 
maintained over the course of the 1ns equilibration simulation. ........................................... 235 
Figure 5.3: Umbrella sampling pathway of the calcium ion as through the pore axis of the 
channel, starting from the extracellular domain (top) towards the intracellular domain 
(bottom).................................................................................................................................. 239 
Figure 5.4: Radius of Gyration (Rg) of the extracellular domain of the α7-nicotinic receptor 
structure in a normal (Ca2+-free) solution, compared with that in the presence of elevated 
[Ca2+] (A). Differences in Rg could occur due to conformational changes within the Ca2+-
affected subunits, particularly the closing of its loop C regions. Root-mean-square-deviation 
(RMSD) calculated with respect to the Cα atoms averaged over all 5 subunits of the 
extracellular domain in Ca2+-free and in Ca2+-affected systems (B). .................................... 242 
Figure 5.5: Average distance between the Cα atoms of C212 and S81 on the adjacent 
subunit. (A) shows the distance between the residues of the receptor in the Ca2+-free ECD 
simulation, while (B) shows the state of the receptor after 10ns of simulation in Ca2+-affected. 
The distance between the loop C cysteine and serine is much less in Ca2+-affected, due to the 
closure of loop C in the presence of Ca2+ ions. ...................................................................... 243 
Figure 5.6: Average number of interactions that each hα7 ECD subunit residue makes with 
the Ca2+ ions in the Ca2+-affected system. The interaction of Ca2+ ions with hα7-E211 and 
R229, which are close to the Cys-Cys residue pair, could be important in causing the 
observed loop C closure. ........................................................................................................ 244 
Figure 5.7: The starting structure of the ECD and the positions of the Ca2+ ions (in large cyan 
spheres) for the Ca2+-affected simulation (A). The state of the system at the end of 10 ns 
                         
xx 
 
simulation (B) indicating the binding of Ca2+ ions to specific sites on the α7 ECD. These sites 
were also identified by Galzi et. al. (469), as important calcium binding sites (marked as red 
spheres). The loop C is also seen to move in closer to the adjacent subunit by the end of the 
10 ns simulation in Ca2+-affected system. ............................................................................. 245 
Figure 5.8: The α7 ECD and transmembrane domains embedded in a bilayer membrane (left 
panel) prior to production MD simulation. Also shown is the structure after 50 ns of 
simulation in the presence of Ca2+ ions (right panel). ........................................................... 247 
Figure 5.9: (A) Root-mean-square-deviation (RMSD) of Cα atoms of the whole receptor 
(ECD and TM domains) in the Ca2+-free and Ca2+-affected systems respectively. Only slight 
differences are apparent between the two receptor structures. (B) The Ca2+-free and Ca2+-
affected receptor subunit structures at 40ns of simulation are overlaid over each other to 
indicate that the structures did not differ much from each other. The Ca2+-free structures are 
colored according to secondary structure, while the Ca2+-affected structures are colored as 
red, orange, gray, green and white for the five subunits respectively ................................... 250 
Figure 5.10: RMSD of the individual M1,M2, M3 and M4 helices (labeled (i), (ii), (iii) and 
(iv) respectively) at the Ca2+-affected whole receptor structure (A). There is a gradual 
increase in the RMSD at the M2 helix (ii) starting at ~ 20 ns of the simulation. The RMSD in 
each of the M1, M2, M3 and M4 helices ((i), (ii), (iii) and (iv) respectively) of the Ca2+-free 
receptor structure in the course of the simulation (B). Unlike the helices in the Ca2+-affected 
channel, the M2 helices in the control shows no gradual increase in RMSD. ....................... 252 
Figure 5.11: Bendix analysis of the bending of the M2 helices at the Ca2+-free (A) and Ca2+ 
affected receptors (B). The helix ‘hinge’ regions are shown in red, while the least and 
moderately bent regions are highlighted in blue and green respectively. The M2 helices of the 
Ca2+ affected receptor are seen to bend in the vicinity of L271 and V274, as seen in previous 
studies. The maximum bending angles of the M2 helices with respect to time for each subunit 
is shown for Ca2+-free (C) and Ca2+-affected (D) systems. ................................................... 255 
Figure 5.12: Bendix analysis of the bending of the M4 helices at the Ca2+-free (A) and Ca2+ 
affected receptors (B). The helix ‘hinge’ regions are shown in red, while the least and 
moderately bent regions are highlighted in blue and green respectively. The M4 helices of the 
Ca2+ affected receptor are seen to bend at different regions. Maximum bending was observed 
around the residues V494 to K499 and C482 to s489. The maximum bending angles of the 
M2 helices with respect to time for each subunit is shown for Ca2+-free (C) and Ca2+-affected 
(D) systems. ........................................................................................................................... 256 
Figure 5.13: RMSD of the M1-M2 loop (A) and M2-M3 loop (B) regions in the Ca2+-free 
system, and the M1-M2 (C) and M2-M3 (D) loops in Ca2+-affected system. Inspection of (B) 
and (D) indicates that there is a change in the loop regions of the Ca2+-affected channel while 
no such changes are seen in the Ca2+-free system. ................................................................ 259 
                         
xxi 
 
Figure 5.14: Overlaid snapshot structures of the M2-M3 region for each of the five 
nominally identical α7 subunits, indicating structural fluctuation of the M2-M3 loops of the 
Ca2+-free (A-E) and Ca2+ affected (F-J) receptor structures over the course of the 
simulations. The M2-M3 loop regions of the Ca2+ affected receptor shows more disruption 
in the loop regions compared to same loop regions at the Ca2+-free receptor, consistent with 
changes in RMSD at the M2 helices at the former. ............................................................... 260 
Figure 5.15: Difference in the average density of the DOPC bilayer at the Ca2+ affected and 
Ca2+-free simulation systems (the latter subtracted from the former) across the simulation box 
during the course of the simulation. The density of the DOPC layer in the Ca2+ affected 
system decreases closer to the center of the simulation box and increases closer to its edges 
relative to the Ca2+-free system. The significant movement that occurs at the transmembrane 
domain of the receptor in the Ca2+-affected system is one likely cause of this difference in 
density. ................................................................................................................................... 262 
Figure 5.16: Minimum ion-channel pore diameter with respect to simulation time at the 
Ca2+-free (red) and Ca2+-affected (blue) structures. ............................................................ 264 
Figure 5.17: Potentials of mean force (PMF) profiles for Ca2+ ion permeation through the 
human α7 receptor simulated in a Ca2+-free (blue) and Ca2+-affected (red) structures 
containing ~3-5mM of Ca2+ ions. The Ca2+-affected channel has a shallower free energy well, 
suggesting greater conductivity for Ca2+ compared to the Ca2+-free channel. ...................... 268 
Figure 5.18: Illustration of the passage of a Ca2+ ion along the pore of a receptor in a Ca2+-
free system (A) and the passage of the ion along the pore of the Ca2+-affected receptor (B). 
The van der Waals’ spheres are colored according to residue name, and indicate the receptor 
residues that caused the most impediment to the passage of the ion, and hence related to the 
variation in the PMF profiles. The Ca2+-affected receptor shows a wider pore diameter 
compared to the Ca2+-free receptor. ....................................................................................... 269 
Figure 5.19: Average number of contacts between each M2 pore-lining residue and Ca2+ ions 
for the Ca2+-free receptor (A) and the Ca2+-affected receptor (B) for the umbrella sampling 
simulations, as the Ca2+ ion permeates through the respective receptors. ............................. 270 
Figure 5.20: Structural snapshots indicating the pore lining residues of the receptor that 
strongly interact with the permeating Ca2+ ion during umbrella sampling simulations. 
Residues α7-E281 and V274 interacted strongly at the Ca2+-free receptor’s pore (A), while at 
the Ca2+-affected receptor there is also strong involvement of T267 along with V274 in the 
interaction with the permeating Ca2+ ion. ............................................................................. 271 
Figure 5.21: The number of contacts that the permeating Ca2+ ion makes with the human α7 
M2 helix residues that have previously been shown to be important in Miyazawa’s study(495). 
The number of contacts made by the Ca2+-free M2-helix residues with the permeating Ca2+ 
ion (A) is more than that at the Ca2+ affected receptor (B), indicative of the fact that M2-
                         
xxii 
 
residues (and thus helices overall) from different subunits are further apart from each other at 
the Ca2+ affected receptor. .................................................................................................... 274 
Figure 5.22: The number of contacts that the permeating Ca2+ ion makes with the human α7 
pore-lining residues that have previously been shown to be important in Miyazawa’s 
study(495). The number of contacts made by the Ca2+-free pore-lining residues with the 
permeating Ca2+ ion (A) is less than that at the Ca2+ affected receptor (B), indicative of the 
wider pore diameter of the latter. ........................................................................................... 275 
Figure 5.23: The number of contacts that the permeating Ca2+ ion makes with the human α7 
girdle-forming residues that have previously been shown to be important in Miyazawa’s 
study(495). The number of contacts made by the Ca2+-free girdle-forming residues with the 
permeating Ca2+ ion (A) is higher than that at the Ca2+ affected receptor (B), indicative that 
the gate is closed at the former. ............................................................................................. 276 
Figure 6.1: Illustration of the MD simulation system containing 35 Ca2+ ions with an 
approximate ionic concentration of ~5mM. Blue spheres indicate the Ca2+ ions, hα7 ECD 
and GID represented as ribbons. hα7 is colour coded according to subunit, while GID is 
represented according to its secondary structure at the ligand binding site that is at the 
junction of the receptor subunits. ........................................................................................... 283 
Figure 6.2: STRIDE secondary structure plots of each [γ4E]-GID residue (y-axes) with 
respect to simulation time (x-axes) for three nominally equivalent hα7 interfaces (A-C 
respectively), under high [Ca2+] conditions. ......................................................................... 285 
Figure 6.3: Conformational cluster identification number with respect to simulation time for 
[γ4E]-GID at the three nominally equivalent hα7 interfaces (A-C respectively). ................. 286 
Figure 6.4: Superimposition of the [γ4E]-GID structures, identified by conformational 
cluster analysis to populate the majority of the respective trajectories for three hα7 interfaces.
................................................................................................................................................ 287 
Figure 6.5: Average number of contacts that each [γ4E]-GID residue made with the hα7 
receptor at a Ca2+ free and Ca2+ affected systems respectively. Panel (A) shows [γ4E]-
GID’s interaction at the principal hα7 subunit, while panel (B) shows GID interactions at the 
complementary hα7 subunit respectively. More number of interactions are formed for the 
Ca2+ affected system compared to that at the Ca2+ free simulation system. ....................... 288 
Figure 6.6: Difference in average number of contacts that each [γ4E]-GID residue made with 
the hα7 receptor at a Ca2+ free and Ca2+ affected systems, calculated by subtracting the values 
from Ca2+-free from Ca2+-affected simulations . Panel (A) shows [γ4E]-GID’s interaction at 
the principal hα7 subunit, while panel (B) shows [γ4E]-GID interactions at the 
complementary hα7 subunit respectively. Generally, more number of interactions are formed 
for the Ca2+ affected system compared to that at the Ca2+ free simulation system. ............... 289 
                         
xxiii 
 
Figure 6.7: Average  C-loop distance (between the hα7(+) loop C Cys212-sulphur and Y54-
Cϒ of the hα7(-) subunit) at the Ca2+ affected and Ca2+ free  simulation systems over the 
60ns trajectory at all 5 α7 subunit interfaces (panels A-E) are shown. The Ca2+ affected 
simulation system at 2/5 interfaces (panels C and E) show closer distance between the above 
mentioned residues than at the other interfaces when compared to the Ca2+ free simulation 
system. ................................................................................................................................... 291 
Supplementary figure 3.1: shows figures comparing the binding modes of all the binding 
sites at the hα7 receptor (Panels A-E), Hα4β2 receptor (Panels F-H) and the Rα4β2 receptor 
(Panels I-K).....................................................................................................................332-334 
Supplementary figure 3.2: Shows the evolution of the minimum distance between [γ4E]-
GID-S7 and Y128 at the rα4(+) receptor and Y210 on the hα7 receptor......…....................335 
Supplementary Figure 5.1: Porcupine plot of normal mode 4 predicted using the anisotropic 
network model 2.0 server (http://anm.csb.pitt.edu/). Arrows indicate direction of concerted 
motion of each residue, each represented by a single 
sphere.................................................................................................................................336 
 
 1 
 
Abstract  
 
Neuronal nicotinic acetylcholine receptors (nAChRs) are important ligand gated ion-channels 
in the brain that play important roles in inter-cellular communication and the release of 
neurotransmitters. However, these channels are also implicated in common 
neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. The α7 and α4β2 
subtypes of nAChRs are amongst the most prevalent subtypes in the brain. Given that 
Alzheimer’s disease (AD) is associated with a significant loss in α7 and α4 subunits, these 
subtypes are likely to play especially important roles in the pathophysiology of this disorder. 
A deeper understanding of the specific roles of these two receptors in AD would be possible 
with the availability of ligands which can modulate the activity of α7 and α4β2 in a subtype-
specific manner.  
α-Conotoxins are a family of cysteine-rich peptides found in marine snails from the genus 
Conus. These small peptides act as antagonists to nAChRs, and some are able to discriminate 
between distinct nAChR subtypes. The α-conotoxin [γ4E]-GID is highly potent towards the 
human α7 nAChR, and is amongst the few known conotoxins which also inhibit α4β2. In this 
thesis, we use computer modelling and simulation techniques to 1) understand the interaction 
of α-conotoxin [γ4E]-GID with both α7 and α4β2 nAChRs at the canonical ligand binding 
site; 2) elucidate subtype-dependent conotoxin unbinding pathways, leading to identification 
of possible alternative sites which may serve as targets for rational conotoxin design; and 3) 
examine the influence of elevated calcium ion concentration on α7 structure and its 
interactions with [γ4E]-GID. Based on simulation data, we propose mutations to [γ4E]-GID 
which may lead to the design of a novel [γ4E]-GID-derived peptide with enhanced selective 
inhibition for α4β2. 
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An introduction to neuronal nicotinic receptors and conotoxins along with a literature review of 
the important studies on receptor-conotoxin binding are presented in Chapter 1. The simulation 
methods, parameters used for this study and other derivative techniques, including umbrella 
sampling, that were employed in this study are described in Chapter 2. Current knowledge of the 
structure of the extracellular domain of the human α7 and human/rat α4β2 nicotinic receptors are 
presented in Chapter 3 along with protein interaction data derived from the simulation of the 
modelled toxin-bound receptor structures. From our simulations, several [γ4E]-GID residues 
were identified as being potentially amenable to improve selectivity of α4β2 over α7 by 
mutation. Results from recent experimental evidence are discussed, in which some of the [γ4E]-
GID sites and mutants identified from simulations appeared to hold promise as selectivity 
enhancing modifications. 
In Chapter 4 atomistic molecular dynamics (MD) simulations and umbrella sampling methods 
were used to elucidate differences in the binding free energies and possible energetically 
favourable unbinding pathways of [γ4E]-GID at α7 and α4β2 which may be responsible for the 
marked difference in potency between the two receptors. This also helped identify important 
alternative binding sites on the receptor that differed between the two receptor subtypes, which 
could be exploited as targets for design of novel [γ4E]-GID-derived mutants.  
High stress levels in the brain could lead to increases in calcium levels. This elevation in calcium 
concentration in specific regions of the brain has been reported in some Alzheimer’s and 
Parkinson’s disease affected human and rat brain models. Thus, in a physiological context, 
especially in diseased brains, the development of novel conotoxins should take into account the 
presence of calcium. Chapters 5 and 6 discuss our attempts to understand the influence of 
Chapter 1: Nicotinic acetylcholine Receptors and Conotoxins                           
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calcium on nAChR structure, as well as the resultant effects on binding between [γ4E]-GID and 
α7.  
In Chapter 5, molecular dynamics simulation methods have shown that an abnormal level of 
calcium ions around the neuronal nicotinic receptor causes changes in receptor structure which 
resemble those associated with activation, even in the absence of agonist binding, especially in 
the M2-M3 transmembrane regions, leading to partial opening of the channel pore. Free energy 
calculations revealed that a calcium-affected partially-open channel displayed less resistance to a 
calcium ion permeation compared to a receptor channel simulated in a calcium-free system. We 
propose that these changes in the presence of elevated calcium concentration might be related to 
chronic activation of the receptor, resulting in continuous signal firing due to prolonged opening 
of the ion channel.  
In addition, the influence of calcium to the receptor structure and allosteric changes suggests that 
the potency of [γ4E]-GID towards the receptor may also be altered. Preliminary results that 
described the interaction of [γ4E]-GID at the extracellular ligand binding site of the respective 
receptor in a calcium-ion affected system is presented in Chapter 6. The study showed that 
[γ4E]-GID interacted more strongly at the calcium-affected receptor in comparison to a calcium-
free simulation system. This was related to the tighter closure of the ligand binding pocket due to 
the presence of calcium ions. Finally, in Chapter 7 an outlook on the research presented and 
ideas in context to continuation of the current research in improving [γ4E]-GID conotoxin-
receptor binding potency is discussed in the Closing thoughts and future directions section of 
this thesis. 
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1. Introduction – Nicotinic Acetylcholine 
Receptors and Conotoxins  
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1.1. Introduction - Protein Structure  
 
Proteins are complex macromolecules that are highly essential for the proper functioning of a 
living organism. Proteins within a mammalian organism can differ in texture, size and hence 
function. These molecules can take up a rigid form and may form a protective layer such as 
finger-nails (Keratin) and skin (Epidermis), or can act as hormones that help in the cell-
signalling, reproductive-cycle, etc. Other proteins such as antibodies act as the body’s defence 
mechanism against a variety of bacterial or viral infections.  
 An amino-acid is the basic building-block of a protein. In other words, a protein is built by a 
group of amino-acids linked to one another via a peptide bond. There are 20 different naturally 
occurring amino-acids, each composed of an amino tail (NH2) and a carboxyl group (COOH) 
head. The NH2 and COOH atoms are linked via a C-α carbon atom, which also holds a 
Hydrogen atom and a unique side chain (R). It is this unique side chain that differentiates one 
amino-acid from another (Figure 1.1). Amino-acids also exist as zwitterions. A Zwitterion is a 
molecule with no overall charge, but holds positive and negatively charged groups. In a neutral 
solution (water) a H+ ions from the Carboxy group leaves to attach itself to the Amino group. 
The ion now contains a positive and a negative charge thereby forming a Zwitterion. Amino-
acids usually exist in this state under neutral conditions. 
.  
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Figure 1.1:  shows a general structure of an amino-acid, where the Cα holds together the NH2 (left) 
and the COOH ends (right) along with the unique side-chain, R. The amino acid in the Zwitterion 
configuration is also shown. 
 
Protein synthesis occurs in various locations in the cell wherever ribosomes are located, 
including the endoplasmic reticulum (rough and smooth), mitochondria and in the cytoplasm, 
and released through the Golgi apparatus via various biochemical processes. However, during 
this process, a peptide bond is formed between the carbon atom of one amino-acid and the 
nitrogen of the amino-side of the other, with the removal of a water molecule (Figure 1.2). The 
protein thus consists of a main-chain and the variable R groups.  
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Figure 1.2: Shows the formation of a peptide bond during the process of protein synthesis. 
 
Amino-acids are thus classified into three groups, namely (i) Hydrophobic , (ii) Charged and (iii) 
Polar according to the R group present. Amino acids with strictly hydrophobic side-chains: Ala 
(A), Val (V), Leu (L), Ile (I), Phe (F), Pro (P), and Met (M) comprise the first group. Charged 
residues Asp (D), Glu (E), Lys (K), and Arg (R), form the second group, while the third group 
contains residues Ser (S), Thr (T), Cys (C), Asn (N), Gln (Q), His (H), Tyr (Y), and Trp (W). 
Glycine (G) is one of the simplest amino-acid wherein the side chain is a hydrogen atom. The 
polar Cysteine residue is important for protein-folding, as cysteine residues can form disulphide 
bonds with one another which is very strong and holds the protein structure together. For 
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example, in the case of the α-conotoxin GID, the structure of the toxin is held together by a 
strong Cysteine-Cysteine disulphide bond. The function and structure of the protein is thus 
dependent on the composition of the R groups that the protein is composed of.  
The function of the protein and its intricate properties also depend on its three-dimensional 
structure. Protein structures can be represented in different structural levels, according to the 
intended study. Different levels of protein structure are represented schematically in Figure 1.3. 
The primary structure of the protein represents the protein in the form of an amino-acid 
sequence. The protein conformation is determined by the φ, ψ, and ω angles of the protein 
backbone. The angle around the N−Cα bond is called the phi (φ) angle, while the rotation around 
the Cα−C bond is called psi (ψ). The rotation around the C−N bond is called omega (ω). 
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Figure 1.3: Shows the primary structural representation of a protein represented by the sequence 
of amino-acids. The secondary structures are represented by ribbons and Alpha-helices. The 
tertiary structure is represented by coils and strands, while the quaternary structure is represented 
by five monomeric subunits, holding the α-conotoxin [ϒ4E]-GID at the respective binding pockets 
formed at the interface of adjacent subunits. 
 
The secondary structure is formed when consecutive residues have similar dihedral angle (φ, ψ). 
The structure and fold of the protein is allowed based on the Phi and Psi angles. In addition, by 
placing the individual amino-acid residues of the protein structure on a Ramachandran plot 
(Figure 1.4), we can gain understanding about the stability of the protein structure(1). There are 
three sterically allowed regions or well defined dihedral angles on the Ramachandran plot, 
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illustrated in Figure 1.4. These regions correspond to secondary structures with well-defined 
dihedral angles, namely α-helix, the left-handed α-helix and the β-strand respectively.  
 
 
Figure 1.4: Shows the Ramachandran plot that marks the allowed regions for the secondary 
structure of a protein. The marked yellow and green regions represent the residues with the most 
desired phi-psi angles. 
 
A common and striking representation of the alpha-helix is the spiral looking structure. The 
alpha-helix is however held in place by hydrogen bond coordination on the protein backbone. 
The hydrogen bond formation, groups α-helices into 310-helix and π-helices, and α-helix, and 
influences the rigidity of the coiling. The ideal α-helix has corresponds to the bottom left 
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quadrant of the Ramachandran plot, while the 310-helix and π-helices are energetically less 
favourable. 
Beta-strands form the next structural level of proteins. The beta-strands are represented in the 
upper left quadrant of the Ramachandran Plot with average dihedral angles of (~120°, ~120°). 
Beta-sheets, namely parallel and anti-parallel beta-sheets are formed by the association and 
hydrogen bond formation between beta-strands on the protein back bone. The formation of β-
amyloid fibrils, associated in Alzheimer’s disease is due to the association of beta-sheet 
structures. 
Tertiary protein structures comprise turns and loop regions of different lengths, due to the 
formation of hydrophobic interactions between secondary structure elements. In other words, 
these structures connect α-helices and/or β-sheets and help increase the flexibility of the structure 
and hence influence its function and stability(2). A β-hairpin is an example of a loop structure that 
connects two adjacent anti-parallel β-strands, as shown in Figure 1.5.     
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Figure 1.5: Shows the β-hairpin structure; a) where the hydrogen bonding (shown as black dotted 
lines) on the protein backbone is shown; b) Cartoon representation of β-hairpin. 
 
The quartenary protein structure refers to a multi-subunit complex formed by the arrangement 
of more than one protein structure. Each protein subunit further consists of alpha-helices, beta-
sheets, strands, turns and loops. A good example that illustrates a quartenary protein structure is 
the human α7 neuronal nicotinic receptor, consisting of 5 monomer subunits, that together forms 
an ion-channel pore. The three dimensional structure of a protein is important and governs its 
function properties and its interaction with other proteins and drugs. This thesis focusses on the 
interaction of α-conotoxin [ϒ4E]-GID at the respective binding pockets of the human α7 and 
α4β2 receptor. In addition, the interaction study of Ca2+ ions with important pore forming 
residues of the receptor is also presented in the sections below. 
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1.2 Identification and isolation of acetylcholine receptors 
Acetylcholine receptors are a large group of neurotransmitter regulating receptors and are 
classified broadly into the muscarinic and the ionotropic nicotinic receptors. Both receptor 
subtypes are activated by acetylcholine and are found in neuronal as well as non-neuronal cells 
in mammals (3, 4). However, unlike fast-activated nicotinic receptors, muscarinic receptors take 
milliseconds to seconds to be activated by muscarine, a toxin secreted by the mushroom Amanita 
muscaria(5), and hence its name. Nicotinic receptors, the class of receptors that will be closely 
looked at in this study, belong to a sub-class of ionotropic nicotinic acetylcholine receptors 
(nAChR). As the name suggests, these receptors are activated by nicotine and to a larger extent 
acetylcholine. The discovery of nicotinic acetylcholine receptors began with the finding of a 
large concentration of nicotinic receptors (~40%) of all the cholinergic synapses present in the 
electric organ of the fish Electrophorus electricus in the 1960’s(6, 7). Over the years, various 
methods were used and improved upon for the purification, identification and isolation of this 
receptor. Affinity labelling was one of the first methods used, which used a chemical that closely 
mimics the structure of the neurotransmitter, and hence covalently attaches itself to the protein. 
For example, this method used p-trimethyammonium benzenediazonium fluroborate (TDF) that 
carries a trimethylammonium group similar to that of acetylcholine, and was allowed to 
covalently bind itself to the E. electricus electroplaque (8). Using various dyes that coloured TDF, 
the regions to which TDF attached to (receptor binding pockets) could be detected under UV 
light. Another method used fractionation and purification of Acetylcholine esterase rich 
membrane fragments (9). The filtered fragments were then sliced and viewed under an electron 
microscope to reveal vesicles that responded to nicotinic agonists. Electrophysiological readings 
of these responses were similar to those obtained by using intact electro plaques. However, a 
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more interesting finding was that of the ability of α-bungarotoxin (αBGT) to block 
neuromuscular transmission in vertebrates as well as to block the response to nicotinic agonists 
in vitro (10). Another α-toxin Naja nigricollis that is also homologous to the α-BGT was 
covalently linked with sepharose beads. The mixing of these toxin bound-beads to the membrane 
extract resulted in 75-100% of the nAChR protein binding to these beads, while 85% or more of  
AChE remained in the extract. This showed that nicotinic receptor and acetylcholine esterase 
were two separate protein entities (11). Furthermore, these studies helped in more specific 
isolation and separation of nicotinic receptors from other proteins, especially those in detergent 
solubilized electric organs. In 1973, nicotinic receptor rich membranes from T. marmorata were 
examined by Cartaud and colleagues under an electron microscope to reveal ring-like structures 
of 8-9nm in diameter with a hydrophilic core (12). These structures were seen to be also 
composed of 4-5 subunits. The images obtained were one of the first to show the structural 
characteristics of a neurotransmitter receptor.         
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1.3 Assembly and structure of neuronal nicotinic receptors  
Nicotinic receptors are important in the transmission of neuronal signals and regulation of 
neurotransmitters, hence are implicated in various neurodegenerative disorders. Neuronal 
nicotinic receptors (nAChRs) are a super-family of ligand gated ion channels neurotransmitter 
receptors (13, 14)). As the name suggests, these receptors may be activated (or deactivated) with 
the binding of appropriate agonists or antagonists respectively. Ligand binding causes the 
opening of important ion channels in the brain that is responsible for the regulation of ion 
concentration. In other words, ligand binding causes the ion channel of the receptor to move 
from a “closed” or resting state to an “open” or active state, thus allowing the flow of Na+ and K+ 
ions across a lipid bilayer membrane. This phenomenon explains the key to efficient 
transmission of neuronal signals. In general, nicotinic receptors control release of various 
neurotransmitters and function at synapses to facilitate effective neurotransmission. However, a 
malfunction of the receptor can cause diseases such as epilepsy and other neuronal syndromes 
such as Myasthenia and other well-known neuronal degenerative disorders such as Alzheimer’s 
and Parkinson’s Diseases(13, 14). This implies that the preservation of the receptor sequence and 
hence structure is highly important.  
The structure of the neuronal nicotinic acetylcholine receptor protein (Figure 1.6a) resembles 
that of a cone, as its narrow apex transverses a lipid bilayer. All nAChRs are similar in 
architecture and consist of five (5) protein subunits (pentameric) arranged around a central pore. 
The pentameric receptor could be composed of one (homomeric) or a combination of the 
following subunits (heteromeric) – α, β, γ, ε and δ – with 17 distinct subunit types in number (15). 
Of these, the muscle type receptors are composed of α1, β1, δ and γ or α1, β1, δ and ε, each in 
the stoichiometric ratio 2:1:1:1. However, neuronal nicotinic receptors predominantly contain α 
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and β subunits and can form homopentamers (e.g. α7) or heteropentamers (eg α4β2 and α3β6) 
(16). Only the α-subunits contain the Cys-Cys motif which lie at the tip of loop C comprising part 
of the ligand binding pocket, and these residues are important in ligand recognition and in 
forming the binding pocket (17, 18). This implies that a systematic combination of the above 
subunits is essential for the overall expression and function of the receptor. For example, the 
α7β2 heteromeric has a higher affinity towards ACh but a lower rate of desensitisation, whereas, 
the α7β3 receptor shows a comparatively faster rate of desensitisation, but a lower affinity 
towards ACh (19). As mentioned above, nicotinic receptors are channels through which ions such 
as Na+, K+ and Ca2+ flow through. Thus altering the stoichiometry or subunit composition can 
have significant changes in ion permeability and selectivity across the receptor channel. A 
change in stoichiometry would cause a change in amino acid residues lining the channel pore 
opening at the M2 helix. For example, in muscle receptors, composed of α3 subunits, the ion 
channel is lined with residues that are polar uncharged in nature. This arrangement allows the 
Na+ ions to permeate over Calcium ions. However, in the case of α7 nicotinic receptors, the ion 
channel is richly lined by Glutamic acid residues that show an increase in Ca2+ permeation(20). In 
addition, the permutations and combinations in subunit composition can also cause a change in 
response, such as an increased sensitivity to a particular ion or result in different 
pharmacological properties altogether (21, 22).  
A closer look into a single nAChR subunit structure (Figures 1.6 (B),(C),(D))  shows the 
presence of a conserved extracellular domain and four (4) transmembrane domains, a 
cytoplasmic loop of variable size amino-acid sequence and an extracellular COOH terminal(14, 
23). The extracellular domain is composed of β-strands that align to form a β-barrel. The Cys-Cys 
residue pair on the C-loop is highly important for the formation of the binding site and the 
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recognition of ligands. However, the Cys-Cys pair is only found on the α-subunit subtypes, and 
thus determines the number of binding sites at the receptor. . Thus for example, α7 receptors , 
that are an assembly of 5 similar α7 subunits, contain 5 receptor binding sites, while the 
(α4)2(β2)3 receptor will host only 2 ligand binding sites due to the presence of only two α4 
subunits. In addition, the subunit composition of the pentamer determines the architecture of the 
binding site and also has implications to the function of the receptor. Of importance are also the 
residues close to the vicinity of the Cys-Cys pair on the α-subunit that contributes to the 
formation of the binding pocket. Ligand binding results in rotation and interaction between these 
residues which is important for channel-gating. 
The transmembrane domain consists of four (4) α-helices (TM1-TM4) that are packed around the 
central hydrophilic pore. This allows the pore to be well hydrated and allow the permeation of 
Na+, K+ and Ca2+ ions that are commonly transported through the channel. The flow of K+, Na+ 
and Ca2+ ions through the nicotinic receptor channel creates a required voltage (action-potential) 
in the presynaptic neuron that causes the release of acetylcholine and has further important 
implications in neurotransmission(24). The sodium gradient, however, is much higher than those 
of potassium or calcium, and plays a dominant role in membrane depolarisation. The trans-
membrane domains are also arranged efficiently according to the function they perform post 
ligand activation. It is the transmembrane domain that traverses through the lipid bilayer. Of the 
4 transmembrane helices, transmembrane helix 2  (TM-helix 2) lines the pore; TM-helix 4 is 
found away from the pore, but is more interactive with the lipid-bilayer, forming an interface 
between the lipid and the receptor; TM-helices 1 and 3 complete the helix bundle. The 
intracellular or cytoplasmic domain continues below the transmembrane domain as a mixture of 
α-helix and β-strands., found between the TM3 and TM4. The exact fold and composition of the 
Chapter 1: Nicotinic acetylcholine Receptors and Conotoxins                           
18 
 
cytoplasmic domain depends on the subunit type and the function the receptor is called to 
perform.    
 
Figure 1.6: Basic structure of nicotinic acetylcholine receptors (nAChRs). A: the basic linear 
sequence of all nAChR subunits appears as a large extracellular domain, four transmembrane 
domains, and a cytoplasmic domain of variable size that resides between TM3 and TM4. (B): the 
EM structure of the Torpedo nAChR is from Unwin, and images were generated using the UCSF-
chimera program with coordinates obtained from the Protein Data Bank ID 1OED.pdb. The 
agonist-binding site is contained in a pocket between the α and the adjacent non-α subunit defined 
on its outer face by the Cys-Cys pair. Also, the extension of the C-loop around ligand is evident. D: 
similar to B, the receptor surface is added to show the relative positioning of each subunit (as 
labelled). Adapted from (14). 
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1.4 Ligand binding site and channel gating 
The ligand binding site of nicotinic receptors is found at the junction of a twin Cys-Cys motif-
containing α-subunit and the adjacent non-α subunit in the case of heteromeric receptors, or 
between two adjacent α subunits in the case of a homopentameric receptor (Figure 1.6C) or 
heteropentameric receptors, such as α9α10. More specifically, the binding pocket is the cleft 
formed by residues surrounding the Cys-Cys pair residues on loop C of the α-subunit and 
residues on the β-strand of the adjacent subunit. The receptor residues participating in ligand 
binding are mostly hydrophobic, and have been identified in detail by previous mutagenesis and 
photo-affinity labelling studies on acetylcholine binding protein (25, 26). Some of the important 
residues comprising the ligand binding site identified by their study were Y93, W149, W190, 
and Y198 apart from the adjacent Cys residues C192-193 on the α-subunit (27-29). At the 
complementary β-subunit, the binding pocket was contributed by residues W53, Q55, R104, 
V106, L112, M113 and Y164(30). In general, the residues contributed by the principal subunit 
(containing the Cys residue pair) dictates the affinity of the receptor towards the ligand, whereas 
the corresponding residues on complementary face determine ligand selectivity (31).  
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Figure 1.7: Upon binding of agonist and capping of the ligand-binding domain, rotational motion in the β-
strands is transmitted through the subunit to residues that are near the TM domain-membrane interface. The 
rotational motion leads to important interactions that result in the rotation of TM4 ∼15° to move the 
hydrophobic gating residues (Val and Leu) away from the pore and the polar residues (Ser) towards the 
channel, resulting in channel-opening. [Model shown is based on the original study of Unwin (32) taken from 
electron microscopy studies of channel gating from theTorpedo nAChR (PDB ID: 2BG9) and from high-
resolution studies of the AChBPs. The different loops of the subunit have also been highlighted. Reference:(14) 
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The composition of the residues making up the binding site is highly important and is hence 
highly conserved. The “aromatic-box” or the “aromatic-cage” is a group of 5 aromatic amino 
acids that are highly conserved among the neuronal nicotinic receptors. Of these 5 amino-acids, 4 
are contributed by the principal subunit (TyrA, Trp B, Tyr C1 and Tyr C2), while the other is 
contributed by the complementary subunit (Trp D). At the human-alpha7 receptor, these residues 
translate to Y115, W171, Y210, Y217 from the hα7(+) subunit, and W77 from the hα7(-) subunit 
(based on the sequence alignment of AchBP) (Figure 1.9). The residue interactions (such as 
cation-π interactions) between the ligand and aromatic-cage help the receptor recognise 
particular ligands. For example, Ach participates in cation-π interactions with TyrA, while 
Epibatidine forms cation-π interactions with TyrC2(33). Figure 1.8 shows the position of the 5 
aromatic residues on the human-α7 receptor, while figure 1.9 shows the alignment of the hα7 
receptor residues with that of the aromatic residues of AChBP and α1 along with its secondary 
structure configuration. 
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Figure 1.8: The location of the aromatic box residues on the hα7 receptor are shown along with the 
residues Glu 211 and Asp 219 beside them. Here GID can also be seen in the binding pocket. 
 
The residues beside the aromatic-cage residues of the binding site, namely Asp and Glu help 
contribute to an overall negative charge.  Previous studies suggest that agonists are selected 
based on their ability to neutralise the negative charge (34). NMR studies have also shown that the 
ammonium moiety of the agonist fits the aromatic box composed of tyrosine and tryptophan 
residues in the binding pocket (at loops A-D), resulting in a cation-π interaction(35, 36). This 
interaction explains the high binding affinity of nicotine and acetylcholine to neuronal nAChRs 
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and the acetylcholine binding protein respectively. Similarly, studies to understand the binding of 
HEPES (N-2-hydroxyethylpiperazine-N’-2-ethanesulphonic acid) to acetylcholine binding 
protein showed that the former stacked its quaternary ammonium onto W143, again making 
cation-π interactions as similarly seen for nicotine binding (37). It is also interesting that although 
an obvious difference in residue composition of the binding pocket exists between the α7 and the 
α4β2 receptors, the differences in residue composition do not affect the aromatic box. Hence, 
agonist binding affinity and selectivity at the ligand binding site depends on the residues that 
make up the aromatic box. 
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Figure 1.9: Shows the sequence alignment of the human-α7(hα7), Human Acetylcholine receptor, 
human-α4, rat- α4, human-β2 and rat-β2 subunits. The aromatic-box residues, namely hα7(+)Y115, 
W171,Y210,Y217 and hα7(-)W77 have been boxed. The residues after hα7-L230 indicate the 
beginning of the transmembrane domain. The residues highlighted in yellow are the gating residues 
that align with Acetylcholine residues S248, L251, S252, V255 and V259.    
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However, for bigger molecules such as toxins, the differences in orientation and interaction with 
residues outside the aromatic box would also most certainly determine its binding affinity. 
Agonist binding additionally results in the capping of the C-loop containing Cys-Cys residues 
into the adjacent subunit, thereby covering almost the entire agonist molecule (38). The closure of 
the C-loop from agonist binding is able to generate a force that transcends towards the 
transmembrane domain that causes opening of the ion-channel pore (14, 39).     
Ligand binding eventually leads to channel-gating or opening of the ion-channel pore. One 
model of channel gating suggests that upon agonist binding, the hydrogen bonds and side chains 
of conserved aromatic residues near the binding pocket at the principal and complementary 
subunits rearrange and reorient themselves towards the ligand(40-42). The C-loop containing the 
double Cys residues now close into loop F on the adjacent subunit, thereby completely 
enveloping the ligand in the binding pocket(40). When this occurs at all ligand binding sites (that 
contain the α-subunit), an overall torque causes the rotation of the extracellular domain, which 
then is transferred towards the M2- helices of the transmembrane, resulting in channel opening 
(14, 39). The C-loop containing the Cys-Cys pair close into the adjacent subunit, thereby forming 
the binding pocket in the cleft of the two subunits (Figure 1.6C). The ligand is further stabilised 
by Trp143 (hα7-Y140) at the α subunit, at the base of the agonist-binding site and α-Tyr185 
(hα7-Y210) via van der Waals interactions (Figure 1.8) (43).  
The motion due to the closure of the C-loop (due to ligand binding) against the β-sheets of the 
adjacent subunit is further passed down towards the transmembrane regions, where the β-strands, 
β1 and β2 move towards the M2-M3 linker. This further causes V44 and P272 to move into the 
conserved hydrophobic pocket. At the same time, the β10 strand moves towards R209. These 
interactions translate into rotational motion of the M2 helices that line the channel pore by ~15°. 
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These motions further results in the movement of residues V255and L251 away from the pore. 
On the other hand, polar residues S248 and S252 are moved toward the pore (Figure 1.7) (14, 39). 
Thus, the conservation of the sequences that lead to channel gating is highly important. Apart 
from increasing pore diameter, the rotational motions of the M2-helices due to ligand binding 
causes the hydrophobic residues to move away from the ion-channel pore, thereby  exposing a 
more hydrophilic environment along the channel’s internal lining that is amenable to the passage 
of ions (44, 45).    
 
1.5 Diversity of nAChR subtypes in the brain 
Neuronal nicotinic receptors are distributed in various parts of the brain. For example, the α7 
receptors richly inhabit the striatum radiatum interneurons of the hippocampus, the 
hypothalamus(46), cortex and motor neurons(47), while β2 and β3 containing receptors populate 
the basal ganglia respectively(48, 49). The homomeric α7 receptor (composed of 5-α7 subunits) is 
the simplest and most commonly found homopentamer(50). The α4 subunit containing receptors, 
for example the α4β2 is another widely distributed receptor subtype in the nervous system 
(accounting for ~70% of the nAChRs) and is not only present in the autonomic ganglia but also 
in the pineal gland, the anteroventral nucleus of the thalamus, the hippocampus, the spinal-cord 
and the retina. [(16); (51)]. The α6 containing receptors are typically present in the dopaminergic 
neurons in conjugation with the β3 subunit where they modulate to maintain dopamine 
concentration in animals such as monkeys (52, 53). Additionally, studies on knock-out mice have 
further proved that under controlled conditions, the α6β2 predominate in regulating the release of 
dopamine by 75% (54-56). These studies prove the importance of the α4, α6, α7 and β2 subunits in 
relation to the influencing brain function. Further, it is interesting to note that amongst neuronal 
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receptors, α and β subtypes are restricted to specific combinations to form a receptor. For 
example, the α2, α3, α4 and α6 subunits can combine with β2 and β4 subunits to form functional 
receptors such as the α4β2. However, β3 and α5 subunits in combination are not able to form 
receptors, but form trinary complex with another subunit type such as α4β2α5 (57).  However it is 
also worthy to note that the α5 subunits, although not completely understood, are found to 
associate with other receptor subunits (for example the α3, α4, β2 and/or β4 subunits) and 
enhance the receptor’s affinity towards nicotine, or changes in ion-permeability, desensitisation 
etc. (58). Previous studies have shown that while the α3β2 receptor is itself different in kinetic 
properties from the α3β4 receptor, the incorporation of the α5 subunit into the α3 and β2 subunits 
increase its burst duration significantly, while also drastically increasing the rate of 
desensitisation at the α4β2α5 receptor (59, 60).   
 
1.6 Nicotinic Receptors in relation to addiction and disease 
Given the impressive diversity of nAChR subtypes and the complex differential expression 
patterns of its various subunits in the brain, it is not surprising that nAChRs are associated with a 
number of neurological and psychiatric disorders. Below, some of the major disorders known to 
involve dysfunction of neuronal nAChRs, and the subtypes involved, are briefly discussed. 
Additionally, we discuss limitations of current treatments aimed at modulating the effects of 
nAChRs in these disorders. In particular, as many neurodegenerative diseases involve the α7 and 
the α4β2 receptors respectively, it is clear that targeting the latter specifically is a crucial step 
towards establishing effective treatments.  
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1.6.1 Addiction and smoking 
Nicotine is used to identify nicotinic receptors due to the latter’s binding affinity. Jie Wu et al., 
2011, show that the nAChR receptors that bind to radio-labelled nicotine with the highest affinity 
contain α4 subunits(57). Further nicotine exposure induces upregulation, especially of the α7 
receptor and α4 subunit containing receptors such as the α4β2 receptor (61, 62). It is interesting to 
note that short-term nicotine exposure causes a stage of reversible desensitisation, while chronic 
exposure to lower concentrations of the same leads to irreversible inactivation and loss of 
receptor function. The phenomenon of desensitisation of nAChRs by nicotine takes us to 
understand addiction from cigarette smoking. Early studies highlight the importance of the 
mesolimbic dopaminergic system (MDS) or “pleasure centres” of the brain to account for 
nicotine addiction (63). However affinity of nicotine to various nicotinic receptor subtypes 
including α7 receptors, prove that addiction is not concerned with the MDS alone. For example, 
α6 and β2 containing receptors such as α4α6β2β3, α6β2β3 and α6β2 have the highest sensitivity 
to nicotine while α4β2 receptors are comparatively low in sensitivity (64-66). Further, as stated 
earlier above, the inclusion of the α5 or β3 subunits in the receptor have also shown to enhance 
the affinity of these receptors towards nicotine. Sudden cessation from chronic smoking leads to 
various other complications from nicotine-craving, anxiety, to promoting the onset of 
inflammatory diseases such as ulcers.  Supporting studies on mice show that a deletion of  α5 
and α7 subunits in mice decreases the physical signs of nicotine withdrawal.(67). Nicotine 
addiction from cigarette smoking was however believed to create a lower incidence of 
Alzheimer’s disease (Perry et al., 1999).  
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1.6.2 Alzheimer’s disease 
Alzheimer’s disease (AD) is a common neurodegenerative disorder involving loss of memory 
and learning disability, including difficulty in maintaining attention, triggered by anxiety and 
depression. These external symptoms are also accompanied by the formation of toxic amyloid 
plaques and neurofibrillary tangles (hyper-phosphorylated Tau proteins), and loss of brain mass 
due to neurodegeneration (68). At the nicotinic receptor level, the progression of the disease 
occurs with degradation of the α4 subunit containing receptors in the cortex and the 
hippocampus of the brain (69). AD is usually treated by the use of acetylcholine esterase inhibitors 
(70), while nicotine administration is also shown to have positive changes. However, treatment 
using acetylcholine esterase inhibitors was found to be limited as the basal cortex neurons were 
degraded with the progression of AD. This correlates to the finding that the α4β2 and α7 
nicotinic receptors are degraded or down regulated during disease progression (71-74). In humans, 
nicotine administration to AD affected patients was found to enhance verbal, memory and 
learning skills (75). In AD, β-amyloid peptide plaques (Aβ)1-42 formed through disease progression 
binds to these receptors, influencing the MAPK pathway. The Aβ initiate the disease by the 
inhibition of glutamate re-uptake by astrocytes. The accumulation of glutamate increases the 
Ca2+ ion concentration leading to the synthesis of toxic oxygen radicals through the activation of 
nitric-oxide synthase (76). These toxic oxygen radicals eventually lead to cell death. Although the 
exact role of nicotine in treating Alzheimer’s disease is not completely understood, it is believed 
to activate the receptors and thereby cognitive functions as well.  
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1.6.3 Parkinson’s disease 
Similar to AD, Parkinson’s disease is characterised by a drastic decline in the concentration of 
heteromeric nAChrs, as compared to an increase in α7 receptors. This disease is characterised by 
difficulties in initiating and coordinating various muscle movements (77). Studies explain PD to 
be due to a loss of dopaminergic neurons of the substantia nigra, causing a plethora of secondary 
responses. The α6β3β2 and the α4β2 receptors cause the release of dopamine from nerve endings 
(78, 79). However, in a PD affected brain, dopamine in the neurons is oxidised to release hydrogen 
peroxidise radicals in the presence of monoamine oxidases (MAOs). Similar to Alzheimer’s 
disease, the release of free radicals through MAOs are of toxic effect and result in disease 
progression, and eventually cell death. In this case nicotine acts as an anti-oxidant by inhibiting 
the MAO pathway and the progression of PD(80, 81). The most common method of treating PD is 
by the use of the dopamine precursor L-DOPA. But this method of treatment only slows down 
disease progression, and can lead to dyskinesia and psychosis (82). L-Dopa induced dyskinesia, 
characterised by abnormal involuntary movements of the head or trunk, is treated by nicotine 
administration. However, nicotine interacts with various other nicotinic receptors as well, and is 
not the best mode of treatment. Hence it was suggested that α6β2 and the α4β2 nicotinic receptor 
targeting drugs could be developed to treat Dyskinesia(83). Agonists varenicline and iodo-A-
85380 that preferentially interact with α6β2 and α4β2 receptors, was observed to help reduce L-
dopa-induced dyskinesia movements by ~50% (84). This observation helps us understand that 
α6β2 and α4β2 neuronal nicotinic receptor subtypes play a definite role in the cause and 
progression of this disease. 
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1.6.4 Schizophrenia 
P50 is a brain response that occurs approximately 50ms after the introduction of a stimulus. It is 
a measure of the brain’s capacity of sensory gating, where unwanted background stimuli is 
filtered (85).  Schizophrenia is a neuro-degenerative disorder where the patient suffers from 
hallucinations, delusions, apathy, shows blunted affection, decline in cognitive behaviour such as 
inability to focus attention, due to the inhibition or reduction of the normal P50 auditory response 
(86-88). One study suggests that high concentrations of dopamine are a cause for schizophrenia. 
Another study, using α-bungarotoxin labelling, showed a reduction in binding at 7 out of 8 
schizophrenic mouse brain samples, as compared to non-schizophrenic samples, implying a loss 
of α7 receptors resulting in a decline in sensory gating control (89). The disease was also 
characterised by a reduction in cytisine binding at the hippocampus indicating a reduction in high 
affinity nicotinic receptors. These results coupled with the observation of a reduction in the α7 
receptor subtype (found in the hippocampal regions of the brain) make certain the involvement 
of the α7 receptor in schizophrenia. Schizophrenic patients and DBA/2 mouse models have 
shown an improvement in sensory gating after nicotine administration, and smoking has also 
been suggested as a form of self-medication (90, 91). A 5HT3 antagonist tropisetron was shown to 
increase inhibition of the P50 auditory response (92). In addition, GTS-21, a compound derived 
from the alkaloid found in marine worms, improved memory-related behaviour and normalised 
auditory gating. However, in the second stage of clinical trials, GTS-21 did not show 
improvement in regard to disease symptoms and cognitive functions (93).     
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1.6.5 Neuropathic pain 
Similar to other forms of body pain, neuropathic or psychogenic pain occurs due to the loss of 
function of the somatosensory system. The pain may be acute or last for a few months or more 
(chronic). Nicotinic receptors, especially the α4β2 have been implicated to pain as nicotine 
treatments have shown to produce analgesic effects (94).  In addition, epibatidine has also shown 
analgesic properties, although it is a non-selective agonist. Due to Epibatidine’s non-selective 
nature, other brain receptors along with the neuromuscular receptors are also activated, leading 
to further complications. Further, testing Epibatidine on animal models also resulted in a 
reduction of muscular and hence locomotory motions. A structural analogue, ABT-594, was thus 
developed to target the α4β2 receptors in order to control pain. ABT594 showed no significant 
analgesic effects; however, at higher doses (~300 mg) the analgesic effects were accompanied by 
nausea and vomiting (95), possibly due to the activation of α3β4 ganglionic receptors. Thus the 
therapeutic use of this analogue was also limited and not successful. Other α4β2 agonists such as 
YC-2696 and 6499 also showed analgesic properties, but were not developed further for similar 
reasons as ABT594 (96). 
Apart from α4β2 receptors, α7 nicotinic receptors are also implicated in neuropathic pain. 
Choline, derived from the enzymatic degradation of acetylcholine esterase, has shown analgesic 
properties in rat models (97). However, the α7 receptor seems to remain selective towards pain as 
α7-receptor agonists SSR-180711 and Tropisetron have failed to act as analgesics. Studies using 
knock-out mice have shown the involvement of α5-subunit containing nicotinic receptors (98). 
However, more recent studies by Xanthos and colleagues show that nicotine administration is not 
a strong answer to neuropathic pain (99). Nerve ligated α5-subunit knock-out mice showed lower 
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antinociception properties, similar to wild type mice. In addition, the α9/α10 subunit containing 
receptors are also implicated towards administering pain relief (100). Neuronal nicotinic receptor 
related diseases listed above are very common in today’s world. Unfortunately, the treatment to 
address these diseases so far has been mostly symptom-specific, with additional complications 
and side-effects. Thus there is a need for target specific drugs. As many neurodegenerative 
diseases involve the α7 and the α4β2 receptors respectively, targeting the latter specifically, 
towards establishing a cure is beneficial.  
 
1.7 Nicotinic receptor antagonists 
Nicotinic receptor antagonists are molecules which inhibit the response elicited by an agonist. 
However, most studies focus on nicotinic receptor agonists and very little is known about 
antagonists (101). In addition, known antagonist pharmacophore geometry is not clear as similar 
structural features in antagonists often do not correspond to similarity in function at the receptor 
binding pocket. More complexity arises due to the existence of many combinations of receptor 
subtypes. For these reasons and more, there is a need to develop receptor-specific antagonists 
resulting in fewer side effects due to off-target interactions. Below are listed some of the 
antagonists to neuronal nicotinic receptors.  
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Figure 1.10: Examples of non-peptide nicotinic receptor antagonists (102). 
 
1.7.1 Dihydro-β-erythroidine (DhβE) 
The alkaloid DhβE (Figure 1.10A) is often used as an nAChR antagonist and shows nanomolar 
affinity towards α4β2 and α3β2 receptor subtypes. More specifically, it has an ~10 fold higher 
specificity towards the human α4β4 than the α4β2 receptor subtype (103), while the rat α4β4 and 
α3β4 receptors show an ~120 fold difference in potency between them(104).  DhβE also well 
inhibits agonist response at the rat α4β2 receptor and also reduces nicotinic receptor self-
administration (IC50 = 370nM) (105). However, at the muscle type receptors in TE671 cells, DhβE 
is a weak antagonist (106). Thus DhβE is not specific across subtypes or species. 
 
Chapter 1: Nicotinic acetylcholine Receptors and Conotoxins                           
35 
 
1.7.2 MLA 
MLA (Figure. 1.10B), a diterpenoid alkaloid isolated is one of the most potent (Ki = 1 nM), 
selective nonpeptide antagonists at the α7 nAChR subtype (107, 108). In fact MLA shows ~200 fold 
greater potency towards the α7 receptor when compared to (α1)2β1γδ receptors 
(109) and ~100 
fold greater potency in comparison to the α4β2 receptor(110). In addition, while MLA is 1000-fold 
more selective for rat α7 compared with rat α4β2 subtype (111), it is unable to inhibit nicotine-
evoked DA release from striatal synaptosomes (112). Structure-Activity relationship studies 
reveals that the presence of the methylsuccinimidobenzoyl portion of the molecule is important 
for high-affinity interaction with the α7 subtype, and removal of the methyl group, the 
methylsuccino, or the entire substituted benzoyl moiety results in a 20-, 1000-, or 2000-fold 
decrease, respectively (113).   
  
1.7.3 α-Lobeline (Lobeline) 
This lipophilic alkaloid (Figure 1.10C), has shown to act as a non-selective antagonist at the 
α4β2 and α3β2* receptor subtypes, with an ability to mimic the activity of nicotine. However, 
while chronic treatment of receptors with nicotine lead to upregulation, this is not true with 
Lobeline (114). Lobeline binds to α4β2 receptors at low nanomolar concentration(115) and inhibits 
the binding of [3H]DhβE (116) and [3H]Methyllycaconitine([3H]MLA), nicotine-evoked 86Rb+ 
from rat thalamic synaptosomes. Lobeline also competitively inhibited nicotine evoked (10 μM) 
[3H]DA release (IC50=200nM) from super-fused rat striatal slices (117).  
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1.7.4 N-Alkylpyridinium halides 
The alkylpyridinium halides showed little or no affinity towards the rat nicotine binding site. 
However, two alkylpyridinium halide analogs, namely N-n-decyclpyridinium iodide(NDPI) and 
N-n-dodecylpyridinium iodide (NDDPI), tested via nicotine-evoked [3H]DA release assay using 
superfused striatal slices showed an IC50 of 110 and 90 nM respectively. This difference in 
activity was credited to the quartenary pyridinium moiety and N-n-alkyl group (118).  
 
1.8 Conotoxins 
Although a large and growing library of small-molecule antagonists have been identified, it is 
clear from the above discussions that many are non-specific, targeting a number of closely-
related nAChR subtypes(119). In principle, larger ligands, such as peptide inhibitors, are more 
promising molecules for engineering of enhanced specificity ligands (whether agonists or 
antagonists), owing to the presence of multiple residues and chemical functional groups, 
providing ample opportunity for modification. Indeed, one class of natural peptide inhibitors 
have been identified- the α-conotoxins isolated from the venom of Conus snails, are known to 
target a wide range of both muscle and neuronal nAChR subtypes, sometimes with high potency 
and specificity(120, 121). Thus, α-conotoxins are especially attractive candidates for engineering of 
novel conotoxins with desired nAChR binding properties. 
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1.8.1 Classification and structure of conotoxins 
Conotoxins are peptides that vary in length (~12-35 amino-acids long)(122), derived from the 
venom of marine snails of genus Conus. Conus snails use their venom to paralyse their prey 
(such as polychaete worms, echiuroid worms, hemichordates, certain mollusks and fish) (123). The 
venom of Conus snails that contain a cocktail of various peptides (~100 different peptides) is 
injected into the soft tissue of the prey using a harpoon-like proboscis structure (124, 125). These 
disulphide-rich peptides are classified as conotoxins when they have two or more disulphides. 
Conotoxins are classified according to three classifications schemes: 1) the gene superfamilies, 
based on the genetic similarities according to sequence similarity of the signal peptide sequence 
in the precursor, 2) the pharmacological families, based the molecular target and mode of action, 
and 3) the cysteine frameworks, based on the arrangement of cysteine residues along the primary 
sequence of the toxin(122). Table 1.1 Shows the name, sequence and receptor subunit selectivity 
for some of the commonly known α-conotoxins, and arranged based on their Cysteine frame-
work.  
Alpha-Conotoxins naturally show strong specificity towards particular nicotinic receptor 
subtypes(126). For this reason, these disulphide rich peptides are of much interest in the field of 
drug-discovery (127). These conotoxins are also preferred over low target-oriented small-molecule 
ligands due to the varied nicotinic receptor subtypes found in mammals. The nature of these 
toxins to target nicotinic receptors and coupled to their small length (~18-20 amino-acids long) 
make them potentially useful as molecular probes to investigate specific nAChR binding 
pockets(128) or to examine neuronal pathways. In addition, conotoxins are also used as potential 
biodegradable toxic agents in veterinary medicine(129). Interestingly, with about 500 Conus 
species known to date, that each produces more than 500,000 peptides, only 0.1% of these cono-
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peptides have been structurally investigated(130). There are a total of 7 super families of 
conotoxins that target nicotinic receptors with a major contribution from the α-conotoxin 
(belonging to A-superfamily)(131, 132). α-conotoxins were first found to bind to muscle-nicotinic 
receptors(131), and subsequent studies have shown that some also bind to neuronal subtypes such 
as the α7 and α9 homomeric subtypes(133). For instance, α-conotoxins SrIA and SrIB can target 
both muscular as well as neuronal receptor binding pockets. For both SrIA and SrIB, the 
presence of Tyr at position 4 bears striking similarity with other α3/5-conotoxins that block 
neuronal receptors such as α1β1γδ nAChR, while the positive net charge of SrIB makes this 
toxin target muscular receptors(134). In addition, the affinity of the α-conotoxins was found to be 
selective towards nicotinic receptors, depending on the latter’s subunit composition, and the 
structural differences or residue composition of the conotoxin. For example, α-conotoxins MII 
targets the α3β2 neuronal nAChr subtype (135), while α-conotoxin ImI selectively targets the α7 
and α9 homomeric receptors(136, 137). In this case, a significant difference in conotoxin structure 
was observed although the arrangement of disulphide bonds was conserved, as seen with other 
conotoxins such as EpI, PnIA and PnIB. Conotoxins in synthetic forms have also been used as 
potential inhibitors of calcium-channels, thereby suppressing neuronal pain(138). X-ray 
crystallographic studies on various α-conotoxins such as GI, PnIA, PnIB, EpI, show a similarity 
in structural framework(139) as well as important features of the binding surface(140). 
The α-conotoxins have a CC-Xm-C-Xn-C framework (with non-zero integers m, n), where the 
presence of a disulphide linkage between the first and third cysteine (I-III), and the second and 
fourth cysteine (II-IV) result in a globular conformation; while I-IV and II-III linkages result in a 
ribbon conformation; and I-II and III-IV linkages result in a bead configuration(141, 142). α-
Conotoxins are classified according to the m/n scheme, indicating the number of residues m in 
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the first loop (loop I) and n in loop II. For example, the 4/7 configuration consists of 4 residues 
in loop-I and 7 residues in loop-II(143). Although the 4/7 configuration is most prevalent among 
conotoxins, other conformations exist, such as 4/6 (AuIB)(144), 4/3 (ImI, RgIA)(145, 146), 4/5 
(Pu1.3)(147), and 4/4 (BuIA)(148). Although the configuration of loop-I is mostly conserved, loop-
II seems to govern the binding affinity and stability of the α-conotoxin interaction with nicotinic 
receptors(149, 150). The importance of these configurations were shown by truncation experiments, 
where Jin and colleagues showed that at the truncation of PnIA (4/7) to a 4/5 and 4/4 
configuration, began to show changes in structure and binding affinity towards the human α7 
receptor, yet still maintaining activity at the same(143). However, truncation to a 4/3 configuration 
caused loss of activity at the human α7 receptor. These changes were related to the loss of 
hydrophobic interactions and hydrogen bonds formed by the residues at loop-II with the ligand 
binding pocket. Although the loop sizes remained the same, truncation of loop-II also caused a 
gradual loss in helical structure stability, until helicity was completely lost again with the 4/3 
configuration. The study also showed a loss in stability of the disulphide bond frame-work when 
>80% of globular conformation was lost at 4/3[A10L]PnIA. These results relate the importance 
of toxin configuration to its stability, binding affinity, and specificity towards neuronal nicotinic 
receptors. Table 1.1 shows conotoxin selectivity towards particular receptor subtypes. It is 
interesting to note here that majority of the 4/7 conotoxins target α and β subunit containing 
neuronal nicotinic receptors, while the 3/5 and 4/3 conotoxin configurations target mostly the δ, 
γ and ε subunit containing muscle receptors. It is important we take into account the importance 
of differences in configuration as these results will also play a role in deciding the suitable 
mutations to be performed on the α-conotoxin [γ4E]-GID that we use in this study. 
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Table 1.1: Shows the name, sequence and receptor subunit selectivity for some of the commonly 
known α-conotoxins. Cysteine positions are highlighted. The toxins have been arranged based on 
their Cysteine framework.  
 
Toxin Sequence Target nAChR 
Cysteine 
Framework 
Ac1.1a NGRCC-HPACGKHFN--C* αβδγ/ε  
3/5 
GI ECC-NPACGRHYS--C* αβδγ/ε 
ImI GCCSDPRCAWR----C* α7 ≈ α3β2 > α9α10  
4/3 
RgIA GCCSDPRCRYR----CR α9α10 > α7 
BuIA GCCSTPPCAVLY---C* α6α3β4 4/4 
AnIA CCSHPACAANNQDYC* α3β2, α7  
 
 
 
 
 
 
4/7 
ArIB DECCSNPACRVNNPHVCRRR α7 ≈ α6β2 > α3β2 
GID# 
(SrIB) 
IRDECCSNPACRVNNOHVC α3β2 ≈ α7 > α4β2 
MII GCCSNPVCHLEHSNLC* α3β2 ≈ α6β2 
PIA RDPCCSNPVCTVHNPQIC* α6/α3β2β3 
PnIA GCCSLPPCAANNPDYC* α3β2 > α7 
PnIB GCCSLPPCALSNPDYC* α7 > α3β2 
TxIA GCCSRPPCIANNPDLC α3β2 > α7 
Vc1.1 GCCSDPRCNYDHPEIC 
α9α10 > α6β2 > 
α3β2 ≈ α3β4 
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The formation of disulphide bonds within the α-conotoxin is of much importance as these bonds 
influence the toxin’s structure, stability and function. Gehrmann and colleagues synthesised 2 
isomers of the 13 residue long α-conotoxin GI based on the connectivity between the Cys 
residues(151). However, the native isomer denoted as GI(2-7; 3-13) was found to be most flexible 
compared to the two isomers, GI(2-13; 3-7) and GI(2-3; 7-13), in that decreasing order of 
flexibility. Thus, this study illustrates an alternative way of changing the molecular conformation 
of the toxin, instead of mutating the sequence alone (151). Recent studies on α-conotoxin Vc1.1 
have also shown that the replacement of its native cysteine [2,8] disulphide bond with a dicarba-
bridge resulted in loss of activity at the α9α10 neuronal receptor(152). It is suggested that the 
synthesised toxin could no longer contribute to stacking interactions with the disulphide bond of 
the C-loop. In addition, the study also highlighted that the [3,16] disulphide bond was important 
for activity at GABAB receptors (153). These studies echo the fact that the structural modification 
of α-conotoxins to target a specific subtype of nicotinic receptors is possible, yet may also be 
challenging.   
Many important binding interactions and binding properties between α-conotoxins and nicotinic 
receptors have been identified due the availability of a number of AChBP bound conotoxin x-ray 
crystallographic structures. Dutertre and colleagues were the first group to study the interactions 
between α-conotoxins and nicotinic receptors using docking simulations (154). They found that 
antagonists prefer to interact more with residues outside the receptor binding pocket than 
agonists. This finding suggested it is possible to design α-conotoxin to interact with residues 
outside the receptor pocket in order to increase potency towards a specific subtype of nicotinic 
receptors. Quiram and colleagues studied the interaction between PnIB[L10] and α7(+)[Y93, 
W149 and Y151], highlighting the importance of the aromatic side chain residues. The study also 
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showed that the hydrophobic nature of PnIB[L10] was necessary for the interaction to take 
place(155). Using thermodynamic mutant cycle analysis, Quiram and colleagues also identified 
residues ImI[D5, P6, R7, W10] to influence potency at the  α7 nAChRs. This study was also 
confirmed by co-crystallization experiments of ImI and AChBP (156, 157). In 2007, two analogues 
of α-conotoxin ArIB, specifically ArIB[V11L, V16A] and ArIB[V11L, V16D] were discovered 
by Whiteaker and colleagues that showed an increased affinity for α7 nAChRs. While the native 
form of the toxin blocked both the α7 and α3β2 receptor subtype, the discovered analogues 
showed a comparatively less affinity towards the α3β2 receptor subtype (158). In 2013, Jin and 
colleagues found that conotoxin MrIC, showed no activity at the endogenous α3β2 and α3β4 
nAChRs, but behaves as an agonist to endogenous α7 when expressed in SH-SYSY cells(159). 
However, when these receptors were expressed in Xenopus oocytes, MrIC was observed to act as 
an antagonist towards the heterologously expressed α7 receptor. In other recent studies, 
investigation of the N-terminal tail of α-conotoxin LsIA was shown to influence its potency 
towards the α7 and α3β2 respectively. Deletion of MrIC[S1] reduced the potency of the toxin 
towards the α3β2 and α7 receptor subtypes by 5- and 2-fold respectively, while deletion of 
MrIC[S1 and G2] reduced further to 9- and 4-fold at the α3β2 and α7 receptors respectively. 
These studies show that the small-sized α-conotoxins can be carefully manipulated in order to 
target a specific subtype of nicotinic receptors. Coupled with a natural affinity towards specific 
neuronal nicotinic receptors α-conotoxins could be used to design potential drugs against various 
neuro-degenerative disorders. Although many conotoxins do exist naturally and have specific 
potency towards a particular nicotinic receptor subtype, we have chosen to study the α-conotoxin 
[ϒ4E]-GID since it is one of the very few conotoxins that exhibit a high potency towards the 
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α4β2 neuronal nicotinic receptor. Further, it is the α4β2 receptor subtype that is one of the most 
common receptors of the human brain and involved in various neurodegenerative disorders. 
 
1.8.2 α-Conotoxin [ϒ4E]-GID  
 
Figure 1.11: The structure and sequence of the α-conotoxin GID. The disulphide bonded cysteine 
residues are represented as yellow dynamic-bonds format, and numbered from I-IV accordingly. 
Residues forming Loop I and Loop II of the conotoxin are also highlighted in red and blue 
respectively. 
 
The α-conotoxin [ϒ4E]-GID (Figure 1.11) is a 4/7 conotoxin that is 19 residues long and 
purified from the venom of cone snail C. geographus. [ϒ4E]-GID possesses a flexible N-
terminal composed of four residues (I1, R2, D3 and E4) before a Cys5 residue. It also contains 
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an amidated C-terminal. It is the N-terminal tail that sets [ϒ4E]-GID  apart from other 
conotoxins, where the truncation of the same has resulted in reduced activity at the α7 nAChR 
and loss of activity at the α4β2 receptor, showing the importance of the tail residues (160). 
Furthermore, two post-translational modifications exist: a γ-carboxyglutamic acid residue occurs 
at position 4, while a hydroxyl-proline is seen in position 16, on maturation of the toxin. As 
mentioned previously, [ϒ4E]-GID is more potent towards the α7 (IC50 = 5nM) and α3β2 (IC50 = 
3nM) receptors compared to the α4β2 receptor (IC50 = 150nM) subtypes (161). At the [ϒ4E]-GID, 
Pro9 is identified as the most important residue that contributes to interaction with at both the α7 
and α3β2 receptors with less contribution from Asp3 and Arg12. It is interesting to note that the 
positively charged [ϒ4E]-GID [R12] is the residue position that confers selectivity towards the 
α4β2 receptor (162). However, in other α-conotoxins, position 12 is mostly filled by hydrophobic 
(Ala, Phe) or uncharged residues (Asn)(163), hence mutations to [ϒ4E]-GID  should be chosen 
wisely. This difference in flexibility may be significant in explaining why [ϒ4E]-GID is highly 
specific for α7 in comparison to α4β2 nicotinic receptors. Alanine scanning mutagenesis 
experiments on α-conotoxin [ϒ4E]-GID  at the α4β2 receptor revealed the importance of all 
residues on [ϒ4E]-GID  except for [ϒ4E]-GID [V13] (160).  Recently, in 2014, Bannerjee and 
colleagues showed that the mutation [ϒ4E]-GID [V18N] increased the selectivity of [ϒ4E]-GID 
towards the α4β2 receptor significantly. Hydrogen bonding between the amide group of Asn at 
[ϒ4E]-GID [V18N] and the hydroxyl group of Tyr95 of the α4(+) subunit was reasoned to be an 
important for the change in potency. Mutants [ϒ4E]-GID [A10S] and [ϒ4E]-GID [V13I] were 
also shown to increase [ϒ4E]-GID ’s selectivity at the α4β2 receptor over the α3β2 subtype(164). 
With a large library of conotoxins available to be screened through such as PnIA, PnIB, MII, 
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AuIB, BuIA, ImI, and many more yet to be discovered, high throughput screening methods are 
of need. 
Including [ϒ4E]-GID , other α-conotoxins identified to selectively target the α4β2 nAChR, such 
as  MII(165), GIC(166), and AnIB(167) indicate that inhibition by these toxins occurs at high 
concentrations (~2-3 micromolar concentrations). However, Beissner and colleagues showed the 
importance of α4(+) subunit residues R185 and P195 of the α4β2 receptor in influencing the 
selectivity of α-conotoxin TxIA[A10L] (168). Replacement of R185 by the corresponding residue 
on the α3(+) subunit (isoleucine), increased the potency of conotoxin MII by atleast 10-fold, 
while increasing that of TxIA and [A10L]TxIA by at least 1000-fold. From these structure-
function studies it is evident that conotoxins which are naturally selective for nicotinic receptors 
can be engineered to increase its potency towards a particular receptor subtype.  
 
1.9 Computational studies of nAChr-conotoxin interactions 
The genome analysis of membrane protein domains suggest that they exist mostly as single 
domains and that oligomerization within the membrane correlates to the diversity in function(169). 
In relation, the difference in subunit composition of nicotinic receptors, most certainly 
determines the differences in receptor function and location. Over time, molecular modelling, 
computational docking, and molecular dynamics simulation techniques have been applied to 
build and investigate the protein surfaces of these receptors and also the interaction of ligands at 
their respective binding pockets (170).  
The publication of the crystal structure of the acetylcholine binding protein (AChBP) structure 
which was of high resolution, revealed the surfaces of the binding site to a great detail (171). This 
Chapter 1: Nicotinic acetylcholine Receptors and Conotoxins                           
46 
 
was of specific importance to the study of nicotinic receptors, as the AChBP structure shared a 
similar binding domain to that of the α7 receptor, with a sequence identity of ~40-60%. The high 
sequence similarity of AChBP to the nicotinic receptor binding site has further brought about 
developments in designing drugs that target nicotinic receptors, given the latter’s importance in 
the implication of neuropathic pain. Molecular modelling techniques have thus implemented the 
AChBP structure successfully as a template to build a model of the neuronal nicotinic receptor 
extracellular binding domain in recent studies(172). Various models of nicotinic receptor 
structures were also modelled with an interest to understand the nature of the binding site and the 
modes of interaction of ligands towards drug-design(173-175). Docking and mutagenesis studies 
further accelerated the need and importance of computational methods to study nicotinic 
receptor-ligand interactions (176). 
An accurate account of the binding modes could be retrieved by docking methods, which is 
invaluable for designing drugs. Docking tools can thus also predict ligand-binding interactions 
and have shown up to 80% accuracy for a particular docking program(177). Docking simulations 
are based on the interaction energy involved(178). The docking algorithm searches for low-energy 
conformations of the ligand as it enters/exits the binding pocket(179). The structures are further 
assigned a score, based on existing scoring rules. Mutagenesis experiments could also aid in 
testing the authenticity of the desired conformations (160, 180). These computational methods are 
hence of much importance while screening α-conotoxins for drug-design related potential. 
Docking simulations and mutagenesis studies accurately confirmed previous structure-activity 
relationship studies involving the binding of conotoxin ImI at the α7 nAChR binding pocket (181). 
The simulation studies showed that ImI entered the binding pocket with its N-terminal tail; van 
der Waals contacts were then established between (+)Y193 and (+)W147 and ImI[D5,P6, R7], 
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while the c-terminus made contact with the complementary face of the receptor(150). The distance 
results between the receptor binding pocket and ImI was in accordance with the size of ImI. In 
addition, mutagenesis studies were able to compare and prove the difference in dissociation 
kinetics between toxins PnIB and ImI. PnIB [L5, P6, P7, A9 and L10] were observed to form 
stronger hydrophobic interactions with W147, Y186 and Y193, in comparison to that with ImI.  
The α7 receptor subunit shares the highest sequence identity with AChBP of all the known 
nAChR subtypes, and with the availability of several high-resolution structures of the same (in 
apo, agonist and antagonist-bound forms), high quality homology models were developed. 
Docking studies then used these models to understand the binding of ImI (a 4/3 α-conotoxin) and 
PnIB (a 4/7 toxin)(182). The toxin structure was preserved after receptor binding, suggesting that 
the solution structure of ImI is inherently biologically active. The docked ImI-α7 complex 
provided insights into the mechanism of α-Ctx competitive antagonism. The toxin occupies only 
a small part of the binding pocket, with insertion of Arg7 and into the aromatic pocket likely 
preventing ACh binding. A hydrogen bond identified between Arg7 and (+)Tyr193 may explain 
the reduced potency of R7A-ImI. 
ImI was also docked with the α7 receptor binding pocket by Ellison and colleagues using Auto-
dock(183). Although there were similarities in the results of this study to that of Dutertre’s 
(association of Arg7 with Tyr195), there were some differences too. Ellison et al. found no close 
association between Asp5 and Trp149 and Tyr195(184), in contrast to Dutertre et al, who found 
that Asp5 is tightly located between these two aromatics(185). This was attributed to the use of 
distance restraints by the latter. This study was also the first to elucidate an α-Ctx (ImII) which 
acts as a non-competitive inhibitor. The docking study of (competitively antagonistic) ImI to α7 
served as a basis for explaining the difference in antagonistic mechanism between ImI and ImII. 
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Pro6 of ImI was predicted to be close to (-)Q117; assuming that ImII has the same backbone 
structure as ImI, substitution of Pro6 for Arg6 in ImII will add positive charges and steric bulk 
that renders interactions with the complementary face unfavourable. Also, Arg6 of ImII removes 
the restriction of the backbone imposed by Pro6 in ImI, potentially producing widespread 
conformational differences between ImI and ImII; loss of conformational rigidity in ImII might 
also make ImII incompatible with simultaneous contacts at the principal and complementary 
faces. Thus, ImII acts as a negative allosteric modulator, binding at a region distinct from the 
canonical agonist binding site. 
A major breakthrough in understanding molecular details of α-Ctx interactions with nAChRs 
arrived with the availability of a high-resolution structure of AChBP in complex with a (A10L 
D14K)-PnIA(186). Interestingly, the structure of the PnIA variant is nearly identical to the crystal 
structures of free PnIA or PnIB, indicating that neither the mutations nor binding to AChBP 
introduces substantial conformational changes. In this study, α7 was modelled using AChBP 
crystal structures, and the A10L, and (A10L D14K) mutant toxins docking (to both AChBP and 
α7) performed with inclusion of pairwise interaction data. The binding position of the double 
mutant toxin is similar between α7 and AChBP; His114 and Lys75 were believed to “repulse” 
Lys14, causing the latter’s solvent exposure. In contrast, Asp14 (for the single A10L mutant) can 
make an additional salt bridge with Lys75. It is proposed that this effect, while enhancing 
binding, is counterbalanced by a shift of the toxin that diminishes the interaction surface, 
resulting in similar calculated α7 interaction energies for both the single and double mutants. The 
model agrees with mutation analysis of α-Ctx PnIB interaction with α7, including hydrophobic 
interaction of Leu5, Pro6, Ala9, and Leu10 with aromatic pocket residues Trp148, Tyr187 and 
Tyr194. The model also identified contacts with Arg185 and Ser34 that are not observed in the 
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Ac-AChBP. The PnIA double mutant docking orientation identified by Celie and colleagues (187) 
was adopted in a subsequent study to examine the binding of A10L-TxIA to α7(188). 
One of the first attempts to explain the role of an α-conotoxin amino-acid from an experimental 
and computational approach was described by Armishaw and colleagues(189). This constitutes the 
first effort to include explicit solvent effects in α-Ctx docking and elucidate the possible roles of 
water in mediating toxin binding. All ImI analogues produced a similar binding conformation to 
that of the AChBP-ImI crystal structure. However, certain analogues were found to adopt mis-
folded, “ribbon” isomers (eg. the P6 3-S-Phenyl analogue) which, interestingly, retained activity 
against α7 (reminiscent of the enhanced potency of “ribbon” AuIB against α3β4). The most 
notable findings, from the perspective of rational design, are, firstly the increased activity against 
α7 exhibited by 5-R-Ph compared with native ImI (CD spectrum suggests random coil, and thus 
ribbon isomer, for this analogue); and secondly, the reduction in activity for all 4-position 
substituents. Docking calculations indicated that the phenyl substituent of 5-R-Ph protrudes less 
deeply into the pocket; as a consequence, (-)Tyr93 can reside at the bottom of the pocket 
allowing for a near-optimal T-shaped interaction between the positive edge of the phenyl ring 
and the negative center of the aromatic ring of (-)Tyr93. 
MD simulations have been applied to generate physically-plausible models of different nAChR 
states. Haddadian et al. constructed a full (LBD and TMD) α4β2 receptor using the Torpedo 
nAChR as a template (190). Normal modes analysis was performed on this closed-pore structure to 
acquire the lowest frequency (largest amplitude) concerted vibrational motion, which appeared to 
correspond to a previously-proposed channel opening mechanism, with counter-clockwise 
rotation of the LBD and a concomitant opposite rotation of the TMD- a “twist to open” 
mechanism. The receptor was embedded in a bilayer in a subsequent all-atom MD simulation. 
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Application of external biasing forces to reproduce the “twist to open” motion on the receptor 
resulted in pore widening and enhanced water and ion permeation, consistent with the proposal 
that this motion is directly involved in channel opening. Furthermore, docking of nicotine was 
only energetically favourable in the open-channel, not closed-channel, model, lending further 
support to the validity of the predicted open-channel structure.  
The first simulation study to examine the dynamics of α-Ctx’s which act on neuronal nAChRs 
was when Globular AuIB (selective for α3β4) was simulated by Karayiannis and colleagues 
using MD with the CHARMM forcefield(191). Based on relatively long (by modern standards) 
simulations of 0.5 microseconds, the size and shape of the toxin was characterised by its radius 
of gyration and eigenvalues of the mass moment of inertia tensor. AuIB was found to exhibit a 
stable conformation and a compact size. Dynamical properties, including rotational and 
translational diffusivity, were also determined and summarised by coarse-grained descriptors, 
which may find application in mesoscale (beyond atomistic) level computational studies of 
toxin-receptor interactions; it is possible that these simple, simulation-acquired descriptors may 
find application in studies of toxin diffusion and subsequent binding to receptors at the micro 
physiological level (eg. synapses). 
In recent times, molecular dynamics simulations to study the interaction of various antagonist 
molecules including conotoxins at the nicotinic receptor binding pocket and support other studies 
in relation to addressing neuropathic pain. α-conotoxin Vc1.1 which has shown to hold analgesic 
activity in rat models. However, in order to help increase the hydrophobic core and thereby 
increase salt bridge interactions, Yu and colleagues designed a new variant by deleting one of the 
two disulphide bonds present(192). MD simulations helped in the determination of which bonds 
need to be deleted by running 30ns of the two mutants [C3A,C16A]cVc1.1 and 
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[C2A,C8A]cVc1.1. The structure of [C2A, C8A]cVc1.1 was found to be more stable than the 
[C3A,C16A], with the former exhibiting an RMSD of ~1.2 that was much lower than that of 
the former (1.5). Moreover, [C2A, C8A]cVc1.1 resembled that of Vc1.1 too. Further studies 
showed that its potency dropped by three-fold in comparison to Vc1.1 and was not able to 
form multiple isomers during peptide synthesis due to the absence of one of the disulphide 
bonds.  
Another study by Rilei and colleagues used MD simulations to probe and understand the 
binding of Vc1.1 with the α9α10 nAChr(193). More specifically, their simulation study implied 
that a difference in interaction occurred with Vc1.1 mutants [N9K]Vc1.1, [N9F]Vc1.1, and 
[N9W]Vc1.1 at the α9α10 and α10α9 binding sites. As suggested by the simulation study, 
electrophysiological experiments showed that the potency of [N9W]Vc1.1 to inhibit the human 
α9α10 was increased. This increase in potency was found to be due to the formation of a 
hydrogen bond between α9(+)59 and the C-terminal of amide of Vc1.1. Further, although 
[N9W]Vc1.1 showed increased potency at the human α9α10, it showed no difference in potency 
when compared to the wild type Vc1.1 at the rat α9α10 nAChr. This implies that difference in 
conotoxin interactions between species do exist and the results from animal testing can 
sometimes be misleading.  
Apart from studying the interaction of conotoxins at various nicotinic receptors, simulation 
studies were also used to closely study the interaction of pharmacological agents that act as 
antagonists at nicotinic receptors and further compete with the agonist acetylcholine. The 
binding of receptor antagonist chlorpromazine (CPZ) was studied by Xu and colleagues via 
steered and conventional MD simulations to picture its inhibitory effect on nicotinic 
receptors(194). The binding free-energy of CPZ identified by simulations was the similar to that 
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identified by experimental studies (~36 KJ/mol)(195). Also, the binding site was identified at the 
region of serine and leucine rings, which were at a close proximity from the pore. CPZ used 
interactions with the extracellular domain of the receptor to guide itself into the binding pocket. 
At the binding site, the flexible CPZ’s Ammonium head interacts with (R), Asp268 (â), Glu272 
(â), Ser276 (â) residues and cause antagonist activity at the respective receptor. However, 
conventional MD simulations identified that the binding of CPZ brings about a restriction in 
conformational transitions, that would have been possible by agonist binding and further 
impedes the function of the nicotinic receptor. These studies highlight the importance and value 
of MD simulations in identifying and understanding the changes that occur at the atomic level in 
a given system, in our case nAChr-agonist/antagonist binding.        
 
1.10 The roles of calcium (Ca2+) in nAChR and its relationship to 
disease 
Neuronal nicotinic receptors especially the α7 receptor are known to be highly permeable to 
divalent ions such as calcium (196-199), where most of the current-carriers are Ca2+ ions. 
Acetylcholine receptors were first discovered to show spontaneous opening in the absence of an 
agonist in embryonic mouse muscle cells (200). Although the current was infrequent, α-
bungarotoxin was shown to act as a channel blocker. Other studies indicated that mutations in the 
M2-helix region of the transmembrane increased channel opening (201). Further, the mutation of 
leucine 247 at the M2-helix was also found to result in a flow of inward current at α7 receptor 
mutants L247T in chick and L248T in human, also in the absence of a ligand but in the presence 
of Zn2+ (202, 203). Another similar mutation study showed that Ca2+ and Zn2+ ions in acted as heavy 
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metal agonists(204). Mutants L247T and S240T also showed ion permeation properties that were 
similar to that of the α7-wildtype, where Ca2+ was shown to interact with specific sites at the 
pore(205). These studies imply the importance of the structural conservation of the receptor on the 
whole and also the importance of the M2-helix region in channel gating, and implicates the role 
of these ions in neurodegenerative disorders.  
Calcium ions are of importance for efficient brain function and help in triggering the release of 
important neurotransmitters at the synapse. Previous studies have shown that increased brain 
activity due to an increase in neurotransmitter release, causes an increase of calcium ions 
induced current(206, 207). Under normal conditions at the presynaptic cleft of the synapse, 
potentiation of the presynaptic membrane by Ca2+ ions cause neurotransmitter-containing 
vesicles to burst once they make contact with the presynaptic membrane, thereby releasing 
neurotransmitters into the synaptic cleft(208). Thus the concentration of Ca2+ and its homeostasis 
is very important.  
Previous studies have suggest that common neurological disorders such as Alzheimer’s and 
Parkinson’s diseases are related to the toxicity induced by the abusive concentration of calcium 
ions in the neuronal regions(209). While the normal concentration of calcium ions during 
neurotransmitter release is ~200-300µM at the presynaptic cleft(210), previous studies have shown 
that high calcium concentration in the range of millimolars exist in diseased brain regions, not to 
mention the presence of calcium dependent proteinases in animal models(211). This increase in 
calcium concentration was shown to modulate the opening of nAChR channels at the presynaptic 
cleft, thereby affecting the amplitude of current from the presynaptic cleft to the receptors at the 
post-synaptic cleft(212, 213). It is proposed that chronic changes in synaptic current (lasting for 
more than a few days)can result in the  rise of various neurodegenerative diseases.  In support of 
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this proposal, it is noticed that neuro-fibrillary tangles (aggregates of hyper- phosphorylated tau 
protein) and the presence of β-amyloid protein fragments in the case of Alzheimer’s disease is 
often accompanied by an increased concentration of calcium ions (214). From these observations, 
it is proposed that Ca2+ ions play a significant role in potentiating the nicotinic receptor in the 
absence of an agonist, and could also lead to an irreversible or partial desensitisation in an open 
state, allowing the continuous flow of disrupted current. Further, this desensitisation could be 
permanent due to the presence of high concentrations of surrounding calcium ions, thereby 
triggering the disease in the first place. 
From the above evidences, it is clear that calcium ions are implicated to not only the release of 
neuro-transmitters and the overall development of the brain, but are also certainly related to the 
genesis of neurodegenerative disorders. Although this thesis focuses on the binding of α-
conotoxin [ϒ4E]-GID at the neuronal nicotinic receptors α7 and α4β2, we believe that the 
binding of the competitive antagonist [ϒ4E]-GID to the respective nicotinic receptor, would not 
only inhibit the binding of calcium ions to the binding pocket. This way the receptor is brought 
to a desensitized state that would further prevent the dynamic motion of the M2-helices and 
thereby the opening of the pore. In support to this, studies have shown that ω-Conotoxins inhibit 
CaV channels and NMDARs respectively, that are implicated to the initiation of a stroke(215). 
Moreover, in such cases of neurodegenerative disorders, where a fluctuation in ionic 
concentration, due the accumulation of calcium ions is common, chemically synthesised 
antagonist may stand ineffective at the vicinity of the nicotinic receptor and may even lead to 
more severe complications. However, as [ϒ4E]-GID is a natural peptide, the probability of 
binding to the receptor binding-pocket is comparatively much greater. However before we 
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understand the effect of Ca2+ ions on [ϒ4E]-GID, we also need to know if the nicotinic receptor 
itself undergoes any changes in conformation in the presence of high concentrations of calcium.    
Unfortunately, not many computational studies focusing on the interaction of calcium ions with 
nicotinic receptors have been conducted. The closest investigation was a study performed by Le 
Nove` re et al.(216) which traced the study of Galzi and colleagues(217). Le Nove` re and 
colleagues constructed a model of the α7 nicotinic receptor to find that two consensus Ca2+ 
binding sequences that were thought to be located on two calmodium-like EF-hands (as proposed 
by Galzi and colleagues), were found along two different β-strands at a large proximity from 
each other. Galzi and colleagues identified mutations to E44 and E173 abolished potentiation. 
Likewise, Le Nove` re et al’s model, suggested that on the same subunit, these residues were 
separated by a large distance (11.4Å), while in adjacent subunits, this distance of separation is 
reduced (10.4Å) and there is a probability that a Ca2+ binding site is formed at the lower 
separation distance of 7.57Å and 8.69Å respectively. Thus, (+)D43 and (-)D41 are much closer 
to E172 in comparison to others mentioned, and here again, a good probability arises that a Ca2+ 
binding is formed by these residues. Thus, calcium binding may alter the allosteric constant(218). 
 
1.11 Aims of this thesis 
In this study, we focus our attention on the α-conotoxin [ϒ4E]-GID, as it is amongst the very few 
conotoxins observed to exhibit any inhibitory activity against α4β2 neuronal nicotinic receptor 
subtypes, making it especially promising for elucidating the pathophysiological roles of this 
subtype in central nervous system disease. However, [ϒ4E]-GID is also much more active at 
other subtypes, including α7, another subunit which is known to be depleted in Alzheimer’s 
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disease. This property of [ϒ4E]-GID severely limits its direct use of this receptor in dissecting 
the specific roles of α4β2 in AD and other disorders.  
In this thesis, we use all-atom molecular dynamics simulations (MDS) to study [ϒ4E]-GID 
interactions with the human α7 receptor and compare them to that of the α4β2 receptor, to 
understand how the potency of [ϒ4E]-GID towards the α4β2 receptor could be enhanced. In 
Chapter 3, we examine the structure and dynamics of [ϒ4E]-GID bound to the canonical binding 
sites of α7 and α4β2, simulating the competitive inhibition mode of the toxin. Several [ϒ4E]-
GID residues were identified as being potentially amenable to improve selectivity of α4β2 over 
α7 by mutation. In silico mutagenesis free energy calculations were performed to propose 
specific [ϒ4E]-GID mutations which might enhance potency at α4β2, while simultaneously 
reducing potency at α7. Results from recent experimental evidence are discussed, in which some 
of the [ϒ4E]-GID sites and mutants identified from simulations appeared to hold promise as 
selectivity enhancing modifications. In Chapter 4, free energy methods (umbrella sampling and 
associated techniques) were used to elucidate differences in the binding free energies and 
possible energetically favourable unbinding pathways of [ϒ4E]-GID at α7 and α4β2 which may 
be responsible for the marked difference in potency between the two receptors. This also helped 
identify important alternative binding sites on the receptor that differed between the two receptor 
subtypes, which could be exploited as targets for design of novel [ϒ4E]-GID -derived mutants 
which might exhibit enhanced binding to these sites on α4β2, thus enabling the receptor to more 
effectively ‘capture’ the toxin. Chapters 5 and 6 discuss our attempts to understand the influence 
of calcium on nAChR structure, as well as the resultant effects on binding between [ϒ4E]-GID  
and α7; in Chapter 5, molecular dynamics simulation methods examined the effects of 
abnormally high levels of calcium ions around the neuronal nicotinic receptor. Structural 
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changes in both the extracellular and transmembrane domains of the receptor due to the presence 
of elevated calcium concentration are consistent with activation of the receptor, and we propose 
that this may result in continuous signal firing due to prolonged opening of the ion channel. 
Finally, Chapter 6 presents preliminary results that describe the interaction of [ϒ4E]-GID at the 
extracellular ligand binding site of α7 in an elevated calcium concentration environment. 
Chapter 7 concludes the findings of this study. 
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2.1 Homology modelling    
2.1.1 Background and theory  
Owing to the lack of experimental structures of complexes of conotoxin-nAChR complexes for 
the neuronal subtypes, it was necessary to construct predicted models. The neuronal nAChR-
[γ4E]-GID models employed in this thesis were derived by homology modelling, which makes 
use of existing experimental structures which are similar to the protein complex under study. 
Homology modelling is a method of building a protein model of a given query or target sequence 
that is similar in structure to that of one or more experimentally derived template protein 
structures. The query sequence is first aligned with the template sequence, after which the model 
is constructed. The three-dimensional model of a protein structure is of significance in 
understanding the protein function and its mode of activity. Protein models can be useful in 
studying the effects of mutations on the protein structure and function; to study ligand binding 
interactions via docking studies; in studying and investigating the binding site; in predicting 
antigenic epitopes; in refining and improving models based on NMR constraints and also in 
explaining experimental observations. 
Another important necessity for homology models arise due to the absence of X-ray 
crystallography and NMR protein structures to despite the existence of a large number of protein 
sequences present in various database repositories. SWISS-PROT and TrEMBL databases 
together hold ~850,000 sequence entries alone, which is about twice the number of available 
protein structures(219). To generate a 3D model of a protein (target) with known sequence data, at 
least one experimental structure (template) that is of significant amino-acid similarity to the 
target sequence must be known. However, with advancements in technology, the availability of 
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templates is also increasing gradually. Homology modelling involves 4 basic steps: i) fold 
assignment, ii) target-template sequence alignment, iii) model building and iv) model evaluation. 
 
2.1.1.1 Fold assignment 
 
As mentioned above, one or more template structures that share close sequence identity to the 
target sequence is of much importance to the homology modelling methodology. Hence, 
structure databases such as PDB(220), CATH(221) and SCOP(222) are searched for templates that 
match the target sequence query. Here the quality of the search results is assessed by the E-value 
or z-score.  
 
2.1.1.2 Target-template sequence alignment and Profile-profile alignment 
 
When the target-template sequence identity between 30-40%, templates can be easily chosen 
using BLAST(223), FASTA(224), SSEARCH(224) sequence alignment methods. Brenner and 
colleagues(225) showed that these methods identified 90% of the homologous relationship when 
the sequence identity was between 30-40%.  
However, when the sequence similarity drops to a range of 10-30% or the “twilight zone”, 
profile sequence methods(226) are used to increase the accuracy of the sequence alignment. Here, 
multiple sequence alignment first creates a profile of the residue types, and this information is 
often in the form of Hidden Markov models(227, 228), or position-specific scoring matrix 
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(PSSM)(229). The target sequence profile is then searched against a database of template 
sequences. Profile sequence methods align ~45% of the residues correctly and are usually 
performed using the following tools: PSI-BLAST(230), SAM(231), HMMER(232), HHsearch(233), 
BUILD_PROFILE (from MODELLER)(234).    
Profile-profile alignments are an extension of profile sequence methods and work by comparing 
the target sequence profile against a database of template profiles (as opposed to the template 
sequences used in the Target Template sequence alignment methods). This method has shown to 
improve alignment accuracy and detect 28% more relationships at the superfamily level(235, 236). 
These alignments are performed using FFAS(237), SP3(238), HHBlits(239), HHsearch(240) and 
PPSCAN in MODELLER(234). 
When the sequence identity drops lower than that of the twilight zone, sequence-structure 
threading methods are used, where these methods can detect common folds between sequences 
that may not show significantly strong sequence identity. The accuracy of this method is 
assessed by comparing the score to that of a corresponding coarse model and the scoring scheme 
is thus based on various characteristics of the protein model such as hydrogen bonding 
properties, solvent exposure and secondary structure, unlike previously described sequence 
alignment methods(241, 242). Commonly used programs that perform sequence-structure threading 
include, 3D-PSSM(243), FUGUE(241), SP3(238), MUSTER(244) and Gen THREADER(245).   
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2.1.1.3 Model Building 
 
The most widely used method for model building is to use a number of aligned protein 
structures. The aligned structures are then broken into fragments based on the conserved core 
regions, loop-regions and side-chains(246, 247). The selected template structures are first 
superimposed to form an average model. Thus the accuracy of the model increases with an 
increase in the number of template structures that are superimposed(248). Next, the coordinates of 
the Cα atoms of the conserved regions are averaged to build the frame of the model. The main 
chain atoms are then assembled into the target model by superimposing the respective segment 
from the template structure. Appropriate loops are selected by scanning a database to identify 
structurally variable proteins that fit the core regions(249). Side-chains are then modelled based on 
the side-chains on the template structure(250). The stereochemistry of the model is improved by 
molecular dynamics simulation refinement (251). Molecular modelling softwares 3D-JIGSAW(252), 
SWISS-MODEL(253) and RosettaCM(254) incorporate this methodology.  
In this study, Modeller 9v2 was used to build the homology models of the required protein 
structures in Chapters 3 and 4, while Modeller 9v12 was used to build the homology model in 
Chapter 5. Modeller is an automated program that uses the i) sequence for which the structure is 
to be built (Target sequence) and ii) an experimentally solved protein structure and its sequence 
(Template)(Fig 2.1). The target-template sequence alignment will then be used hereafter by 
Modeller. Based on the alignment with the template 3D structure, distance and dihedral angle 
restraints are applied on the target sequence. These constraints are applied using statistical data 
obtained by understanding the relationship between many pairs of homologous structures. To be 
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more precise, the statistical analysis used a database of 105 family alignments that included 416 
proteins with known 3D structures(255). 
Using the database, correlations between important structural features such as dihedral angles 
and Cα - Cα distances were obtained. The calculation of the spatial restraints were affected by 
i)the residues considered, ii) the residue conformation, and iii) the sequence similarity between 
the proteins. These spatial restraints obtained were expressed as probability density functions. 
The spatial restraints thus obtained are quite accurate as they are derived empirically from a 
database of structure alignments.  
CHARMM energy terms are then added to the obtained constraints and an objective function is 
derived. The objective function is then optimised in Cartesian space to obtain the required model. 
The model is optimised using conjugate gradients methods and molecular dynamics simulations. 
Modeller also automatically optimizes the loop regions of the model/PDB, or allows the user to 
restrain optimisation to specific regions. Modeller uses various scoring functions and 
optimisation protocols to deal with loops(256). 
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Figure 2.1: Comparative Protein Modelling by Modeller: The target sequence to be modelled is 
aligned on the template 3D structure. Next, Spatial features of the template structure such as Cα -
 Cα distances, hydrogen bonds, and main-chain and side-chain dihedral angles, are applied to the 
target. The 3D model that is finally obtained by satisfies the obtained restraints as close as possible. 
Adapted from: Šali & Blundell, 1993(234). 
 
 
 
 
 
 
 Chapter 2: Computational Methods for Protein study                          
65 
 
2.1.1.4 Model Evaluation 
 
When the sequence identity between the query sequence and template drops to lower than ~30%, 
the model must be checked to evaluate if an incorrect template was used or if there was an error 
in the alignment although the template chosen was correct. Tools such as 
VERIFY3D(257),DFIRE(258), SOAP(259), DOPE(260), Prosa2003(261), ANOLEA(262) are often used 
to assess if the precision of the template to the target. In addition to this, features related to the 
stereochemistry of the model, such as bond-angle, torsion-angle, nonbonded contacts, etc can be 
evaluated using PROCHECK(263) and WHATCHECK(264). A large number of errors indicated by 
PROCHECK could relate to errors in the alignment.   
Depending on the question of interest, the models need not be always accurate. Models that have 
less than 25% of sequence identity between the target and template sequences may still contain 
correct fold information which is sufficient to understand the protein’s biochemical function. 
Consequently, a higher sequence identity of ~35% can still be used to study ligand binding 
interactions, since the ligand binding site is more conserved than the rest of the fold. Models 
corresponding to an accuracy of ~50% sequence identity match that of low-resolution X-ray 
structures or (3Å resolution) or medium resolution NMR structures. 
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2.1.2 Methodologies and procedures 
In this study, the extracellular domain of the human and rat – α7/α4β2 receptor subtypes (bound 
to [γ4E]-GID) were built by retrieving the respective subunit sequences from the Uniprot 
database(265).The template chosen was the crystal structure of Acetylcholine-Binding protein 
(AChBP) from Aplysia Californica in complex with an α-conotoxin PnIA variant (PDB 
ID:2BR8)(266). A comparison between the template sequence and the human α7/α4/β2, and rat 
α4/β2 receptor subunits showed a sequence identity of ~28-29% with a higher percentage 
identity of ~40% at the conserved ligand binding domain. All models in this study that contained 
the extracellular domain alone were assembled using MODELLER 9, Version 2(267), while the 
models that contained the transmembrane domain (used in chapter 5) were built by MODELLER 
9, Version 12. This was due to the software updates that were frequently released by Sali’s lab.  
The extracellular domain of the neuronal nicotinic sequences human α7, rat-α4, rat-β2, human-
α4 and human-β2 receptor (Uniprot ID: P49582, P09483, P12390, P43681 and P17787) 
respectively was downloaded from the Uniprot database. The human α7 sequence was aligned 
with the template sequence of 2BR8 using ClustalW (Fig. 2.2), then residues 1-9 of α7 were 
manually adjusted to remove the 3-residue gap between K9 and E10 to ensure a continuous N-
terminal alpha-helix in the homology model. The human α4 and β2 subunits were multiply 
aligned with the 2BR8 sequence using ClustalW (Fig. 2.3), as were the rat α4 and β2 
sequences(Fig. 2.4). Based on the sequence alignment below, the models used in this study were 
built. 
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Figure 2.2: Shows the ClustalW sequence alignment results that used the query sequence of the 
human α7 extracellular domain and the template sequence at the PDB ID 2BR8. 
 
 
 
Figure 2.3: Shows the ClustalW sequence alignment results that used the query sequences of the 
human α4 and β2 extracellular domain and the template sequence at the PDB ID 2BR8. 
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Figure 2.4: Shows the ClustalW sequence alignment results that used the query sequences of the rat 
α4 and β2 extracellular domain and the template sequence at the PDB ID 2BR8. 
 
2.2 Molecular modelling 
Molecular modelling describes the use of theoretical and computational methods to build a 
model, such that the built model mimics the behaviour of an actual system of molecules. The 
system to be modelled could range from a few atoms to large biological systems or to atoms 
describing different materials.  
Molecular modelling of protein structures was first inspired by Corey and Pauling(268), who built 
wood models (held together by steel rods) and plastic models to illustrate atomic interaction. 
Their models were based on the data from x-ray diffraction studies. In 1960, Walter Koultan 
improved Robert-Corey’s model, known as the Corey-Pauling-Koltun (CPK) model which 
represented atoms using spheres. This model more accurately represented the arrangement of 
atoms, however, it is difficult when the atoms obscure the chemical bond and other atoms as well 
from the viewer, in particular conformations.  
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Today, simulation techniques are classified based on the time-scale and the system studied. The 
most accurate methods are use quantum mechanics (QM), consisting of Density Functional 
Theory (DFT) and ab-initio methods. QM methods are used to investigate systems where 
interactions such as bond-formation/breakage and electron rearrangement are to be studied. As 
protein-structures are large systems in comparison to electronic structures, semi-empirical 
methods are used to simulate the former. 
 Molecular mechanics allows the study of physical interactions of large systems, especially when 
longer simulation time scales are required. The Born-Oppenheimer approximation is the theory 
behind molecular mechanics and eliminates description of the electronic movement from the 
Hamiltonian system. In addition, Molecular mechanics describes bond stretching, angle bending, 
and rotations about a single bond (torsion), more efficiently than ab initio methods.  
Coarse-grained simulations are advantageous when an accurate description considering a large 
system and long simulation times that cannot be achieved by simple atomistic methods is 
required. Although this method was initially implemented on detergent and lipid molecules (269), 
more complex proteins with membranes, such as anti-microbial peptides have been studied(270). 
This method considers groups of atoms as a single particle and hence complex interactions must 
be described by a small number of parameters (271). However, the coarse-grained simulation 
method is continuously being improved on. 
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2.3 Molecular dynamics simulations 
A molecular dynamics simulation is a computational method to view, and understand the motion 
of molecules when placed within a user defined system. As the properties of each molecule 
within the simulated system are also defined by force-field parameters, the virtual system can 
replicate an actual experiment. The first bio-molecular simulation was performed in 1975 on 
Bovine pancreatic trypsin Inhibitor, in a vacuum for only 9.2ps(272). The simulation removed a 
wrong notion that proteins were relatively rigid structures. Today, MD simulations have come a 
long way, where one can run microseconds of simulations over shorter periods of time. 
Moreover, Ligand binding, drug-designing and understanding of binding energy of a molecule in 
focus are few of the recent advances of MD simulations in regards to biology alone, while many 
other applications exist(273, 274).  These simulations give an in-depth understanding of important 
interactions and events that occur at an atomic lever may not be observed from experiments. 
Particularly for biological molecules such as proteins and ion-channels where experimental 
observations are often if not always the result of interactions occurring at a nanomolar level, MD 
simulations are of much importance. MD simulations requires a number of ‘components’, which 
are each described in the following sub-sections 
 
2.3.1 Background and theory 
2.3.1.1 Force-fields and potential energy function 
Empirical force-fields are a set of rules or parameters to calculate the potential energy of a 
system of atoms, in this case a biological system(275). In combination with the potential energy 
function, the force-field also incorporates geometric and energy-related parameters. The force-
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field helps us study structure-activity relationships of the system and given its accuracy, is able 
to mimic various experimental observations. 
The most commonly used force-fields to generate and study simulations of a biological system 
are GROMOS(276), CHARMM(277), AMBER(278), OPLS-AA(279) force-fields, where atoms and 
their properties are well defined usually by numerical values. For example, force-field 
parameters include description of the atomic mass, partial charges of the atoms, van der Waals 
radius, bond-angle, bond-length and dihedral angles for a particular atom in the system. Hence 
these parameters are distinct from each other while considering a system of atoms. Other force 
fields that have been created for protein simulations include MM4(280), MMFF(281), UFF(282), 
CVFF(283) and ECEPP(284). A brief introduction to underlying description of the commonly used 
force-fields is given below.      
Force-fields describe the potential energy function due to bonded (Ebonded) and non-bonded 
(Enonbonded) interactions between atoms of a system. Eother describes other terms that may be 
specific to a force-field (285).  
                                            Etotal  = Ebonded  + Enonbonded  + Eother                                            (2.1)                                   
Bonded interactions describe the rotation of dihedral angles, valence angle bending and bond-
stretching. On the other hand, the functional form of non-bonded interactions are described by 
electrostatic and van der Waals interactions.   
Ebonded = ∑ K𝑏(𝑏 − 𝑏0)2𝑏𝑜𝑛𝑑𝑠  + ∑ 𝐾𝜃(𝜃 − 𝜃0)2𝑎𝑛𝑔𝑙𝑒𝑠  + ∑ 𝐾𝛾(1 + cos(𝑛𝛾 − 𝛿)𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠                                                         
                                                                                                                                                                                                                              (2.2) 
While,  
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Enon-bonded = ∑ {ε𝑖𝑗[�𝑅𝑚𝑖𝑛,𝑖𝑗 𝑟𝑖𝑗⁄ �𝑛𝑜𝑛𝑏𝑜𝑛𝑑𝑒𝑑 𝑎𝑡𝑜𝑚𝑠 
𝑖,𝑗 𝑝𝑎𝑖𝑟  12   - 2�𝑅𝑚𝑖𝑛,𝑖𝑗 𝑟𝑖𝑗⁄ �6] + 𝑞𝑖𝑞𝑗 𝑟𝑖𝑗⁄ }      
          (2.3) 
The first term of equation 2.2 resembles Hook’s law, and describes the stretching of bonds in a 
quadratic form. The equation represents the sum over all bonded pairs of atoms, where b is the 
bond length, Kb and b0 are the parameters describing the stiffness and the equilibrium length of 
the bond, respectively. Similarly, the second term involves triplets of consecutively bonded 
atoms and describes the bending of the angle (θ) formed by them. Kθ and θ0 are the parameters 
describing the stiffness and equilibrium geometry of the angle, respectively. The third term from 
the bonded interaction energies equation describes the energetics associated with rotation of the 
dihedral angle defined by quadruplets of consecutively bonded atoms, where γ is the value of the 
dihedral, Kγ is the energetic parameter that determines the barrier height, n is the periodicity and 
δ is the phase. 
As mentioned earlier, equation 2.3 describes the non-bonded interactions defined by the force-
field. Here, the first term of the equation represents the van der Waals term, where the attractive 
and repulsive nature of the atoms are accounted for. εij is the dielectric constant while Rmin, ij is 
the distance between the atoms i and j and describes the Lennard-Jones energy. Both εij and Rmin, 
ij depend on the interacting atoms. The second part of Equation 2.3 describes the electrostatic 
interactions between non-bonded pairs of atoms. As previously described, rij is the interatomic 
distance, while qi and qj describe the effective charges on atoms i and j. These charges are partial 
atomic charges and represent the overall charge distribution of a molecule.  
The differences between the four most commonly used force-fields are incorporated into the 
term Eother(286) according to different force-fields. For example, among the 4 mentioned 
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commonly used force-fields, CHARMM uses an additional Urey-Bradley term that describes 
angle bending. Further this term also provides an accurate reproduction of vibrational spectra 
during parameterisation. Differences in the scaling factor applied to lennard Jones and van der 
Waals interactions by the respective force fields to improve electronic polarizability is 
contributed by the non-bonded interactions. 
 
2.3.1.2 Force-field Parameterisation 
In order to complete the force-field parameters, the potential energy function (discussed above) 
must also be parameterised along with the geometric properties of the interacting atoms. This is 
important to ensure that the simulation replicates experimental observations. This data needed 
for parameterisation is obtained from thermodynamic, crystallographic and also quantum 
mechanics methods. The OPLS, CHARMM, GROMOS and AMBER force-fields are designed 
to deal with biological problems such as Proteins and DNA. Hence, these force-fields are 
parameterised accordingly by using properties derived from electron, or X-ray diffraction 
structures, relative conformational energy and solvation free energy studies. While there are 
some similarities between the force-fields, there are also some significant differences that set 
them apart. Both Amber and CHARMM involve use of the quantum mechanical methods to 
obtain atomic partial charges. Amber uses the restrained electrostatic potential (RESP) method to 
determine partial charges which reproduce the electrostatic potential obtained by Hartree-Fock 
calculations, while CHARMM employs fitting of the partial charges to reproduce experimental 
gas-phase dipole moment values(287). 
Over time, the standard force-fields have been improved to closely replicate experimental data. 
Important modifications to the torsion potentials to the AMBER and CHARMM force-fields, 
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have shown an increased accuracy of the simulation, when compared to experimental results(288). 
There are several variations available of the AMBER force field. The standard AMBER force-
field has also been modified again by incorporating differences in partial atomic charge 
derivation (289).  Recently, the Amber ff99SB has been refined by optimising the χ torsion 
potential of certain amino-acids (Ile, Asp, Asn, Leu) by a 3-step procedure(290). First, the side-
chains that deviated from expected behaviour were selected. The new torsion potentials were 
assigned to the four amino-acids by modifying the ab initio DF-LMP2 (291) dihedral scans. The 
modified force-field was then compared with a large set of NMR data to show improved 
accuracy.  
 
2.3.1.3 Solvation 
Most (if not all) bio-chemical events occur in the presence of a solvent. Moreover, the solvent is 
important in bringing about certain interactions with the bio-molecule in its vicinity, such as the 
formation of water bridges. In MD simulations, the selection of a particular force-field indirectly 
determines the solvent used. This is because it is important to consider the compatibility of the 
solvent with the force-field. For example, the TIP3P water-model is coupled with the OPLS, 
AMBER and CHARMM force-field. GROMOS uses the SPC and F3C models. However, apart 
from the commonly used TI3P and SPC models, AMBER force-fields now support TIP4P, 
TIP5P, TIP4PEW and SPCFW(292, 293). An elaborate study on various solvent models showed that 
the SPC water model suited the AMBER99, GROMOS 53A6, and OPLS-AA forcefields 
best(294). The SPC and TIP3P solvent model preserved the protein structure well. While 
comparing hydration energy, GROMOS 53A6 force field proved better performance-wise.    
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 2.3.1.4 Equations of motion 
MD simulations theoretically originate from Newton’s Law, F= ma. At a molecular level a 
simulation system can be described by position and momentum of the respective molecules. The 
force due to the potential energy of atoms E(rN) in the system is thus given by  𝐹𝑗= −𝑑𝐸𝑑𝑟                                                                         (2.4) 
                                                                                            𝐹𝑗 𝑚𝑗=𝑑2𝑟𝑑𝑡2                                                                          (2.5)                       
where, Fj is the force acting on the atoms of the system, and rN describes the 3N atomic 
coordinates of the atoms (position) of the system.  
These equations can be represented in terms of momentum and velocity, according to the 
question being asked. In addition, the force between atoms can be calculated by any finite 
difference method which may be computationally less expensive. The most commonly used 
efficient finite difference methods used in MD simulations are the Verlet Algorithm(295). Thus the 
velocity of the atoms at each step using the Verlet algorithm is calculated by the formula,  
                                                vi(t)=[ri(t + h)-ri(t - h)]/2h                                                     (2.6)                                                            
where, h the time increment is equal to 0.032. 
The positions of the atoms in the system are described by the Taylor series expansion, where the 
position of the rth+1 step can be found by: 
                                          r(1+∆t) = 2r(t) – r(t-∆t) + ∆t2a(t)                                                (2.7)                                           
Compared to the Gear-predictor algorithm(296) that is also used, the Verlet is computationally 
more conservative especially at large time-steps, although its accuracy is compromised.  
The leap-frog algorithm (a modified Verlet algorithm) improves accuracy in velocity calculation, 
by calculating the velocity at every half-time step: 
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                                          v(t) = 1
2
 [v(t + 1
2
∆t) + v(t - 1
2
∆t)]                                                   (2.8)                                                                                                        
where the position of the atom at  
                                           r(t + ∆t) = r(t) +  v∆t(t + 1
2
∆t)                                                     (2.9) 
The velocity of the particle thus calculated at t + 1
2
∆t “leaps-over” its position. In addition, the 
velocity v and the position r are not simultaneously calculated. Although the leap-frog algorithm 
is efficient, a different algorithm must be chosen if accuracy must be improved.  
 
2.3.1.5 Periodic boundary conditions 
Periodic boundary conditions are a set of limiting conditions that place a large simulation system 
within a unit-cell. This way, we can analyse a huge system efficiently, using limited 
computational resources. In the simulation, the system is placed within a box, which is 
surrounded by mirror images of itself. Hence in 2-dimension, a box is surrounded by 8 mirror 
images (Figure 2.5).  
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Figure 2.5: Shows a 2-dimensional representation of a unit-cell. The grey box represents the actual 
system, while the boxes in white represent mirror images of the system. 
 
Additionally, if a particle of the system passes through any edge of the box, it will be removed 
and reappear on the opposite edge with the same velocity. However, interaction of the original 
system with its images must be avoided. Thus a system must be placed in a box of appropriate 
dimensions or shape, depending on the system, the results to be obtained and to increase 
computational efficiency. The different of space-filling boxes available are cubic unit cell, 
rhombic dodecahedron, truncated octahedrons and the triclinic unit-cell(297). Within the boundary 
conditions, the particles of the system may also be placed in bulk fluid to avoid edge effects.  
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Figure 2.6: shows the protein in focus (α7 nicotinic receptor) in a solvent-filled (red dots) triclinic 
simulation box. 
 
2.3.1.6 Calculating non-bonded forces 
 
Calculating and mapping non-bonded forces or long-range electrostatics is quite a 
computationally intensive part of a simulation. One method to deal with this is to apply a certain 
cut-off distance from the particle to be studied, where all the interaction energy with other 
particles in the system, but within a particular cut-off distance is calculated(298). Likewise, the 
interaction energy with particles beyond the cut-off distance is ignored as most of the 
interactions would be contributed by closely neighbouring particles. This method known as the 
non-bonded cut-off method is of limited application since the cut-off cannot be set to more than 
half the length of the cell. In addition, this method can also become computationally expensive, 
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and is erroneous especially when considering a system with relatively large number of 
particles(299). 
The Ewald sums algorithm(300) addresses some of these issues by treating the system as infinitely 
periodic and calculating the interaction energy beyond a particular cut-off. The method 
calculates long-range electrostatic forces by Fourier transformation methods. However, this 
algorithm was also criticized to be computationally expensive and low on accuracy (301). Hence, 
Particle mesh Ewald method(302) was formulized which increased efficiency by 40% as particle 
positions are calculated continuously. Other grid-methods such as the Link-Cells method(303) are 
also recent where the unit-cell is divided into smaller cells of equal dimension and required 
interactions are alone monitored. 
 
2.3.1.7 Temperature coupling 
Due to the movement and friction of particles within the unit-cell or errors due to thermal drift, 
there is a high probability that the heat generated within the simulation system could rise rapidly 
and affect the expected interactions or results. To thus control and maintain the temperature 
within the simulation system, according to canonical ensembles, the Berendsen(304) and the nose-
Hoover (305, 306)schemes are commonly used.  
The Berendsen temperature coupling algorithm aims to mimic the slight perturbations due to 
friction that may occur in an ideal physical experiment. Previous methods introduce 
approximations that often vary the Hamiltonian altogether (HMLE method)(307, 308). However, the 
Berendsen coupling scheme introduces a weak (309) frictional force to the equations of motion till 
the desired temperature for the system is reached. 
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                                                     mi 
𝑑𝑣𝑖
𝑑𝑡
 = Fi - mi γ ( 𝑇𝑜𝑇  – 1 ) vi                                             (2.10) 
where, γ is the friction constant of the particles ; To represents the fixed reference temperature of 
the system that is coupled to a heat bath ; T is the temperature of the system due to coupling ; 
and Fi is the systematic force. In addition, to achieve a reliable temperature coupling, the 
coupling time can be increased to ~0.5 ps.  
The velocity of each particle is thus scaled per time step by a factor λ,  
                                                          λ = [1 + 𝛿𝑡
𝜏𝑇
 (𝑇0
𝑇
 – 1)] ½                                                (2.11) 
where, 𝜏𝑇 is the scaling time constant, and is close to the temperature coupling time constant. In 
addition the increase in temperature is slightly less than the scaling temperature as the velocity of 
the particles may be dissipated in the form of kinetic and potential energies. The Berendsen 
temperature coupling method is efficient for stabilising the temperature of a system to a desired 
one during equilibration and easy to implement, however it is not able to achieve correct 
ensembles for large systems.  
The description of canonical ensemble simulations is improved by the Nosé-Hoover temperature 
coupling algorithm which was first proposed by Nosé(306) and modified by Hoover(305). This 
algorithm is an extension of the Berenson, where a thermal reservoir is introduced in addition to 
a friction constant ξ. Thus including the friction force, the equations of motions according to 
Hover’s formula can be simply rewritten as, 
                                                               𝑑
2𝑟𝑖
𝑑𝑡2
 =  𝐹𝑖
𝑚𝑖
 – ξ 𝑑𝑟𝑖
𝑑𝑡
                                                   (2.12) 
where the equation of motion for ξ is given by  
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                                                                   𝑑𝜉 𝑑𝑡 = 1𝑄(T-T0)                                                     (2.13) 
where Q is the coupling strength, and T0 denotes the reference temperature while T is the current 
temperature of the system. The Nosé-Hoover algorithm is different from the Berendsen in that by 
applying the former, an exponential relaxation is obtained, while the latter results an oscillatory 
relaxation. In simpler terms, the Berendsen algorithm relaxes the system and reaches the target 
temperature more rapidly, while the Nosé-Hoover algorithm takes longer periods and oscillates 
around the required ensemble. The Nosé-Hoover algorithm thus is more likely to setup an 
ensemble that is closer to physical experimental conditions. Thus maintaining constant NVT 
conditions would help replicate actual experimental surroundings closely.   
 
2.3.1.8 Pressure coupling 
As much as temperature coupling for the system is required, pressure coupling for the system is 
also likewise necessary. The Berendsen barometer (304) and the the Parrinello-Rahman 
algorithms(310) are used commonly to address pressure coupling. Similar to temperature coupling 
the system is coupled to a constant pressure bath during pressure coupling for the system to be 
properly described. This method is often run together with temperature coupling algorithms. 
The pressure change towards the reference pressure P0 is given by  
                                                                 (𝑑𝑃
𝑑𝑡
) = 𝑃0−𝑃 
𝜏𝑃
                                                         (2.14) 
while the pressure is calculated by  
                                                               P = 2
3𝑉
 (𝐸𝑘 − 𝐸)                                                   (2.15)                                                                                   
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Where, Ek is the total kinetic energy of the system, while E is the kinetic energy for pair additive 
potentials. The pressure change in the system by the Berendsen algorithm occurs by scaling 
inter-particle distances. However, according to the algorithm the box length is rescaled per time 
step by a scaling factor µ0 as the pressure of the system moves towards P0. 
The scaling factor 
                                                           µ0 = 1 - 
𝛽∆𝑡
3𝜏𝑃
 (𝑃0 − 𝑃)                                                (2.16)                                                                                                 
where β = 4.6 × 10-5 bar-1 (for water at 1 atm and 300 K) and represents the isothermal 
compressibility of the system. 
The Parrinello-Rahman algorithm gives a more accurate description of pressure coupling within 
the system, by extending the Nosé-Hoover temperature coupling algorithm. Similar to the Nosé-
Hoover algorithm, the variable describing the unit cell vectors is independent allowing the 
visibility of various structural changes during the simulation experiment. The change in box-
vectors given by the matrix b: 
                                                        𝑑𝑏
2
𝑑𝑡2
 = VW-1b`-1 (P - Pref)                                              (2.17) 
Where V and W represent the box volume and the matrix parameter respectively and together 
describe the strength of the pressure coupling.  
Thus the equations of motion change accordingly to accommodate the box vectors 
                                                         𝑑
2𝑟𝑖
𝑑𝑡2
 =  𝐹𝑖
𝑚𝑖
 – M 𝑑𝑟𝑖
𝑑𝑡
                                                        (2.18)                                                                 
                                                        M = b-1[b 𝑑𝑏`
𝑑𝑡
 + 𝑑𝑏
𝑑𝑡
 b`] b`-1                                                                  (2.19)           
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The Parrinello-Rahman algorithm along with the Nosé-Hoover thermostat, an accurate 
isothermal-isobaric ensemble can be generated, however, some drawbacks of this method is that 
it is quite slow to achieve a statistically desired ensemble. For a simulation approximated by 
periodic boundary conditions, one would desire to place the system under constant and 
controlled pressure (NPT) as the simulations would closely replicate experimental evidences. 
 
2.3.2 FoldX 
FoldX is a tool to quantitatively provide a quick estimate of the interactions between two 
proteins, specifically to understand the effect of mutations on the stability of the interaction(311). 
Apart from predicting information regarding the stability, FoldX also predicts the positions of 
protons, water bridges and metal binding sites and the analysis of the free energy of complex 
formation. Predicting the stability of the protein via Alanine scanning is also available. Hence 
FoldX calculates ∆G, which is the free energy of folding of a target protein and can also provide 
numerical information regarding the stability of a protein complex. The various energy terms 
used by FoldX have been carefully derived from empirical protein engineering studies.  
To calculate the free energy of binding (∆G), FoldX uses important energy terms that describe 
protein stability. In FoldX, the free energy of unbinding of the target protein ∆G is given by the 
equation,  
  ΔG= ΔGvdw + ΔGsolvH + ΔGsolvP + ΔGwb + ΔGhbond + ΔGel+ ΔGKon + ΔSmc + ΔSsc 
where ∆Gvdw is the sum of the van der Waals contributions of all atoms with respect to the same 
interactions with the solvent; ∆GsolvH and ∆GsolvP are the differences in solvation energy for 
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apolar and polar groups respectively when these change from the unfolded to the folded state ; 
∆Ghbond is the free energy difference between the formation of an intra-molecular hydrogen 
bond compared to inter-molecular hydrogen-bond formation (with solvent) ; ∆Gwb is the extra 
stabilizing free energy provided by a water molecule making more than one hydrogen bond to 
the protein (water bridges)(312) ; ∆Gel is the electrostatic contribution of charged groups, 
including the helix dipole ;  ∆Smc is the entropy cost of fixing the backbone in the folded 
state(313) ; ∆Ssc is the entropic cost of fixing a side chain in a particular conformation(314). In this 
study, we make use of the in silico mutagenesis option in FoldX, to estimate the stability of 
nAChR-conotoxin complexes (Chapters 3 and 4).    
 
2.3.3 Methodologies and procedures 
The following section describes the general simulation procedures used in this study, however, 
more specific details, such as simulation times, cut-offs are described in detail in the 
methodology sections of the respective chapters that follow.  
The simulation systems in this study were built and run using the Gromacs simulations 
packages(315) (versions 4.5.5 to 5.0). This was due to the fact that Gromacs released new versions 
of the suite and restricted access to previously available versions. The respective versions of 
Gromacs used have been mentioned accordingly in the methodology section of the relevant 
chapters. The structures of the extracellular domain and the transmembrane domains of the 
channel were modelled using Modeller 9.12(234) (chapter 5), and then parameterised based on the 
Amber forcefield(316). Here again, while the extracellular domain of the receptors were built 
using Modeller 9.2 (chapters 3 and 4), the release of newer versions of Modeller during 2012-
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2015 forced us to use later versions of Modeller. Once the topology for the protein was obtained, 
the latter was placed in a simulation box, such that the edges of the box were set to maintain a 
minimum distance of 10Å to the periphery of the protein. This was done to eliminate any cross-
interactions of errors due to periodic boundary conditions. The box was then filled with solvent 
molecules, in this case explicitly represented water molecules. If the system contained an overall 
non-zero charge, counter ions were added in place of solvent molecules.  
Membranes are an integral part of any cell and are also of functional importance. At the neuronal 
nicotinic receptor channel a bilayer lipid membrane envelopes the transmembrane helices M1-
M4. In Chapter 5, the effect of calcium ions on the gating-motion that occurs at the 
transmembrane helices are studied. Thus before the modelled extracellular-transmembrane 
regions containing receptor is placed into a simulation-cell the transmembrane helices are first 
shielded by a layer of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC).  For this purpose, we 
obtained the structure of DOPC from Lipid-book (https://lipidbook.bioch.ox.ac.uk/lipid/). Next, 
using VMD, the modelled receptor-channel was inserted into the bilayer. The layers of DOPC 
that were within a range of 3Å of the receptor were removed, to ensure a cavity in the bilayer is 
produced which can accommodate the protein. This structure was finally used as the starting 
structure to simulate the influence of calcium ions on the nicotinic receptor (Chapter-5).  
Once the system was neutralised, energy minimisation was performed using the first-order 
steepest descent method, to rid the system of any steric clashes between the protein and water 
molecules. The minimisation was considered converged when the maximum force exerted on the 
system was less than 20 KJ/mol/nm. Next the protein was restrained and the solvent was 
equilibrated at constant pressure (NPT), where T = 300 K, and P = 1 bar.  The leap-frog 
algorithm contained the Newtons equations of motion and was used in the Gromacs package. 
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The trajectories of the resulting simulations were analysed mostly using tools found on the 
Gromacs 4.5.5 suite itself, visual of the structural representations of the system were performed 
using Visual Molecular Dynamics (VMD)(317). 
 
2.4 Advanced molecular dynamics techniques: Umbrella sampling 
Molecular dynamics simulations are accurate and useful in producing a detailed account of the 
time-dependent changes in a system. Apart from this, simulations are also able to help us 
understand the free-energy profile of a system around local minima. However, in the cases of 
protein-binding, protein-folding and protein-aggregation, the various minima can be separated by 
large energy barriers. Thus the simulation can fail to describe the entire energy surface, 
especially when there is a large energy barrier between the minima. Thus a method that would 
help sample rare events and picture slight changes in configuration thereby crossing large energy 
barriers is needed.  
Two commonly used methods to help explore a wider conformational space in protein folding 
and binding studies are Umbrella sampling(318), Replica Exchange Molecular Dynamics 
methods(319) and the more recently developed Bias-Exchange Metadynamics (320). However, only 
the umbrella sampling methodology will be discussed in the following sections. Other sampling 
techniques include local elevation method(321) and conformational flooding(322) where the 
potential energy surface is studied by either smoothening or disrupting it. 
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2.4.1 Background and theory 
Calculating the free energy of toxin-receptor is essential in this study. Free energy calculations 
using explicit solvent MD allow quantitative prediction of ligand binding energies, and will 
provide accurate measures of toxin binding affinity. Weighted Histogram Method was used to 
calculate the Potential of Mean force (PMF) from a set of Umbrella sampling simulations at each 
receptor pocket.(323).  
Umbrella sampling (324) involves the application of an energy bias that ensures efficient sampling 
along the reaction coordinate (x). The umbrella sampling is performed by applying a biasing 
potential W(x) to the ligand at closely chosen intervals along the reaction coordinate. This 
harmonic potential places the sampled particle (the toxin, in the present work) in regions of high 
energy.  
 
The biased distribution of the toxin position, ρ(x)biased , is thus given by: 
                                            {ρ(x)}I = 𝑒−𝛽𝑊𝑖(𝑥). {ρ(x)}i {𝑒−𝛽𝑊𝑖(𝑥)}                                  (2.20)                                                       
The pmf of the i-th window from the unbiased distribution is 
                            Wi(x) = -β-1 ln {ρ(x)}i /{ρ(x0)} – Wi(x) + Fi + W(x0)                             (2.21)                                                
                                                           𝑒−βFi = {e−βWi(x)}                                                 (2.22)  
 
The Weighted Histogram Method (WHAM) finds the values of Fi, the (unknown) free energy 
contributions due to the use of biasing potentials. The WHAM equations are given by: 
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                                 {ρ(x)} = ∑ 𝑛𝑁𝑤𝑖=1 𝑖 {ρ(x)}i /∑ 𝑛𝑁𝑤𝑖=1 𝑗 𝑒−βwj(x)  −  𝐹𝑗                           (2.23)  
and 
                                                      𝑒−βFi = ∫dx e−βWi(x) {ρ(x)}                                      (2.24)   
                                           
Equations (2.23) and (2.24) are solved self-consistently to derive Fi , and  are done so iteratively. 
In practise, multiple number of simulation windows are carried out with different harmonic 
potentials, where each simulation window concerns a particle at a particular position along the 
reaction coordinate, X. Each window, Wi(X) is chosen to overlap the next, such that the reaction 
coordinate of interest is thoroughly sampled. These simulation windows are stringed together to 
result in a biased density. The PMF of the ligand is obtained by using the WHAM Algorithm to 
convert the biased potential. The WHAM method is used to convert the biased potential into the 
required PMF. The PMF method is illustrated in Figure 2.7. Details of the simulation parameters 
have been listed in chapter 4 (section 4.2.3 of this thesis). 
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Figure 2.7: shows the biased distribution of a system along the reaction coordinate in the form of 
umbrella sampling windows (red). The free-energy is derived (Blue) from the biased potential. 
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3.1 Introduction 
As described in Chapter 1, neuronal nicotinic receptors (nAChRs) are a super-family of ligand 
gated ion channel neurotransmitter receptors (13);(14). As the name suggests, these receptors may 
be activated or deactivated with the binding of appropriate ligands (or agonists) or antagonists. 
Ligand binding causes the opening of important ion-channels in the brain that is responsible for 
the regulation of ion concentration and is a vital key to efficient transmission of neuronal signals. 
In general, nicotinic receptors control release of various neurotransmitters, and functions to 
facilitate effective neurotransmission(325). However a malfunction of the receptor can cause 
diseases such as epilepsy and other neuronal syndromes such as myasthenia gravis and other 
well-known neuronal degenerative disorders such as Alzheimer’s and Parkinson’s Diseases (14), 
(13). This implies that the preservation of the receptor sequence and hence structure, such as its 
binding site conformation, can have dramatic influences on the receptor’s ability to bind ligands. 
This thesis focuses on α4β2 and α7 neuronal nicotinic receptors, as these are the main subtypes 
involved in central nervous system disorders such as Alzheimer’s disease.  
Previous experimental data point to conotoxins as potential candidates for novel therapies or as 
probes of nAChR function(326, 327). These short peptides (~20 amino acids long), extracted from 
the venom of cone snails are selected for their high specificity towards nicotinic receptors.  
While a large array of conotoxins have been identified which specifically inhibit various 
subtypes of neuronal nAChR, none are known to inhibit α4β2 receptor subtypes with high 
potency.  One of those which do exhibit low but detectable potency, however, is the 4/7 
conotoxin G1D, derived from the venom of the snail Connus geographus(328). The 19 residue 
long GID (natural form) contains a carboxy-Glutamic acid residue at position 4 on its N-terminal 
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tail, whereas, the derived molecule ([γ4E]-G1D) that will be focussed on in this study will 
contain a Glutamic Acid residue at position 4, replacing the former. This derivative, [γ4E]-G1D, 
exhibits a higher potency (IC50= 56.8nM) compared to the natural peptide GID (IC50 = 128.6 
nM)(329).  
However, it has a higher potency towards the α7 and α3β2 compared to the α4β2 receptors, 
which renders it currently of limited use for understanding the physiology of the latter 
subtype(330, 331). With the prevalence of various neurodegenerative disorders as those mentioned 
earlier, this study aims at understanding the differences in interactions between α-conotoxin 
[γ4E]-GID with the human α4β2 and the human α7 receptor subtypes. Understanding these 
differences will pave the way towards rational design of a conotoxin inhibitor which is highly 
potent and specific for the α4β2 subtype, avoiding off-target effects at α7.  
The marked difference in [γ4E]-GID potency against α7 compared to α4β2 has previously been 
probed by both experimental and computational methods, revealing both conotoxin and receptor 
residues which may play a role. In terms of experimental work, Millard et al. showed that the 
truncation of the N-terminal IRDE tail of the [γ4E]-GID α-conotoxin resulted in a loss of activity 
at the α4β2 receptor but did not affect activity at the α7 receptor(329). Previous studies on the 
α4β2 receptor, by Beissner et al. using MD simulations showed that a constriction of the α4β2 
receptor binding pocket occurs due to the presence of α4-Arg 185 and Pro 195, which explained 
the lack of low-nM potency conotoxin inhibitors of the α4β2 receptor(332). This could be due to 
poor shape complementarity similar to that seen in the interaction between the α10α9 receptor 
and conotoxin LvIA(333). At the α7 receptor however [γ4E]-GID[E4A] did not alter the potency 
substantially. Their study also highlights that the selectivity of [γ4E]-GID could be influenced by 
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positions 10, 13 and 18. If the differences in modes of interaction of [γ4E]-GID at the α7 and 
α4β2 receptors respectively are correctly identified, they could help in the design of a lead 
molecule that would help increase selectivity of the same towards the α4β2 receptor, in 
comparison to the α7 receptor. While a number of studies have employed MD simulations to 
examine conotoxin-nAChR complexes, as described in Chapter 1, few have been performed on 
[γ4E]-GID(334-336), and one study has specifically focused on differences in [γ4E]-GID 
interactions between α7 and α4β2(337). This Chapter describes the use of equilibrium (i.e. no 
external biasing force) MD simulations to examine the structure, dynamics, and inter-residue 
interactions between [γ4E]-GID and the extracellular domain (ECD) of α7 and α4β2 subtypes. 
MD simulation methods help in unveiling the structural changes that may occur at the molecular 
level due to toxin binding. Simulation tools such as Gromacs(315), used in this study, help produce 
a more statistically relevant picture of the toxin-receptor interactions, compared to ‘static’ 
homology modelling methods. Also, accurate use of the various tools to analyse the accessible 
surface area and the toxin-interaction surface, from the trajectory of MD simulations helps 
determine the importance of the particular toxin residues in the interaction with the receptor.  
This chapter also relates current MD results with previous studies to further validate the 
importance of the identified residues (329, 338). Overall, this study aims to shed light into the 
significant toxin-receptor residue interaction that occurs within the receptor binding pocket 
between the α-conotoxin [γ4E]-GID and the α7 and α4β2 nicotinic receptors respectively, and a 
methodology to predict and identify them. One of the major outcomes of the study is to help 
understand better the important residues that cause these specific and selective interactions and 
may also serve as a guide as to how these toxins could be amended to play a more specific role at 
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desirable nicotinic receptors. These data could be supported further by experimental in vivo and 
in vitro studies. 
This chapter focuses on the differences in binding modes between the α7 and α4β2 subtypes and 
[γ4E]-GID. In this chapter, it is assumed that the conotoxin inhibits nAChR competitively; i.e. 
whereby the toxin is bound at the canonical agonist binding pocket between a principal α subunit 
and a complementary alpha (α) or beta (β) subunit. The interaction of [γ4E]-GID with the human 
α4β2 receptor is also compared with that of rat α4β2. The human subtype is of direct relevance to 
potential therapy development. In particular, the following are examined: 
 
1) The motions and flexibility of [γ4E]-GID at different binding interfaces. For example, 
one of the differences found through this study was that most of the [γ4E]-GID residues 
especially those at the N-terminal had marginally more freedom of movement at the α7 
receptor than at the α4β2. 
2) The differences in pairwise contacts between [γ4E]-GID and α7 and α4β2 residues. 
3) In silico mutagenesis and approximate mutational free energy calculations were 
employed to propose [γ4E]-GID mutants that might enhance the binding affinity at α4β2, 
while lowering the affinity for α7. 
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3.2 Methods 
3.2.1 Homology models 
 
Figure 3.1: Molecular models of the extracellular domain of (A) the human α7 receptor bound with 
five [γ4E]-GID conotoxins at the binding pockets located at the interface between adjacent 
subunits; and (B) the rat α4β2 neuronal nicotinic receptor with [γ4E]-GID found at three binding 
pockets located at the interface between the α4 subunit and the adjacent β2 subunit and the α4-α4 
subunit interface. The models were generated using Modeller9(234), while the template used was the 
crystal structure of Acetylcholine-binding protein (ACHBP) from Aplysia californica in complex 
with α-conotoxin PnIA variant (PDB ID: 2BR8). 
 
Homology models of the extracellular ligand-binding domain of the human/rat (α4)3(β2)2 and 
human α7 nAChR bound to [γ4E]-GID (Fig. 3.1) were constructed using the crystallographic 
coordinates of Aplysia californica AChBP cocrystallised with the double mutant α-conotoxin 
PnIA[A10L,D14K] (Protein Data Bank (PDB) accession code 2BR8) as a template. In this work, 
we have focused on the α4-rich stoichiometry as it affords an opportunity to explore conotoxin 
binding at the α4α4 interface, which have not been examined previously, in addition to the well-
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characterised α4β2 interface. Given that conotoxins typically inhibit nAChRs via competitive 
mechanisms (131, 339), these homology models provided a plausible 4/7 α-conotoxin-bound 
conformation of the receptor for subsequent molecular dynamics (MD) simulations and analyses, 
in which the toxin is bound at the orthosteric site. Rat α4, β2 and human α7 sequences were 
obtained from the Swiss-Prot database (codes O70174, Q9ERK7 and P49582 respectively), and 
aligned with the template sequence using the ClustalW server (Chapter 2). BLOSUM 80 was 
used as the scoring matrix.  
The consistency between the sequence alignment and experimental structures of AChBP was 
examined to ensure no gaps exist in the sequence of AChBP which coincide with the secondary 
structure (especially beta strands) of the known AChBP structure. As can be seen in figure 3.2, 
the gaps in the AChBP sequence when aligned with the hα7 receptor, for example, corresponded 
to gap between AChBP residues P102 and Q103 (red spheres), which lie within coil or turn 
regions. Similarly a gap exists between AChBP residues T128 and G129 when aligned with α7. 
For α4β2, alignment with AChBP resulted in gaps abetween Q98 and V99; and between G129 
and G130. All gaps in the sequence lie in regions lacking secondary structure, and therefore do 
not result in “broken” beta strands in the homology models produced. 
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Figure 3.2: Shows the coil regions on the AChBP structure that corresponded to gaps in the 
alignment with the hα7/hα4β2 receptor pocket. 
 
Based on the multiple sequence alignment, 10 hα7/hα4β2/rα4β2-[γ4E]-GID complex homology 
models were built. However, all 10 models produced are similar, with per-subunit backbone 
RMSD < 1Å between them, for the α7 and α4β2 models. As an example, the 10 models 
generated for the human α7 receptor are overlayed and showed in the figures 3.3(A) and (B) 
below; the receptor backbone is similar between all the models. This is likely due to the high 
quality of the structural template used, which is of high resolution and contains no missing loops 
that would require significant structural refinement of the resulting target structure by Modeller 
(except for the short IRDE tail of GID). The [γ4E]-GID structure in the loops I and II regions are 
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also similar to one another. The main areas of difference lie in the IRDE tail of [γ4E]-GID (as 
seen in figure 3.3 (C)), and in the coil and turn regions at the top and bottom of the receptor. 
Similarity in receptor structure was also observed when the homology models of the rat/human 
α4β2-[γ4E]-GID complex models were superimposed (not shown). Finally, there are some 
published examples in which Modeller was used to generate 10 models, with MD simulations 
performed on the highest scoring of the models: for example, PnIA-nAChR(340) and more 
recently for other membrane proteins of similar size (341, 342).  
 
Figure 3.3: 10 homology models of the hα7 receptor are superimposed (panels A and B) to show the 
similarity between the structures. The [γ4E]-GID structures were also superimposed (Panel C), 
where differences were noted only in the orientation of the N-terminal. 
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The 10 models that were generated were also aligned to observe the orientation of the side-chain 
rotamers in the vicinity of the C-loops (Fig. 3.4). At the hα7 receptor binding pocket, there are 2 
Trp residues (hα7(+)-W171 and hα7(-)-W77) (Fig 3A). The orientation of hα7(+)-W171 remains 
the same over all the 10 models and interfaces, however, the orientation of hα7(-)-W77 is seen to 
change with the models generated (see Fig. 3.4A, showing either a Cα-Cβ-Cγ-Cδ1 dihedral angle 
of -75o (red; “parallel” orientation) or ~0o (pink; “perpendicular” orientation)), as well as 
interface. Hα7(-)W77  corresponds to  Y53 at AChBP, and at AChBP has a Cα-Cβ-Cγ-Cδ dihedral 
angle of ~0o (“perpendicular”). Thus, Modeller seems to have altered this at some interfaces, 
perhaps because hα7-W77 is bulkier than AChBP-Y53. For the top scoring DOPE model, both 
W77 orientations were found; for example, the “parallel” at Tox-1 interface, and the 
“perpendicular” at Tox-3.  
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Figure 3.4: The alignment of tryptophan residues (at the binding pocket) between 2 selected 
homology models of the hα7 receptor for which a difference in Trp rotamer conformation is present 
(A). The orientation of the aromatic residues between α9 (red sidechains) and α7 (blue side chains) 
showed slight differences in the orientation of hα7 Tyr corresponding to α9-Y95(B). 
 
Similarly the rα4β2/hα4β2 receptor models were superimposed to check for differences in the 
Trp residues especially at the binding pocket. Similar to the alignment of the hα7 receptor 
models, at the rα4β2 receptor, α4(+)W184 and β2(-)W81 were identified (Fig 3.5). Of these Trp 
residues, α4(+)W184 was seen to maintain the same orientation across the different models and 
interfaces, however, β2(-)W81 showed 2 conformations, (dihedral = -75o (red) or ~0o (pink) 
(most favoured for top DOPE model)) amongst the 10 models for rα4β2 and hα4β2. Thus, 
Modeller seems to have altered this at some interfaces, because β2(-)W81 is bulkier than the 
corresponding AChBP-Y53. Rotamers of the aromatic residues were again very similar to that of 
the alpha9 receptor. Only very slight variation at rα4-Y98 (a9-Y95) was observed (Fig 3.5B).  
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Figure 3.5: The alignment of tryptophan residues (at the binding pocket) between 2 selected 
homology models of the α4β2 receptor for which a difference in Trp rotamer conformation is 
present (A). The orientation of the aromatic residues between α9 (red sidechain) and α4 (blue 
sidechain) showed slight differences in the orientation of rα4-Y98 compared to α9-Y95. 
 
Nevertheless, the impact of using a higher number of Modeller-generated structures on the 
homology model was also assessed. 100 toxin-receptor models of each of the [γ4E]-GID-human 
α7, [γ4E]-GID-human α4β2 and [γ4E]-GID-rat α4β2 complexes were generated using 
Modeler9v6(343) and the DOPE energy was used to assess the quality of the models. Comparison 
of the structures that corresponded to the maximum and minimum DOPE score revealed that the 
back-bone of the structures did not differ (Fig. 3.6). Only negligible differences were noticed in 
the loop regions. In addition, the RMSD of the nAChR-GID complexes corresponding to 
minimum and maximum DOPE scores, differed only by less than 1Å. The orientation of the 
Tryptophan residues at on the receptor was thoroughly studied and showed only slight 
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differences in orientations between the structures, in a similar manner to that described above for 
the 10 models generated.  
 
Figure 3.6: The hα7 homology models (out of 100 models) that showed the minimum (shown as 
secondary structures) and the maximum (Blue) DOPE scores respectively are superimposed. 
Differences were seen in the loop regions and orientation of the tryptophan residues. 
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It is acknowledged that alpha1 and alpha9 have higher sequence similarity to alphα7 and alpha4 
(with ~40% in the ECD) compared to AChBP (~25%) and could have been used as structural 
templates. However the alpha1 and alpha9 experimental structures were not bound with 
conotoxin, and it would be reasonable to assume that conotoxin binding could have influences on 
side-chain conformations. For this reason, the AChBP structure is chosen as the current best 
template for modelling conotoxin-bound neuronal nAChR in our study. This is consistent 
practice with a number of previous simulation studies. , for example, Schapira et al.,2002(344) and 
recently by  Chiodo et al.,2015(345) have also used the AChBP structure as their template.  
Nevertheless, the top-scoring homology models (based on the DOPE score) of α7 and α4 have 
been compared with the experimental a1 and a9 structures, focusing on overall fold and binding 
site rotamers of aromatic residues (Fig. 3.7). As can be seen in the figure below, the overall folds 
are similar. When the rotomers of the aromatic residues on the α9 subunit (namely Tyr) was 
compared to that of the α4 and α7 subunits, no ambiguity in orientation was observed. However, 
orientations of rotomers differed only slightly in regions further away from the binding pocket. 
More specifically, the aromatic sidechains in the binding pocket were overlayed for the hα7 
homology model and a9 (in Figure 3.4C), and similarly for rα4 (Figure 3.5C). The sidechains are 
coloured blue for hα7 (rα4) and red for a9. The only sidechain which exhibits variation in 
rotamer conformation is hα7-Y115 (rα4-Y125), which only differ slightly from a9-Y121.  Thus, 
the rotamers are consistent in the same type of subunit. 
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Figure 3.7: The experimental structures of the α1 and α9 were superimposed with the top scoring 
models of the α7 and α4. Tyrosine residues have also been highlighted.  
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The models were validated using PROCHECK (346, 347). According the results, human α7 nAChr 
complex showed ~1.3% of its residues were found to lie in the disallowed regions of the 
Ramachandran plot. Similarly, analysis of the human and rat α4β2 receptor complexes showed 
that only 1% and 0.8% of the residues lied in the disallowed regions of the Ramachandran plot. 
These disallowed residues were mostly Valine. The overall fold of the homology models are 
qualitatively similar.  
 
3.2.2 Molecular dynamics simulations 
Each of the α7 and α4β2 receptor complexes was placed in cubic simulation boxes with edge 
lengths of 111 x 111 x 111 and 119 x 119 x 119 respectively. The simulations were all 
performed in a cubic box in accordance to previous simulation studies conducted(181). Also a 
larger solvent-volume was needed in anticipation of using the models described in this chapter 
(Chapter 3) to conduct umbrella sampling simulations in the subsequent Chapter 4 of the thesis. 
The simulation box was not very large in comparison to the size of the protein, yet boxed the 
protein tightly, with enough spaces around the edges; also the solvent was homogenous in nature 
and hence did not require more than 100 ps of equilibration. Moreover, the system was seen to 
be equilibrated and the solvent molecules were well distributed at the end of 100ps of simulation. 
During all the simulations, the frames were saved every 10ps. The position restraints used on the 
proteins were straight release. 100ps is a typical length for the restrained-backbone equilibration 
phase of a MD simulation run(348). In the case of our simulations, this length was more than 
sufficient for the relaxation of the water solvent in the simulation box, as explained below.  The 
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boxes were solvated with 39,111 (for α7) or 50,270 (α4β2) SPC water molecules. To neutralize 
charge, 15 Na+ ions (for α7) and 32 Na+ ions (for α4β2) were added to the solvent. All 
simulations were performed using GROMACS version 4.5.5 (349, 350), with the Amber 99SB-
ILDN force-field (Lindorff-Larsen et al., 2010). Before the production MD simulations, the 
complexes were energy minimized using the steepest descent algorithm and an energy gradient 
convergence criterion of 0.01 kcal/mol/Ǻ. All subsequent simulations were performed using a 
constant particle number, pressure and temperature (NPT) ensemble, with temperature 
maintained at 300 K using the Nose-Hoover temperature coupling algorithm (351, 352), and 
pressure maintained at 1 bar using the Berendsen pressure coupling algorithm (304). Time steps of 
2 fs were used to integrate all simulations. Solvent equilibration simulations of 100 ps lengths 
were performed. In these simulations, the non-hydrogen atoms of the receptor and toxins were 
position restrained so the solvent and ions could relax from a semi-crystalline structure.  
In order to ascertain the convergence of water distribution, the density of the water molecules 
were plotted during various frames of the equilibration simulation to understand the distribution 
of the water molecules across the simulation box containing both the human α7 (Fig. 3.8A) and 
hα4β2 (Fig. 3.8B) receptors. A similar graph was also displayed when the distribution of water in 
the simulation box that contained the rα4β2 receptor was analysed. At 0 ps (picoseconds), the 
density plot shows a haphazard distribution of water molecules (Figure below). However, by 
20ps (red line), the water molecules are seen to be comparatively well equilibrated. Beyond this 
time-frame, the density map shows no significant changes at both the human α7 and α4β2 
receptor complex systems. The map shows that the density of water remained at 1000Kg.m-3 
close to the edges of the box, while the density of water molecules reduced close to the centre of 
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the box, due to the presence of the receptor complex. Hence, it is safe to say that 100ps of 
simulation is sufficient for the water molecules to be properly distributed.     
 
Figure 3.8: Shows the density of the water molecules using various frames of the equilibration 
simulation to understand the distribution of the water molecules across the simulation box 
containing both the human α7 (Panel A) and α4β2 (Panel B) receptors. 
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The trajectories of the MD simulations at the respective receptor subtypes were analysed. To 
improve conformational sampling, we performed 6 independent simulations of 10ns each for 
each [γ4E]-GID-receptor complex using different random seeds to assign initial particle 
velocities.  Unless indicated, all simulation data presented in this chapter were taken as an 
average over the 6 independent simulations. Molecular graphics were produced using VMD 
version 1.9.2 (353). All analyses were performed using a combination of VMD, GROMACS(354) 
analysis software suite and in-house scripts. 
 
3.2.3 Analysis methods  
Secondary structure analyses of [γ4E]-GID were performed using STRIDE(355). Structural cluster 
analysis was performed to identify the most prevalent conformations of the α-conotoxin 
interacting at the receptor pocket during the course of the simulations. The g_cluster method 
from the Gromacs suite was used in this analysis.  This method clusters together similar toxin 
conformations which appear throughout the trajectories, based on defined RMSD values of 
between 0.5 and 0.7 Å (depending on flexibility of the toxin bound at the respective subtype) 
calculated for the peptide Cα backbone atoms, and assigns a unique identification number to 
each new conformation identified in the course of the simulation trajectory. The average 
accessible and contact surface areas between the toxin and each receptor subunit residue which 
makes contact with the toxin, was analysed using Surface Racer 5.0 (356). A probe of radius 1.4Å 
was used to scan the accessible surface of each residue in the toxin-receptor interface.  
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The binding free energies of [γ4E]-GID and its single-site mutants to the respective α7 and α4β2 
binding pockets were calculated using FoldX (357, 358), which estimates the fold stability and 
binding properties of proteins using energy terms fitted to empirical data obtained from protein 
engineering experiments. The change in binding free energy at each position as a result of 
mutation to all other natural amino acids was also estimated using FoldX to propose possible 
mutants with enhanced potency and selectivity for α4β2.  
 
3.2.4 Position Scan – Mutation Analysis 
The position scan option from FoldX mutates an amino acid residue of interest into all other 21 
amino acids (including itself) and calculates the binding energy (∆G) of the whole protein 
molecule. Thus the influence of the mutation on the binding affinity can be studied using this 
tool. 
Position Scan can be run from the command-line using the following code: 
FoldX –command=PositionScan –pdb=interest.pdb 
where, interest.pdb is the pdb which we wish to investigate. 
Firstly, Position Scan mutates the residue of interest into Ala, and then records details of the 
neighbouring amino acids. ∆G is then calculated. Next the residue of interest is mutated to its 
own wild-type, and so are the neighbouring residues. Again ∆G is calculated and the 
neighbouring residues are optimised accordingly. Next the residue of interest is again mutated 
into the various amino acids and ∆G is calculated respectively.    
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For example we can use the following command to mutate a particular residue: 
position=KD21a (Format: residue, chain, number, mutation) 
The above code mutated residue Lys 21 in chain D to all other 20 amino acids and the ∆G value 
is calculated respectively. Once the command is run FoldX produces an output file, which is 
usually labelled as the first pdb file on the list of pdb files that have been queued for analysis, 
unless a label-name is not specified by the user. This output file contains the ∆G values after the 
respective mutations that were made on the residue of interest. In this study we used 
PositionScan to understand how the proposed mutations in [γ4E]-GID had affected its potency 
towards the hα7 and the α4β2 receptor. 
 
3.3 Results and Discussion 
3.3.1 Secondary structure of [γ4E]-GID at α7 and α4β2 
The human α7 (hα7), human (α4)3(β2)2 (hα4β2) and rat (α4)3(β2)2 (rα4β2) receptor structures 
with conotoxin [γ4E]-GID bound to all available loop C canonical agonist binding sites were 
simulated for a total of 60 ns respectively. Firstly, the differences in the conformation and 
flexibility of [γ4E]-GID bound to the α7 and the two α4β2 receptors were examined. In this 
thesis all five interfaces of the hα7 are studied. 
Visual inspection of the trajectories showed that [γ4E]-GID largely maintained its helical fold 
throughout the simulations at all 5 (five) and 3 (three) canonical binding sites of the α7 and α4β2 
receptors respectively between [γ4E]-GID-P9 and [γ4E]-GID-N14. This was confirmed by 
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examination of the secondary structure evolution of the toxins with respect to time using 
STRIDE  (359), as shown in Fig. 3.9. This analysis enables determination of more subtle 
differences in [γ4E]-GID secondary structure while bound to the α7 and the α4β2 receptor 
binding pockets. At the hα4β2 receptor, the α-helical fold is maintained between residues P9 and 
V13 of [γ4E]-GID (Fig. 3.9F-H), highlighting the importance of structural stability at these 
residues for receptor binding. This is also true for [γ4E]-GID at the rat α4(+)β2(-) receptor 
pockets (Fig. 3.9I and J), but not at the rat α4(+)α4(-) pocket where [γ4E]-GID[P9] shows coils 
(Fig. 3.9K). At the hα7 receptor however, the α-helix  is found to transform into 3-10 helices or 
turns for ~2% of time frames of the simulation between [γ4E]-GID[P9 and V13] (Fig. 3.9A-F). 
This difference in secondary structure between [γ4E]-GID[P9-V13] could contribute to the 
differences between the behaviour of the toxin at the α7 receptor pocket and the α4β2 receptor 
subtype pockets.  
The IRDE tail of [γ4E]-GID maintains coils and few turns at the five hα7 receptor binding 
pockets considered (Fig. 3.9A-E). This behaviour in secondary structure is also apparent at the 
rα4β2 receptor pockets, especially at the rat α4(+)α4(-) interface (Fig. 3.9K), where [γ4E]-
GID[E4] shows a fluctuation of turns, 3-10 helices and few coils. At all the binding sites 
considered [γ4E]-GID[C19] consistently maintains a coil structure throughout the simulations. 
Similarly [γ4E]-GID[C5-S7] maintained 3-10 helices consistently at the human α4β2 receptor 
pockets and were rarely interrupted by turns (Fig. 3.9F-H). However, this was not so at the 
human α7 and rα4β2 receptors which showed a greater preference for turns conformation in 
comparison. [γ4E]-GID[N8] took on coils through ~98% of the entire simulation at the hα4β2 
receptor pockets, however, [γ4E]-GID[N8] took on comparatively more turns than coils 
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especially at the hα7 interfaces and at rα4(+)α4(-) (Fig. 3.9K). The similarity in secondary 
structure evolution especially between hα7(+)α7(-) and rα4(+)α4(-) suggests possible similarity 
in [γ4E]-GID interaction between these two interfaces, as opposed to the hα4(+)β2(-) interface. 
 
Figure 3.9: STRIDE secondary structure plots of each [γ4E]-GID residue (y-axes) with respect to 
simulation time (x-axes) for the hα7 interfaces (A-E); the α4β2 (D-E) and α4α4 (F) interfaces of 
hα4β2; and the α4β2 (G-H) and α4α4 (I) interfaces of rα4β2. (In each panel, results from all six 
independent are combined and the segments demarcated and labelled as Sim-1, etc., as 
indicated on the x-axes.) 
 
At the Hα7 receptor the initial binding modes of [γ4E]-GID at all the 5 receptor binding pockets 
was compared (Fig 3.10). For the sake of clarity, Panel (A) shows the comparison of [γ4E]-GID 
only at positions 1 and 5. It is clear from panel A, and also from Panel B, that while there are 
differences in the orientation of the side chains of the [γ4E]-GID residues, however the influence 
of these on the evolution of the secondary structure would be minor compared to main 
difference, which is in the initial conformation of the IRDE-tail residues, which differ between 
the interfaces to a large extent. Thus, rather than relatively subtle differences in initial side chain 
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rotamers, the main difference in structure between the interfaces lies in the conformation of the 
IRDE tail. This could explain why the secondary structures of the toxin vary at the different 
binding sites, and particularly why there were quite a few differences noticed in the evolution of 
secondary structure of [γ4E]-GID at the hα7 receptor binding pockets. 
 
Figure 3.10: Shows the superimposition of the initial binding modes [γ4E]-GID structures at the 
hα7 binding pockets 1 and 5 in panel (A) and the structures from all respective binding pockets in 
panel B. A clear difference in the orientation of the IRDE-tail residues is seen. 
 
Comparing [γ4E]-GID at the two rα4β2 binding pockets, we noticed again that the difference in 
conformation was most striking only at the [γ4E]-GID[I,R]-tail residues of the toxin (Fig 3.11A). 
As in the case of the hα7 receptor, there are again slight differences in orientation of some of the 
side-chains of the toxin. When the starting structure of [γ4E]-GID at the rα4α4 pocket was 
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compared with the [γ4E]-GID structures from the rα4β2 pockets, again more changes in 
conformation were observed, mostly at the IRDE-tail of the toxin (Fig 3.11B). This could 
explain why there were no distinct differences in secondary structure in [γ4E]-GID between the 
two α4/β2 pockets while more differences could be made out when [γ4E]-GID at the α4/α4 
pocket was compared. 
 
Figure 3.11: Shows the superimposition of [γ4E]-GID structures at the rα4β2 pockets 1 and 2 
(Panel A) and also a comparison of the [γ4E]-GID structures at the 2-α4/β2 receptor pockets and 
the α4/α4 pocket (Panel B). Panel A shows a slight difference in the conformation at the IRDE tail. 
However, [γ4E]-GID at the α4/α4 binding pocket showed a striking difference in the orientation of 
the IRDE-tail.  
 
 
 Chapter 3:  Equilibrium Molecular Dynamics Simulations of [γ4E]-GID 
Interactions with α7 and α4β2 Nicotinic Receptors 
       
115 
 
When [γ4E]-GID at the two hα4β2 receptor binding pockets was compared, a quite distinct 
conformational difference was noticed again at the [γ4E]-GID [I, R] residues only (fig3.12A). 
Again very few differences in the orientation of the other [γ4E]-GID residues were noticed. 
When the conformation of [γ4E]-GID at the rα4α4 receptor was compared (fig 3.12B), it was 
found that not only was there a distinct difference in the orientation of the IRDE-tail residues, 
but the tail seemed to be slightly coiled and drawn closer to the rest of the toxin-body, compared 
to the other [γ4E]-GID toxin structures at the hα4β2 binding pockets, that were more distended. 
Hence, this difference in tail orientation could account for the difference in secondary structure 
evolution of [γ4E]-GID between the α4/β2 and the α4/α4 binding pockets respectively.  
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Figure 3.12: Shows the superimposition of [γ4E]-GID structures at the hα4β2 pockets 1 and 2 
(Panel A) and also a comparison of the [γ4E]-GID structures at the 2-α4/β2 receptor pockets and 
the α4/α4 pocket (Panel B). 
 
3.3.2 Flexibility and conformational clusters of [γ4E]-GID at α7 and α4β2 
There are important differences in flexibility at the N-terminal and C-terminal tails of [γ4E]-GID 
when bound to α7 or α4β2 receptor binding pockets, as illustrated by comparing the root-mean-
square fluctuation (RMSF) values of the toxin residues at the respective subtype (Fig. 3.13). The 
RMSF of the toxin residues were computed by superimposing the C-alpha carbon atoms using 
the function g_rmsf in the Gromacs suite. A closer look at the toxin revealed that at the hα7 
receptor, the IRDE tail was slightly more flexible compared to that at the rat/human α4β2 
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receptor subtypes by a very thin margin, (at some interfaces). The C-terminal end of the toxin 
showed less fluctuation compared to the N-terminal end, and fluctuated at ~1.5Å. In addition, 
[γ4E]-GID[P9-V13] show the least fluctuation in comparison to other residues at all receptor 
binding pockets considered.  These differences in flexibility of [γ4E]-GID at the α7 and α4β2 
receptor pockets could be attributed to the changes in conformation of the IRDE-tail, and also the 
difference in stabilising interactions between the α4(+)β2(-)  binding pocket and the hα7 
receptor, as discussed below. 
The graph in Fig 3.13(A), describes the RMSF of each [γ4E]-GID residue at each of the 5 
binding pockets of the hα7 receptor. It is clear that the IRDE-tail shows more flexibility 
compared to the other residues of the toxin. However, when compared to the [γ4E]-GID residues 
of the α4β2 receptor, there seems to be marginal differences (0.03-0.1Å). Each residue also acts 
differently at each of the respective pockets, a trend can be figured from panel A, where 
maximum fluctuation of [γ4E]-GID at the hα7-binding pocket occurs at [γ4E]-GID[I1]. The 
fluctuation is gradually seen to decrease from [γ4E]-GID [R2] onwards. The graph seems to 
show a gradual decrease in fluctuation till [γ4E]-GID[C11], after which it again seems to 
increase gradually to ~1Å at [γ4E]-GID[C19] at the C-terminal. On the C-terminal of [γ4E]-GID, 
residues [γ4E]-GID[O16,H17, V18 and C19] are seen to show similar fluctuation, while [γ4E]-
GID[R2 and D3] on the N-terminal show similar fluctuation.  
Panels B and C of figure 3.13 show the RMSF of [γ4E]-GID at the Rat and Human α4β2/α4α4 
interfaces respectively. Between the two α4β2 receptor subtypes, [γ4E]-GID at the rat α4β2 
receptor shows slightly more flexibility (~0.08-0.6Å-at [γ4E]-GID[I1]) at the IRDE tail. 
However, beyond [γ4E]-GID[R12], the C-terminal residues of the [γ4E]-GID at the hα4β2 
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receptor begin to show slightly more flexibility (0.04Å-0.4Å) than that at the rα4β2 receptor. At 
the α4α4 binding pockets, the C-terminal residues after [γ4E]-GID [R12] are more flexible at the 
rat-α4α4 binding pocket, compared to that at the human subtype. These differences in flexibility 
of the toxin, (although minor) could arise due to different stabilising interactions between the 
IRDE-tail and the receptor pocket, which could further affect the toxin’s structure and function. 
Also, when comparing the RMSF values [γ4E]-GID at the α4β2 receptors, to that at the α7 
receptor, a marginal difference is only seen (0.05-0.6Å), with [γ4E]-GID at some hα7–binding 
pockets more flexible than that at the rat/human α4β2 receptors. However, on average, rα4β2 has 
higher RMSF values in the loop I and II regions compared to at α7. In summary, taking into 
account all of the interfaces examined, the main difference in RMSF between α7 and α4β2 lie in 
the IRDE region, with marginally higher fluctuation for α7. These differences in RMSF suggest 
that the interactions within the binding pocket (even at the IRDE tail) might be important for 
[γ4E]-GID’s function. 
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Figure 3.13: Average Root Mean Square Fluctuation of each toxin residue at the human α7 (A) 
rα4β2 (B) and hα4β2 (C) receptors respectively along the course of the 60ns simulation respectively. 
The RMSF of the toxin residues is seen to vary marginally between the receptor subtypes. 
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Figure 3.14: The average RMSD of [γ4E]-GID and the respective receptor subunit pockets during 6 
simulations is shown. The stability of the system can be seen from these graphs. 
 
The RMSD of [γ4E]-GID and the respective receptor subunit pockets during the 6 simulations 
was also assessed by comparison of the C-alpha atoms. The RMSD of the receptor subunits were 
seen to stabilise to ~2.5Å by the end of each of the 6 simulations at the human α7 and rat α4β2 
receptor pockets (Fig 3.14(A),(C) and (E)). Similarly, [γ4E]-GID showed an average RMSD of 
~1.5-2Å at the human α7 and rat α4β2 receptor pockets (Fig 3.14(B),(D) and (F)). However, at 
the human α4β2 receptor pockets, [γ4E]-GID and the respective subunits showed a maximum of 
~1.5Å. From this analysis, we could understand if the system was stable during the MD 
simulation. The fluctuation of RMSD exhibited by [γ4E]-GID at the hα7 and rα4β2 receptors is 
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most probably due to the vigorous movement of the IRDE-tail. On the other hand, the movement 
of the toxin within the binding pockets do not relate to a specific pattern of interaction with the 
receptor residues. This can be seen from supplementary figure 3.1 that shows the most exhibited 
binding modes of the toxin and receptor conformations at the respective hα7 and α4β2 receptors. 
The trajectory showed only slight differences in the orientation of the receptor residues 
highlighted. 
To gain further insight into more subtle differences in [γ4E]-GID conformation upon binding the 
α7 and α4β2 nAChR subtypes, cluster analysis was performed on all respective trajectories (Fig. 
3.15) using the g_cluster code implemented in Gromacs. g_cluster scans through the trajectory 
and assigns a unique cluster identification number whenever a new conformation is identified. 
The C-Alpha atoms have been used for cluster analysis. The RMSD cut-off of 0.6Å was chosen, 
since a lower cut-off produced too many clusters which were eventually uninformative, on the 
other hand, a higher cut-off value results in too few clusters for meaningful analysis. Thus, the 
final value of 0.6 Ang was reached by “tuning” this parameter and observing the number of 
distinct clusters identified, resulting in a value that enabled identification of some conformational 
transitions. Fig. 3.15 shows that the clusters formed were from 6 different simulation runs. For 
the sake of presentation clarity, cluster analysis of [γ4E]-GID at only one binding pockets has 
been highlighted in the figure (panel A). Also, only the clusters that showed a significantly high 
presence in the simulation are highlighted in this figure, and numbered accordingly.  
With an RMSD cut-off of 0.6 Å, it was found that the toxin chain at rat α4β2 was assigned 
almost a single cluster number (i.e. all conformations exhibit backbone RMSD values which 
differ from each other by no more than 0.6 Å) within ~100ps from the start of the simulation, and 
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remained constant for the duration of the trajectory (Fig. 3.15C), and could be indicative of 
stabilising interactions with between the toxin and the receptor binding pocket.  
 
Figure 3.15: Conformational cluster identification number with respect to simulation time for 
[γ4E]-GID at human α7 (A), human α4β2 (B) and rat α4β2 (C). The N-terminal tail was found to be 
more distant from the remaining toxin body, in comparison to [γ4E]-GID at the α7 receptor. Also, 
[γ4E]-GID at the α7 receptor pocket showed less fluctuation in structure along the time-frame, and 
accommodates itself with the binding pocket easily in comparison to that at the α4β2 receptor 
subtypes. The clusters that showed a significantly high presence in the simulation are highlighted in 
this figure, and numbered accordingly. (In each panel, results from all six independent are 
combined and the segments demarcated and labelled as Sim-1, etc., as indicated on the x-axes.) 
 
At the human α4(+)β2(-) interface, [γ4E]-GID showed a total number of 22 clusters at a cut-off 
of 0.52Å (Fig. 3.15B). Of the total number of clusters, cluster 5 was observed during 48% of the 
trajectory while cluster 15 was observed 8.5% of the simulation time. At the hα4(+)α4(-) binding 
pocket, fewer cluster were seen, as cluster 1 was observed at ~85% of the trajectory, while 
cluster 15 was observed for ~5.2% of the trajectory (Fig. 3.15B). 
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Table 3.1: shows the population of the clusters exhibited at the human α7 (A) and α4β2 (B,C)  
receptor pockets. 
A) Cluster Population (%) - Hα7 receptor 
Cluster ID 
hα7α7-
1 
hα7α7-
2 
hα7α7-
3 
hα7α7-
4 
hα7α7-
5 
1 63.6 91.2 95.0 1.0 79.5 
2 0.3 0.2 0.2 93.2 0.5 
12 14.3 0.2 0.2 0.3 1.5 
13 16.3 0.2 0.3 0.2 0.2 
21 0.2     0.2 14.8 
 
B) Cluster Population (%) - Rα4β2  
Cluster ID rα4β2-1 rα4β2-2 rα4α4 
1 66.2 94.7 92.8 
4 25.6 0.2 0.2 
8 0.2 1.5 2.8 
 
C) Cluster Population (%) - Hα4β2  
Cluster ID Toxin-6 Toxin-7 Toxin-8 
1 1.0 1.0 84.0 
2 0.2 96.0 0.3 
3 31.8 0.2 0.2 
4 0.2 0.2 0.2 
5 47.6 0.2 0.2 
6 8.5 0.2 0.3 
 
In contrast, at the α7 receptor, the rapid increase in the number of uniquely identified clusters 
(Fig. 3.15A) suggests that the toxin exhibits high flexiblity within the receptor pocket and 
underwent rapid structural transitions, enabling it to form a wide variety of contacts (discussed 
below) with the α7 receptor. This is consistent with the RMSF analysis discussed above, which 
indicate that the IRDE tail was more flexible for the toxin bound at α7. At a cut-off of ~0.6Å, 
[γ4E]-GID forms 23 clusters at the human α7 receptor binding pocket (hα7) of which cluster 1 
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appears in ~64% of the 60ns timeframe and cluster 12 and 13 appeared at ~15% and ~17% of the 
simulation time (Table 3.1A).  
When the most highly populated cluster of the [γ4E]-GID structures from all the 5-hα7 and 3-
human/rat α4β2 receptor binding sites were superimposed over each other (Fig. 3.16), a clear 
difference in the orientation of the IRDE tail residues was observed between [γ4E]-GID at the 
hα7 receptor and the human/rat α4β2 receptor binding pockets, reaffirming the fact that the 
IRDE tail contributed substantially to the differences in conformations observed. 
 
Figure 3.16: Superimposition of the major [γ4E]-GID structures, identified by conformational 
cluster analysis to populate the majority of the respective trajectories. Clearly shown is that the 
IRDE tail of the [γ4E]-GID structures at the hα7 receptor (A) are more close to the toxin body 
compared to that at the rat (B) and human (C) α4β2 and α4α4 interfaces. 
 
For the hα7 and α4(+)α4(-) interfaces, the IRDE tail was found in close contact with the rest of 
the toxin body, with the N-terminal tail almost perpendicular to the remaining loop I α-helix 
(Fig. 3.16). In comparison, at hα4β2 receptor, the IRDE tail lies approximately parallel to the 
loop I α-helix (Fig. 3.16C). Additionally, figure 3.16 suggests that the IRDE tail of the [γ4E]-
GID structures at the hα7 receptor (Fig 3.16A) and hα4β2 (Fig. 3.16C) is more flexible, with a 
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greater diversity of major conformations, compared to that at the rat (Fig. 3.16B). Also while the 
conformation of the [γ4E]-GID structures corresponding to residues between N8-C11 remained 
similar through the clusters, slight differences in orientation of the C-terminus tail was seen, 
especially at the α4β2 receptor pockets.  
To summarise the above discussions on secondary structure and flexibility of [γ4E]-GID: 
secondary structure analysis indicates rapid structural transitions between α-helix conformations 
and coils or turns especially between the toxin residues P9 and V13, with the changes in 
secondary structure more pronounced at the α7 receptor compared to the toxin at both the human 
and rat α4β2 receptor subtypes. However, the RMSF data on the [γ4E]-GID indicated marginal 
differences in fluctuation [γ4E]-GID residues, with [γ4E]-GID at the hα7 receptor indicating 
slightly more flexibility compared to the rat and human α4β2 receptors. Given that the residues 
P9-V13 are important in maintaining the overall structural framework of the toxin at the receptor 
pocket, our results suggest that the toxin is given more freedom by the α7 receptor to structurally 
conform to the shape of the binding pocket, however, more stabilising interactions between 
[γ4E]-GID (N-tail residues) at the α4β2 receptor, (which may be absent/less prominent pockets 
at the α7 receptor pocket) may position the toxin to conform to a configuration that may not be 
suitable for efficient binding. 
The experimental structure of [γ4E]-GID in solution shows a very large diversity in 
conformation at the IRDE tail, similar to its simulated behaviour when bound to hα7. The MD 
simulations also show a marginally higher RMSF at the hα7 receptor binding pockets compared 
to that at the rat (fig. 3.13B) and human α4β2 (Fig. 3.13C) receptor pockets. The marginally 
higher flexibility of the IRDE tail after binding at the hα7 receptor when compared to that at the 
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rat and human α4β2 receptor receptors suggest that the [γ4E]-GID is slightly more entropically 
disfavourable for binding at the α4β2 receptor subtypes compared to the human α7 receptor.  
Also, from the marginally less flexibility exhibited by the IRDE-tail of [γ4E]-GID at the rα4β2 
receptor subtype pocket compared to that at the hα7 receptor pocket, it can be suggested that 
certain stabilising interactions between [γ4E]-GID’s IRDE-tail at the rα4β2 receptor were absent 
or different at the hα7 receptor. Most of the interactions discussed below are persistent 
throughout the simulations, and present an average of at least ~30 contacts over the simulation 
time (600 frames) and/or remain at a distance of less than 4Å between the interacting residues 
atleast for more than 50% of the simulation time. We noticed that at the rα4β2 receptor, 
hydrogen bonding was noticed between rα4(+)K180, R223 and [γ4E]-GID[D3]. Hydrogen bonds 
were also noticed between rα4(+)Y225 and [γ4E]-GID[D3, E4]. At the rα4(-) D388 were seen to 
form hydrogen bonds with all the residues of the IRDE-tail (Average of ~10 contacts at each 
residue), while D389 showed a considerable number of contacts with [γ4E]-GID-R2 (~7 
contacts) and D3 (~17 contacts), again showing electrostatic interactions. At the hα7 receptor 
hydrogen bonding was noticed between hα7(+)-R208 and [γ4E]-GID[D3 and E4], showing an 
average of ~9.2 contacts. Hydrogen bonding was also noticed between hα7(+)-Y210 and [γ4E]-
GID[D3 and E4] (average of ~7 and 30 contacts) respectively. At the hα7(-) subunit, hydrogen 
bond interactions were noticed between [γ4E]-GID[R2] and hα7(-)D186 and S188 respectively. 
Weak hydrophobic interactions (~8 contacts) were also noticed between hα7(-)P192 and [γ4E]-
GID[I1] at different interfaces. 
At the Rα4α4 receptor pocket, [γ4E]-GID[E4] was seen to make electrostatic interactions with 
Rα4(+)-R223(~8 contacts on average). rα4(+)E226 also showed ~8.5 contacts with [γ4E]-GID[I, 
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R] respectively. Good number of Van der Waals interactions were also suggested between 
rα4(+)Y225 and [γ4E]-GID[E4] (~ 30 contacts). At the rα4(-) receptor subunit, [γ4E]-GID 
residue L203 was seen to exhibit strong hydrophobic interactions with [γ4E]-GID[R2 (~30) and 
E4(~7 contacts)].  
At the Hα4β2 receptor pockets, hydrogen bonds were seen to form between hα4(+)Y223 and 
[γ4E]-GID[R2] (average of ~21 contacts). However, strong electrostatic interactions and 
hydrogen bonds were also noticed between hβ2(-)D195 and [γ4E]-GID-I1(54 contacts) and 
R2(65 contacts). Electrostatic interactions were also found between hβ2(-)D196 and [γ4E]-
GID[R2](~38 contacts). At the hα4α4 receptor, hα4(+)H195 is seen to form repulsive 
interactions with [γ4E]-GID[R2] (~53 contacts), while R197 is seen to form hydrogen bonds 
with [γ4E]-GID-I1(~75 contacts) and R2 (17 contacts). Van der Waals contacts were noticed 
forming between hα4(+)V198 and the IRDE tail residues. Electrostatic interactions were again 
noticed between hα4(+)D199 and [γ4E]-GID-R2 (~57 contacts). On the hα4(-) subunit, hα4(-) 
Y223 was also seen to form strong hydrogen bonds (~31 contacts) with [γ4E]-GID[E4]. These 
interactions help us understand that more stabilising interactions were formed between the 
IRDE-tail residues of [γ4E]-GID and the α4β2/α4α4 receptor pockets compared to that at the 
hα7. The interactions could thus cause the marginal difference in fluctuation (RMSF) of the 
IRDE tail residues at the different receptor pockets. [γ4E]-GID at the α4β2 could thus be forced 
to stabilise in a conformation that is less favourable to binding compared to that at the hα7 
receptor.      
The transition in secondary structure of [γ4E]-GID is seen from the STRIDE analysis and the 
structures that populate the various clusters at both the α7 and α4β2 receptor subtypes. The fact 
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that Cluster analysis of [γ4E]-GID at the α4β2 receptor shows stable simulations and the analysis 
of secondary structure showed no changes in secondary structure of the toxin, compared to 
[γ4E]-GID at the alpha7 receptor, suggests that [γ4E]-GID (especially at the IRDE-tail) was 
more stabilised by interactions at the α4β2 receptor than that at the hα7 receptor. This could be a 
reason why [γ4E]-GID exhibited marginal differences in RMSF between the three receptor 
subtypes. Further, these stabilising interactions at the α4β2 receptor could have left [γ4E]-GID 
pinned-down in an unfavourable state for binding. It could also be suggested that [γ4E]-GID 
made alterations in secondary structure to accommodate itself within the α7 receptor binding 
pocket, which was not very possible at the α4β2 receptors. 
Cluster analysis also showed that at majority of the obtained structures, [γ4E]-GID’s N-terminus 
tail at the α7 receptor was observed to be more flexible and distended from the rest of the toxin 
in comparison to [γ4E]-GID’s at the human α4β2 receptor pocket. At the α4(+)/β2(-) and 
α4(+)/α4(-)  receptor binding pockets it seemed that [γ4E]-GID’s structure was constricted most 
certainly due to the compactness of the receptor binding pocket. This also explains the restriction 
in the fluctuation of the clusters observed (Figure 3.15B and 3.15C) at the α4β2 receptor. In 
addition to the fluctuation in secondary structure conformation, the freedom of the tail residues 
and its interactions with the receptor could certainly be responsible for the overall stability and 
functioning of the toxin. This is consistent with findings from previous studies which showed 
that the truncation of the toxin at the α4β2 receptor was responsible for a loss in toxin function 
(329). 
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Figure 3.17: Shows the superimposition of [γ4E]-GID structures at the hα4β2 pockets 1 and 2 
(Panel A) and also a comparison of the [γ4E]-GID structures at the 2-α4/β2 receptor pockets and 
the α4/α4 pocket (Panel B). 
 
 
Figure 3.18: Shows the average number of contacts exhibited by [γ4E]-GID at the hα7(panel A), 
rα4β2 (panel B) and the hα4β2 receptors (panel C). 
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The average overall buried surface area (Figure 3.17) and average number of contacts (Figure 
3.18) exhibited by [γ4E]-GID at the respective binding pockets was computed.  At the hα7 
receptor binding pockets, [γ4E]-GID exhibited an average (over the five interfaces) of 4600 
contacts. At the rα4β2 receptor, [γ4E]-GID toxin-1 showed ~4500 contacts while toxin-2 showed 
~5000 contacts, and [γ4E]-GID at the rα4α4 pocket showed an average of ~3800 contacts across 
the 6 simulations.  The hα4β2 receptor was seen to make ~5700 contacts with toxin-1, 4700 
contacts at toxin-2 and ~5300 contacts at the hα4-α4 interface. Therefore overall, the number of 
contacts between the toxins and receptor shows little clarity in the trend that differentiates α7 
from α4β2. In particular, α7 make similar total number of toxin-receptor contacts as rα4β2; but 
less number of contacts than hα4β2. Additionally, α7 makes more contacts than rα4α4, but fewer 
contacts than hα4α4. This seems to suggest a species difference, in that the human α4β2 
interfaces generally form higher number of contacts than α7, whereas the rat α4β2 interfaces 
form lower number of contacts. Experimental studies will be required to determine whether there 
would be a significant species difference in [γ4E]-GID activity at the human α4β2 receptor 
compared with rat α4β2. For BSA, there is again little clarity in trend considering the overall 
BSA between [γ4E]-GID and receptors. The BSA of the rα4β2, hα4β2, and rα4α4 are all very 
similar to that of α7 (all averaging ~ 100Å2), while hα4α4 is marginally less (average of ~95Å2). 
Thus, while there is a weak trend in considering number of toxin-receptor contacts, the overall 
BSA provides no explanatory power in explaining nAChR subtype differences in potency for 
[γ4E]-GID. Thus, in subsequent sections, we analyse individual [γ4E]-GID and nAChR residue 
contacts and contact surface areas to identify more clear trends that could correlate with the 
known activity of [γ4E]-GID at α7 and α4β2.  
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3.3.3 [γ4E]-GID per-residue contacts with α7 and α4β2 
To elucidate the specific toxin-receptor interactions which give rise to the observed differences 
in toxin structure and dynamics discussed above, we have examined the contact surface area 
between each toxin residue and the respective receptors using the Surface Racer program(356), 
and the number of interatomic contacts using the Gromacs suite(315) of analysis tools. 
 
 
Figure 3.19: shows the average number of contacts exhibited at the hα7/α4β2 receptor pockets (A) 
and α4α4 receptor subtype pockets (B). Panels C and D also show the contact surface area exposed 
by [γ4E]-GID at the hα7/α4β2 receptor pockets (C) and α4α4 receptor subtype pockets (D). The 
error-bars represent the standard deviation obtained from the data at 5-hα7 and 2-α4/β2 receptor 
binding pockets respectively. 
 
The panels in figure 3.19 show the average number of contacts (A-B) and the average contact 
surface area (C-D) exhibited by [γ4E]-GID over the simulation trajectory. It is clear to see that 
[γ4E]-GID interacts quite differently not only at the various subunit interfaces but amongst the 
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respective toxin residues. At the various interfaces, [γ4E]-GID maintains an average of ~20-175 
contacts across the hα7, α4β2 and α4α4 interfaces. Among the human-α7(+) interfaces, [γ4E]-
GID maintains an average buried surface area in the range of ~20-60Å2, while at the rα4β2 and 
hα4β2 [γ4E]-GID maintains an average of ~15-70 Å2. Common among the panels A and C is 
that the number of contacts and surface area of the IRDE-tail residues of [γ4E]-GID are quite 
variable (indicated by the large standard deviation). Further there is a slightly higher standard 
deviation in the average number of contacts and surface area exhibited by [γ4E]-GID at the α4β2 
interfaces indicating more variation in the ability of the toxin to form contacts at these interfaces, 
in comparison to the hα7 receptor.  
The number of contacts at the rα4/β2 was found to be higher at most of the [γ4E]-GID residues 
when compared to the contacts maintained at the hα7 and the hα4/β2. However the number of 
contacts at the rat and human α4/β2 interface are also accompanied by high standard deviation 
when compared to that at the hα7 interface. The number of contacts could also be qualitatively 
related to the change in secondary structure of [γ4E]-GID at the rα4β2 interfaces alone (figure 
3.9(I),(J)). For example, fluctuation in secondary structure is clearly seen between [γ4E]-GID 
residues E4-N8, P9-V13, N14-V18.Most of the residues mentioned above also showed a higher 
standard deviation in the number of contacts maintained at the rα4β2 interface. These residues do 
not have such high standard deviation values at the hα7 and hα4β2 receptors. These results could 
suggest that [γ4E]-GID at the rα4/β2 interface can adopt different conformations (with different 
secondary structure, as described above) in order to interact more closely with various residues 
in the ligand binding pocket.  In contrast, the lower standard deviation maintained by the [γ4E]-
GID residues at the hα7 receptor suggest that [γ4E]-GID interacts with residues at these 
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interfaces in a more consistent manner (i.e. consistent between each interface, and each of the six 
simulations), unlike at the rα4β2 receptor interface. Hence, in this case, despite the fact that 
[γ4E]-GID exhibits on average marginally more number of contacts at the rα4/β2 interfaces 
compared to α7, it might be more important to also consider the standard deviation of such 
contacts to explain the toxin’s potency. We propose that a higher standard deviation in number of 
contacts between toxin residues and the receptor might be related to the lower potency of [γ4E]-
GID at α4β2, However, as discussed in Section 3.3.2 (Flexibility), we noted that [γ4E]-GID at 
rα4β2 exhibits marginally lower RMSF (especially in the IRDE region), as well as possessing 
less number of conformational clusters (suggesting less flexibility) compared to α7. Why does 
lower [γ4E]-GID flexibility at α4β2 result in higher standard deviation in contacts? We propose 
that the rigidity of [γ4E]-GID at α4β2 results in the toxin being able to adopt only a very limited 
number of conformations that either form relatively high contact with α4β2, or low contact with 
α4β2. The relative rigidity of the toxin might mean that it is less able to easily transition between 
the “low contact” and “high contact” states. This manifests, in short timescale MD simulations, 
as high standard deviation when contacts are averaged across different interfaces. For α7, on the 
other hand, the higher flexibility of [γ4E]-GID results in it being able to readily access different 
conformations to adapt to changes in the binding pocket, resulting in lower standard deviation in 
contacts as examined by short timescale MD simulations.  
Additionally, we make some further general observations about the overall binding pattern of 
[γ4E]-GID residues, especially with regard to species differences. For all receptors, the cluster of 
residues P9, A10, R12, V13, N14 and O16 make the most contacts numbers, as well as contact 
surface areas. These are generally quite similar in number between α7 and α4β2. The IRDE 
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residues also make contact at all interfaces. While the absolute values of the contact numbers and 
surface areas are lower than those of the “cluster” of residues described above, it is here that the 
main differences can be observed between α7 and α4β2. The major source of difference lies at I1 
and R2. For hα4β2, higher contacts and surface area (as well as error bars) compared to α7 can 
be observed at I1 and R2. However, for rα4β2, the opposite is true: α7 has marginally higher 
contacts and buried surface area compared to rα4β2. These observations again suggest some 
possible species differences between hα4β2 and rα4β2, in terms of contacts in the IRDE tail. A 
similar species difference can be observed at I1 and R2, for the α4α4 interfaces: while hα4α4 has 
higher contacts compared to α7, rα4α4 has lower contacts compared to α7. Whether this 
translates to actual species differences in terms of inhibitory potency remains to be probed 
experimentally. 
Since experimental data is only available for rα4β2 and hα7, we make some hypotheses about 
differences in contacts between these subtypes which might explain their different influences by 
[γ4E]-GID. These differences between α7 and α4β2 , which are more clearly shown and 
discussed in the difference plots below, in which we subtract the number of contacts (or BSA) 
for each [γ4E]-GID residue for α4β2 from that for α7 (Figure 3.20). Thus, if a residue has higher 
contacts at α7, the bar is shown as “up”, whereas if a residue has higher contacts at α4β2, the bar 
is shown as “down”. 
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Figure 3.20: Differences in the number of contacts over the combined 60ns simulation between 
[γ4E]-GID at the human α7-receptor and the respective human (A) or rat (B) α4β2 and α4α4 
receptor binding pockets; and differences in the contact-surface area displayed by each [γ4E]-GID 
residue at the human α7 and the respective human (C) or rat (D) α4β2 and α4α4 receptor binding 
pockets.  
 
 Figures 3.20A and 3.20B shows the trajectory-averaged difference in the number of contacts 
between the human α7 receptor pockets and the rat/human α4β2 receptor for each [γ4E]-GID 
residue (x-axis) (with positive values indicating greater number of contacts at α7(+)α7(-) 
compared to α4(+)β2(-) or α4(+)α4(-)), while the corresponding differences in contact surface 
areas per toxin residue are shown in Fig. 3.20C and 3.20D. At the hα4β2 receptor (Fig. 3.20A), 
the toxin residues generally show a greater number of contacts than at the hα7 receptor. In 
addition, the contact surface area between the individual [γ4E]-GID residues and the hα4β2 
receptor binding pockets was also found to be generally significantly higher for both hα4β2 
interfaces than at the hα7 receptor binding pockets (Fig. 3.20C). These results suggest that [γ4E]-
GID does not bind ‘loosely’ within the human α4(+)β2(-) interfaces, and could be interpreted as 
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being held by strong stabilizing interactions with the receptor walls that forces [γ4E]-GID into a 
conformation that is not suitable for binding. In contrast, the relatively lower number of contacts 
with hα7 suggests that the stabilizing interactions favor [γ4E]-GID to take on a (or more) 
conformation(s) that is more suitable for binding. These trends in contact-surface area and 
number of contacts are also noticed while comparing the hα7 receptor binding pockets to that of 
the rα4β2 receptor (Fig. 3.20B and D). This could explain why the N-terminal tail of the toxin at 
the hα7 receptor pocket was more flexible than at the rat/human α4β2 and α4(+)α4(-) pockets. 
From figure 3.20A however, [γ4E]-GID[R12 and V13] are seen to make more number of 
contacts at the hα7 receptor. [γ4E]-GID[R12 and V13] could be of interest and if mutated such 
that these residues make more contact at the hα4β2 receptor could help decrease the number of 
contacts at the IRDE tail at the hα7 receptor. 
      
 
Figure 3.21: Average number of contacts that individual [γ4E]-GID residues form with the Cys-Cys 
pair residues at the hα7 (A), rα4β2 (B), rα4α4 (C), hα4β2 (D) and hα4α4 (E) binding pockets 
respectively. 
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In addition to examining the contacts between [γ4E]-GID residues and the entire receptor, it is 
also of interest to examine differences in contacts between [γ4E]-GID residues with the loop C 
twin Cys motif. It has been hypothesised that contacts between conotoxins and the twin Cys 
motif may play an important role in the inhibitory activity of the toxins (153).  Thus, elucidating 
the differences between α7 and α4β2 subtypes in the closeness of this potentially crucial contact 
might provide further insights into the difference in subtype activity of [γ4E]-GID. Indeed, the 
Cys-Cys residues contributed by the α-subunit of the binding pocket are important for agonist 
binding (360, 361). Thus [γ4E]-GID’s interaction with the Cys-Cys pair at the hα7 (Cys 212 and 
C213), hα4(C226 and C227) and rα4 (C227 and C228) is compared in this study. The average 
number of contacts between each [γ4E]-GID residue and the twin Cys motifs of the respective 
receptor interfaces are shown in Fig. 3.21.  
We first focus on contacts between [γ4E]-GID C5/C11 and the nAChR twin Cys. This is because 
the corresponding C2/C8 residues of Vc1.1 (362) as well as RgIA (363) have been proposed to be 
essential for the inhibitory activity of these conotoxins, by virtue of their close contact with the 
nAChR loop C Cysteine residues. At hα7 (Fig. 3.21A), both C5 and C11 show contact with α7-
C212 and C213. At rat α4(+)β2(-), C5 makes contact with both receptor Cystine residues (Fig. 
3.21B), but C11 only makes contact with α4-C227. At rat α4(+)α4(-), only C5 makes contact 
with the receptor cysteine residues (Fig. 3.21C). Based on this, it is tempting to conclude that 
potent inhibitory activity of [γ4E]-GID at nAChR requires contact between [γ4E]-GID C5/C11 
residues with both loop C Cysteine residues, as is observed for hα7 (Fig. 3.21A) but not rα4β2 
(Fig. 3.21B and C). However, at hα4β2, both [γ4E]-GID C5/C11 make contact with α4-C226 
AND C227 (Fig. 3.21D and E), yet [γ4E]-GID is known to have similarly (low) potency at this 
species subtype. Thus, while it is still possible that interaction between the Cys pairs of [γ4E]-
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GID and that of loop C plays some role in inhibition, it is probably not the determining factor. 
Further work is required to fully understand the significance of the interaction between the Cys 
pairs in conotoxins and nAChR loop C. 
A more marked difference is observed for the IRDE tail, and might be more significant. We can 
further elucidate the influence of the N-terminal tail at the binding pocket as well as the 
interactions with other toxin residues. This is particular of interest, since the IRDE tail is crucial 
to inhibition at α4β2 but not at α7(329). The [γ4E]-GID N-terminal residues R2 and D3 were 
found to interact with the C212 of the hα7(-) subunit (Fig. 3.21A). At the rα4(+)β2(-) binding 
pocket (Fig. 3.21B), R2 and E4 (but not D3) interacted with C227 while at the rα4(+)α4(-) 
binding pocket (Fig. 3.21C), the entire IRDE tail made considerable contact with the twin Cys 
residues. D3 also was found to be in contact with hα4(+)C226 at the hα4(+)α4(-) binding pocket. 
The negligible number of interactions between the loop C, Cys pair and the N-terminal tail 
residues could help explain the decreased potency of the toxin at the hα4(+)β2(-) receptor 
binding pocket. Negligible contact refers to low (when the number of contacts in 6000 frames is 
less than 5 per residue) number of contacts over the simulation compared to contacts made by 
other residue pairs during the same simulation. It is also possible that contact with D3 may be 
important (as is observed for hα7, but not for the rat nor human α4(+)β2(-) interfaces). 
Interestingly, D3 does make contact with the loop C Cysteine residues at the α4(+)α4(-) 
interfaces of both species, and it may be hypothesised that [γ4E]-GID may exhibit more potent 
activity at α4-rich α4β2 receptors (this possibility is explored further in Chapter 4). 
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3.3.4 Proposed α4β2 selectivity-enhancing mutations based on conotoxin-
nAChR contact analysis 
 
We have also determined the number of contacts made between each receptor residue within the 
binding pocket with the toxin, in order to elucidate the roles of the receptors to differential 
interactions between the subtypes examined. The data is presented as toxin-receptor contact 
maps, as shown in Fig. 3.20. Based on the contact map and the pairwise contacts described here, 
we discuss the implications for designing a [γ4E]-GID analogue with enhanced selectivity for 
α4β2. In particular, we propose four possible (single-site) mutations at the [γ4E]-GID, using the 
[γ4E]-GID-α7 nAChR receptor interaction map as a guideline, which might enhance its 
interaction at the α4β2 receptor, especially the human species subtype, which has more 
pharmaceutical relevance.  
 
3.3.4.1 [γ4E]-GID-R2 
At rα4β2, the contact surface as well as inter-atomic contacts of residue [γ4E]-GID-R2 with the 
receptor are both relatively high compared to α7, as shown in Figure 3.20. Visual inspection 
(Fig. 3.22B) showed that [γ4E]-GID-R2 was found to be in close proximity with positively 
charged rα4(+) subunit residues K180, R223 and K224. At the human α4(+)β2(-) receptor 
binding pocket (Fig. 3.22C), [γ4E]-GID-R2 was found to make strong electrostatic interaction 
with hα4-Y126(~20 contacts) and remains in close contact with hα4-R221(~15 contacts). At the 
hβ2(-) subunit comparatively almost no contacts  (~2 contacts) were noticed with W81  (Fig. 
3.22C). These results indicate that the placement of [γ4E]-GID-R2 within the α4β2 receptor 
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subtypes cause repulsion due to the overall charge similarity between [γ4E]-GID-R2 and the 
previously mentioned positively charged residues.  
At the hα4(+)α4(-) binding pocket (Fig. 3.23B) , [γ4E]-GID-R2 was found to make no contacts 
with the hα4(+)E224 and C225 of loop C, probably due to the distance and orientation of the 
Arg2. However, a much stronger interaction between Arg2 and the hα4(-) subunit interface, 
where H195 and D199 were seen to form electrostatic interactions with an average of ~53 and 55 
contacts respectively. Hydrogen bonds were also seen forming with L201 (~32 contacts). [γ4E]-
GID-R2 was also found to make comparatively weaker interactions with hα4-V198 (~9 
contacts). The residues interacting with [γ4E]-GID-R2 at the hα4(+)α4(-)  were found to 
correspond well to those that interacted at the rat-α4(+)α4(-)  receptor binding pocket. At the 
rα4(+) subunit (Fig. 3.23A), residues E226 (~12 contacts) and C227 (~9 contacts) on the C-loop 
were found to interact better with [γ4E]-GID-R2 than the residues at the hα4(+) subunit. 
However, at the rα4(+) receptor [γ4E]-GID-R2 made no contact with L203  which corresponds 
to L201 on the hα4(+) subunit, showing ~32 contacts. Few contacts were noticed between 
rα4(+)-C227 and [γ4E]-GID-R2 (~2 to 3 contacts on average). From the above mentioned 
interactions, especially between [γ4E]-GID-R2 and the Cys-Cys pair residues of the human/rat 
α4(+)α4(-) binding pocket, it is quite clear that the Cys-Cys pair will be important to help 
increase the  potency of [γ4E]-GID towards the hα4α4 receptor. On the other hand, the strong 
interactions between [γ4E]-GID-R2 at the hα4(-) subunit, similar to that observed at the hα7(-) 
subunit, could be due to the fact that both the receptor subtypes under consideration were derived 
from human, and the binding pockets are both composed of alpha subunits.  
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Overall, an interaction similar to that seen at the α7 receptor could be engineered involving a 
negative or uncharged, planar residue at position 2. In support of this, [γ4E]-GID-R2 at the α7 
receptor was found to be in close contact with negatively charged residues Asp and Glu at their 
respective receptor subunits. For example, [γ4E]-GID-R2 was found to make contacts with E184 
and D186 of the α7(-) face of the receptor subunits at hα7/hα7-3 binding pocket.  Hence, at the 
hα7 receptor binding pocket, the mutation [γ4E]-GID[R2D] would result in a repulsion between 
the neighbouring hα7 subunit residues, unlike at the rα4β2 receptor. [γ4E]-GID-R2 is also 
essential for binding with the α4β2 receptor subtypes. Millard and colleagues (328) showed that 
[γ4E]-GID-[R2A] caused loss of activity at α4β2 and an increase in IC50 at the human α7 
receptor pocket. However, Beissner and colleagues have shown that efficient binding of [γ4E]-
GID to the α4β2 receptor was prevented by the protrusion of α4(+)-R185(364) (as well as other 
positively charged residues described above) which in our simulations, make contact with R2. 
Thus, it is not clear at present why R2A would result in a loss of activity at α4β2, since 
presumably removal of a positive charge at position 2 would also reduce repulsion with R185. It 
is possible that removal (or even reversal) of charge at position 2 could improve activity of 
[γ4E]-GID at α4β2 further by reducing electrostatic repulsion between R185 and R2; for 
example, [γ4E]-GID[R2D].  It might be that it is the size or shape of R2 which is essential to its 
activity at α4β2, rather than its positive charge. Thus, we suggest that [γ4E]-GID[R2D]  might 
help increase affinity to α4β2 by formation of a salt bridge between the sidechains of R2D and 
R185. Although this mutation is not well understood, due to lack of previous studies on the 
same, other studies have also shown that the synthesised mutation [γ4E, R2K]-GID lost its 
inhibitory effect at the receptor(365). While a qualitative interpretation of the MD simulation 
results suggest that R2D might be selective for α4β2, as described above, we also note that the 
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IRDE tail is highly flexible, and it is likely that other alternative conformations and interactions 
might exist that can only be sampled with substantially longer simulations or higher number of 
simulations. It is also possible that [γ4E]-GID activity at α4β2 requires position 2 to retain some 
structural feature similar to that of Arg (which might explain the known loss of activity at α4β2 
of both R2A and R2K mutants; despite the retention of positive charge of the latter mutant). It is 
possible that position 2 requires a planar sidechain, for example R2F or R2Y (from the FoldX 
results (Table 3.4), it can be seen that [γ4E]-GID[R2F], will be the closest mutation that will 
increase affinity towards the α4β2 receptor; see more detailed discussion below). Additionally, 
an aromatic residue at position 2 would also turn the interaction from a strong, electrostatic 
attraction between R2 and α7-E184/D186, into a substantially weaker interaction between 
(aromatic) position 2 and the α7-D184/D186 residues(366). To explore other mutations at this 
position, we use mutational free energy estimates (detailed in Section 3.4 and 3.5. below).  
 
Figure 3.22: Representations of the interaction of the hα7 (A), rα4β2 (B) and hα4β2 (C) receptor 
residues that maintain close proximity and possibly interacting with the toxin residue Arg2. The 
orange ribbon represents the whole toxin chain, while the other representations symbolise the 
interacting residues. 
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Figure 3.23: Residues on the rat α4(+)α4(-)  receptor binding pocket (A) and the residues on the 
human α4(+)α4(-)  receptor binding pocket (B) than make the most number of contacts with [γ4E]-
GID-R2 respectively. 
 
3.3.4.2. [γ4E]-GID-S7 
The next strip of toxin residues in focus is those comprising the loop II (residues C5 to C11). 
Previous studies have shown that this band of residues is important in maintaining the overall 
integral structural framework of the toxin. A mutation to residues within this band (S7 to C11) is 
detrimental for the toxin’s inhibitory activity for all nAChr subtypes studied (329). This is 
consistent with our simulations which showed that the pattern of contact numbers and contact 
surface are generally similar for the toxins at the rat α4β2 and the α7 receptor within this region 
(Fig. 3.20B and C). However, [γ4E]-GID-S7 when mutated to Ala, was showed a significant 
increase in IC50 value at both the α4β2 and the α7 receptors when compared to [γ4E]-GID-
S7(328).However, [γ4E]-GID-S7 at the rα4β2 forms an exception with the other residues in the 
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band, in that it makes fewer number of contacts compared to the surface area of the residue in 
contact. Analysis of the trajectory showed that [γ4E]-GID-S7 made contact with Y210 at the α7 
(+) (Fig. 3.24A) and the Y128 of the rα4(+) subunit (Fig. 3.24B and supplementary figure  3.2). 
Moreover, [γ4E]-GID-S7 also maintained contacts with, L60, D186, S188, G189, F55 and Q183 
at the α7(-) (Fig. 3.24A) while also maintaining contact with A191, S192, L193, D194 and F196 
at the rβ2(-) face (Fig. 3.24B). In addition, [γ4E]-GID-S7 interacted with residues neighbouring 
Q183 at the α7(-) nAChR that corresponded, in position, to residue rβ2(-)-Q65 although [γ4E]-
GID-S7 did not make contact with Gln65 at the rβ2(-) subunit. Although this difference is slight, 
it might still be important due to the fact that [γ4E]-GID-S7 is located within the crucial loop I. 
At the human α4(+)β2(-) receptor binding pockets, [γ4E]-GID-S7 was seen to make negligible 
contact with hα4(+) residues Y126, K178 and Y213 (~1-2 contacts)(Fig. 3.24C). In comparison, 
hβ2(-) residues S193(~6 contacts), D195 (~28 contacts), D196 (~4 contacts) were seen to show 
stronger interaction with [γ4E]-GID-S7. Consistent with this, models from previous studies(365), 
have also shown S7 to form a hydrogen bond with the carboxyl group of D169  and S36 in the β 
subunit. However, similar to our observations made at the rat α4β2 receptor binding pocket, no 
interactions were noticed with [γ4E]-GID-S7 and hβ2(-)Q66, that corresponds to Q65 at the 
rβ2(-) interface. In addition, the distance between hβ2(-)-Q66 and [γ4E]-GID-S7 was also found 
to be larger in comparison to that at the rα4β2 receptor. Given the lack of contacts between S7 
and hβ2-Q66/rβ2-Q65, and (in contrast) the presence of contacts with the corresponding region 
at hα7, we propose that this fact might be exploited to develop a S7 mutant with enhanced 
selectivity for α4β2. However if [γ4E]-GID-S7 is to be replaced, it should ideally retain the 
structure and properties of Ser and also maintain interaction with Gln65 at the rβ2(-) subunit (to 
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improve selectivity for rat α4β2) or increase interaction with Y126, Y213 at the human α4(+) 
subunit interface (to improve selectivity for human α4β2). A neutral, polar residue similar to Ser 
could thus be chosen to replace the latter in order that could in turn affect the positioning of the 
neighbouring residues of this band. A possible choice of substitution in this instance would be 
Thr, as it is similar to Ser but contains a bulkier CH3 group that could make favourable contacts 
with human α4(+)-Y126 or Y213; its larger size compared to Ser might also enable it to make 
contact with rβ2-Q65 or hβ2-Q66 more easily .   
On comparing the human and rat α4(+)α4(-)  subunit binding pockets (Fig. 3.25A), it was found 
that [γ4E]-GID-S7 interacted more strongly at the hα4(+)α4(-) binding pocket (Fig. 3.25B) in 
comparison to the rat subtype although both species showed similar interacting residues. At the 
hα4(+) subunit, strong hydrophobic interactions were seen with L201(~46 contacts) and 
hydrogen bond interactions with D202 (~16 contacts). On the rα(+), the residue corresponding to 
hα4(+)L201, ie., rα4(+)L203 showed no interactions with [γ4E]-GID[S7]. Similarly, while hα4(-
)R221 was shown to make considerable contact(~32 contacts), its counterpart at the rα4(-) 
subunit-R223, was seen to make no contact with Ser7 throughout the simulation. Thus, similar to 
the case seen with the interactions of [γ4E]-GID-R2 at the hα4(+)α4(-)  binding pocket, [γ4E]-
GID-S7 is seen to display more number of interactions at the hα4(+)α4(-)  compared to the rat 
species counterpart.  
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Figure 3.24: Representation of the [γ4E]-GID interaction at the hα7(A), rα4β2(B) and hα4β2(C) 
receptor residues that maintain close proximity and interacting with [γ4E]-GID-S7. At the rα4β2 
and hα4β2 receptor, Gln65 of the β2 subunit is represented differently in VDW from other residues 
to show that although the residue was in close proximity, it did not interact with Ser7. 
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Figure 3.25: Residues on the rat α4(+)α4(-)  receptor binding pocket (A) and the residues on the 
human α4(+)α4(-)  receptor binding pocket (B) than make the most number of contacts with [γ4E]-
GID-S7 respectively. 
 
3.3.4.3. [γ4E]-GID-V13 
As in the case of [γ4E]-GID[R2 and S7], [γ4E]-GID[V13] Alanine scan mutagenesis studies by 
Millard and colleagues again showed a slight increase in IC50 value at the α7 receptor, but 
completely lost activity at the α4β2 receptor binding pocket(329).  Visual inspection also 
highlights [γ4E]-GID-V13 as a potential site of mutation for enhancing selectivity for α4β2 (Fig. 
3.26 and 3.27). At the rα4β2 receptor [γ4E]-GID-V13 form contacts with the benzyl ring-
containing residues rβ2(-)-F143, V135 and W144, apart from other rα4(+) residues such as T185 
and N133(Fig. 3.26B).  
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At the hα7(+) receptor subunit, [γ4E]-GID-V13 was found to interact with hα7(+) residue S172 
considerably (~20 contacts) while also interacting with hα7(-) residues Q79 (~4 contacts), R101 
(~12 contacts), L131 (~38 contacts), Q139(~28 contacts) and L141(~33 contacts) (Fig. 3.26A). 
At the hα4(+) receptor binding subunit, [γ4E]-GID-V13 is seen to make strong interactions 
particularly with T183 (~42 contacts)(Fig. 3.26C). More contacts are noticed at the hβ2(-) subunit, 
with residues V136 (~51 contacts), F144 (~8 contacts) and L146(~43 contacts) making strong 
interactions with [γ4E]-GID-V13 corresponding to the residues on the rβ2(-) subunit interface (Fig. 
3.26B). 
However, the residues surrounding [γ4E]-GID-V13 at the rα4β2 receptor binding pocket are less 
involved in the interaction (based on the number of contacts) when compared to those at the hα7 
receptor (Fig. 3.26A). In addition, the contact surface area exposed by [γ4E]-GID-V13 is greater 
at the α4(+)β2(-) interfaces (refer to the data for V13 in Fig. 3.20A-D). With these factors in 
mind, [γ4E, V13G]-GID is proposed as a possible candidate for enhancing selectivity for 
α4(+)β2(-). Whereas Valine is a bulky and neutral residue by nature Glycine lacks a side-chain, 
and thus allows for more conformational flexibility within the binding pocket due to its compact 
nature and also readily allows the formation of hydrogen bonds (via its backbone) with its 
neighbours. Removing the side-chain would make it impossible to potentially form H-bonds with 
S172, Q79 and R101 and others. However, V13 does not make substantial contact at α4β2 
interfaces in any case, so removing the side-chain should not lead to substantial change in 
activity. Thus, V13G could serve to improve selectivity for α4β2, not by enhancing potency at 
α4β2, but by reducing potency at hα7, but only under the (untested) assumption that the 
additional conformational flexibility conferred by Glycine at this position does not substantially 
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interfere with the native fold of [γ4E]-GID. This is questionable in light of recent experiments 
(see Conclusions and Fig. 3.31).  
There are also differences between the rat and human α4(+)α4(-) interface contacts with [γ4E]-
GID (Fig. 3.27A and B). At the rat α4(+)α4(-) binding pocket, rα4(+)-T185 interact strongly 
(~30 contacts) with [γ4E]-GID-V13, while at the rα4(-) subunit, residues K92 (~2 contacts) and 
R114 (~15 contacts) (Fig. 3.27A) interacted weakly in comparison. However, the number of 
contacts with corresponding residues on the hα4(+) interface (Fig. 3.27B), namely T183 (~8 
contacts),  also showed to be less that that at the rα4(+) subunit (Fig. 3.27A). Comparatively 
more number of contacts were made at the hα4(-) subunit as well, where the highest average 
number of contacts was exhibited by H142 (~35 contacts), R112 (~28 contacts) and K90 (~18 
contacts; while T152 (~15 contacts), F144 (~8 contacts) and Q150 (~9 contacts) also showed 
fewer contacts with [γ4E]-GID-V13. From the residue interactions it is quite clear that while 
more number of interactions were seen at the hα4(+)α4(-) subunit in comparison to that of the 
rα4(+), the interactions with [γ4E]-GID showed some similarity between the receptor types. 
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Figure 3.26: Residues that are in close contact with [γ4E]-GID-V13 at the human α7 receptors (A), 
rat α4β2 receptor (B) and human α4β2 receptor (C) respectively.   
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Figure 3.27: Highlights the residues on the rat α4(+)α4(-)  receptor binding pocket (A) and the 
residues on the human α4(+)α4(-)  receptor binding pocket (B) than make the most number of 
contacts with [γ4E]-GID-V13 respectively. 
 
3.4. Mutational free energy analysis 
 
FoldX was used to estimate the free energy change (ΔΔG) resulting from single-site mutations of 
every residue of [γ4E]-GID (except for Hyp and Cys) to all of the other 19 natural amino acids. 
By determining the extent to which different mutants alter the stability of the [γ4E]-GID-nAChR 
complex (with [γ4E]-GID bound at the canonical ligand binding site), some insights might be 
gained into which [γ4E]-GID sites might be most amenable to mutation for improving the toxins’ 
selective activity at α4β2 over α7. FoldX is an approximate, empirical method, and is presently 
employed only to provide qualitative insights into possible mutations at [γ4E]-GID that could 
alter its potency at α7 and α4β2.  
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Firstly, to determine the reliability of FoldX for predicting mutational free energies of binding, 
we performed in silico mutagenesis calculations on the ImI-hα7 complex, which was constructed 
using Modeller v9.6 (367). The AChBP complex (PDBID: 2BYP) was used as structural template. 
This complex was chosen due to the wealth of available experimentally-determined Kd data on a 
large number of ImI mutants interacting at hα7, which could be translated into approximate 
mutational ΔΔG values (relative to wild type ImI). A similar approach was taken by Yu et al. (338) 
, in which ImI mutational ΔΔG values were estimated using MM-PBSA and MM-GBSA 
methods(368). It was found, in that work, the methods examined gave linear r2 values between 0.5-
0.7. In the present work however, FoldX was used to estimate the mutational ΔΔG of the ImI-
hα7 complex, for ImI mutants that have published experimental Kd data. The predicted ΔΔG 
values and the corresponding values estimated from experiments are given in Table 3.2. A plot 
of FoldX-predicted values with respect to those estimated from experiments is also given in Fig. 
3.28. The best r2 reported in Yu’s study(369) is 0.74, therefore slightly better than the correlation 
reported here with FoldX (0.70). 
Interestingly, there are two apparent outliers: [R7E]-ImI and [R7K]-ImI (highlighted in bold 
Table 3.2 and circled in Fig. 3.28). The presence of these outliers indicates that FoldX 
underestimates the influence of the R7K mutation in ImI. Nevertheless, the good correlation 
between calculations and experiments indicates that FoldX is a valid method for estimating 
mutational free energies for conotoxin-nAChR complexes, and may be considered to be similar 
in accuracy to MM-PBSA and MM-GBSA.  
Having established the validity of using FoldX, the mutational ΔΔG values of each residue of 
[γ4E]-GID except Hyp and Cys (which are essential for maintaining the structural integrity of the 
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peptide), to each of the 20 natural amino acids, were calculated. For both [γ4E]-GID-hα4β2 and 
[γ4E]-GID-α7 complexes, the ΔΔG values were calculated using the final MD trajectory frame 
of each of the 6 independent simulations. The ΔΔG values are here reported as averages over all 
the equivalent α4(+)β2(-) or α7(+)α7(-) sites over the 6 simulations. We note that results and 
discussions are shown for human α4β2, but similar values were obtained for rat α4β2.  
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Table 3.2: Mutational free energy values for ImI-α7 complex predicted by FoldX and from 
literature. Uncertainties are given as standard errors of the mean over the 5 nominally identical 
interfaces of α7.  
ImI mutant FoldX-
predicted ΔΔG 
(kcal/mol)* 
Exptl ΔΔG 
(kcal/mol)** 
S4A 0.1 ± 0.2 0.3 ± 0.2 
D5A 3.9 ± 0.2 2.1 ± 0.1 
D5K 5.0 ± 0.7 4.0 ± 0.2 
D5N 2.9 ± 0.5 2.8 ± 0.2 
R7A 4.2 ± 0.6 3.0 ± 0.3 
R7E 7.5 ± 0.7 3.9 ± 0.2 
R7K 1.4 ± 0.9 2.9 ± 0.2 
R7L 3.5 ± 0.6 3.3 ± 0.6 
R7Q 4.4 ± 0.6 3.5 ± 0.2 
A9S 0.9 ± 0.2 -0.1 ± 0.2 
W10A 0.8 ± 0.4 1.1 ± 0.1 
W10F 0.1 ± 0.3 0.8 ± 0.5 
W10T 1.4 ± 0.3 2.0 ± 0.2 
W10Y 0.6 ± 0.3 0.1 ± 0.3 
R11A 1.2 ± 0.4 -0.2 ± 0.2 
R11Q 0.9 ± 0.2 0.3 ± 0.3 
* FoldX uncertainties calculated as standard errors of the mean over the five equivalent 
interfaces of human α7. **From Yu et al(181). 
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Figure 3.28: Correlation between FoldX-predicted and experimentally-estimated mutational free 
energy (ΔΔG, kcal/mol) for the ImI-α7 complex. Outlier ImI mutants are circled in red. Linear 
regression equation is inset.  
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Table 3.3: FoldX-predicted mutational free energy (ΔΔG) for [γ4E]-GID residues (columns) 
mutated to each of the 20 natural amino acids (rows), for [γ4E]-GID bound to hα7 at the canonical 
binding site. Negative values are indicated in shades of red, positive values in shades of blue.  
 
Matrices of mutational ΔΔG values for all single-site mutants of [γ4E]-GID are shown in Table 
3.3 (for α7) and Table 3.4 (for hα4β2). Negative values indicate mutations which are predicted to 
confer increased stability to the mutant [γ4E]-GID-nAChR complex relative to [ϒ4E]-GID, 
while positive values indicate the opposite (thus, for example, the A10H mutation is predicted to 
reduce the stability of both the [γ4E]-GID-hα7 and [γ4E]-GID-hα4β2 complexes).  
Additionally, although FoldX predicts mutational free energies reasonably well for ImI and its 
analogues at α7, it is necessary to determine its effectiveness at predicting the same for [γ4E]-
GID analogues at α7 and α4β2. The pIC50 values from Millard’s study (which focused on Ala 
mutants) were correlated with the ΔΔG values obtained from FoldX (Tables 3.3 and 3.4), and the 
correlation between the two were plotted concerning [γ4E]-GID at the hα7 and hα4β2 receptor 
 Chapter 3:  Equilibrium Molecular Dynamics Simulations of [γ4E]-GID 
Interactions with α7 and α4β2 Nicotinic Receptors 
       
157 
 
(Fig. 3.29). While the number of data points is small compared to that available for ImI-α7, and 
therefore the correlation can only be considered qualitative, both curves indicate the expected 
trend, with higher predicted ΔΔG correlating with lower potency (higher pIC50). At the human 
α7 receptor a positive correlation of R2=0.435 was observed, while at the human α4β2 receptor, a 
correlation of R2 = 0.528 was seen. While a physically meaningful correlation appears to exist, 
the fit is not as good as that for ImI-α7. Possible reasons for this are the relatively lower number 
of data points for [γ4E]-GID, as well as greater uncertainty in the quality of the simulated model 
of the [γ4E]-GID-nAChR complexes (which contain a highly flexible N-terminus tail at [γ4E]-
GID), compared to the more structurally well-characterised ImI-α7 complex. Given the R2 
values for the GID-nAChr complexes, we emphasise again that the present FoldX analysis may 
only provide qualitative insights into [γ4E]-GID mutants that might substantially alter potency at 
α7 and α4β2.  
 
Figure 3.29: shows the correlation between pIC50 values from Millard’s study(329) and those 
obtained from FoldX at the Human α7 and α4β2 receptors respectively. 
 
For [γ4E]-GID-hα7 (Table 3.3), some positions on [γ4E]-GID appear to be already optimal for 
binding to hα7, and cannot be mutated to natural amino acids to improve stability; these residues 
include R2, S7, A10, and R12, most of whose mutants result in positive ΔΔG. In particular, these 
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positions do not tolerate mutation to bulky, aromatic residues (W, Y, F, H- categorised as ‘Ring’ 
in Table 3.2), as evidenced by the particularly high positive ΔΔG values. Such mutations might 
be exploited to deliberately destabilise toxin interaction at hα7, and thereby improve selectivity 
at hα4β2 (more on this point below). (It is noted that the mutational free energy of A10H appears 
to be exceptionally high, with ΔΔG = +41 kcal/mol. Indeed, inspection of the [γ4E]-GID-hα7 
structure indicates that the A10 position is very tightly packed against the surface of the principal 
face, allowing little room for change.) In contrast, some [γ4E]-GID positions are predicted to 
permit many potentially stability-enhancing mutations, across all categories (polar, basic, etc.) of 
natural amino acids, including I1, D3, E4, and H17. And although it is not the aim of the present 
thesis (in fact, the opposite), it is also noted that replacing N8 with an acidic residue (N8E and 
N8D) results in greater stability of the [γ4E]-GID-hα7 complex.  
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Table 3.4: FoldX-predicted mutational free energy (ΔΔG) for [γ4E]-GID residues (columns) 
mutated to each of the 20 natural amino acids (rows), for [γ4E]-GID bound to hα4β2 at the 
canonical α4(+)β2(-) binding site. Negative values are indicated in shades of red, positive values in 
shades of blue.  
 
For [γ4E]-GID-hα4β2 (Table 3.4), as with hα7 (discussed above), some positions on [γ4E]-GID 
appear to be already optimal for binding to hα4β2 and cannot be mutated to natural amino acids 
to improve stability; these also include R2, S7, A10, and R12; nor, like hα7, do these positions 
tolerate mutation to bulky, aromatic residues. In particular, A10H also results in an anomalously 
high ΔΔG. For the purpose of this thesis, however, the main interest is in [γ4E]-GID positions 
that permit many potentially stability-enhancing mutations, across all categories (polar, basic, 
etc.) of natural amino acids: these also include I1, D3, E4, and H17. Of most interest are 
positions which show the highest negative ΔΔG, which are most amenable to be exploited to 
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enhance selectivity of the mutant [γ4E]-GID for hα4β2. Reversing the charge at position 4 with 
an E4R or E4K mutation improves the stability of the [γ4E]-GID- hα4β2 complex, with ΔΔG = -
1.56 and -1.36 kcal/mol respectively. The other position offering potential for significantly 
enhancing activity at hα4β2 is V13, in particular V13L and V13M (ΔΔG = -1.04 and -1.13 
kcal/mol respectively).  
The data in these tables can be compared qualitatively with the changes in potency at the two 
receptors in Millard’s study(329), for the Ala mutants. For α7, electrophysiology data indicated 
that the Ala mutants with highest impact (reduction) on potency are D3A, N8A, P9A (not studied 
with FoldX), R12A, and N14A. This is consistent with the high, positive predicted ΔΔG values 
(Table 3.3) for N8A, R12A and N14A. However, consistency is poor for D3A, which is 
predicted to only be slightly destabilising, and yet is known to significantly increase IC50; and 
V18A, predicted to be very destabilising but is known not to reduce potency substantially at α7. 
For α4β2, Millard et al. showed that nearly all Ala mutants of [γ4E]-GID markedly reduce (by at 
least 10 fold) or eliminate potency altogether, and this is generally consistent with the results in 
Table 3.4, which show that R2A, N8A, R12A, V13A, N14A, N15A and V18A are all predicted 
to be strongly destabilising. However, there are some possible inconsistencies: electrophysiology 
experiments showed that γ4A has negligible effect (while Table 3.4 suggests E4A would 
increase potency at α4β2); and V13A has been shown to increase IC50 by twofold (while Table 
3.4 suggests a possibly more marked loss of potency). Thus, considering the predictions for α7 
and α4β2 and comparing them with known effects of Ala mutations, the most reliable regions for 
prediction of the influence of mutations on α7 and α4β2 inhibition appear to be loop I (S7, N8) 
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and loop II (R12; N14-H17). In contrast, the highly flexible IRDE tail, and also the C-terminus, 
may be considered less reliable for the present analysis. 
While the matrices (Tables 3.3 and 3.4) discussed above suggest a large number of possible 
mutants which might increase affinity of [γ4E]-GID for α4β2, what is required is selectivity- i.e. 
high affinity for α4β2, but also low affinity for α7. To identify mutants which might improve 
affinity for α4β2 more than for α7, we calculate a matrix of mutational ΔΔG difference between 
α7 and α4β2 (Table 3.5). Each element of the matrix is computed as ‘Δ(ΔΔG) = ΔΔG(hα4β2) – 
ΔΔG(hα7)’. Thus, in the Δ(ΔΔG) matrix, negative values indicate mutants which are predicted to 
improve the toxin’s affinity for α4β2, more than it improves the affinity for α7.  Based on 
experimental IC50 values (Millard et al. 2009) we note that the difference in binding free energy, 
∆G, for [γ4E]-GID at the α7 is roughly at least 1.0 kcal/mol lower than for α4β2, based on crude 
estimates.  
 Thus, for the purpose of identifying possible mutants which confer selectivity for α4β2 over 
alphα7, [γ4E]-GID mutants should satisfy two criteria:   
i) A low, and preferably negative, value of ΔΔG at hα4β2 (this criterion ensures that the 
mutant is predicted to have greater inhibitory activity, or at least, not too much lower 
activity, than [ϒ4E]-GID); and  
ii) The Δ(ΔΔG) value should be lower than -1.0 kcal/mol.  
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Table 3.5: Difference in FoldX-predicted mutational free energy (Δ(ΔΔG)) between hα4β2 and hα7 
for [γ4E]-GID residues (columns) mutated to each of the 20 natural amino acids (rows). Negative 
values suggest selectivity for hα4β2 and are indicated in shades of red. Positive values suggest 
predicted selectivity for hα47 and are indicated in shades of blue.  
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Figure 3.30: Shows graphical representations of [γ4E]-GID residues whose mutants are predicted 
to enhance selectivity for hα4β2. [E4R]-GID is predicted to only weakly increase affinity at hα7 (A), 
but substantially increases affinity at hα4β2 due to close interaction with β2-D196 (B). [R12F]-GID 
is predicted to improve selectivity for hα4β2 by reducing electrostatic repulsion with β2-K188 (C), 
while no basic residues are in the vicinity of [γ4E]-GID-R12 at hα7. 
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Interestingly, all but one single-site mutant is predicted to satisfy both criteria: [E4R]-GID has 
ΔΔG(hα4β) = -1.56 kcal/mol, and Δ(ΔΔG) = -1.04 kcal/mol. This can be explained by 
comparing [γ4E]-GID-E4 interactions with hα7 (Fig. 3.30A) and with hα4β2 (Fig. 3.30B). When 
bound at the canonical ligand binding site, E4 is in close contact with β2-D196 (Fig. 3.30B). 
Thus, for hα4β2, reversing the charge at position 4 will reduce electrostatic repulsion while 
introducing electrostatic attraction between E4R and β2-D196, improving binding affinity. On 
the other hand, no such advantage can be gained for this mutation at hα7 (Fig. 3.30A), the closest 
acidic residue being α7-D186 and quite distant (average of 5.9Å) from [γ4E]-GID-E4 in 
comparison to the average distance between [γ4E]-GID-E4 and hβ2-D196 (4.5Å). One other 
mutant is worthy of note, and that is R12F, which apparently vastly improves selectivity for 
hα4β2 over α7 (Δ(ΔΔG) = -3.60 kcal/mol). Indeed, the introduction of any aromatic residue in 
position 12 is predicted to apparently improve selectivity for α4β2. However it actually 
destabilises [γ4E]-GID-α4β2 complexes (ΔΔG(α4β2) = +1.11 kcal/mol), although it destabilises 
the [γ4E]-GID-α7 complex even more (ΔΔG(hα7) = +4.83 kcal/mol). The relatively lower 
destabilisation at hα4β2 can be explained by the closeness of R12 to β2-K188 (Fig. 3.30C); 
removing the positive charge at R12 by replacing it with Phe effectively lowers the electrostatic 
repulsion. No such reduction in electrostatic repulsion can take place at hα7, however. Finally, 
we note that V13 offers a number of possible, apparent improvement in selectivity for hα4β2 
over α7; these include V13H with Δ(ΔΔG) = -2.65 kcal/mol. However, this mutation is also 
predicted to vastly destabilise both [γ4E]-GID-hα7 and [γ4E]-GID-α4β2 complexes, with ΔΔG = 
+9 and +6 kcal/mol respectively. Another mutation, V13R, relatively weakly destabilises hα4β2 
(ΔΔG = +1.08 kcal/mol), but destabilises α7 much more (ΔΔG = +2.97 kcal/mol). It is particular 
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interesting that the V13 position is identified as a possible site for favourable mutation, and is 
partially consistent with experiments (see Conclusions below).  
In summary, E4R appears to be a particularly attractive candidate for future experimental studies 
to enhance the selectivity of [γ4E]-GID derivatives for α4β2 over α7. R12F and V13R are also 
worthwhile probing experimentally. A similar approach might also be applicable for designing 
subtype-selective conotoxin mutants of other conotoxin-nAChR complexes. 
 
3.5 Conclusions 
Alzheimer’s disease, Parkinson’s disease schizophrenia are today’s common growing 
neurological diseases prevalent in the senile population(370). These diseases are marked by a 
slow, yet progressive decline of the nAChR receptors present in the brain that are vital for brain 
activity/function(371-373). The α7 and α4β2 subtypes are amongst the most prevalent in the central 
nervous system(374, 375), and are also amongst the most significantly affected subtypes in 
Alzheimer’s disease(376, 377). While a number of conotoxins are known to inhibit the α7 subtype 
with high potency, much fewer are known to inhibit α4β2. Studies indicate that α-conotoxin 
[γ4E]-GID is one of very few conotoxins which do so (378, 379). This innate characteristic of the 
[γ4E]-GID is of interest in terms of drug discovery and formulation. However, [γ4E]-GID is 
more specific for the α7 nAChR than the α4β2 subtype, limiting its use as a pharmacological tool 
for dissecting the role of α4β2 in neurological disease. This could be due to the fact that at the 
α4β2 receptor, [γ4E]-GID is stabilised by interactions with the narrow walls of the binding 
pocket, thereby conforming its structure to one that disfavours binding. Our study helps 
 Chapter 3:  Equilibrium Molecular Dynamics Simulations of [γ4E]-GID 
Interactions with α7 and α4β2 Nicotinic Receptors 
       
166 
 
understand the interactions and behaviour of the toxin at the α7 and α4β2 nAChr, and hence their 
differences.  
Using equilibrium molecular dynamics simulations to study [γ4E]-GID bound at the respective 
α7 and α4β2 receptors, the structure and dynamics of the toxin at the different interfaces were 
elucidated, highlighting the difference in behaviour depending on the interface to which the toxin 
is bound. Cluster analysis of [γ4E]-GID at the α7 showed that the N-terminus was found to be 
more flexible, and hence the contacts it made were not very persistent. This flexibility was also 
shown by the RMSF graphs, and also explains why truncation of the IRDE tail caused no effect 
at the α7 receptor as it did at the α4β2. Also, [γ4E]-GID exhibited a change of secondary 
structure conformation at the α7, where the α-helical residues between P9 and V13 alternated 
between coils and turns.  However, this was not noticed at the [γ4E]-GID in the α4β2 receptor 
pocket, where the core was more rigid in comparison. The rigidity of the core residues of [γ4E]-
GID at the α4β2 may explain its sensitivity and its low activity compared to its activity at the α7 
receptor. Conformational cluster analysis also revealed differences in [γ4E]-GID structure, 
particularly at the N-terminal tail, depending on the receptor subtype to which it is bound. 
Additionally, using equilibrium MD simulations and mutational free energy analyses, we 
propose several point mutations to [γ4E]-GID which might improve its selectivity for α4β2, 
either by reducing its interactions at α7, strengthening its interaction at α4β2, or both. In 
particular, structural analysis of MD-simulated structures suggests that the R2D, S7T, and V13G 
mutants might improve selectivity for α4β2. Mutational free energy analysis suggests, 
furthermore, that E4R and R12Y might also be effective. With a growing library of newly 
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discovered conotoxins, this study also provides a simple yet potentially robust method for 
analysis of nAChR-conotoxin interactions, with an aim to aid future studies.       
 
Figure 3.31: Electrophysiology measurements of relative inhibition of nAChR current for hα7 and 
hα4β2 by [γ4E]-GID variants (unpublished; data provided courtesy of Prof. Dr. David J. Adams 
and Dr. Han Shen Tae, RMIT University). The Standard Error of mean error bars are also shown 
respectively. 
 
It is of interest to compare the sites we identified as being potentially amenable to improve 
selectivity by mutation with experimental studies. Recent experimental evidence after testing the 
mutants show slight improvements at some residues, relating to inhibition at the α4β2 receptor 
by [γ4E]-GID. Recent experimental electrophysiology and site-directed mutagenesis indicated 
that of all the mutants tested, [γ4E]-GID-R2D and V13G held some promise as selectivity 
enhancements (Table 3.3). [γ4E]-GID-R2D nearly abolished activity at both subtypes, although 
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it showed very slight selectivity for α4β2. This is partly predicted as by our simulations; 
mutating R2 to a negative residue probably did, indeed, cause repulsion with the α7 binding site, 
although it also apparent resulted in nearly zero (though slightly higher than α7) inhibition at 
α4β2. Indeed this was predicted by our FoldX calculations, detailed in Tables 3.3 and 3.4, 
showing positive ΔΔG values for R2D at both α7 and α4β2. [γ4E, V13G]-GID, on the other 
hand, showed a substantial increase in inhibition current amplitude for α4β2, compared to the 
base-line [γ4E]-GID. However, the relative inhibition at the α7 receptor was found to still be 
stronger. [γ4E, S7T]-GID did not show a change in the inhibition for either subtype. R12H, 
interestingly, also resulted in higher inhibition of α4β2 compared to the baseline [γ4E]-GID, 
suggesting that this site, as predicted by mutational free energy analysis, is important. Our 
mutations have shown partial accuracy. [γ4E]-GID[R2D] shows slight increase in inhibition at 
the hα4β2 receptor when compared to the hα7 receptor, [γ4E]-GID[V13G] showed an increased 
inhibition compared to [γ4E]-GID, however, the [γ4E]-GID still inhibited the hα7 more in 
comparison. Additionally, the [γ4E]-GID[S7T] mutant proposed in the simulations had little 
effect, preserving its potency at both receptors.  It would be of interest for future studies to 
examine the effects of the other mutants proposed in this chapter, namely E4R and specifically 
R12Y. It might also be worthwhile introducing multiple mutations. For example, the double 
mutant, [R2D, V13G] might eliminate inhibition of α7, while at the same time enhancing 
inhibition of α4β2. These results highlight that mutation of α-conotoxin [γ4E]-GID is very much 
possible, however, better evaluation methods to select a particular mutation are important. 
Furthermore, we acknowledge that the [γ4E]-GID binding site might not be the same as the 
canonical binding site. Indeed, the binding pocket of α4 might not accommodate 4/7 
conotoxins(332). In the next chapter (Chapter 4), we explore whether alternative binding sites 
 Chapter 3:  Equilibrium Molecular Dynamics Simulations of [γ4E]-GID 
Interactions with α7 and α4β2 Nicotinic Receptors 
       
169 
 
exist, and therefore provide opportunities to propose mutations which enhance binding to sites 
further away from the agonist binding site.  
 170 
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Various sections of this chapter is published in the Journal of Molecular Graphics 
and Modelling 2016; 70, 109-12, under the title, “Molecular simulation study of 
the unbinding of α-conotoxin [ϒ4E]GID at the α7 and α4β2 neuronal nicotinic 
acetylcholine receptors”.  
 
4.1. Introduction 
In Chapter 3, MD simulations were performed on [γ4E]-GID-nAChR complexes, based on the 
assumption of competitive inhibition, with the complexes modelled using currently available 
crystal structures of PnIA-derivatives bound to AChBP. From our simulations, several [γ4E]-
GID residues were identified as being potentially amenable to improve selectivity of α4β2 over 
α7 by mutation. Results from recent experimental evidence were discussed, in which some of the 
[γ4E]-GID sites and mutants identified from simulations appeared to hold promise as selectivity 
enhancing modifications. [γ4E, R2D]-GID nearly abolished activity at both subtypes, although it 
showed very slight selectivity for α4β2. This is partly predicted as by our simulations; mutating 
R2 to a negative residue probably did, indeed, cause repulsion with the α7 binding site, although 
it also apparent resulted in nearly zero (though slightly higher than α7) inhibition at α4β2. [γ4E, 
V13G]-GID, on the other hand, showed a substantial increase in inhibition current amplitude for 
α4β2, compared to the base-line [γ4E]-GID. However, the relative inhibition at the α7 receptor 
was found to still be stronger. R12H, interestingly, also resulted in higher inhibition of α4β2 
compared to the baseline [γ4E]-GID, suggesting that this site, as predicted by mutational free 
energy analysis, is important. These results highlight that mutation of α-conotoxin [γ4E]-GID 
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might be a reasonable strategy to improve selectivity. However, it was acknowledged that the 
[γ4E]-GID binding site might not be the same as the canonical binding site. Beissner and 
colleagues (2012) used automated docking to understand the interaction of α4-R185 with 
conotoxin TxIA[R5](380). α4[R185I] resulted in 10-1000 fold enhance potency towards the α4β2 
receptor subtype, implying that α4(R185) prevented efficient binding of the ligand at the binding 
pocket. They thus identified residues Arg185 and Pro195 at the α4 subunit as playing critical 
roles in preventing efficient binding of 4/7 α-CgTxs. In other words, the binding pocket of α4 
might not accommodate 4/7 conotoxins due to the presence of R185 and P195 at the mouth of 
the α4β2 binding pocket. Apart from helping understand conotoxin-receptor interactions, these 
studies indicate the possibility of the α-conotoxin [ϒ4E]-GID being engineered to enhance its 
specificity towards α4β2. By understanding the residues of the [γ4E]-GID that are important at 
the α7 receptor subtype and not at the α4β2 receptor, we can piece together how [γ4E]-GID may 
favour to bind with the former than at the latter. Hence, we can suggest mutations to [γ4E]-GID 
accordingly. For example, Bannerjee and colleagues have shown that [ϒ4E]-GID[V18N] has 
increased potency towards the α4β2 receptor, while mutations [ϒ4E]-GID[A10S] and [ϒ4E]-
GID[V13I] improve selectivity(381).   
In the present study we employed atomistic molecular dynamics (MD) simulations and umbrella 
sampling methods to elucidate differences in the unbinding energies and possible energetically 
favourable unbinding pathways of [ϒ4E]-GID at α7 and α4β2 which may be responsible for the 
marked difference in potency between the two receptors. Furthermore, elucidation of possible 
unbinding pathways enabled identification of sites at the receptors which might be able to form 
close contacts with the toxin; the biological relevance of these sites may then be probed 
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experimentally, especially in regard to their relevance to conotoxin inhibition. Identification of 
these regions on the receptor may also help efforts to engineer conotoxins with increased 
selectivity for the α4β2 receptor, for which there is currently no known low-nM potency 
conotoxin inhibitor. We examine the unbinding pathways of [γ4E]-GID at the distinct inter-
subunit ligand-binding interfaces formed by human α7(+)α7(-),  human and  rat α4(+)β2(-), and 
human and rat α4(+)α4(-). We also examine the influences of unbinding on the structure and 
dynamics of the toxin, as well as the influence on the motions of loop C. Although the biological 
relevance of the tight-binding regions of the nAChR requires experimental verification, the 
computational strategy employed might contribute to designing a conotoxin which can inhibit 
α4β2 selectively without directly targeting the orthosteric site, which for α4-contatining 
receptors, might be especially resistant to conotoxin binding.  
In particular, the following are examined: 
1) The energy of unbinding of [γ4E]-GID at interfaces formed by α4β2 and α7 subtypes. 
2) The pathways of unbinding from these interfaces and the residues which line them. In 
particular, we focus on differences in the pathways and contact residues between i) hα7 and ii) 
interfaces of human and rat α4β2; and 
3) The effects of [γ4E]-GID unbinding on its own structure and dynamics, as well as the 
motions of loop C 
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4.2. Methods 
4.2.1 Homology models 
Homology models of the extracellular ligand-binding domain of the rat (α4)3(β2)2, human 
(α4)3(β2)2 and human hα7 nAChR bound to [ϒ4E]-GID were constructed using the 
crystallographic coordinates of Aplysia californica AChBP cocrystallised with the double mutant 
α-conotoxin PnIA[A10L,D14K] (Protein Data Bank (PDB) accession code 2BR8) as a 
template(382). This provided a suitable 4/7 α-conotoxin-bound conformation of the receptor. Rat 
α4, β2, human α4, β2 and hα7 sequences were obtained from the Uni-Prot (Universal Protein 
Resource) database (codes O70174, Q9ERK7, P43681, P17787 and P49582 respectively)(383), 
and aligned with the template sequence using the ClustalW server. BLOSUM was used as the 
scoring matrix. From the results of the multiple sequence alignment, 10 models each of the 
[ϒ4E]-GID-hα7 and [ϒ4E]-GID-α4β2 complexes were generated using Modeler9v6(343). The top 
ranking model of each was selected and validated using PROCHECK(384, 385). MD simulations 
were subsequently run using the top model of each receptor complexes. The overall fold of the 
homology models of the three complexes are qualitatively similar as described in Chapter 3. 
The human α7 and rat α4β2 receptor models were built in this study, so as to compare the results 
from our simulations with previously published experimental evidence from studying GID-
nAChR binding(329, 386). Further, comparison between the human and rat α4β2 receptor subtypes 
would help understand differences in binding properties across species. It is worth noting here 
that sequence comparison using BLAST showed ~97% similarity between the rat and human 
α4β2 receptor subtypes.  
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4.2.2. Molecular dynamics simulations  
In the present work, we study the unbinding of an analogue of α-conotoxin [ϒ4E]-GID, from the 
binding pocket (at the extracellular domains) of the human α7/α4β2 and the rat α4β2 receptors 
respectively. This was done to identify important receptor and toxin residues within and outside 
the putative binding pocket which may play an important role in the differential inhibitory 
potency of [γ4E]-GID at the two receptor subtypes. As ligand binding and unbinding take place 
over a time frame of milliseconds, conventional MD simulations cannot reach that time scale in 
this study(387). Hence we make use of umbrella sampling simulations, where [ϒ4E]-GID is 
restrained at a prescribed set of distances with respect to the binding pocket by applying a 
harmonic restraint potential, subsequently allowing an estimation of the free energy of binding 
(ΔGwell ). 
The structures were solvated in an SPC water box. The hα7 receptor complex was centred in a 
cubic simulation box with edge lengths of 111Å x 111Å x 111Å, while the rat and human α4β2 
receptor complexes were placed in cubic boxes of dimensions 119 Å x 119 Å x 119 Å each. This 
enabled accommodation of [ϒ4E]-GID within the simulation cell for all umbrella sampling 
windows. To maintain an overall ionic strength of 150 mM NaCl for both receptors, 218 Na+ 
ions and 203 Cl- ions were added to the hα7 receptor complex system. Similarly 235 Na+ ions 
and 203 Cl- ions were added to the α4β2 receptor complex system too. The systems were then 
energy minimised over 2000 steps using the steepest descent minimisation algorithm and further 
equilibrated (with heavy atoms restrained) for 100ps of NPT equilibration each using the 
Berendesen thermostat at 300 K. The pressure was isotopically maintained at 1.0 bar using the 
Berendsen barostat(304). The Berendsen barostat was used as it is consistent with the protocol 
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described in Sorin and Pande (2005)(388), where they described the porting of the Amber 
forcefield into Gromacs. All simulations performed in that study (to validate the port) used the 
Berendsen barostat. Electrostatic interactions between non-covalent atoms were computed using 
particle-mesh Ewald (PME)(389). All MD simulations were performed using Gromacs (Version 
4.5.5)(390). All MD simulations in this study were performed using the Amber 99SB-ILDN force 
field(391). 
 
4.2.3. Umbrella sampling 
The structures obtained prior to equilibration were used as starting structures to begin pulling 
simulations which would then be sampled. [ϒ4E]-GID was pulled from all 5 binding sites at the 
hα7 and all 3 binding pockets at the hα4β2 and rα4β2 receptors respectively over 500ps at a rate 
of 0.1Å.ps-1. During the pulling simulations only the subunit that mirrored the binding pocket 
containing the [γ4E]-GID peptide of interest (that was to be pulled) was position restrained, 
using a force constant (kpr) of 1000 kJ mol-1 nm-2. (For example, if the five nAChR subunits were 
labelled A-E, and the pocket of interest lies at the interface between subunits A and B, then 
subunit D would be restrained. This was done to understand the influence of the receptor subunit 
residues (that made the respective binding pocket) without creating any sort of bias. In addition, 
the entire system was also anchored by this position restraint. Rather than providing a specific 
direction to dictate the unbinding pathway, the “pulling” simulation involved gradual increase in 
the distance between the centre of mass of (COM) of the toxin and the principal subunit of the 
nAChR interface at which the toxin was originally bound. This resulted in the toxin adopting an 
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unbinding pathway that generally brings it in a direction tangential to loop C, without major 
disruption in the loop. Thus as long as the toxin-subunit COM distance is increased, there is no 
other external directional bias on the toxin. Although more work (experimental and 
computational) would be required to ascertain and fully justify this choice of pulling path, it 
seems reasonable to assume that the toxin would adopt an unbinding pathway that minimises 
loop C distortion. A spring potential of 10 kJ mol-1 Å-2 was applied to [ϒ4E]-GID during these 
simulations. Snapshots of the pulling trajectory were then collected to proceed with the umbrella 
sampling. [ϒ4E]-GID was pulled out of each receptor binding pocket with respect to the 
principal subunit via its Center of Mass over a distance of ~60 Å. At the hα7 nAChr the pulling 
trajectory was sampled over all 5 binding pockets, while at the α4β2 receptor [ϒ4E]-GID  was 
only pulled out of three binding pockets, i.e., 2 (two) α4β2  and 1 (one) α4α4 subunits forming 
pockets.  
Potentials of mean force (PMF) profiles were subsequently obtained for [ϒ4E]-GID unbinding 
from each interface. We employed umbrella sampling and WHAM (described in Chapter 2) (392) 
to determine the PMF as a function of separation distance between the centres-of-mass (COM) of 
the [ϒ4E]-GID and the nAChR extracellular domain. “well depth” (or ∆Gwell after Rashid et al., 
Sci Reports 4, Article number: 4509 (2014)(393)), which for each profile is defined as the 
difference between the value of the PMF at furthest toxin-receptor separation, and the lowest 
value of the PMF (at close separation) obtained over the receptor-toxin distance covered in the 
present umbrella sampling simulations To acquire a PMF profile for each interface, a series of 
simulations (windows) are performed in which the separations between the COM of the peptides 
were restrained in each window by Hookean functions with force constants of 1000 kJmol-1nm-2. 
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Umbrella sampling covered a distance range of 0 to 55 Å for hα7 and up to 50 Å at the hα4β2 
receptor respectively, between the COM of [ϒ4E]-GID and the nAChR. Generally, adjacent 
windows were separated by a distance of 1 Å to each other. In some cases, the number of 
windows was increased between specific COM distances to correct problems of convergence in 
the WHAM procedure, or to provide further structural detail at specific distances.  A maximum 
number of 41 and 61 windows were used to sample unbinding pathways of [ϒ4E]-GID at the 
α4β2 and hα7 receptors respectively. Each selected window was equilibrated for 100ps with 1 ns 
of production MD simulation each. Overall 45ns and 65ns of simulation time were required to 
converge PMF at the hα7 and α4β2 receptors respectively. Analysis of results was performed 
using the g_wham function in the Gromacs suite(394). The centre-of-mass (COM) distance was 
calculated using g_dist from the Gromacs suite. The number of contacts made between loop C 
and the respective binding pockets of the hα7 and α4β2 receptor pockets within a cut-off of 4.5 Å 
were calculated using g_mindist from the Gromacs suite. The number of contacts between the 
receptor binding pockets and [ϒ4E]-GID have been also derived from the toxin-unbinding 
simulation trajectory (45-65ns or ~4000-5000 frames) or over particular separation distances 
between [ϒ4E]-GID and the binding pocket, consisting of 100 frames each. For example COM 
separation distances that were considered between [γ4E]-GID and the α7 receptor binding pocket 
were at 23,6Å, 28.5 Å, 38.5 Å and 52.5 Å, while at the rα4β2 receptor, COM distances of 24.4 
Å, 25.7 Å, 35.6 Å and 37.5 Å were considered. For the hα4β2 receptor, COM separation 
distances of 24.7 Å, 27.8 Å, 37.4 Å and 44.5 Å respectively were considered. From this data, the 
average number of contacts between the toxin and receptor was derived over the given time and 
has often been displayed in this chapter.  
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4.3. Results and Discussion 
4.3.1. Potentials of mean force profiles at all interfaces studied 
MD simulations and umbrella sampling were performed to determine the energy well-depth 
(ΔGwell)(395)  defined for each profile as the difference between the value of the PMF at furthest 
toxin-receptor separation and the lowest value of the PMF (at close separation) obtained over the 
receptor-toxin distance covered in the present umbrella sampling simulations, for [ϒ4E]-GID 
unbinding  at human α7 (hα7) and human and rat α4β2 (hα4β2 and rα4β2) receptors. We also 
identify the residues at both receptors and toxin which form interacting pairs during the course of 
unbinding; and to study the structural changes at both the receptor and toxin, associated with 
toxin unbinding.  
We note that while there are five α7(+)α7(-) and two α4(+)β2(-) interfaces in each of the two 
respective subtypes, unless otherwise noted, we will focus only on two types of pathways: 1) the 
interfaces associated with the highest predicted ΔGwell  value at each of the α7(+)α7(-) or 
α4(+)β2(-) interfaces; and 2)  the unbinding pathways associated with the lowest structural 
deformation of [ϒ4E]-GID and receptor loop C (also generally corresponding to profiles with 
lowes ΔGwell, as discussed in section 4.3.7). Both types of pathways are potentially important: 
the maximum-ΔGwell pathways involve generally more atomic contacts between toxin and 
receptor, and the identification of such high contact-number receptor regions (outside of the 
orthosteric site) may subsequently serve as input to experiments to determine whether they are 
biologically relevant in terms of conotoxin inhibition.  On the other hand, the lowest-deformation 
pathways involve least structural distortions, generally exhibit the lowest PMF values, and are 
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therefore most likely to be the highest frequently accessed unbinding pathways. Also, while the 
PMF obtained via MD simulation cannot be associated directly to the binding-free energy(396), 
we refer to PMF as ∆Gwell. Hence, ∆Gwell is the difference between the maximum and minimum 
PMF’s obtained, as defined above.    
In order to determine whether the simulation length per umbrella sampling window (i.e. 1 ns) 
was sufficient for convergence, we have employed block analysis to examine the change in 
estimated ΔGwell with respect to sampling window simulation length. In this analysis, we 
employed WHAM to determine the PMF of [γ4E]-GID unbinding from each interface using 
simulation trajectory ‘blocks’ of between 100 and 1000 ps in length, with increments of 100 ps. 
The ΔGwell values estimated from the respective PMFs with respect to trajectory length are 
shown in Fig. 4.1, which indicates that the difference in estimated ΔGwell value between 900 ps 
and 1000 ps vary by no more than 1 kcal/mol. Thus, 1ns windows appear to be sufficient for the 
obtaining reasonably converged PMF profiles. 
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Figure 4.1: The average predicted ΔG value obtained from the plateau region of potentials of mean 
force (PMF) profiles, calculated using WHAM on trajectories of varying length (from 100ps to 1000 
ps). 
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Figure 4.2: Potential of mean force (PMF) profiles of [ϒ4E]-GID unbinding from the canonical 
agonist binding site (distance ~0Å) at the hα7 (A), rα4β2 (B) and hα4β2 (C) receptor pockets 
respectively. Note that ‘Tox-3 of the α4β2 receptors correspond to α4α4 interfaces.  
 
The PMF profiles for all five interfaces of α7, all three interfaces of rat α4β2 and all three 
interfaces of human α4β2 are shown in Figure 4.2. The unbinding pathways with the maximum 
well depths are readily identified from this figure: namely, Tox-1 for α7, and Tox-3 at the rα4β2 
and Tox-2 at the hα4β2 receptor. These are discussed in detail in the following sections 4.3.2-
4.3.6. The path with least deformation of toxin and receptor are most likely to be the most 
frequently taken unbinding pathway, but require identification by examining the RMSD plots of 
the toxin and loop C; this is discussed in section 4.3.7, while the lowest-deformation pathways 
and their contacts involved are described in sections 4.3.8-4.3.10. We note that only one α4α4 
interface was examined each for the rat and human species subtypes; these are discussed in 
section 4.3.11.  
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4.3.2. Maximum-ΔGwell PMF profiles 
Figure 4.3 shows the overlaid maximum-ΔGwell PMF profiles of [ϒ4E]-GID with respect to 
distance from the binding pocket, for hα7 and rat/human α4β2 receptor interfaces. Inspection of 
the PMF curves suggests markedly different values of estimated ΔGwell for [ϒ4E]-GID at the 
interfaces studied, and suggests possible different unbinding pathways (discussed in the 
following sections). All of the interfaces exhibit maximum PMF values at COM separations of 
~25 Å, a distance at which [γ4E]-GID completely loses contact with the respective interfaces. At 
the hα7 receptor, the PMF reached a maximum value of~32.2  kcal.mol-1, while the  maximum 
PMF  at all other interfaces were substantially lower, ranging from ~25 kcal.mol-1 at the rα4α4 
and hα4β2 receptors, respectively. Thus, ΔGwell of the toxin from the hα7α7 interface is predicted 
to be higher than all of the interfaces present in the rα4β2 and hα4β2 subtypes. This observation 
is in accordance with experimental [ϒ4E]-GID-receptor electrophysiology studies which showed 
that [ϒ4E]-GID is more potent towards the α7 than the α4β2 receptor subtypes(397). Furthermore, 
such values are roughly consistent with those obtained previously for ImI unbinding from 
AChBP (338, 398).  
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Figure 4.3: Maximum- ΔGwell PMF profiles of [γ4E]GID unbinding from the canonical orthosteric 
site  at the hα7, hα4β2 and rα4β2 receptor pockets. 
 
Between a COM separation distance of ~20-30Å, the PMF at all interfaces steeply rise until a 
maximum stable PMF is reached. This rise in PMF is a result of the breaking of contacts between 
[ϒ4E]-GID and the receptor pocket. The relatively steep rise of the PMF at the hα7α7 interface 
(from ~17kcal/mol at 20Å to ~27kcal/mol at 30Å) suggests that [γ4E]-GID must break stronger 
interactions at the α7 receptor than at the α4β2 subtypes (for example, the hα4α4 interface only 
exhibits a rise from ~16kcal/mol at 20Å to ~20kcal/mol at 30Å) while exiting the respective 
binding pocket. Furthermore, the similarity in the PMF gradient between 20-30Å   for the rα4α4 
and hα4β2 interfaces suggests that [ϒ4E]-GID preferentially adopts a similar binding pathway at 
the two respective interfaces of the α4β2 subtype, while the unbinding pathway of hα7α7 differs 
markedly.  
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4.3.3 Maximum- ΔGwell unbinding pathways 
The differences in the maximum- ΔGwell PMF profiles of [γ4E]-GID at the interfaces examined 
suggests the possibility of distinct, qualitatively different interface-dependent unbinding 
pathways. To determine these differences, we have examined the trajectories of the umbrella 
sampling simulations of [γ4E]-GID unbinding at all of the interfaces. In addition, the average 
number of contacts has been calculated at various separation distances over the 1ns window (100 
frames).  At the hα7α7 interface, [ϒ4E]-GID makes considerable contact with residues along the 
axis of the loop C of the principal subunit as it exits the receptor binding pocket (Fig. 4.4A), 
while retaining close contact with the complementary subunit up to a toxin-receptor COM 
separation distance of ~40Å. The interaction during the course of unbinding suggests a possible 
binding mechanism whereby [ϒ4E]-GID first attaches to a location on the complementary 
subunit distant from the ligand binding site, and, via formation, breakage and subsequent re-
formation of toxin-receptor contacts, gradually interacts along the surface of the complementary 
subunit until it reaches the binding pocket. In particular, [ϒ4E]-GID between the adjacent hα7 
subunits (Fig. 4.4A and B) traverses steadily along the direction tangential to the loop C. [ϒ4E]-
GID is seen to move along this direction until it is in proximity to the Cys-Cys pair residues on 
the loop C of the adjacent subunit before changing direction to move at an angle ~30° to the axis 
of the channel. Liu and colleagues(399) also observed and described this motion in their studies of  
the unbinding of nicotine from AChBP using steered MD simulations, and concluded that the 
most favourable pathway for nicotine to enter the binding pocket was through the principal 
binding subunit following a curvilinear path. Yu and colleagues also observed that IMI favoured 
to unbind from the α7 receptor pocket in a direction opposite to the C-loop while studying the 
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unbinding of IMI from the α7 receptor pocket using RAMD simulations(338). Thus, our present 
results suggest that [ϒ4E]-GID may follow a similar binding mechanism to nicotine. In contrast, 
the unbinding pathway of [ϒ4E]-GID differs for the hα4β2 and rα4β2 interfaces. The toxin 
unbinds via a pathway that does not involve persistent contact with the complementary face, but 
rather, exits directly via a path that is approximately perpendicular to the surface of the α4β2 
interface (Fig. 4.4C and D). 
 
Figure 4.4: Combined umbrella sampling windows illustrating the unbinding pathways of [ϒ4E]-
GID out of the hα7 (different perspectives shown in (A) and (B)) and rat α4β2 (C and D) receptor 
binding pockets respectively. Centre-of-mass distances between the principal subunit and the toxin 
are indicated in (A) and (C). [ϒ4E]-GID is seen to make contact with the residues of the adjacent 
receptor subunit as it makes its path away from the respective binding pocket. In comparison to the 
hα7 nAChR [ϒ4E]-GID does not make as many contacts with the residues of the adjacent receptor 
subunit as it makes its way away from the extracellular domain of the β2 subunit. The Cys loop has 
also been highlighted to appreciate any changes in secondary structure as the toxin separates from 
the binding pocket 
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Thus, the number of receptor residues which make contact with [ϒ4E]-GID along the chosen 
unbinding pathway (based on the highest PMF exhibited and the lowest RMSD exhibited by 
[ϒ4E]-GID) for both human and rat α4β2 receptor subtypes examined is lower than that for hα7, 
and this may partly explain the lower potency of [ϒ4E]-GID at the former subtype as well. In 
addition, the exit path taken by [ϒ4E]-GID at the human and rat α4α4 receptor pockets were 
similar to that noted at the respective α4β2 interface (Fig. 4.5). The existence of distinct 
unbinding pathways depending on interface (one for hα7α7, and another for hα4β2, hα4α4, 
rα4β2 and rα4α4) strongly suggests that differences in the mechanism of initial interaction 
between the conotoxin and nAChR are related to the toxin’s inhibitory potency. We suggest that 
an unbinding pathway which involves closer association with the complementary subunit (as in 
Fig. 4.5A and B) may be related to higher potency. Therefore, more generally, qualitative 
examination of the unbinding pathway may provide one extra, possible criteria by which to judge 
the potential nAChR inhibition properties of newly designed or discovered conotoxins. It is 
interesting to note that Yu et al.(400) found that both ImI and PnIA exhibited similar unbinding 
pathways at AChBP. They concluded that different conotoxins (even with different number of 
residues) may have similar interaction pathways with AChBP. Our present study shows that, on 
the other hand, the same conotoxin might exhibit different unbinding pathways depending on the 
subunit composition of the interface. Thus, we propose that it is the receptor that determines the 
unbinding pathway, rather than the conotoxin. Further work on other conotoxin/nAChR 
complexes is required to explore this area further. 
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Figure 4.5: Shows concatenated umbrella sampling windows illustrating the unbinding pathways of 
[ϒ4E]-GID from the rat α4α4 (different perspectives shown in (A) and (B)) and human α4α4 (C and 
D) receptor binding pockets respectively. The X (blue), Y (green) and Z (red) axes are indicated by 
thick coloured arrows at the bottom left corner of each panel. 
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4.3.4. Residues involved in [ϒ4E]-GID interaction with α7α7: maximum ΔGwell 
pathway (‘Tox-1’) 
To shed further light on differences in interactions during [γ4E]-GID unbinding from hα7 and 
the rat and human α4β2 subtypes, we have determined specific toxin and receptor residues which 
made significant contact with each other along the most energetically favourable unbinding 
pathway at each interface. The residues identified from this analysis may subsequently be probed 
by experimental site-directed mutagenesis studies.  
At hα7α7 (Fig. 4.6), the overall unbinding mechanism involves the following interactions: at far 
separation, most of the contacts are formed at the complementary subunit, mainly by the loop II 
residues of [ϒ4E]-GID. A few contacts are made at the principal subunit (especially E211 and 
C212). Then as the toxin nears the canonical binding pocket, more contacts begin to be formed at 
the principal subunit with loop I residues of [γ4E]-GID starting to contribute to these contacts. 
Then once the toxin is firmly embedded into the binding pocket, the aromatic cage residues of 
both faces of the receptor also form contacts with [ϒ4E]-GID. Finally, the N-terminal IRDE 
residues of [γ4E]-GID also then contribute to contacts with the receptor.  
Several specific interactions are worth noting. At the furthest separation examined, the first 
contacts that are formed involve [ϒ4E]-GID-O16/H17 with hα7(-)-Q49 (Fig. 4.6B and D) at a 
COM distance of ~52 Å. At a closer distance of ~38.5Å, [γ4E]-GID-R12 and other neighbouring 
residues form further contacts with the receptor, mostly with hα7(-)-Q79. Though outside the 
canonical binding pocket, the importance of this residue is highlighted by previous studies 
indicating that the mutation of α7-Q79E reduced its activation by the agonist neo-nicotinoid 
insecticides(401). At this separation, hα7(-)-Q183 also forms contacts with [γ4E]-GID-R12 and 
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surrounding residues. Interestingly, hα7(-)-Q183 and E184 were also identified by Yu et al.,(402) 
as one of the important residues at the mouth of the binding pocket with which α-conotoxin ImI 
was found to associate in several unbinding sub-pathways. Another nearby residue, D186, is also 
known to play a role(149). At a closer distance of 28.5Å, the most number of contacts were formed 
by hα7(-)-Q79 and L141, which have also been shown to form close contact with apoE-derived 
peptides(403). At 23.6Å, the IRDE-tail of [γ4E]-GID begins to interact strongly with hα7(+)-R208 
to C213; residues in this region have been identified to play an important role in the agonist 
binding pocket of the receptor though cation-π interactions(35, 404-406), (407, 408). Previous studies 
have also shown ImI-R7 to interact strongly with α7-Y217 via cation-π interactions(407, 408), 
where it was suggested that this interaction helped fix ImI firmly into the receptor pocket. hα7(-
)-Q79 was also identified by experimental methods to  play a role in ImI binding(149). Other 
residues with high numbers of interatomic contacts at close toxin-receptor separation, including 
hα7-L131 and Q139 (Figure 4.6B), were also identified by previous studies to form van der 
Waals interactions with ImI-A9 at the binding pocket (409). From the interactions described 
above, it is suggested that [ϒ4E]-GID is well seated in the aromatic box constituted by most of 
the above hα7(+) residues. The aromatic box is hence of much apparent importance for both 
agonist and α-CgTx binding. 
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Figure 4.6: Plots of number of inter-atomic contacts between receptor residues of the principal (A) 
and complementary (B) subunits of the hα7 receptor binding pocket-1 with [γ4E]- GID, at a 
number of selected centre-of-mass separation distances (colour coded as indicated in the legends). 
Also shown are the number of inter-atomic contacts between each [ϒ4E]-GID residue and the 
principal (C) and complementary (D) subunits of hα7. 
 
4.3.5. Residues involved in [ϒ4E]-GID interaction with rat and human α4β2: 
maximum ΔGwell pathways (‘Tox-2’) 
At rα4β2 (Fig. 4.7) and hα4β2 (Fig. 4.8), the overall unbinding mechanism differs in important 
respects from that of hα7α7, and involve the following interactions: at long separation (above 35 
Å), contacts are made with both principal and complementary subunits (unlike that of hα7α7, 
which at far toxin-receptor separation mainly involve contacts with the complementary face 
only). These principal-subunit contacts at far separation mainly involve interactions with the 
loop II residues (R12-H17), and include α4(+)-Y-226 and the vicinal disulphide α4(+)-C227 and 
C228. The above contacts are further increased when the toxin is closer to the canonical binding 
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site (at toxin-receptor separations below 26 Å). Additionally, at far separation, although contacts 
are made between [γ4E]-GID and α7(-)-Y54 (Fig. 4.6B), no contacts are made at all with the 
equivalent position at rat β2(-)-Q58 (Fig. 4.7B) and far fewer for human β2(-)-Q58 (Fig. 4.8B). 
Also different from hα7α7 is the fact that contacts with the vicinal disulfide residues are 
decreased when the toxin is nearly embedded into the canonical binding site, compared to larger 
separation. Thereafter, the contacts are qualitatively similar to hα7α7; for example, the IRDE tail 
of [ϒ4E]-GID mainly forms contact with the receptor only when it is embedded into the 
canonical binding pocket, where aromatic cage residues (including α4(+)-W184, Y226 and β2(-)-
F143)) of both faces of the receptor also contribute to interactions. In the following sections, we 
consider a number of specific inter-residue contacts between receptor and toxin, with particular 
attention to regions around the loop C vicinal disulfide (which have been proposed to play 
especially important roles in facilitating conotoxin inhibition) and α4-R-185 (and its α7 
equivalent), proposed to be responsible for the peculiar absence of known conotoxins targeting 
α4-containing nAChR subtypes.  
Regarding differences between hα7 and rα4β2 / hα4β2 in loop C vicinal disulfide contact with 
[γ4E]-GID, one notable difference is that higher number of contacts were maintained at hα7(+)-
C212 (~100 contacts, Fig. 4.6A) of the Cys-Cys residue pair compared to that at rα4(+)-C227 at 
a COM separation distance of ~25-35Å (~50 contacts, Fig. 4.7A). A similar interaction involving 
Cys residues at the [γ4E]-GID-C5 and C11 was also noticed in previous toxin studies involving 
Vc1.1(153) , RgIA (at α9α10)(410) and AuIB (at α3β4)(411), where the studies highlighted the 
importance of the double cysteine residues for inhibition by conotoxins. Our present results 
indicate that [γ4E]-GID made more contact with the double cysteine residues at the hα7(+), 
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while at the rα4β2 and hα4β2 pockets, [γ4E]-GID made more contact with the complementary 
face of the binding pocket. In addition, a higher number of contacts were observed between 
residues rα4(+)-S183 to D187 (which lie on an adjacent strand to loop C) compared to the 
corresponding residues on the hα7(+) subunit. This indicates that [γ4E]-GID was positioned 
differently at both receptor pockets and also suggests the significance of the Cys-Cys pair 
residues in ligand binding.        
 
Figure 4.7: Plots of number of inter-atomic contacts between receptor residues of the principal (A) 
and complementary (B) subunits of the rα4β2 receptor binding pocket-2 with [γ4E]-GID, at a 
number of selected centre-of-mass separation distances (colour coded as indicated in the legends). 
Also shown are the number of inter-atomic contacts between each [ϒ4E]-GID residue and the 
principal (C) and complementary (D) subunits of rα4β2. 
 
The N-terminal IRDE-motif tail of [γ4E]-GID contribute to the interactions at the α7(-) (Fig. 
4.6D) subunit in contrast to the lack of interaction of this segment with the rβ2(-) and hβ2(-) 
subunits (Fig. 4.7D and 4.8D). It was also noticed that R208 (corresponding to R185) on the 
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α7(+) face made less number of contacts (~20 at ~28 Å and ~40 at 23 Å) compared to rα4(+)-
R223, which makes a relatively high number of contacts (~50 contacts) even at a COM 
separation distance of ~26Å. These observations are relevant to the study made by Beissner and 
colleagues, where they showed that conotoxin TxIA-binding was adversely affected by the 
presence of R185 (corresponding to R223 in the present work) on the α4 subunit that protruded 
into the binding pocket(412). Amongst the tail residues that did make contact with α4(+)-R185, we 
found [γ4E]-GID-R2 contributed the most. Hence, we suggest that the unfavourable electrostatic 
repulsion with R185 made with [γ4E]-GID[R2] might be partially mitigated by replacement with 
an uncharged residue with a less voluminous sidechain, such as Gly (though not Ala, which is 
known to result in loss of inhibition at α4β2). 
 
 
Figure 4.8: Plots of number of inter-atomic contacts between receptor residues of the principal (A) 
and complementary (B) subunits of the hα4β2 receptor binding pocket with [γ4E]-GID, at a 
number of selected centre-of-mass separation distances (colour coded as indicated in the legends). 
Also shown are the number of inter-atomic contacts between each [ϒ4E]-GID residue and the 
principal (C) and complementary (D) subunits of hα4β2. 
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When [ϒ4E]-GID was well within the canonical binding pocket at a COM distance of ~27 Å, the 
strongest interactions were contributed by α4(+) residues Y223(~71 contacts), E224(~13 
contacts) and Y230(~18 contacts) at both hα4β2 and hα4α4 interfaces. [ϒ4E]-GID-R2,C5, N8, 
P9,A10, C11, N14 and N15 contribute to the interaction with the α4(+) subunit, while on the β(-) 
face, interactions were found to mostly originate at loop-II of [ϒ4E]-GID, beginning at [ϒ4E]-
GID-S7 to P9, R12,V13 N14. Although these interactions at small COM separation distances 
occurred due to the formation of hydrogen bonds, Janes showed that at the human α4β2 receptor, 
[γ4E]-GID-E4 was also found to form salt-bridges with α4(+)-R221 and Y223 respectively(142). 
Although the residues 222-235 are found to be conserved, R221 is of importance to binding at 
the α4β2 receptor. The position of this residue is shown in Fig. 4.9. The equivalent α7-Arg208 is 
shown in Fig. 4.14A, while α4-R221 is shown in Fig. 4.14B. At this distance of separation, the 
β2(-) subunit residue interactions particularly with T83 and F144 are of interest as these residues 
have also shown importance in nicotine binding(413). Mutant [ϒ4E, R12A]-GID has also showed 
a complete loss of activity according to previous studies (328, 329). 
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Figure 4.9: Shows the presence of R221 at the principal face of the α4β2 receptor pocket that 
protrudes within the binding pocket (Panel C) and behaves as a hindrance to [ϒ4E]-GID binding 
properly at the receptor pocket. However, at the α7 receptor binding pocket, R208 on the α7 (+) 
face poses no hindrance to [ϒ4E]-GID binding. 
 
4.3.6. Loop C structural behaviour at maximum-ΔGwell pathways 
The behaviour of loop C is worth closer examination here as it is known to be closely correlated 
with channel opening (414). The inhibitory activity of conotoxins is likely to stem from their 
modulation of the structure and motion of this key segment of the extracellular domain. Thus, the 
properties of the loop C is an additional consideration in determining the atomic-level influences 
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of [ϒ4E]-GID binding to the hα7 and α4β2 subtypes, which may further help explain the 
differential activity of the conotoxin at these receptors. To determine the role of [ϒ4E]-GID’s 
interaction with the hα7 receptor in the opening/closing motion of the loop C, we measured the 
COM distance between C212-sulphur on the loop C and the Cα atom of Y115 on the β sheet of 
the complementary subunit of the hα7 receptor (which serves as a rough approximate of loop C 
‘closure’), with respect to the [ϒ4E]-GID-nAChR distance along the umbrella sampling 
pathways (Fig. 4.10). Similar plots are shown for the corresponding residues at hα4β2 and rα4α4 
interfaces.   
 
Figure 4.10: Distance between the Cys residues at the ‘tip’ of loop C and a selected position at the 
complementary subunit for hα7, hα4β2 and rα4α4 interfaces with respect to toxin-receptor COM 
separation. A gradual closure of the binding pocket at the hα7 receptor is observed, much more 
clearly than at either of the other interfaces. 
 
Figure 4.10 shows that at a distance of ~30 Å along the [γ4E]-GID-nAChR distance, the loop C 
distance begins to gradually decrease from ~21 Å to ~16 Å at the hα7 receptor subunit interface. 
Around this time frame, visual inspection also confirmed that [ϒ4E]-GID was interacting with 
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the residues mentioned earlier on the complementary subunit. However, this gradual closure is 
not observed at rα4β2, where the distance between α4-C227-sulphur  and the Cα carbon atom of 
β2-Q58 show a sudden drop in inter-atomic distance from ~18 Å to ~12 Å beyond a COM 
distance of ~25 Å along the [γ4E]-GID-nAChR distance (not shown). Similar to our results, 
Pavlovicz and colleagues (415) also show that at the rat α4β2 receptor, the distance between the 
α4-C191 Cα atom at β2(-)-Q58  was 19.24 Å when the binding pocket contained α-conotoxin 
IMI. Visual inspection of the simulation trajectory reveals that at the rα4β2 receptor, this point 
on the [γ4E]-GID-nAChR distance marks the final few interactions on the complementary β2 
subunit (as mentioned above), before [ϒ4E]-GID begins to move towards the upper regions of 
the extracellular domain, away from the agonist binding pocket. At the human α4β2 receptor, a 
small drop in loop C distance (from ~20Å to ~16Å) is also observed at COM distance of ~30 Å 
between [ϒ4E]-GID and the principal face of the receptor. This change is small in comparison to 
the loop C distance at the rat subtype. However, similar to the rat-α4β2 subtype, the loop C 
distance at the hα4α4 subunit interface is more or less higher than at the other two binding 
pockets.   
The loop C distance at the rα4α4 subunit interface is strikingly distinct from that of the α4β2 
subunit interface (especially between 30-50 Å). Between the distances of 30-50 Å, the loop C is 
seen to close back into the adjacent subunit more quickly at the α4α4 subunit pocket in 
comparison to the other two α4β2 subunits, thereby closing the mouth of the binding pocket. At 
this point [ϒ4E]-GID was also seen to make slight contact with the complementary α4(-) 
subunit. This could mean that interaction of [ϒ4E]-GID residues with the complementary 
subunit residues of the α subunits might be important for the receptor pocket to recognise [ϒ4E]-
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GID. Overall, the results indicate that loop C of hα7 undergoes more fluctuation (more readily 
‘opens’ and ‘closes’) than rat and human α4β2, and thus ‘relaxes’ more rapidly than the latter 
subtypes in the course of [γ4E]-GID unbinding. This could indicate more ready accommodation 
of the binding site to [ϒ4E]-GID  for the hα7, which more rapidly ‘opens its door’ to allow the 
conotoxin access to the canonical binding site, compared to that of the α4β2 interface.  
We also compared the loop C-complementary subunit distance for the AChBP structure bound to 
ImI (PDB ID: 2BYP), as well as AChBP in the apo-state (PDB ID: 2W8E), with our hα7, hα4β2 
and rα4β2 receptor interfaces at the beginning and end of the umbrella sampling trajectories (i.e. 
with the conotoxin fully bound within the canonical binding site, and with the conotoxin fully 
extracted from the binding site). This is shown in Fig. 4.11. Close similarities in loop C distances 
were observed. It is interesting to note that the ‘initial’ (toxin bound) and ‘final’ (toxin extracted) 
loop C distances are very similar for all of the interfaces examined, with the toxin-extracted 
distances around 15Å, similar to that of the apo-AChBP structure, while the [γ4E]-GID-bound 
structures have loop C distances of around 20Å, also similar to the corresponding distance for 
ImI-bound AChBP. The difference between the toxin-bound and toxin extracted (closed) C-loop 
distance is greater for the neuronal nicotinic receptors compared to that of the AchBP structures, 
suggesting greater flexibility in loop C which might enable a better acceptance to 4/7 conotoxin 
such as [ϒ4E]-GID. The agreement of our structures with those from the experimentally-
determined AChBP structures lends support to the validity of our simulations, in the following 
sense:  the template used to build the homology model of α7 was indeed the AChBP structure 
(PDB ID: 2BR8). However, this AChBP template was bound to a conotoxin PnIA variant; thus 
the α7 homology model (bound to [γ4E]-GID) also corresponds to that of the inactive state, with 
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‘open’ loop C. After pulling of the toxin out of the binding pocket, loop C adopted a 
conformation that was consistent with the apo state, with a similar extent of loop closure to that 
of apo AChBP (PDBID: 2BYN), which was not used as the template. Thus, the simulations were 
able to reproduce an apo-like conformation after the toxin exited the pocket, whilst starting from 
an inactive inhibitor-bound conformation. This is indeed expected, and not surprising, but lends 
support in the sense that the simulations were at least of sufficient length to sample an apo-like 
conformation, starting from an inhibitor-bound, inactive conformation, once the inhibitor ([γ4E]-
GID) was removed.  
 
Figure 4.11: Loop C distances at the start (toxin still bound at canonical agonist binding site; blue) 
and end (after toxin fully removed from canonical binding site; red) of the respective umbrella 
sampling trajectories at the hα7, rα4β2 and the rα4β2 receptors. The loop C distances are 
compared to that of the AChBP structure in the apo state (left-most bars; blue) and with ImI bound 
to the canonical binding pocket (left-most bars; red). 
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4.3.7. Minimum-deformation pathways: selection based on toxin and receptor-
loop C structural changes 
In order to aid selection of the PMF profile corresponding to the least deformation of the toxin 
and the receptor residues in its vicinity, the RMSD of [ϒ4E]-GID was analysed during the 
unbinding process at all 5 binding pockets of the hα7 receptor and 3 binding pockets of the 
human and rat α4β2 receptors respectively (Fig 4.12). The RMSD of [ϒ4E]-GID at the 
respective binding pocket was derived based on the superimposition of the respective C-alpha 
carbon atoms. At the hα7 receptor, [γ4E]-GID at position 5 showed the lowest RMSD, while at 
the rα4β2 receptor, [γ4E]-GID at position 1 showed lowest average RMSD; at the hα4β2 
receptor GID at position-2 showed the lowest RMSD in comparison to the other binding pockets. 
Hence, the unbinding process and interacting residues at hα7 pos-5 and rα4β2 pos-1 was alone 
added into this thesis. In addition, the unbinding process of [γ4E]-GID at position 2 has already 
been analysed in this thesis.  
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Figure 4.12: Shows the fluctuation in RMSD of [ϒ4E]-GID as it unbinds from the Human α7 (A), 
Rat α4β2 (B) and Human α4β2 (C) receptors respectively. 
 
The RMSD of the C-loop was also analysed at each of the receptor binding pockets at the hα7, 
rα4β2 and hα4β2 receptors respectively (Fig 4.13). It is interesting to note that the toxins that 
showed the lowest RMSD during the unbinding process from the respective receptor pockets 
showed a comparatively larger C-loop RMSD compared to the other receptor positions. 
However, even this difference in C-loop RMSD is not large. Hence, we take into account the 
toxin positions that showed the lowest RMSD during the unbinding process. Based on the 
RMSD of [γ4E]-GID, at the hα7 receptor, [γ4E]-GID at position-5 was analysed, while at the 
rα4β2 receptor [γ4E]-GID at position-1 was analysed as the minimum-deformation pathways. 
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Figure 4.13: Shows the changes in RMSD of the C-loop at the Human α7 (A), Rat α4β2 (B) and 
Human α4β2 (C) receptor binding pockets respectively. Toxins that showed the lowest RMSD 
during the unbinding process showed a comparatively larger C-loop RMSD. 
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4.3.8 Minimum-deformation PMF profiles and unbinding pathways 
 
Figure 4.14: Minimum- ΔGwell PMF profiles of [γ4E]GID unbinding from the canonical orthosteric 
site  at the hα7, hα4β2 and rα4β2 receptor pockets. 
 
 
Figure 4.14 shows the overlaid ΔGwell PMF profiles of [ϒ4E]-GID, based on the lowest 
deformation pathway with respect to distance from the binding pocket, for hα7 and rat/human 
α4β2 receptor interfaces. Inspection of the PMF curves suggests markedly different values of 
estimated ΔGwell for [ϒ4E]-GID at the interfaces studied, and suggests possible different 
unbinding pathways (discussed in the following sections). [ϒ4E]-GID toxin-5 at the hα7 receptor 
that showed the lowest deformation unbinding pathway reveals a quite steep increase in PMF till 
~5.4 kcal.Mol-1 at 10Å, after which the PMF is again seen to gradually increase in steps, where 
the PMF reaches ~8.3 kcal.Mol-1 at 20Å. Beyond this point, at ~30.7Å [ϒ4E]-GID exhibits a 
maximum of 11.7 kcal.Mol-1 and flattens out further. The gradual increase in PMF seen at the 
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hα7 receptor suggests that throughout the simulation, [ϒ4E]-GID was well in contact with the 
walls of the receptor compared to the α4β2 receptors. [ϒ4E]-GID at the rat and hα4β2 receptors 
show a steep increase in PMF to ~17.3 kcal.Mol-1 till about 20Å, after which the PMF slope 
flattens out but gradually increases to a maximum of ~20.7 kcal.Mol-1 at ~50.7Å. Similar to the 
PMF profile at the rα4β2 receptor, the hα4β2 receptor, [ϒ4E]-GID at position 2 shows a steep 
increase in PMF of ~23 kcal.Mol-1 close to ~18Å. Beyond this point, The PMF reaches a 
maximum of 26.8 kcal.Mol-1 at ~24Å. Comparison of the unbinding profiles suggests that [ϒ4E]-
GID at position-5 at the hα7 receptor breaks away more easily from the receptor pocket than that 
at the human and rat α4β2 receptor. However, the fact that these [ϒ4E]-GID profiles were 
chosen as they showed minimum deformation also suggests that low number of contacts were 
maintained with the receptor pocket during the unbinding simulations compared to the pathways 
that showed the maximum PMF profile. 
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Figure 4.15: Combined umbrella sampling windows illustrating the unbinding pathways of [ϒ4E]-
GID out of the hα7 (different perspectives shown in (A) and (B)) and rat α4β2 (C and D) receptor 
binding pockets respectively. In comparison to the hα7 nAChR in Fig.4.4 [ϒ4E]-GID does not make 
as many contacts with the residues of the adjacent receptor subunit as it makes its way away from 
the extracellular domain of the α7(-) subunit. The X (blue), Y (green) and Z (red) axes are indicated 
by thick coloured arrows at the bottom left corner of each panel. The Cys loop has also been 
highlighted to appreciate any changes in secondary structure as the toxin separates from the 
binding pocket. 
 
 
The differences in the minimum deformation PMF profiles of [γ4E]-GID at the interfaces 
examined suggests the possibility of distinct, qualitatively different interface-dependent 
unbinding pathways. At the hα7α7 position-5 interface (Fig. 4.15(A, B)), [ϒ4E]-GID makes 
contacts with residues close to the Cys-Cys residue pair at a distance of ~25Å. However, most of 
the contacts made between [γ4E]-GID and the receptor subunits are either similar or much less 
Chapter 4:  Unbinding pathways of α-conotoxin [ϒ4E]-GID at the α7 and α4β2 
subtype receptors 
       
207 
 
(less than double) than the average number of contacts established by [γ4E]-GID at position-1. 
For instance, at position-5, the average number of contacts made residues Y210, E211, Y217 
with [ϒ4E]-GID at a COM separation distance of 25Å were ~133, 3 and 89 contacts 
respectively. However, at position-1 [γ4E]-GID showed ~143 contacts(Y210), ~18 
contacts(E211) and 127 contacts(Y217).  At a COM distance of ~30Å between the receptor and 
[γ4E]-GID, again less number of contacts were seen at the hα7 binding pocket at position-5 than 
at position-1. The number of contacts computed from various COM separation distances between 
the receptor pocket and [ϒ4E]-GID also showed similar differences in contact between positions 
1 and 5.  Further Inspection of the unbinding trajectory at position 5 of the hα7 receptor also 
showed that [ϒ4E]-GID did not establish much contacts with the complementary hα7(-) face of 
the receptor compared to that established by [ϒ4E]-GID at position-1. The unbinding trajectory 
of [ϒ4E]-GID at the hα7 position-5 seemed more like that of [ϒ4E]-GID at the α4β2 receptors. It 
could also be suggested that these contacts with the complementary subunit (or lack thereof) 
coupled the comparatively less number of contacts with [ϒ4E]-GID at position-5 may have 
certainly influenced the PMF curve. However, at the hα4β2 and rα4β2 interfaces (Figure 4.15 
(C),(D)), the unbinding trajectory of [ϒ4E]-GID was similar to that observed at the other α4β2 
interfaces seen before (Section 4.3.3). From these results, we suggest that [ϒ4E]-GID 
establishing contacts with the complementary face of the receptor is of importance with regards 
to binding.  
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4.3.9. Residues involved in [ϒ4E]-GID interaction with α7α7: minimum-
deformation pathway (‘Tox 5’) 
 
 
Figure 4.16: Plots of number of inter-atomic contacts between receptor residues of the principal (A) 
and complementary (B) subunits of the hα7 receptor binding pocket-5 with [γ4E]- GID, at a 
number of selected centre-of-mass separation distances (colour coded as indicated in the legends). 
Also shown are the number of inter-atomic contacts between each [ϒ4E]-GID residue and the 
principal (C) and complementary (D) subunits of hα7. 
 
 
At the hα7 receptor, apart from the [γ4E]-GID toxin-1, that does show the highest ∆Gwell , it is 
also worth considering the toxin-5 that shows the lowest RMSD of the 5 toxins. Toxin 5 shows a 
maximum RMSD of ~2.3Å (Figure 4.12A). We consider toxin-5 with the belief that the ideal 
unbinding path will most probably exhibit the least deformation to the toxin and hence the 
receptor in comparison to the unbinding pathways of [γ4E]-GID at the hα7 receptor. On 
comparing the contacts made at the toxin-1 with the contacts made at toxin-5, it is clear toxin5 
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exhibits comparatively less number of contacts. The comparatively less number of contacts 
exhibited by toxin-5 could result in a lower RMSD observed. In the subsequent paragraphs the 
interactions made by [γ4E]-GID toxin-5, with the surrounding hα7 receptor subunits is described 
(fig 4.16).  
The unbinding interactions are similar to those identified for the maximum-ΔGwell pathways 
described above. For the principal face, the numbers of contacts are comparable between the 
max-ΔGwell and minimum-deformation pathways. However, for the complementary face, there 
are less total number of contacts for the minimum-deformation pathway (the maximum number 
of interatomic contacts for the max-ΔGwell pathway is nearly 190, for R12 at α7(-); while it is 
only ~150 contacts for the minimum-deformation pathway described here).  
The overall unbinding mechanism for the minimum-deformation pathway involves the following 
main interactions: at far separations (51Å to 38 Å), only the complementary face makes contact, 
mainly via α7(-)-Q79, Q183 and Q184. Specifically, at 51Å and 41Å, loop II residues R12 and 
V13 make contact with α7(-)-Q183 and α7(-)-Q184. At 38 Å, in addition to the above contacts, 
residues P9 and O16 also contribute, and form contacts with α7(-)-Q79. From the observed 
interactions, above a COM separation distance of 30Å, it can be hypothesised that the residues 
closer to the C-terminus of the toxin played a more important role in recognising the binding 
pocket than those at the N-tail. This is in agreement with Millard’s study that showed that 
mutation of [γ4E]-GID residues P9, R12 and V13 to Alanine showed significant loss in receptor 
activity at the α7 receptor while the  truncation of the N-terminal [γ4E]-GID tail resulted in no 
difference in activity at the same(416). Only below 29 Å (with the toxin within the binding pocket) 
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do the loop 0 (RDE) residues form contacts with the receptor, mainly at the principal face, with 
R2 and E4 in contact with α7(+)-R208 to C212.  
With the toxin in the binding pocket, the loop I residues (N8, P9, A10) make contact with the 
aromatic cage residues at the principal face (α7(+)-Y115, W171, Y210, Y217); while the loop II 
residues (R12, V13) make contact with aromatic cage residues at the complementary face (α7(-)-
Y54 and W77)). Notably, I1 makes negligible contact with the receptor throughout the unbinding 
pathway, and this is consistent with the known retained potency of the mutant [γ4E, I1A]-GID at 
α7(417). Finally, there is close contact between the cysteine sulphurs of C5-C11 with those of the 
receptor loop C, with ~40 interatomic contacts formed at α7(+)-C212 at the closest toxin-
receptor separation. The number of contacts involving α7(+)-C212 and C-213 is higher at 
reduced toxin-receptor separation compared to that at larger separation, as similarly observed for 
the maximum-ΔGwell unbinding pathway (section 4.3.4). 
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4.3.10. Residues involved in [ϒ4E]-GID interaction with rat α4β2: minimum-
deformation pathway (‘Tox-1’) 
 
Figure 4.17: Plots of number of inter-atomic contacts between receptor residues of the principal (A) 
and complementary (B) subunits of the rα4β2 receptor binding pocket-1 with [γ4E]-GID, at a 
number of selected centre-of-mass separation distances (colour coded as indicated in the legends). 
Also shown are the number of inter-atomic contacts between each [ϒ4E]-GID residue and the 
principal (C) and complementary (D) subunits of rα4β2. 
 
As in the case of the hα7 receptor, the average RMSD of [γ4E]-GID from the unbinding pathway 
was calculated and compared. [γ4E]-GID at the rα4/β2 binding pockets (positions 1 and 2) 
showed RMSD averages of 1.7Å and 2Å respectively. Based on the RMSD results, [γ4E]-GID at 
position-1 of the rα4β2 receptor is studied. Similar to the case of the hα7 receptor, [γ4E]-GID at 
position-1 of the rα4β2 receptor showed a comparatively less number of contacts on average 
when compared to [γ4E]-GID at position-2. No other differences in interacting residues were 
noted. In the subsequent paragraphs the interactions made by [γ4E]-GID toxin-5, with the 
surrounding hα7 receptor subunits is described. We note again that the hα4β2 minimum-
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deformation pathway coincides with that of the maximum-ΔGwell pathway, which is discussed in 
section 4.3.5. Thus we focus on comparison of the rα4β2 and α7 minimum-deformation pathway 
below. 
As with α7, the unbinding interactions for the minimum-deformation unbinding pathway for 
rα4β2 (Fig. 4.17) is similar to those identified for the maximum-ΔGwell pathways described in 
section 4.3.4. Furthermore, for rα4β2, the minimum-deformation pathway also involves lower 
number of interatomic contacts compared to the max-ΔGwell pathway; in particular, while the 
max-ΔGwell pathway has a maximum contact number of ~190 (at R12), the highest contact 
number for the minimum-deformation pathway presently discussed is only ~140, also at R12.  
The overall unbinding mechanism for the minimum-deformation pathway involves the following 
main interactions: at the furthest separation examined (40Å), the only interaction is between I1 
and β2(-)-D189, and this involves an electrostatic contact involving the positive N-terminus and 
the Asp sidechain. Millard’s study also showed that the [γ4E, I1A]-GID mutant is known to have 
markedly reduced potency at α4β2 compared to [γ4E]-GID (though it does not eliminate potency 
altogether). Additionally, at far separation, although contacts are made between [γ4E]-GID and 
α7(-)-Y54 for the minimum-deformation pathway (Figure 4.16B) as well as the maximum-ΔGwell 
pathway (Fig. 4.6B), no contacts are made at all with the equivalent position at rat β2(-)-Q58 
(Fig. 4.17B) for the minimum-deformation pathway. At 36Å, for the principal α4(+) face, the 
loop II residues (N8, P9, A10) form contacts primarily at α4(+))-Y225; while at the 
complementary face, R12 and V13 make contact mainly with K187. Once again, alanine scan 
mutagenesis experiments have shown that disturbance to [γ4E]-GID residues N8, P9 and R12 
caused a complete loss of activity at the α4β2 receptor(416).  Below 27 Å (with the toxin within 
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the binding pocket) the loop 0 residues D3 and E4 form contacts with the receptor, mainly at the 
principal face; the D3A mutant is known to eliminate [γ4E]-GID inhibition at α4β2(417).  
However, we note that R2 makes negligible contact throughout the minimum-deformation 
unbinding pathway, in contrast to α7 where R2 makes ~120 contacts. This result is difficult to 
explain, given the known loss of activity at α4β2 of the [γ4E, R2A]-GID mutant, and most likely 
suggests a limitation in the conformational sampling of the present umbrella sampling 
simulations, especially for the highly flexible loop 0. Though much more simulation and 
experimental work must be done to test this, we propose the following speculative mechanism 
and explanation for the known elimination of potency of R2A mutant (while acknowledging that 
our simulations only examine unbinding pathways): when [γ4E]-GID is far from the α4β2 
receptor, one of the first interactions might be between I1 and β2(-)-D189 (as suggested by 
Figure 4.17D). It is possible that mutating R2 (which is, of course, in close proximity to I1) to a 
neutral residue disrupts, or at least reduces, the strength of the initial I1 contact with β2(-)-D189. 
The cause for this reduction in I1 affinity for β2(-)-D189 could be reduction of the nominal +2 
charge for (wild type) I1-R2 to +1 for (mutant) I1-R2A. However, as mentioned above, I1A 
mutation only reduces the potency of [γ4E]-GID, but does not eliminate it altogether as R2A 
does; therefore the above proposed mechanism cannot fully explain the effects of R2A mutation 
on [γ4E]-GID activity at α4β2. It is also possible that R2, while not making direct contact with 
α4β2, nevertheless serves to indirectly facilitate contact of the surround [γ4E]-GID residues (I1, 
D3 and E4) with α4(+) (Figure 4.17C) at close toxin-receptor separation.  We stress, again, that 
this is speculative, and further work, such as direct simulation of the [γ4E]-GID mutants binding 
to α4β2, is required.  
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Finally, with the toxin in the binding pocket, at a separation of 23Å, the loop I residues (N8, P9, 
A10) make contact with the aromatic cage residues at the principal face (mainly α4(+)-Y225 and 
Y232); while the loop II residues R12 and V13 (both known to be crucial to α4β2 inhibition by 
[γ4E]-GID) make contact with the complementary face (mainly α4(-)-F143 and L145)). Contacts 
are also formed between the cysteine sulphurs of C5-C11 and those of α4(+)-C227 and C228; 
however, in contrast to α7, the number of contacts for the receptor loop C cysteine residues 
decrease slightly at lower toxin-receptor separation, an observation also present for the 
maximium-ΔGwell unbinding pathway and already discussed in section 4.3.5.  
 
4.3.11. Residues involved in [ϒ4E]-GID interaction with rat and human α4α4: 
sole pathways in the present study (‘Tox-3’) 
While the maximum-ΔGwell and minimum-deformation PMF profiles of α7α7, rα4β2 and hα4β2 
interfaces were examined and discussed in the above sections, a limitation of the present work is 
that, due to subunit stoichiometry, only a single PMF each was obtained for rα4α4 and hα4α4. 
Although further, future simulations of the α4α4 interfaces is required to ensure sufficient 
conformational sampling, nonetheless several comparisons may be made with the hα7α7 
interface, which highlights some possible similarities and differences in the manner in which 
[γ4E]-GID may unbind from these two types of interfaces. 
 At rα4α4 (Fig. 4.18), the overall unbinding pathway is qualitatively similar to that of hα7α7, and 
involves the following interactions: at the furthest separation, most of the contacts are made by 
D3, S7 and R12 with the complementary face residues, α4(-)-H197 (~91 contacts) and R199(~71 
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contacts) (Fig. 4.18 B and 4.18D). At < 40Å, the number of atomic contacts are increased for the 
above interactions, and additionally, several principal face residues α4(+)-E226 (~25 contacts) 
and C227(~31 contacts) are also formed with N14. At the closer separation of ~25-27Å, higher 
numbers of atomic contacts are formed with α4(+) compared to α4(-), with loop I (N8-A10) and 
loop II (V13-N15) forming interactions with the aromatic cage residues α4(+)-W164, Y165, 
Y225, and Y232. However, it is noteworthy that α4(+)-R223 showed relatively low number of 
contacts (only ~15 contacts) with [γ4E]-GID, suggesting that at the rα4α4 interface, R223 and 
P233 do not  obstruct the entry of conotoxins  compared  to  that  at  the  α4/β2  subunit  
interfaces  discussed  in a previous study by Beissner and colleagues(332).  The absence of this 
obstruction for the α4(+)α4(-) interface might be a factor in enabling the higher affinity of [γ4E]-
GID at the binding pocket, resulting in a higher predicted ΔGwell (Fig. 4.2). At this close 
separation, the α4(-) face interacts with the highest number of atomic contacts with R12 and 
V13. On comparing our interaction data with that of Millard’s results, we further speculated 
[γ4E]-GID[V13] to be a residue of interest for mutation (discussed in detail in chapter-3).  
All of the [γ4E]-GID residues that interacted above were shown to be important according to 
Millard’s study wherein an alanine scan of the above residues rendered [γ4E]-GID to partially or 
completely loose its activity at the respective receptor pocket(329). As with the lowest-
deformation rα4β2 interface (section 4.3.10), R2 makes negligible contact throughout the 
unbinding pathway, despite its known importance for [γ4E]-GID inhibition of α4β2, as well as 
I1. A similar speculative argument as that in section 4.3.10 can be made here, regarding the 
possible function of R2 in inhibition; namely, that it might serve to facilitate contact between the 
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nearby D3 and E4 (the latter of which does make contact at close separation, as shown in Fig. 
4.18C) with the receptor.  
 
Figure 4.18: Plots of number of inter-atomic contacts between receptor residues of the principal (A) 
and complementary (B) subunits of the rα4α4 receptor binding pocket with [γ4E]-GID, at a 
number of selected centre-of-mass separation distances (colour coded as indicated in the legends). 
Also shown are the number of inter-atomic contacts between each [ϒ4E]-GID residue and the 
principal (C) and complementary (D) subunits of rα4α4. 
 
 
Comparing the rα4α4 unbinding pathway with that of the lowest-deformation hα7 receptor 
pocket (‘Tox-5’), we note that the double-cysteine residues α4(+)-C227 and C-228 (making ~40 
contacts, at the closest separation), and the C5-C11 (with 80 and 40 contacts, respectively), 
interact to a similar extent to that of hα7(+) (~40 for α7(+)-C212 and C213; and ~60-80 for C5-
C11). As noted previously, it has been proposed that contacts between the cysteine residues of 
conotoxins and nAChRs might be a requirement for inhibition(418). Given this, we speculate that 
the similarity in contacts between the cysteine residues of the receptor and toxin, for rα4α4 and 
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hα7α7, might suggest that [γ4E]-GID is able to inhibit rα4β2 by binding to the α4α4 interface, 
and that its potency might be higher for the α4-rich form of α4β2 compared to the β2-rich form. 
 
Figure 4.19: Plots of number of inter-atomic contacts between receptor residues of the principal (A) 
and complementary (B) subunits of the hα4α4 receptor binding pocket with [γ4E]-GID, at a 
number of selected centre-of-mass separation distances (colour coded as indicated in the legends). 
Also shown are the number of inter-atomic contacts between each [ϒ4E]-GID residue and the 
principal (C) and complementary (D) subunits of hα4α4. 
 
At hα4α4 (Fig. 4.19), the overall unbinding pathway is similar to that of rα4α4, and we here 
outline the following general interactions: at the furthest separation studied, most of the contacts 
are formed at the complementary subunit, mainly by the loop II residues of [γ4E]-GID. Nearer 
the canonical binding site, contacts are formed at both principal and complementary subunits. 
Similar to hα7α7, at ‘intermediate’ separation distance, contacts are formed with C226. 
However, contacts are also formed with the aromatic cage residue, Y223, even at an intermediate 
separation distance of ~30Å. And similar to hα7α7, the IRDE tail of [γ4E]-GID mainly forms a 
good number of contacts with the receptor once it is embedded into the canonical binding pocket, 
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where aromatic cage residues of both faces of the receptor also contribute to interactions. We 
note that, in contrast to rα4β2 and rα4α4, R2 does make substantial contact at close separation 
(over 180 contacts below 27 Å). This could also be an important reason why alanine scan 
mutations at the IRDE-tail or truncation of the same caused the complete loss of activity at α4β2 
receptor in Millard’s study(329).  
Comparing the hα4α4 unbinding pathway with that of the lowest-deformation hα7 receptor 
pocket (‘Tox-5’), we note (as with rα4α4 discussed above) that the double-cysteine residues 
α4(+)-C227 and C-228 and the C5-C11 pair also interact to a similar extent to that of hα7(+); 
thus, like the rat subtype, we propose that [γ4E]-GID might be able to inhibit hα4β2 by binding 
to the α4α4 interface, with its potency also possibly higher for the α4-rich form of hα4β2 
compared to the β2-rich form. 
 
4.4. Conclusions 
The α7 and α4β2 neuronal nicotinic receptor subtypes have been implicated in various 
neurodegenerative disorders, including Alzheimer’s diseases. Although a growing library of α 
conotoxins have been identified which are selective for specific nAChR subtypes, very few are 
known to selectively target the α4β2 subtype(419) (Table 1.1). However, only at high nanomolar 
concentrations conotoxins GID(420), MII(421) and AnIB(167) have been shown to block this 
receptor. Also, while conotoxin PnIA(422) and PnIB(423) differ by two amino-acids at positions 10 
and 11,  conotoxin PnIA was seen to be strongly potent towards the α3β2 receptor, while PnIB 
showed more potency towards the α7 receptor(424, 425).  Likewise, conotoxin MII(421) blocks α3β2 
and α6-containing nAChrs, while conotoxin LvIA(333) was discovered as the first potent α3β2-
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subtype selective nAChr ligand. Similarly, conotoxin TxID(426)  targets α3β4 receptors by a 60 
fold higher potency than conotoxin AuIB.  Amongst this exclusive class of conotoxins is [γ4E]-
GID, found in the marine Conus snails, which is highly potent towards the hα7 and α3β2 
receptor subtype while showing comparatively considerable potency towards the α4β2. 
In this study, we used umbrella sampling molecular dynamics simulations to compute the PMF’s 
of unbinding of [ϒ4E]-GID at the hα7 and the α4β2 receptor subtype binding pockets, their 
respective unbinding pathways, and to identify toxin-receptor inter-residue contacts at a number 
of points along the pathways.  We directly compared the [ϒ4E]-GID unbinding pathways and 
interactions at the α7 interfaces with those present at the (α4-rich) α4β2 subtype in order to shed 
further light on their differences; in particular, an understanding of the differences in receptor 
residue contacts at sites distant from the canonical binding pocket may help guide the eventual 
design of a conotoxin, perhaps an analogue of [γ4E]-GID, with enhanced activity and selectivity 
at α4β2.  
Two different unbinding pathways were selected for α7α7 and rα4β2; that with the highest-PMF, 
corresponding to unbinding pathways involving regions of nAChR which potentially form high 
number of contacts with the toxin;  and lowest-deformation pathway, which is more likely to be 
frequented by the toxin during unbinding. 
For the maximum-∆Gwell pathways, potential of mean force (PMF) profiles for [ϒ4E]-GID 
unbinding indicated that the toxin is most stably bound at the α7(+)α7(-) interface compared to 
all others studied in the present work, consistent with the experimentally known higher potency 
of [γ4E]-GID for the α7 subtype.  In addition, for the rat α4β2, our results suggest that [γ4E]-
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GID binds more strongly to the α4(+)α4(-) interface (compared to α4(+)β2(-)), while for human 
α4β2 it binds more strongly to the α4(+)β2(-) interface. These results suggest that efforts to 
engineer a [γ4E]-GID-derived analogue with enhanced potency for α4β2 must also take into the 
account the particular interface to be targeted, as well as species-specific differences. 
 The curvilinear path that [ϒ4E]-GID  took to exit the hα7 receptor was interesting and was also 
observed in previous simulation studies involving the binding of nicotine to AChBP(399), which 
may be described as a ‘catch-and-hold’ mechanism whereby the conotoxin forms initial contacts 
with sites at the complementary subunit distant from the canonical binding pocket, followed by 
progressive advancement of the toxin into the binding pocket In contrast, such a mechanism 
appears to play less of a role for the hα4β2 and rα4β2 interfaces. For these receptors, the toxin 
unbinds via a pathway that does not involve persistent contact with the complementary face, but 
rather, exits directly via a path that is approximately perpendicular to the surface of the α4β2 or 
α4α4 interfaces respectively. Thus, the number of receptor residues which make contact with 
[ϒ4E]-GID along the chosen unbinding pathway for both α4β2 receptor subtypes examined is 
lower than that for hα7, and this may partly explain the lower potency of [ϒ4E]-GID at the 
former subtype. Inspection of the entire unbinding trajectory at both the α7 and α4β2 subtypes 
furthermore suggests that, at α7, [ϒ4E]-GID’s interaction with the complementary subunit  is 
concurrent with the opening of  loop C to  enabling [ϒ4E]-GID  to enter the binding site. At the 
α4β2 interfaces, no such opening of loop C was observed.  
We have examined specific toxin and receptor residues which form considerable contacts along 
the unbinding pathway of [γ4E]-GID from the nAChR interfaces. This provided two important 
streams of information. Firstly, we identified receptor residues important for [γ4E]-GID 
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interactions, which differ between interfaces and whose specific contribution to toxin inhibition 
may in future be probed with experimental mutagenesis techniques. Secondly, residues on the 
[γ4E]-GID which play important roles throughout the unbinding process were identified. 
Understanding the conotoxin residues involved in the entire process of interaction with nAChR 
(from initial approach, to contact, to final stable binding at the interfacial pocket) will better 
inform future efforts to engineer [γ4E]-GID analogues for improved selectivity between the α7 
and α4β2 interfaces. 
Considering the receptor side, we note that [ϒ4E]-GID showed marginally more interactions 
with the aromatic box residues at the hα7 receptor in comparison to those at the α4β2 interfaces 
(compare Figures 4.3.6A and B with Figure 4.3.7A and B). This difference in interaction with 
the aromatic box may contribute to the difference in affinity between the conotoxin and the two 
receptors. More interestingly, residues which lie outside of the binding pocket are known to play 
important roles in conotoxin interaction with α4β2. Most recently, Beissner and colleagues 
studied the α4β2 and the α3β2 receptor interactions with conotoxin TxIA and found that α4-
subunit residue R185 and P195 hindered the conotoxin from reaching the binding pocket (332). 
When the residues from the study were translated to our homology models of the α7 and α4β2 
receptor, it was again observed that the corresponding residues to R185 at the hα4β2 (R221) and 
rα4β2 (R223) protrude into the receptor binding pockets respectively, thereby narrowing the size 
of the binding pocket and resulting in hindrance. However, this level of hindrance was not 
observed at the α7 receptor binding pocket where R208 was observed to be facing downwards, 
more towards the transmembrane domain. These observations help explain why [ϒ4E]-GID 
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could not accommodate itself easily into the α4β2 receptor binding pockets, as well as the 
alternative pathway the toxin adopted to unbind from the interfaces compared to α7. 
Considering the conotoxin side, based on identifying [γ4E]-GID and receptor residues which 
interact in the course of toxin unbinding, we propose that R2 makes most contacts with R185, 
therefore mutants particularly R2G may be worthwhile exploring for possible enhancement of 
binding to a site of α4β2 distant from its known agonist-binding site, while reducing its affinity 
for a similar location on hα7, thus overall leading to better selectivity for α4β2. 
Some notable differences are observed between the unbinding pathways of α4β2 and α7. At far 
separation, although contacts are made between [γ4E]-GID and α7(-)-Y54 (Figure 4.6B and 
4.14B), far fewer contacts are made with the equivalent position at rat and human β2(-)-Q58 
(Fig. 4.11B and 4.13B). There are also differences at closer toxin-receptor separations; 
specifically, the number of contacts between the cystines C5-C11 of [γ4E]-GID and the loop C 
cystines of are higher at reduced separation for α7, but the opposite is true for α4β2: at reduced 
separations, the contacts become lower (Fig. 4.6A) Similar interactions involving Cys residues in 
previous studies of other conotoxins, Vc1.1(153) , RgIA (at α9α10)(410) and AuIB (at α3β4)(411),  
proposed that close contact between the double cysteine residues might play a role in inhibition 
of nAChRs by conotoxins. In this regard, α4α4 behaves similarly to α7α7, with increased 
contacts between toxin and loop C cystines at lower toxin-receptor separations. We speculate 
that [γ4E]-GID might therefore target the α4α4 interface more potently compared to α4β2 
interfaces, and that α4-rich forms of α4β2 could be more sensitive to [γ4E]-GID inhibition. And 
finally, another difference between α7 and α4β2 is that, at least for the minimum-deformation 
unbinding pathways for rat and human α4β2, R2 does not make contact with the receptor at any 
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toxin-receptor separation studied, despite its known importance for [γ4E]-GID inhibition of 
α4β2. It is speculated that the importance of R2 might be indirect, and it might serve to facilitate 
contact between the nearby [γ4E]-GID residues with α4β2 rather than forming direct close 
contacts with the receptor itself. 
Overall, this study helped picture the dynamics of [ϒ4E]-GID as well as the hα7, rα4β2 and 
hα4β2 receptor subtypes to a considerable extent. Future studies aim at studying the α3β2 system 
in comparison to the α4β2 as the two systems are more similar to each other, yet show striking 
differences in response to  [ϒ4E]-GID.  
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5.1. Introduction 
In the previous chapters (3 and 4), molecular dynamics (MD) simulations were used to examine 
the interactions between [γ4E]-GID and the extracellular domains (ECD) of α7 and α4β2 nAChR 
subtypes, both at the canonical binding site and at possible ‘pathway sites’. These simulations 
examined nAChR and conotoxin interactions in the presence of only Na+ and Cl-. However, in 
the central nervous system, divalent cations, in particular, Ca2+, is also present in significant 
amounts(427). In the mammalian brain, the  external calcium concentrations range from 1.5 to 
2.0 mM(428) , while the intracellular Ca2+ ion concentration  ([Ca2+]i) ranges from 50 to 100 nM, 
inducing a chemical gradient for the Ca2+ ions to move across an open ion channel(429). Thus, to 
more fully understand how conotoxins interact with nAChR in environments more closely 
resembling that in the nervous system, it is necessary to take into account the effects of Ca2+ 
ions.  
Furthermore, in terms of potential therapeutics, any conotoxins developed to target specific 
nAChR subtypes are likely to be deployed in the context of disease states, which in some cases 
(as in Alzheimer’s disease, discussed below) may involve elevated Ca2+ concentrations(430). Thus, 
an understanding of how Ca2+ affects conotoxin interactions with nAChR is vital to developing a 
novel toxin analogue that ‘actually works’ in a pathophysiological context. 
However, to date, very little work has been done to elucidate the effects of Ca2+ on the structure 
and dynamics of nAChR itself(431). Prior to examining the effects of Ca2+ on conotoxin binding to 
nAChR, it is necessary to firstly explore how Ca2+ affects the receptor intrinsically. In this 
chapter, we use equilibrium MD simulations to understand and compare the structures of the full 
receptor structure of the α7 subtype, including the ECD and transmembrane (TM), in the 
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presence and absence of Ca2+, as well as umbrella sampling to study the permeation energetics 
for Ca2+ ions through the pore. In the final chapter (Chapter 6), we present preliminary results on 
directly studying the effects of Ca2+ on [γ4E]-GID binding to the α7 ECD. Below, we further 
outline our rationale for examining the influence of, particularly, high Ca2+ concentration on 
nAChR, based on neurobiology and pathophysiology associated with elevated Ca2+.  
 
5.1.1. Overview of Ca2+-related pathophysiology and nAChRs 
Under normal physiological conditions in neurons, a voltage generated due to membrane 
depolarization called an action potential reaches the end of the presynaptic neuron of the synaptic 
cleft(432) (Fig. 5.1). Membrane depolarization further causes voltage gated ion channels, including 
voltage-gated calcium channels, to open, allowing calcium ions to flow into the presynaptic 
neuron from the synaptic cleft(433). The inflow of calcium ions causes neurotransmitter containing 
vesicles in the presynaptic neuron to move towards the membrane(434). Once again, the calcium 
ion concentration leads to membrane depolarization, and the vesicles containing the 
neurotransmitters fuse with the membrane and break, causing the release of the neurotransmitters 
into the synaptic cleft.  
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Figure 5.1: A schematic sketch of the synapse indicating the fundamental mechanisms involved in 
synaptic neurotransmission. (adapted from (435))]. 
 
The molecular basis for many neurological disorders, such as Alzheimer’s, Schizophrenia or 
Parkinson’s diseases, could involve faulty synapses, especially when there is a disruption, delay, 
lag or repetition of unnecessary electric impulses causing a dysregulation of Ca2+ ion 
homeostasis(436).  These diseases are characteristically also marked by a loss of neuronal nicotinic 
receptors, during the progression of the disease.  For example, Alzheimer’s disease patients 
present a selective loss of α4β2 neuronal nicotinic receptors(71) while Schizophrenia presents a 
loss in the α7 receptor subtype(437).  
A number of molecular-level manifestations are known to involve α7 neuronal nicotinic 
receptors. It has been suggested that α7 may undergo chronic activation by high affinity Aβ (1-
42)(438), thereby down-regulating the ERK2-MAPK signaling pathway, known to be of 
importance in memory formation. The down regulated ERK2-MAPK pathway would further 
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create a positive feedback loop for the production of Aβ (1-42)(439). Interaction of Aβ (1-42) with 
α7 neuronal nAChRs has also been shown to affect GABAergic signaling, that play an important 
role in long-term learning. Another important mechanism of Aβ-induced damage in the neuronal 
synapse is by promoting excessive glutamate stimulation (439). Glutamate stimulation causes a 
strong influx of calcium into the intracellular stores of the post-synaptic neuron via the activation 
of the NMDA receptors. The high concentrations of calcium influx activate the NO synthase and 
the formation of peroxides, eventually leading to cell death (440). Studies also show that α4β2 
receptor agonists may play a role in maintaining the glutamate and the internal store of Ca2+ (441).  
Thus, one character of AD is the presence of high levels of calcium ions in the intracellular 
spaces of the post-synaptic neuron, followed by strong calcium currents and signals in patients 
affected by this disease. The effect of calcium in the role of Alzheimer’s can be reiterated by the 
finding that cognitive impairment is common among those with chronic kidney disease (442). 
Previous studies also showed that nephrectomy in adult rats, caused cognitive decline within a 
short period of time(443). The study has also implicated the presence of unusually high, 
dysregulated concentrations of calcium levels in the brain compared to normal neurons, 
especially in the initial stages of disease progression. Large spikes in whole cell Ca2+ instigated 
currents in the hippocampal regions of aged animals were noticed. This could also be due to an 
increased activity of L-type voltage-gated calcium channels (L-VGCC) that released abnormal 
levels of calcium into the intracellular spaces of the post-synaptic neuron. Interestingly, 
antagonists of VGCC have shown to improve learning in some patients of dementia. 
Although the initiation point or the factors causing AD and other neurodegenerative diseases are 
still not clearly understood, limited evidence show that the severe symptoms of 
neurodegenerative diseases develops over a large period of time beginning with anxiety(444), 
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stress(445, 446), or even physical injuries in the brain(447), resulting in dysregulation of calcium 
concentration in the brain. It is important to note that apart from external symptoms, these 
conditions cause an increased neurotransmitter activity in the synapses of the neuron. With the 
release of neurotransmitters, large variations of Ca2+ ions are also released in the range of 2-4 
millimolar, which in comparison to a healthy synapse (that can take up to 2 micro-molar 
concentration of Ca2+ ions), is very high.  Hence these conditions if remain unnoticed and 
untreated, could pave a way for the fatal AD. From these studies, it is clear that accumulation of 
Ca2+ in synaptic spaces has influences on α7 and α4β2 nicotinic receptors activation, 
consequently leading to a dysregulated signal response which is of importance to AD 
progression. 
 
5.1.2. Previous simulation and modeling studies of Ca2+ interactions with 
nAChR 
Early MD simulation studies by Dani and colleagues on homology models of muscle nAChR 
showed the importance of residues N47, E83 and D97 at the extracellular vestibule of the human 
α1 subunit, arranged in a ring like fashion to be important for Na+ ion conduction and 
selectivity(448). A more recent MD simulation study by Lipovsek and colleagues on the homology 
model of rat α9α10 nAChR showed important interactions with residues homologous to the three 
ring residues identified by Dani and colleagues(449). Their study showed that during evolution, α9 
subunit residues D110 and S127 on the extracellular vestibule has caused an increase in Ca2+ 
permeability due to the exposure of adjacent residues E129 and D125, and also eliminating steric 
hindrance. The residues resulted in a less negative electrostatic potential, thereby increasing the 
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conduction of Ca2+ ions. However, the identified residues at the human-α9 subunit were 
mammalian specific. Thus the introduction of these residues into the chicken receptors, caused a 
high negative electrostatic potential at the extracellular vestibule, and further impeded the flow 
of Ca2+ ions to flow towards the transmembrane domain. From these studies it is clear that the 
extracellular domain does have a role in Ca2+ ion conductance towards the transmembrane 
domain.    
Previous studies have shown that the formation of Beta-amyloid plaques during the onset of 
Alzheimer’s disease causes a disruption to the calcium-signaling pathway thereby increasing 
Ca2+ signaling and conductance(450, 451), eventually leading to cell death. In this study, we wish to 
study the effect of Ca2+ ions on α7 nicotinic receptors through simulation methods. Our 
simulation studies on the extracellular and transmembrane domains of the α7 receptor indicate 
that elevated concentrations of Ca2+ ions, lead to the partial opening of receptor channels in the 
absence of an agonist, reminiscent of (‘normal’) receptor activation. Prolonged activation is well 
known to lead to receptor desensitization (lack of channel opening despite the presence of 
agonists). Although reversible receptor desensitization may benefit synaptic transmission, it is 
likely that prolonged receptor activation due to elevated Ca2+ could result in permanent 
desensitization, leading to further complications.  
However, as described above, prolonged receptor activation by Ca2+ could further push the 
metabolic pathway to increase Aβ (1-42) formation. Ca2+ induced receptor activation that causes 
the open channel pore may not be as significant as channel-opening by agonist binding in terms 
of pore size. However, this could still result in ‘abnormal’ influx of Ca2+ ions across the 
membrane. The short signals Ca2+ ion signals propagated over long periods of time are what is 
termed as Long term Depression (LTD). The brain is more tuned to LTD in the senile 
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population, and this often leads to a shrinking of brain volume and dendritic spines(452, 453). Thus, 
there might be a positive (but pathological) feedback loop whereby elevated Ca2+ concentration 
leads to partially-open nAChR states, enhancing permeability of Ca2+ through the channel, 
resulting in further abnormal increase in intracellular Ca2+ concentration. 
 
5.1.3. Aims of this chapter 
In order to closely examine the effect of Ca2+ ions on the human α7 nAChR, we subdivided this 
study into 3 parts. In particular, we examine the effects of elevated Ca2+ on: 
i) The structure and dynamics of the extracellular domain in isolation. This was done by 
simulating the agonist-free extracellular domain of the hα7 receptor in a solvent 
system containing of 25 Ca2+ ions alone (3-4mM). 
ii) The structure and dynamics of the partially-complete receptor containing the 
extracellular and transmembrane domain embedded in a layer of DOPC. Particular 
attention is focused on the effects of elevated Ca2+ concentration on pore dimensions 
and helix structures. 
iii) The energy of Ca2+ permeation through the nAChR channel pore, in the presence and 
absence of elevated levels of Ca2+.  
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5.2 Methods  
5.2.1 Homology models 
The homology model of the extracellular domain alone was built using the respective human 
alpha7 extracellular domain sequence (uniprot id: P36544, ACHA7_HUMAN). The homology 
model of the α7 nicotinic receptor structure was built on the template of the crystal structure of 
Acetylcholine Binding Protein (AChBp) in complex with an alpha-conotoxin PNIA variant 
(PDB ID: 2BR8). For the ECD-only simulation, a high resolution template of AChBP was 
desired to construct the α7 ECD model (2BR8), as this enables use of a high quality α7 ECD 
homology model to study the effects of Ca2+ on its conformation.  
The receptor channel structure containing the extracellular membrane and transmembrane helices 
were modeled based on the template of a nicotinic receptor at 4Å resolution. The template used 
to build this model was the membrane-associated Torpedo acetylcholine (ACh) receptor at 4Å 
resolution (PDB ID: 2BG9). The TMECD alpha7 homology model was used to examine the 
effects of Ca2+ on the TM region, while effects of Ca2+ on the ECD were examined using the 
ECD-only structure described above. In this part of the study, 60 Ca2+ ions were added into the 
transmembrane containing modeled receptor system to create an overall positive charge of +70. 
However, the control contained only 35 Na+ ions, enough to just neutralize the system. All 
homology models used in this study were built using Modeller 9v1.  
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5.2.2. Simulation systems 
5.2.2.1. Extracellular domain (ECD)-only simulations 
The extracellular domain was placed solvated in a box of dimensions 111*111*111 Å3 and 
solvated with SPC water molecules. The systems were then duplicated and 15 NA+ ions alone 
were added to the system that was meant to not be influenced by Ca2+ (hereafter termed ‘Ca2+ 
free’), while a total of 25 Ca2+ ions were added to the system which the influence of calcium was 
to be noticed. Thus the calcium containing system carried an overall positive charge of 100. Both 
systems were then minimized over 1000 steps, using the steepest descent minimization 
algorithm. The systems were then subjected to NVT equilibrations using v-rescale method where 
the temperature of the system was gradually increased to 300 K. NPT equilibrations were then 
carried out using Parrinello-Rahman method for another 100ps. During both phases of 
equilibration, the PME electrostatics was maintained using particle Mesh Ewald method. 
Production phase MD simulations were then carried out on both systems for 10 ns each using the 
amber ff99SB-ildn force field force field. 
5.2.2.2. Extracellular and transmembrane domain (ECTMD) simulations 
The receptor channel structure was first solvated in a SPC water box of dimensions 
115*115*115 Å3. The system was then neutralized by the addition of 55 NA+ ions using genion, 
from the Gromacs suite. The system was then minimized over 1000 steps, using the steepest 
descent minimization algorithm. Over the next 100ps (50,000 steps), the system was heated to 
300 K using the v-rescale method.  The system was also maintained at 1 atm using the 
Parrinello-Rahman method for another 100ps. PME electrostatics was maintained by Particle 
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Mesh Ewald method during the NVT and NPT equilibration phases. The channel was first 
equilibrated to remove steric clashes within the structure. 
DOPC was selected as the lipid-bilayer membrane that would surround the transmembrane 
region of the α7 receptor. Previous computer simulation studies have used fully hydrated lipid 
membranes containing DMPC and DPPC to study the effect of anesthetics on the lipid 
membrane (454, 455). On the other hand although studies have also shown that DOPC membranes 
do not support a functional nAChR that undergoes conformational changes well(456, 457). 
However, this study is well within the time-frame of nanoseconds, whereas large conformational 
changes occur only in milli-seconds. In addition, DOPC membranes containing Chol are more 
effective in creating an environment suitable for the nAChR compared to POPC mixtures(458). 
Thus, DOPC is a relevant lipid to simulate the membrane surrounding nAChR. The topology and 
its corresponding force field parameters of the 3Å3 DOPC slab was obtained from the reliable 
public repository of lipids and other detergent molecules - Lipid Book 
(lipidbook.bioch.ox.ac.uk). The protein-lipid bilayer system was then assembled using VMD, 
where the equilibrated receptor structure was placed into the DOPC bilayer using, such that the 
bilayer almost completely covered the transmembrane helices of the receptor. The region of 
bilayer within the channel was removed. Other DOPC molecules within 5Å from the 
transmembrane helices were also removed.  
The assembled system was then ready for another round of equilibration simulations to allow the 
lipids, now surrounding the receptor channel to position itself around the latter. Now, the 
simulation system was generated by placing the bilayer-protein structure in a box of dimensions 
125X 125 X 138Å3 and solvated with Simple Point Charge (SPC) water molecules. In the system 
that was meant to not be influenced by Ca2+ (hereafter termed “Ca2+ free”), only 53* NA ions 
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were added to neutralize the whole system. However, to another simulation system where the 
effect of Ca2+ was to be observed on the receptor channel, 100 Ca2+ molecules were added to the 
system, thereby introducing an overall positive charge to the same. Both systems were then 
minimized over 1000 steps of steepest descent minimization method. After energy minimization, 
both systems were subjected to a temperature elevation to 300 K over 100 ps using the v-rescale 
method, maintaining a pressure of 1atm using Parrinello-Rahman method for another 1ns. The 
system was then further NPT equilibrated for 1ns.  This was important to give the lipids enough 
time to equilibrate and adjust around the receptor helices. The z-axis length of the simulation cell 
(related to bilayer thickness) and x (or y)-axis size of the lipid bilayer remained stable through 
the first nanosecond of the simulation (Fig 5.2).  Here again, electrostatic interactions between 
non-covalent atoms were maintained using particle-mesh Ewald (PME) method. MD simulations 
on both (normal and Ca2+ containing) systems were performed for 50ns each using the Amber 
force field.   
 
 
Figure 5.2: Shows that the thickness of the lipid bilayer (across the X-Y and Z axes) is maintained 
over the course of the 1ns equilibration simulation. 
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5.2.3. Helix structure and flexibility analysis 
To study the flexible nature of the α-helix especially at the transmembrane domain of the 
receptor we used Bendix(459). This is a pluggin in VMD and helps us to picture the 
opening/closing of the receptor channel pore due to the bending to the M2-helices. 
 
 
5.2.4. Ca2+ ion permeation umbrella sampling simulations 
In order to understand the effect of the channel opening due to increased Ca2+ ion concentration, 
the Potential of Mean Force (PMF) was calculated for a Ca2+ ion driven through the axis of the 
channel pore (Z-axis). The PMF was calculated using WHAM analysis, via umbrella sampling 
simulations. Umbrella sampling simulations were able to place the Ca2+ ion at regular positions 
at consecutive window positions along the z-axis, and thereby generate the biased energy 
distribution accordingly.  
In the present work, we observe the dynamics of the channel pore due the presence of a high 
calcium concentration in the system. If the calcium-affected channel-pore is wider in comparison 
to that simulated in a normal concentration, then an ion passing through the calcium-affected 
channel will incur less resistance than that along a closed-channel pore at normal 
concentration(460, 461). In this case, a calcium ion of radius 1.8Å is passed through the axis of the 
calcium affected and calcium-free channel and the PMF was plotted accordingly to understand 
the differences in the pore cavity between the structures (Fig 5.3). Important interactions 
occurring between the ion and the channel residues that helped impede the passage of the 
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calcium-ion (at the calcium-affected channel) could also be identified by analyzing the sampling 
trajectory.  The PMF was calculated using WHAM analysis, via umbrella sampling simulation 
windows. Umbrella sampling simulations were able to place the Ca2+ ion at regular positions at 
consecutive window positions along the z-axis, and thereby generate the required unbiased 
energy distribution accordingly. A total of 70 windows, defined by harmonic potential functions, 
positioned in 0.5-Å increments from z=-30 to 20 Å, were carried out concurrently, in parallel. 
Initial configurations of the calcium-free and calcium-affected structures were selected from an 
unbiased MD trajectory, generated in the present work, as described in section 5.2.2.2, where the 
structures were simulated for 50ns each in a calcium-rich concentration (higher than normal 
concentration) and a Ca2+ -free concentration respectively. To ensure convergence of the PMF, 
each window was simulated for 1ns each.  
 At approximately 10Å above the beginning of the channel pore (on the extracellular domain), a 
calcium ion was randomly placed at both the calcium-free and calcium-affected channels. This 
ion will be pulled through the ion-channel to generate the required sampling windows. The 
structures were solvated in an SPC water box. The hα7 receptor calcium-free and calcium-
affected channels were centered in a cubic simulation box with edge lengths of 130 Å x 130Å x 
190 Å. This enabled accommodation of the calcium ion to remain within the simulation box even 
after it exits the channel pore. To maintain an overall ionic strength of 150mM NaCl at systems, 
338 Na+ ions and 290 Cl- ions were added to the hα7 receptor system, in the presence of 54617 
water molecules. The systems were then energy minimized over a maximum of 1000 steps using 
the steepest descent minimization algorithm and further equilibrated (with heavy atoms 
restrained) for 1ns of NPT equilibration each using the Berendsen thermostat at 300 K. The 
pressure was isotopically maintained at 1.0 bar using the Berendsen barostat(304).  Electrostatic 
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interactions between non-covalent atoms were computed using particle-mesh Ewald (PME)(389). 
All MD simulations were performed using Gromacs (Version 5.0.2)(390). All MD simulations 
specific to this study were performed using the Amber 99SB-ILDN force field(391). 
The structures obtained prior to equilibration were used as starting structures to begin pulling 
simulations which would then be sampled (see Fig. 5.3). The calcium ion at the beginning of the 
extracellular domain was pulled along the z-axis towards the transmembrane domain over 1.25ns 
at a rate of 0.1Å.ps-1. During the pulling simulations one of the protein-chains (chain-A) was 
restrained, using a force constant (kpr) of 1000 kJ mol-1 nm-2. This was done to prevent the 
channel (along with the lipid-bilayer) from moving out of place during the course of the pulling 
simulation. The Ca2+ ion was given freedom of motion only along the Z-axis as it was axis of the 
ion-channel. A spring potential of 10 kJ mol-1 Å-2 was applied to [ϒ4E]-GID during these 
simulations. A Series of windows were obtained from the pulling trajectory to proceed with the 
umbrella sampling. 
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Figure 5.3: Umbrella sampling pathway of the calcium ion as through the pore axis of the channel, 
starting from the extracellular domain (top) towards the intracellular domain (bottom). 
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A total of 70 windows, defined by harmonic potential functions, positioned in 1-Å increments 
from z=-30 to 20 Å, were carried out concurrently, in parallel. We employed umbrella sampling 
and WHAM)(392) to determine the PMF, or binding free energy (ΔGbind), as a function of 
separation direction as the Ca2+ ion passed through the channel. The number of windows was 
also increased specifically between specific COM distances, in case more detail of the pulling 
simulation was required.  Each selected window was equilibrated for 100ps with 1 ns of 
production MD simulation each. Overall 45ns and 65ns of simulation time were required to 
converge PMF at the hα7 and α4β2 receptors respectively. Analysis of results was performed 
using the g_wham function in the Gromacs suite(394). The Centre of Mass (COM) Distance was 
calculated using g_dist from the Gromacs suite. The number of contacts made between the 
calcium ion and the residues lining the ion channel within a cut-off of 4 Å were calculated using 
g_mindist from the Gromacs suite.  
 
5.3. Results and Discussion 
5.3.1. Effects of Ca2+ on overall extracellular domain structure  
We simulated the extracellular domain (hereafter ECD-only) of the α7 receptor in the absence 
and presence of elevated [Ca2+]. Hereafter, we refer to the ‘control’ simulations without Ca2+ as 
‘Ca2+-free’, and we refer to simulations in high [Ca2+] as ‘Ca2+-affected’. Firstly, we compare the 
overall structures of the ECD-only simulations under the two different conditions. For the Ca2+-
affected ECD-only simulation, as the simulation proceeded towards 1ns, it was clear that the 
loop C (containing the Cys-Cys residues), moved closer towards the adjacent subunit, until it 
covered the entire mouth of the binding pocket, as though an agonist was present. Interestingly, 
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this phenomenon was observed at 4 out of 5 subunit interfaces, at almost the same time frames. 
A similar observation was made in the control system containing a Ca2+-free solution of Na+ and 
Cl- ions, but to a lesser extent compared to the Ca2+-affected system. Moreover, the radius of 
gyration (Rg) along the length (Y-axis) of the Ca2+-affected extracellular vestibule was found to 
be less than the one in the control (Fig. 5.4A and B). The production simulation begins with Rg 
of both the controlled and calcium-affected structures at 24.6Å. As the simulation proceeds, the 
radius of gyration increases to ~25.5Å in both Ca2+-affected and Ca2+-free structures at about 6 
ns of simulation. Beyond this time frame, the radius of the extracellular vestibule of the control 
increases drastically in comparison to the radius of the calcium affected counterpart. At the end 
of the simulation (at ~10 ns), the calcium affected structure to shrink towards the central pore, 
marked by an overall Rg of ~24.5Å. However the Rg of the control structure was found to 
increase to ~26.5 Å.   Preliminary analysis also showed that the RMSD of both structures 
gradually increased to ~2.5Å by the end of 10 ns in both cases, with the RMSD of the Ca2+ 
affected structure slightly higher than that of the control, with the difference in RMSD being 
attributed to the difference in Rg. To further highlight the closure of loop C in these simulations, 
we measured the distance between the C212 Cα atom at the principal subunit and the S81 Cα 
atom on the complementary subunit, for both the Ca2+ - free and Ca2+ affected ECD-only 
structures. The structure affected by Ca2+ ions showed an average Cα-Cα distance of 12.1 Å (Fig. 
5.5B) while the receptor structure simulated in a Ca2+-free system showed an average Cα-Cα 
distance of 16.2Å between the residues (Fig. 5.5A).  
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Figure 5.4: Radius of Gyration (Rg) of the extracellular domain of the α7-nicotinic receptor 
structure in a normal (Ca2+-free) solution, compared with that in the presence of elevated [Ca2+] 
(A). Differences in Rg could occur due to conformational changes within the Ca2+-affected subunits, 
particularly the closing of its loop C regions. Root-mean-square-deviation (RMSD) calculated with 
respect to the Cα atoms averaged over all 5 subunits of the extracellular domain in Ca2+-free and in 
Ca2+-affected systems (B).  
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Figure 5.5: Average distance between the Cα atoms of C212 and S81 on the adjacent subunit. (A) 
shows the distance between the residues of the receptor in the Ca2+-free ECD simulation, while (B) 
shows the state of the receptor after 10ns of simulation in Ca2+-affected. The distance between the 
loop C cysteine and serine is much less in Ca2+-affected, due to the closure of loop C in the presence 
of Ca2+ ions. 
 
5.3.2. Identification of extracellular domain Ca2+ binding sites 
We identified the preferred binding locations of Ca2+ ions to the ECD-only Ca2+ affected 
structure. Initially, sixty Ca2+ ions were placed at random in the simulation box. The initially 
randomly scattered Ca2+ ions (at the beginning of the simulation) were found to interact with 
specific binding sites on the receptor by the end of 10 ns of the production simulation. Although 
these calcium binding sites were not necessarily found at the ligand binding pocket, calcium 
binding could still be responsible for the observed allosteric change. After comparing the number 
of contacts that each receptor residue made with the calcium ions in the system, the residues that 
made the most contact with Ca2+ were identified. These residues were namely, E32, Q49, D64, 
D66, E67, E120, D123, E184, D186, S188, E195, E211 and R229. A graph indicating α7 
residues and the average number of contacts made with Ca2+, for each of the five subunits, is 
shown in Fig. 5.6. Illustrations of the sites on the ECD-only structure are shown in Fig. 5.7, with 
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the initial distribution of Ca2+ indicated in Fig. 5.7A, while the distribution after 10 ns of 
production simulation is shown in Fig. 5.7B. 
 
Figure 5.6: Average number of interactions that each hα7 ECD subunit residue makes with the 
Ca2+ ions in the Ca2+-affected system. The interaction of Ca2+ ions with hα7-E211 and R229, 
which are close to the Cys-Cys residue pair, could be important in causing the observed loop C 
closure. 
 
Except for residues E211 and R229, all other residues mentioned above were found on the 
principal subunit. However, more striking was the fact that except for Q49 and E32, the other 
residues (listed above) were also identified by Galzi et al., through mutagenesis experiments, as 
important calcium binding sites (462). Residues E67, E211 and R229 showed particular strong 
involvement in binding to calcium (Fig. 5.6). Interestingly, in the same study, Galzi and 
colleagues also showed that the mutation E195Q was found to completely abolish potentiation 
by Ca2+ at the receptor. These calcium binding sites are also of interest as they were identified by 
previous studies (463-465). These sites are also analogous to those found in metal binding sites of 
calcium binding proteins (Fig. 5.7). Also, the interaction of Ca2+ ions with E211 and R229 which 
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are residues adjacent to and found along loop C, close to the Cys-Cys residue pair, could have 
initiated the closure of loop C, as described above. These residues on the nicotinic receptors 
could serve as allosteric sites responsible for receptor potentiation, leading to more ready channel 
opening in the presence of agonists, especially during high dysregulated calcium concentrations 
in neuronal environments. 
 
Figure 5.7: The starting structure of the ECD and the positions of the Ca2+ ions (in large cyan 
spheres) for the Ca2+-affected simulation (A). The state of the system at the end of 10 ns simulation 
(B) indicating the binding of Ca2+ ions to specific sites on the α7 ECD. These sites were also 
identified by Galzi et. al. (466), as important calcium binding sites (marked as red spheres). The loop 
C is also seen to move in closer to the adjacent subunit by the end of the 10 ns simulation in Ca2+-
affected system.  
 
In addition to the enhanced closure of loop Cs against the complementary subunits compared to 
the Ca2+-free structure, the phenomenon of calcium binding to sites that resisted hydrolysis and 
its implication to receptor activation provides an important additional rationale to this study. We 
propose that calcium would initially induce partial receptor activation, and certainly increase the 
sensitivity of α7 to agonist-induced, full activation, as is well known. However, this activation 
subsequently leads to chronic stimulation. If Ca2+ ions did potentiate the receptor by activating 
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these sites, there is a good chance for chronic activation to occur in this scenario as the the Ca2+ 
ions at these sites would be present for a comparatively long duration unlike the sites that did 
resist hydrolysis. Further, chronic activation would eventually lead to reversible and irreversible 
desensitization according to the extent of stimulation and concentration of calcium respectively, 
as highlighted by previous studies (467, 468). By definition, receptor desensitization involves the 
loss of functional response of the receptor due to repeated or continuous exposure to a particular 
stimulus or agonist (469). Although the α7 receptor among others, is known to desensitize the 
fastest when compared to other acetylcholine receptor subtypes (470), the cause of receptor 
desensitization is not clearly understood (471). One model suggests that desensitization requires 
the occupancy of agonists’ at all five receptor binding pockets, in order to explain the behavior 
of αBTX-sensitive receptors in the hypothalamus. The model also suggests that high agonist 
concentration would cause complete receptor desensitization, while low-concentrations would 
allow prolonged channel opening (472). Our current results, indicating that Ca2+ can cause 
enhanced closure of loop C at most of the interfaces, despite the lack of direct binding to loop C 
residues themselves, suggest that in the presence of high Ca2+ concentration, even a relatively 
low concentration of agonist (e.g. acetylcholine, nicotine) may cause receptor desensitization, 
due to the potential ‘mimicry’ effects of Ca2+ ions as pseudo-agonists.  
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5.3.3. Effects of Ca2+ on the transmembrane helices 
In order to understand better the effect of Ca2+ ions binding on the receptor, we built a model of 
the human α7 receptor containing both the extracellular and transmembrane domains (here after 
ECTMD, as opposed to the ECD-only structures described in the above sections). The 
transmembrane region was embedded into a lipid bilayer of DOPC. Under ‘normal’ 
physiological conditions, the intracellular concentration of calcium and irrespective of other ions 
in the brain regions is approximately 50-100 nM only(429). However, the simulation was set up to 
mimic an AD affected environment where the Ca2+ ions concentration could alone rise to 3-4mM 
externally and 1-2 mM internally.  
 
 
Figure 5.8: The α7 ECD and transmembrane domains embedded in a bilayer membrane (left panel) 
prior to production MD simulation. Also shown is the structure after 50 ns of simulation in the 
presence of Ca2+ ions (right panel). 
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By visual inspection, the production phase simulation of the receptor embedded in a bilayer of 
DOPC lipids at both Ca2+-free and Ca2+-affected systems did not show significant observable 
overall structural changes after 10 ns of simulation (Fig. 5.7). However, by the end of 50 ns 
simulation, it was observed that loop C on three out of the five nominally identical subunits 
closed around the binding site, and formed contact with the adjacent complementary subunit, 
although only loosely, similar to the previous simulation of the extracellular domain of the 
receptor alone (discussed in the sections above).  
By superimposing the structure at the start of the 50ns simulation in the presence of Ca2+ ions 
with that at the end of the simulation, we were able to identify some significant structural 
changes (Fig 5.9B). The helices in the extracellular domain, especially at the apex of this region 
were seen to have been unwound into coils at some of the subunits. These changes in secondary 
structure were less pronounced at the M1-M4 transmembrane helices, which maintained its 
secondary structure well. However, at the transmembrane region, the M1-M3 helices were seen 
to have tilted away from the axis of the ion channel pore at most (4/5) subunits. The M4 helices 
were also seen to have been bent away from the axis of the ion channel pore. In consensus, all 
the helices were disturbed from their position during the course of the simulation.  
There is a ~10o tilt of the entire ECD relative to the transmembrane domain in the course of the 
Ca-affected simulation, as can be seen in Figure 5.8B, commencing at roughly 30 ns and 
persisting to the end of the simulation. Additional multiple simulations would be required to 
ascertain whether this is a genuine effect due to high Ca2+ concentration. Nonetheless, in order to 
determine whether such a motion is feasible, we have predicted the major vibrational motions of 
the α7 nAChR pentamer using the anisotropic network model server ANM 2.0(473) 
(http://anm.csb.pitt.edu/), which predicts concerted motions (normal modes) of macromolecules 
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within the framework of a coarse-grained, single-site representation of individual residues 
connected via elastic spring potentials to their nearest neighbours. The first three normal modes 
correspond to well-known twisting motions of the ECD and TMD, possibly related to gating 
motions(474). However, the fourth normal mode involves concerted bending of the entire ECD 
and TMD relative to each other, with the central hinge region located roughly in the 
juxtamembrane domain between the ECD and TMD. This motion is illustrated using a 
“porcupine plot” shown in Supplementary Figure 5.1 in the Appendix, indicating 
“anticlockwise” rotational motion of the ECD at the same time as “clockwise” rotation of the 
TMD, when viewed along the membrane plane. This type of motion strongly resembles that 
observed in the present Ca-affected simulation. Further work is required to determine whether 
this motion is of biological or functional relevance, as well as the role of Ca2+ in promoting such 
a motion in nAChR. 
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Figure 5.9: (A) Root-mean-square-deviation (RMSD) of Cα atoms of the whole receptor (ECD and 
TM domains) in the Ca2+-free and Ca2+-affected systems respectively. Only slight differences are 
apparent between the two receptor structures. (B) The Ca2+-free and Ca2+-affected receptor subunit 
structures at 40ns of simulation are overlaid over each other to indicate that the structures did not 
differ much from each other. The Ca2+-free structures are colored according to secondary 
structure, while the Ca2+-affected structures are colored as red, orange, gray, green and white for 
the five subunits respectively 
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Despite the similarity of RMSD of the ECTMD in the two environments, there are more 
substantial differences present which may be related to the presence and influence of Ca2+ ions. 
Firstly, we examined the RMSD plots of the transmembrane M1, M2 and M3 helices, by 
overlaying them individually along the course of the simulations for Ca2+-affected and free 
systems (Fig. 5.10A(i-iv) and B(i-iv), respectively). The M1 helix of the transmembrane domain 
maintained an average RMSD of ~1.5 Å at both Ca2+-affected and Ca2+-free systems (Fig. 
5.10A(i) and B(i), respectively). For the M2 helix, the Ca2+-free system maintained an average 
RMSD of ~0.1-0.5 Å throughout the simulation. However, the M2 helices of the channel in the 
system of calcium ions gradually rose to 0.2 Å at ~20ns from an initial of 0.05 Å. Additionally, 
for M2 in the Ca2+-affected simulation, a change of RMSD variation pattern between all five M2 
helices was observed (Fig. 5.10A(ii)), in comparison to the Ca2+-free system (Fig. 5.10B(ii)), 
which shows relatively uniform RMSD for four of the five subunits. 
For the M3 helix, there is no significant variation in RMSD in the Ca2+-free structure, except in 
subunit E, between 30-40 ns (Fig. 5.10B (iii)). At the Ca2+-affected system, M3 of chain E rose 
to an average of almost 0.25Å between ~8 - 40ns of the simulation (Fig. 5.10A(iii)). Thus, the 
RMSD graphs clearly pinpoint that a small change in structural conformation is occurring, and 
that there are subtle but distinct differences in helical fluctuation between structures in the two 
different solvent environments. Further, we note that the root-mean-square-fluctuation (RMSF) 
of individual residues of the M1 and M3 helices do not show clear variation along the course of 
the simulation, between the normal and calcium affected systems (not shown).  
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Figure 5.10: RMSD of the individual M1,M2, M3 and M4 helices (labeled (i), (ii), (iii) and (iv) 
respectively) at the Ca2+-affected whole receptor structure (A). There is a gradual increase in the 
RMSD at the M2 helix (ii) starting at ~ 20 ns of the simulation. The RMSD in each of the M1, M2, 
M3 and M4 helices ((i), (ii), (iii) and (iv) respectively) of the Ca2+-free receptor structure in the 
course of the simulation (B). Unlike the helices in the Ca2+-affected channel, the M2 helices in the 
control shows no gradual increase in RMSD. 
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Given the discussion above, it is especially interesting to consider the difference in RMSD 
behavior for the pore-lining M2 helices between the two simulations, as the M2 helices contain 
the pore-lining residues which directly affect the permeability of ions and therefore the 
biophysical activity of the receptor. (14). Inspection of the MD trajectory revealed that the sudden 
and substantial change in RMSD observed in the Ca2+-affected M2 transmembrane helix (Fig. 
5.10A (ii); compared to the relatively ‘stable’ RMSD of Fig. 5.10B(ii)) is likely related to the 
movement of M2 towards the M3 helix.  
Previous studies have shown that during channel opening, the M2 helices bend between specific 
hinge forming residues, and this hinge is stabilized by hydrogen bonds formed due to 
hydrophobic interactions with the M1 and M3 helices (475, 476). The helices can thus bend to an 
angle of 15°-45° about the hinge. The hinge forming residues between residues L9’ and V13’are 
conserved and found on the M2-helix. At the human α7 receptor, these residues correspond to 
residues between L270 and V274. The bending of the M2-helices at this hinge along with 
rotational motions is believed to close and open the pore accordingly. However, asymmetrical 
helix motions (for example, rotation or bending of two out of the five M2 helices) are often 
observed in simulations of the human α7 receptors and suggest a sequential mode of channel 
gating.  
To further characterize and quantify the motions observed in M2, we employed Bendix (477)  to 
identify the hinge regions, as well as estimate the extent to which M2 helices underwent bending 
motions in the course of the simulations. The analysis of the M2 helices using Bendix showed a 
kink or strong bending occurring in the region of residues L270 and V274 at chains A and C 
(indicated by red regions in the ‘sausage’ representations of the M2 helices, shown in Fig. 5.11A 
and B). Although the M2 helix of chain A is seen to bend inward towards the axis of the pore, 
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the M2 helix of chain C bends towards the M1 and M3 helices, thereby widening the pore of the 
receptor. The asymmetric bending of helices has been observed in previous studies (478) and 
could also be due to a short simulation time used in this study. In addition, Fig. 5.11A also shows 
that the M2-helices at the Ca2+-free receptor do not display strong bending in comparison to 
those affected by the Ca2+ ions. Although the M2 helices of at both systems shows a similar 
average deviation in bending angles at different subunits (Fig. 5.11C and D), it is possible that 
the bending that did occur at the Ca2+  free receptor did not cause the channel to open. This could 
be due to the fact that the bending only caused the helices to close the channel axis. From these 
results, it is evident that there is a significant change in conformation is occurring in the M2-
helices that line the pore of the Ca2+ -affected nicotinic receptor, leading the receptor to a 
possible partially open state (characterizations of the pore dimensions and permeation energetics 
are discussed in subsequent sections). 
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Figure 5.11: Bendix analysis of the bending of the M2 helices at the Ca2+-free (A) and Ca2+ affected 
receptors (B). The helix ‘hinge’ regions are shown in red, while the least and moderately bent 
regions are highlighted in blue and green respectively. The M2 helices of the Ca2+ affected receptor 
are seen to bend in the vicinity of L271 and V274, as seen in previous studies. The maximum 
bending angles of the M2 helices with respect to time for each subunit is shown for Ca2+-free (C) 
and Ca2+-affected (D) systems. 
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Figure 5.12: Bendix analysis of the bending of the M4 helices at the Ca2+-free (A) and Ca2+ affected 
receptors (B). The helix ‘hinge’ regions are shown in red, while the least and moderately bent 
regions are highlighted in blue and green respectively. The M4 helices of the Ca2+ affected receptor 
are seen to bend at different regions. Maximum bending was observed around the residues V494 to 
K499 and C482 to s489. The maximum bending angles of the M2 helices with respect to time for 
each subunit is shown for Ca2+-free (C) and Ca2+-affected (D) systems. 
 
The M4-helices of the Ca2+ affected structure also underwent substantial bending. Bendix was 
also used to analyze the bending of the M4-transmembrane Helices (Fig 5.12). At the Ca2+ free 
receptor structure, the M4 helices were seen to bend to an angle of ~15°-25° on average. The 
helices were seen to bend the most around residues T483 and I486 at one of the M4 helices 
(Chain J). Likewise, the degree of M4-helix bending was also analyzed for the Ca2+ affected 
receptor structure. Here, the maximum bending was exhibited by the M4-helix was ~50°. 
Further, the helices were seen to bend away from the axis of the channel, around the residues 
C482 to S489 and between V494 to K499. Studies on TRAAK/TREK K2P potassium channel 
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have shown that conformational changes at the M4-TM helixes opens a pore lateral to the 
pore(479). Previous studies on the Torpedo califomica acetylcholine receptor’s M4 helices have 
further shown that disturbances in the M4-helix can affect the function of the ion-channel, with 
regards to channel-gating(480, 481). In comparison, the TM4-helices of the Ca2+ free receptor 
structure did not show as much bending as the helices of the Ca2+-affected structure. It can be 
suggested that the bending of the M4 helices in the Ca2+ affected structure (that was not observed 
at the Ca+2 free structure) could possibly be significant enough to play a role in channel-opening.  
        
5.3.4. Effects of Ca2+ on the interfacial M1-M2 and M2-M3 loop regions 
It is tempting to speculate whether there is a possible relationship between the motions observed 
in the M2 helices in the Ca2+-affected structure in our present simulations, and receptor 
activation, desensitization and recovery. For example, it is known that there is close relation 
between receptor desensitization and phosphorylation of nicotinic receptors in vivo; 
phosphorylation of the receptor brings the receptor back from a desensitized state to a resting 
state (482-484). These phosphorylation sites lie between helices M3-M4 in the transmembrane 
domain, close to the mouth of the pore(485). Thus, given that the main difference between the 
Ca2+-affected and Ca2+-free structures lie in M2, it is intriguing to consider whether, during the 
course of our simulation, the calcium ions played any role in structural changes related to the 
desensitization of the receptor, by its interaction with the respective pore lining residues 
mentioned above. If so, then it is also profitable to consider whether the fluctuations observed in 
M2 for the Ca2+-affected structure are also involved in altering the exposure of phosphorylation 
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sites on the M2 helix, thereby potentially facilitating phosphorylation, and restoration of the 
receptor to an activatable, resting state.     
To identify some of the structural effects of Ca2+ on the regions of the receptor that are targetable 
by protein kinases (i.e. phosphorylation sites), and which are involved in the recovery of the 
receptor from desensitization, as well as possible sources of conformational change on the 
helices (discussed above), we examined the RMSD of the individual M1-M2, and M2-M3 loop 
regions for the Ca2+-free and Ca2+-affected structures. Our results (Fig. 5.11) show no significant 
change in RMSD or RMSF between the M1-M2 loop region in the Ca2+-free and Ca2+-affected 
systems. However a rapid rise in the RMSD of the M2-M3 loop regions in the calcium affected 
system was observed from 20ns to the end of the simulation (Fig. 5.13D), which is not observed 
in the Ca2+-free simulation (Fig. 5.13B).  
This observation along with the change in RMSD of the M2 helix (Fig. 5.10A(ii)) suggests that 
the forces initiating the conformational change in the M2 helix itself, started from the M2-M3 
loops and moved down towards the intracellular region.  
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Figure 5.13: RMSD of the M1-M2 loop (A) and M2-M3 loop (B) regions in the Ca2+-free system, 
and the M1-M2 (C) and M2-M3 (D) loops in Ca2+-affected system. Inspection of (B) and (D) 
indicates that there is a change in the loop regions of the Ca2+-affected channel while no such 
changes are seen in the Ca2+-free system. 
  
Molecular graphics of the changes in the M2-M3 loop region are shown in Figure 5.14, which 
overlays snapshot structures of the M2, M2-M3 loop and M3 regions over the course of the 
trajectories of the Ca2+-free and Ca2+-affected simulations, for each of the five subunits. 
Inspection of the overlaid snapshots suggests that the Ca2+-free receptor (Fig. 5.14 A-E) exhibits 
less flexibility in the M2-M3 loop region, compared to the Ca2+-affected receptor loops (Fig. 
5.13 F-J). This is consistent with the RMSD plots in Fig. 5.13. Inspection of the M2/M2-M3/M3 
structures also shows that, for the Ca2+-affected systems, not only are the M2-M3 loops more 
flexible, but that their flexibility extends significantly down even into the middle of the M2 helix 
(especially obvious in Fig. 5.14F, 5.14G and 5.14I). Thus the structural changes in the M2-M3 
loops appear to be correlated with the structural changes occurring in the M2 helices themselves, 
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for the Ca2+-affected system. Given the close, direct linkage between the M2 and M3 helices, it 
is also likely that the movements observed at the M2 helix affects the M3 helices via the M2-M3 
loop regions. 
 
 
Figure 5.14: Overlaid snapshot structures of the M2-M3 region for each of the five nominally 
identical α7 subunits, indicating structural fluctuation of the M2-M3 loops of the Ca2+-free (A-E) 
and Ca2+ affected (F-J) receptor structures over the course of the simulations. The M2-M3 loop 
regions of the Ca2+ affected receptor shows more disruption in the loop regions compared to same 
loop regions at the Ca2+-free receptor, consistent with changes in RMSD at the M2 helices at the 
former. 
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5.3.5. Effects of Ca2+ on bilayer density 
The presence of elevated Ca2+ concentration appears to have substantial effects on α7 receptor 
structure in both ECD and TM regions. It is likely that not only the protein structure, but the lipid 
bilayer environment around the protein, may also be affected by the presence of Ca2+, and this 
may in turn have an influence on the structure and function of the receptor itself. To obtain a 
brief, general picture of any such difference, the differential DOPC bilayer density for Ca2+-free 
and Ca2+-affected environments was calculated, by firstly estimating the atomic density of the 
DOPC bilayer along the Z-direction (i.e. the bilayer normal direction) for both simulations, then 
subtracting the density profile of the Ca2+-free from the Ca2+-affected systems. The ‘density 
difference profile’ is shown in Figure 5.15. The Ca2+ affected system shows a depleted density of 
DOPC at the upper leaflet of the bilayer (on the extracellular side) in contact with the receptor 
protein (especially at +10 Å with respect to the box/bilayer center) relative to the Ca2+-free 
simulation, but enhanced density in the lower leaflet (especially at -40 Å, on the intracellular 
side). It could be said that the transmembrane domain of the Ca2+ affected receptor pushed the 
surrounding DOPC outwards and away from the receptor on the upper leaflet, but more strongly 
attracted lipids on the lower leaflet, compared to the Ca2+-free simulation, resulting in the 
observed differences. Whatever be the case, it is clear that some amount of disturbances in the 
receptor occurs due to the presence of Ca2+ ions in the system, and this is clearly correlated with 
the structural differences in the receptor discussed above.         
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Figure 5.15: Difference in the average density of the DOPC bilayer at the Ca2+ affected and Ca2+-
free simulation systems (the latter subtracted from the former) across the simulation box during 
the course of the simulation. The density of the DOPC layer in the Ca2+ affected system decreases 
closer to the center of the simulation box and increases closer to its edges relative to the Ca2+-free 
system. The significant movement that occurs at the transmembrane domain of the receptor in the 
Ca2+-affected system is one likely cause of this difference in density.   
 
 
5.3.6. Effects of Ca2+ on channel pore-dimensions 
To determine if the striking difference in RMSD of the M2-M3 loop region and the M2 helices is 
translated into channel opening, we estimated the diameter of the constriction region of the pore 
(i.e. the region of the pore with the lowest diameter along the length of the channel), with respect 
to simulation time, for both Ca2+-free and Ca2+-affected simulations. We note that the pore is 
lined by both hydrophilic and hydrophobic M2 helix residues, amongst which include D257, 
S258, G259, E260, and K261, and that these residues were in contact with the calcium ions in 
the latter simulation. Further to this, significant difference in the pore radius of the receptors in 
either systems, confirmed that the channel pore opens in the presence of an elevated 
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concentration. This change in pore diameter to the open-state in the calcium affected structure is 
definitely related to the change in RMSD at the M2 domain. In support of these observations, 
Bertrand et al., (1993) have shown that mutations of M2-domain residues E237A and V251T 
(found towards the cytoplasmic end of the receptor) have caused a reduction in calcium 
permeability, while increasing affinity towards acetylcholine by 10-100 fold. In addition, these 
mutations would further bring about an absence of ionic current desensitization (486). These 
studies further highlight the importance of the M2 domain with regards to desensitization due to 
the influence of calcium.  
Pore-walker (487) was used in this study to characterize the contour of the receptor channel, and 
more specifically estimate the diameter of the ion channel with respect to simulation time. The 
point on the channel closest to the end of the channel opening and of minimum diameter was 
chosen as the point of constriction for the diameter of the ion channel pore. The point of 
constriction at both Ca2+-free and Ca2+ affected channels were found to have a diameter of~3.5-
4.0Å along the axis of the channel beyond the beginning of the transmembrane region (Fig. 
5.16). Prior to production simulation, the pore was lined by threonine and isoleucine residues at 
the constriction point for the channel under both simulation conditions. These residues, identified 
as I266 and T267, were found to be contributed by three out of five of the subunits of the 
receptor. The diameter of the pore formed by the above residues was at a minimum of ~3.5Å at 
both the channels (Fig. 5.16). From the pore diameter plots, it could be observed that the Ca2+-
free receptor not only maintained its pore diameter throughout various stages of the simulation 
(except at one point during the trajectory, at ~15 ns), but also quite closely maintained the point 
of constriction throughout the simulation. In contrast, the pore profile at the Ca2+-affected 
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channel varied significantly beyond 20 ns at intervals over only 5 ns. A substantially higher pore 
diameter was observed in comparison throughout much of the simulation trajectory. 
 
Figure 5.16: Minimum ion-channel pore diameter with respect to simulation time at the Ca2+-free 
(red) and Ca2+-affected (blue) structures. 
 
In addition, the initial point of constriction was also adopted by different residues at the Ca2+ 
affected receptor, especially beyond 20 ns of simulation. This was one of the obvious reasons for 
the change in pore radius. From Figure 5.16 it can be clearly seen that the ion-channel pore in the 
Ca2+-free system maintained a diameter of ~2-4Å at most time points, while the calcium-affected 
channel showed fluctuating pore diameters between 4-12Å in diameter. These results indicate 
that the calcium-affected channel prefers to take a partially open channel over most of the 
simulation, unlike the Ca2+-free simulation.  In addition, results from Pore- walker also showed 
that although the pore was initially constrained by residues I266 and T267 prior to production 
phase at the Ca2+ affected receptor , it was joined (for example) by V268 at the end of 20 ns. By 
the end of 30ns, residues P39, P103, Q106 and W108 were seen to form the constriction point. 
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However it is interesting to note that I266 and T267 formed the point of constriction at the end of 
the equilibration phase again formed the point of constraint at the end of 50 ns, where at both 
systems the diameter dropped to ~2Å. The pore profile at the end of 50 ns showed slight 
similarity to the structure after equilibration. However, in comparison to the beginning of the 
production phase, the point of constraint was moved by almost 10Å towards the mouth of the 
pore by the end of 50ns. These observations suggest that over the course of the simulation the 
Ca2+-affected receptor attains a partially open pore configuration through rearrangement of the 
residues in the vicinity of the pore axis.   
It is of interest to compare our pore diameter results with previous simulations. In 1996, 
Sankararamakrishnan and colleagues, compared pore profiles of open and closed states of chick 
α7 receptor using MD simulations (488). Their studies found that the closed-state model showed a 
pore diameter of less than 4Å, while the minimum diameter of the open-state model was ~12Å. 
The point of constriction in the closed state was found to be close to residue L11’ (corresponding 
to human α7-L270). In the open state, the point of constriction was found to be close to residue 
T8’ (corresponding to hα7-T267). Another study focusing on the structural dynamics of receptor 
due to the binding of an agonist such as acetylcholine, also showed the pore diameter to increase 
to ~11 Å (489).  These studies are encouraging and help validate our results of the pore profiles 
observed. 
Our MD simulations on the extracellular domain suggest that Ca2+ causes loop C closure, while 
simulations focusing on the transmembrane domain suggest Ca2+ causes pore widening. Both 
these observations suggest Ca2+ serves to shift the receptor towards a conformation more closely 
resembling an active state than an inactive one. In the absence of an agonist, it seems likely that 
the receptor has adopted a conformation that may be described as more readily activatable by 
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agonist- perhaps in an ‘excited’ state, one that can more easily transition to a fully active state 
upon agonist binding. In addition, our simulation results thus far is consistent with the potential 
for chronically high Ca2+ concentration to lead to prolonged channel opening, and thus more 
rapid receptor desensitization. In addition, the observation that the loop Cs at the binding sites do 
not fully close against the adjacent complementary subunit, for both the Ca2+-free and Ca2+-
affected systems, suggests that the opening of the channel pore does not fully depend on the 
complete closure of loop C when in the presence of high Ca2+ concentration.  
 
5.3.7. Ca2+ permeation through the Ca2+-free and Ca2+-affected pores 
In order to quantify the effects of the pore widening on the permeation of Ca2+ ions through the 
channel, especially for the Ca2+-affected channel, we employed umbrella sampling to estimate 
the free energy of permeation of a Ca2+ ion through the channel and obtained potentials of mean 
force (PMF) profiles for both Ca2+-free and Ca2+-affected channel structures. 
The Ca2+-affected receptor channel structure, obtained at the end of 50ns of MD simulation in 
the presence of ~4mM of Ca2+ ions, and the calcium free receptor channel structure, obtained at 
the end of 50ns of simulation in a Ca2+-free system, were used to obtain the free energy profile of 
the channel under respective Ca2+ conditions. Figure 5.17 shows the PMF profiles for both 
systems. At the calcium free channel, the Ca2+ion came through the channel and crossed an 
energy well of ~-24kcal.mol-1 at a distance close to the beginning of the transmembrane domain 
at Z=-18Å. However, at the calcium-affected channel, the calcium ion encounters a more shallow 
energy well (~-12 kcal.mol-1) at a similar distance along the axis of the channel. This difference 
in the energy barrier (between -18 to 20Å) is significant to this study as it correlates to the 
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difference in ion channel opening due to the movements of the M2-helices at the calcium-
affected channel compared to that of the calcium free structure. In both cases, the existence of a 
broad energy well suggests the existence of a stable Ca2+-binding site within the pore of the 
channel, composed of residues D123 and E281, amongst others (indicated in Fig. 5.17, 5.18). 
Once inside the energy well, to fully permeate the channel, the Ca2+ ion must overcome energy 
barriers imposed at Z ~ 20 Å. This barrier (to escape the energy well) is much higher for the 
Ca2+-free structure (~30 kcal/mol required) compared to the Ca2+-affected structure (~20 
kcal/mol). It is expected, therefore, that the Ca2+-affected structure is more permeable than the 
Ca2+-free structure. We propose that the Ca2+ ions stimulate the TM2 helices to move away from 
the central pore due to a change in conformation, enlarging the pore (see discussion above) as 
well as reducing the depth of the energy well. Fritsch and colleagues studied the energy barrier 
induced to Na+ ions passing through the ion-channel pore of Gloeobacter violaceus (GLIC) 
using Umbrella sampling simulation techniques too. Their study found that Na+ ion passed 
easily through the pore, and exhibited a PMF of ~1 to -2 kcal.mol-1 as it reached the end of the 
transmembrane region close to the intracellular domain(490). Thus, elevated Ca2+ concentration 
leads to higher Ca2+ permeability, which, in turn, may further enhance intracellular Ca2+ 
concentration, further exacerbating calcium dysregulation in disease states.  
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Figure 5.17: Potentials of mean force (PMF) profiles for Ca2+ ion permeation through the human α7 
receptor simulated in a Ca2+-free (blue) and Ca2+-affected (red) structures containing ~3-5mM of 
Ca2+ ions. The Ca2+-affected channel has a shallower free energy well, suggesting greater 
conductivity for Ca2+ compared to the Ca2+-free channel. 
 
In addition to the PMF profiles discussed above (Fig. 5.17), we also examine the points of 
impediment to the Ca2+ ion as it is passed through the respective channels. In addition, we were 
also able to picture the pore-lining residues that interacted with the Ca2+ ion, and which were 
therefore responsible for causing impediments at the respective receptors. By visual inspection, 
we were able to put together the chain of receptor residues that contributed the most to the 
interactions with Ca2+ as it passed along the axis of the pore and responsible for the obtained 
PMF.  
At the Ca2+-free receptor, for the first ~22Å along the channel axis, the Ca2+ ion was not impeded 
by any receptor residue other than N36 (closer to the tip of the extracellular domain) briefly. At a 
distance between ~-28Å and -10Å along the z-axis, D66, D123, R121 are seen to contribute to 
the lowering of the PMF at this distance (Fig. 5.17, 5.18A). As the Ca2+ ion moves along the z-
axis another 30Å, that is from Z = ~-10Å to Z = ~20Å, strong interaction are contributed by 
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E281 and V274 that guard the entrance to the pore. A substantial number of interactions are also 
contributed by S271 at this point. A significant increase in the PMF is observed for the next 
~15Å from z = ~25Å to z=~40Å, and is formed as the Ca2+ ion loses its interactions with 
residues E281 and V274. Beyond this point, the PMF drops slightly to ~4kcal.mol-1 when it 
encounters E260 briefly at the mouth of the pore. Additionally, since the Ca2+ ion is impeded by 
E260 at only two subunits at this point, there was only a slight lowering of PMF.  
 
Figure 5.18: Illustration of the passage of a Ca2+ ion along the pore of a receptor in a Ca2+-free 
system (A) and the passage of the ion along the pore of the Ca2+-affected receptor (B). The van der 
Waals’ spheres are colored according to residue name, and indicate the receptor residues that 
caused the most impediment to the passage of the ion, and hence related to the variation in the PMF 
profiles. The Ca2+-affected receptor shows a wider pore diameter compared to the Ca2+-free 
receptor. 
 
At the Ca2+ affected receptor, a different PMF profile was observed as the Ca2+ made its way 
through the axis of the pore. As Ca2+ enters the extracellular domain, it makes contact with H127 
(Fig. 5.18B). Although Ca2+ did not bind strongly with His at this point, it resulted in a slight 
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reduction of the PMF curve from z = ~-27 Å. Beyond this point for another ~8Å, the Ca2+ ion 
makes a series of interactions contributed mostly by D64, E120, D123, and other adjacent 
residues,  resulting in the lowering of PMF to ~-12kcal.mol-1. Beyond this point, up to ~22Å, 
comparatively strong interactions take place between the Ca2+ ion and receptor residues V274, 
E281 and I282. The PMF slope gradually increases to ~-4kcal.mol-1, as the Ca2+ ion now 
interacted with S263, T267 and adjacent residues found closer to the opening of the pore.           
 
 
Figure 5.19: Average number of contacts between each M2 pore-lining residue and Ca2+ ions for the 
Ca2+-free receptor (A) and the Ca2+-affected receptor (B) for the umbrella sampling simulations, as 
the Ca2+ ion permeates through the respective receptors.   
 
Bar graphs indicating the average number of inter-atomic contacts between M2 channel residues 
and the Ca2+ ion, in the course of the umbrella sampling simulations, provide further information 
regarding the residues which are encountered by Ca2+ as it undergoes permeation through the 
pore. These graphs are shown in Figure 5.19. At the Ca2+-free channel, the passing Ca2+ ion 
made persistent contact at D123, E260, L270, S271, V274, L278 and E281 (Fig. 5.19A). 
However, at the Ca2+ affected channel, only a few pore-lining residues such as D64, D123, 
H127, T267, L278 and E281 made substantial interactions with the Ca2+ ion, and were in most 
cases less than the number of interactions that the Ca2+-free channel made with the passing Ca2+ 
ion (Fig. 5.19B).  In addition, most of the interactions with the Ca2+ ion involved more than two 
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M2 helices at the Ca2+-free channel, while at the Ca2+ affected channel more interactions 
involved only one M2 helix in comparison. The lack of interaction from the M2 helices of the 
Ca2+ affected receptor in comparison to the Ca2+-free structure is consistent with the former 
channel’s pore being wider. From all the above mentioned residues that did make contact with 
the permeating Ca2+ ion, E281 at the Ca2+-free channel and T267 at the Ca2+ affected receptor 
contributed to persistent contacts at the transmembrane domain from the majority of receptor 
subunits. Thus, overall, from Figure 5.19, it is clear that the pore-lining residues at the calcium 
affected channel made much less contact with the passing Ca2+ ion in comparison to the calcium-
free structure. 
 
 
Figure 5.20: Structural snapshots indicating the pore lining residues of the receptor that strongly 
interact with the permeating Ca2+ ion during umbrella sampling simulations. Residues α7-E281 
and V274 interacted strongly at the Ca2+-free receptor’s pore (A), while at the Ca2+-affected 
receptor there is also strong involvement of T267 along with V274 in the interaction with the 
permeating Ca2+ ion. 
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Alternative views of the Ca2+-free and Ca2+-affected receptor, focusing on some of the key 
residues in contact with the permeating Ca2+ ion down the pore, is shown in Figure 5.20. 
Residues E281 and V274 at the Ca2+-free receptor (Fig. 5.20A) line the entrance of the pore 
through which the ion must pass through. Thus, the Ca2+ ion forms strong electrostatic 
interactions with E281, which might be partly responsible for the deeper energy well for the 
Ca2+-free channel. However, at the Ca2+ affected channel, T267 and V274 contribute to the 
formation of this filter which was also found to be closer to the intracellular domain compared to 
E281(Fig. 5.20B). Unlike for the Ca2+-free receptor, there is no strong electrostatic attraction for 
Ca2+ in the filter region, and this difference in the character of residues forming the filter may 
further explain the lower depth of the energy well for the Ca2+-affected structure, and also the 
difference in the level of impediment to the passing Ca2+ ion at either receptor. The change in 
conformation of the M2 helices at the Ca2+ affected receptor not only brought about change in 
the pore-guarding residues, but also caused a change of interaction at other residues such as 
T267, S271, V274 and L278 when compared to the interacting residues at the Ca2+-free receptor. 
From these observations, it is clear that the increase of Ca2+ ion concentration in the system 
causes a change in orientation of the pore-lining residues of the TM2 helices, which is further 
responsible for the difference in conductivity of Ca2+ through the pore. Although previous 
studies especially by Galzi and colleagues(491) had identified important residues at the 
extracellular domain of the α7 receptor that influences calcium binding, the transmembrane 
region residues identified by this computational study could also be important to understand how 
Ca2+ potentiates the receptor. 
It is of interest to compare the residues identified in this work with those known to be important 
for cation permeation. In 2003, Miyazawa and colleagues studied the structure and gating 
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mechanism of the α1-subunit containing Acetylcholine receptor from Torpedo marmorata (492). 
Their study focused on the α-subunit residues of the M2-helices and those lining the 
transmembrane pore that involved themselves with the interrupted a passing ion when the 
channel was closed. They identified four different categories of residues depending on their 
position on the transmembrane domain and their impediment to the passing ion. The categories 
described were: (i) M2-helix residues that affected ion conduction, (ii) pore-lining residues close 
to the end of the transmembrane region and (iii) Girdle residues. While most of the residues on 
the M2-helix were non-polar in nature, negatively charged α1 subunit residues E286, S290 and 
E265 were stated to increase cation transport. In addition, mutation of one of these ring of 
residues resulted in affecting the flow of cations. A BLAST sequence alignment showed that 
Torpedo marmorata α1-subunit residues E286 and E265 were conserved and corresponded to 
E260 and E281 on the human α7 receptor. However, α1 subunit residue S290 corresponded to 
A285 on the human α7 receptor. This difference in the M2-helix residues could thus make the 
human α7 receptor less inert towards ion flow compared to the T. marmorata α1 receptor. When 
the number of contacts made by the permeating Ca2+ ion with the M2-helix residues (mentioned 
above) was analyzed, we noticed that less number of contacts was made by M2-helix residues at 
the Ca2+ affected receptor in comparison to that at the Ca2+-free system (Fig. 5.21). This further 
implied that the M2 helices had moved apart from each other, allowing more free passage to the 
Ca2+ ion at the Ca2+ affected receptor.      
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Figure 5.21: The number of contacts that the permeating Ca2+ ion makes with the human α7 M2 
helix residues that have previously been shown to be important in Miyazawa’s study(492). The 
number of contacts made by the Ca2+-free M2-helix residues with the permeating Ca2+ ion (A) is 
more than that at the Ca2+ affected receptor (B), indicative of the fact that M2-residues (and thus 
helices overall) from different subunits are further apart from each other at the Ca2+ affected 
receptor. 
 
Similarly, we also specifically examined the pore-lining residues α1(T268 and S272) highlighted 
in Miyazawa’s study to human α7 residues S263 and T267. These residues are located much 
closer to the intracellular end of the transmembrane domain. However, most ions would be 
blocked before this point if the receptors channel was closed. While studying the number of 
contacts that the permeating Ca2+ ion in our study made with the pore lining residues traced from 
Miyazawa’s study, we found that a lower number of contacts was made by the permeating Ca2+ 
ion with these residues at the Ca2+-free receptor (Fig. 5.22A) compared to that at the Ca2+-
affected receptor (Fig. 5.21B). This is consistent with the notion that the Ca2+-free receptor 
would have ‘detained’ the passing Ca2+ ion before this point due to the constriction of the 
channel by the M2 helices. However due to a comparative broadening of the channel radius at 
the Ca2+ affected receptor, the Ca2+ in our study is able to access these pore lining residues more 
easily (Fig. 5.22B).  
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Figure 5.22: The number of contacts that the permeating Ca2+ ion makes with the human α7 pore-
lining residues that have previously been shown to be important in Miyazawa’s study(492). The 
number of contacts made by the Ca2+-free pore-lining residues with the permeating Ca2+ ion (A) is 
less than that at the Ca2+ affected receptor (B), indicative of the wider pore diameter of the latter. 
 
Miyazawa’s study also highlighted the importance of the girdle residues formed by α1 residues 
L275, S276, V279 and F280. These highly conserved residues are found in the middle of the 
transmembrane domain axis and are arranged adjacent to each other in a semi-circular fashion. 
The integrity of the above residues is important as the hydrophobic interactions between these 
residues form the gate that guards the rest of the channel. The closure of loop C causes rotations 
towards the M2-helices. This rotational force is transmitted to the 4 residue girdle. The force 
causes the hydrophobic interactions of the girdle to break amongst each other and the residues 
form hydrophobic interactions with the residues away from the pore-axis. If the integrity of the 
girdle forming residues is important then a mutation to any of the residues could result in 
increased channel opening. The girdle residues on the human α7 receptor corresponded to L275, 
S276, V279 and F280. We also studied the number of interactions the passing Ca2+ ion made 
with the girdle residues at the Ca2+-free receptor (Fig. 5.23A) and compared it to the Ca2+ 
affected receptor (Fig. 5.23B). We found that the Ca2+ ion made more number of interactions at 
the Ca2+-free human α7 receptor consistent with previous results in this chapter. This means that 
the girdle residues are held well together at the Ca2+-free receptor which remains in a closed 
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state. However, at the Ca2+ affected receptor, the comparatively low number of interactions 
suggests that the girdle forming residues are far apart from each other and are now positioned 
differently, likely due to the wider opening of the channel. These data thus clearly show that 
elevated Ca2+ ion concentration in the environment of neuronal nicotinic receptors cause many 
structural changes to the receptor that resemble those induced by agonist binding, and may be 
related to an ‘excited’ state of the receptor that would be more readily activatable by agonist 
binding. These changes may also differ from that induced by agonists and its effects may last 
longer in comparison to agonist binding, and may play a role in various neurodegenerative 
disorders.   
 
 
Figure 5.23: The number of contacts that the permeating Ca2+ ion makes with the human α7 
girdle-forming residues that have previously been shown to be important in Miyazawa’s study(492). 
The number of contacts made by the Ca2+-free girdle-forming residues with the permeating Ca2+ 
ion (A) is higher than that at the Ca2+ affected receptor (B), indicative that the gate is closed at the 
former. 
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5.4. Conclusions 
Abnormally high concentrations of calcium ions are often found in brains of individuals 
suffering from neurodegenerative disorders. In this chapter, we aimed to examine the influence 
of high Ca2+ concentration on α7 ECD and TM domain structures. Our studies using MD 
simulations of the human α7 receptor’s extracellular domain alone showed loop C closing into 
the adjacent complementary subunits, in the presence of high concentrations of Ca2+ ions, in the 
absence of an agonist at the ligand binding site. This was also manifested in differences in the 
RMSD of the structure with respect to time compared to a simulation run in a Ca2+-free system. 
Interestingly, the Ca2+ ions were also observed to make strong contacts with metal binding 
hydrolysis-resistant sites on the receptor. These residues - hα7-E32, Q49, D64, D66, E120, 
D123, E167, E184, D186, S188, E195 and E211, were also previously identified by Galzi and 
colleagues(493). This suggests that Ca2+ ions could be responsible in potentiating the receptor by 
binding to these sites. 
In order to get a more complete understanding of the effects of high Ca2+ ion concentration 
especially at the transmembrane domain, we modeled the extracellular and transmembrane 
domain embedded in a lipid bilayer. Our simulations of the receptor placed in a high Ca2+ ion 
concentration showed significant changes in RMSD at the pore lining M2 helices. Likewise the 
M2-M3 loops also showed a significant difference in RMSD in comparison to the M1-M2 loops. 
However no significant changes in RMSD were seen at the helices M1, M3 and M4. Likewise no 
such abrupt changes were observed at the Ca2+ ion free system. Differences in DOPC density 
across the simulation box were also observed between the Ca2+-free and Ca2+-affected systems, 
which showed that the DOPC density was higher towards the edges of the box in comparison to 
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the center, for the Ca2+ ion affected system, thus indicating a link between structural differences 
observed at the receptor TM domain and effects on its lipid environment.  
Studies of the channel pore indicated that the Ca2+ affected receptor pore radius was ~6Å on 
average, while the Ca2+-free receptor showed fluctuations in radius around ~2Å only.  This 
clearly showed that the pore was widening in the presence of Ca2+. Moreover, the residues at the 
point of constriction of the Ca2+ affected receptor was also seen to fluctuate at different time 
intervals, while at the Ca2+-free receptor the residues that caused constriction remained similar to 
that at the start of the simulation.      
We also propose that changes in RMSD for the M2 transmembrane helix and the M2-M3 loop, 
for the Ca2+-affected simulation, may underscore a structural movement related to receptor 
desensitization. There is close relation between receptor desensitization and phosphorylation of 
nicotinic receptors in vivo. Phosphorylation of nicotinic receptors occurs mostly when the 
structure of the receptor is altered (due to ligand binding) and becomes a viable target for kinases 
and phosphatases. Protein kinase C (PKC) and tyrosine-specific protein kinase (PKA) are 
responsible for phosphorylation. Phosphorylation of the receptor brings the receptor back from a 
desensitized state to a resting state. Additionally, Ca2+ interaction with PKC could affect its 
phosphorylation of nAChRs(494). Previous studies have shown that activation of PKC and 
inhibition of the same accelerates and decelerates the rate of recovery of desensitized α4β2 
receptors respectively. Likewise, activation of PKC accelerates recovery from desensitization in 
the presence of calcium. Phosphorylation could also help maintain balance of desensitized and 
activated receptors in the absence of a ligand. Hence, phosphorylation is known to bring about 
allosteric changes between the activated and desensitized states (431, 495). More interestingly, these 
phosphorylation sites lie between loop regions in the M2-M4 transmembrane domain. 
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Furthermore, we studied and compared the PMF of a Ca2+ ion permeating through a Ca2+ affected 
and Ca2+-free receptor pore, respectively, in order to determine whether elevated Ca2+ 
concentration could affect permeation  of the same ion, thereby leading to further imbalance in 
extra- and intra-cellular Ca2+ levels under pathological conditions. The study helped identify the 
pore-lining residues that would cause hindrance to the Ca2+ ion, that is, the important residues 
along the M2-helix that played an important role in ion passage. Comparison of the obtained 
PMF profiles showed that the Ca2+ ion passing through the Ca2+ affected receptor channel 
encountered less hindrance from the pore guarding residues in its vicinity. On the other hand, a 
Ca2+ ion passing through a receptor that was not affected by Ca2+ ions previously was hindered 
by conserved residues along the M2-helix that were shown to gate the channel according to 
previous studies. Thus the difference in hindrance to the Ca2+ ion showed more ‘dampening’ of 
the PMF profile as the ion passed through the M2-helices of the Ca2+-free receptor. Moreover, 
this is consistent with inter-residue contact profile plots which show the average number of 
contacts made by various M2 residues with the permeating Ca2+ ion. 
We acknowledge that multiple simulations would improve sampling and statistical significance 
of conformational differences observed. However, it should be noted that the major conformation 
differences observed between the Ca2+-free and Ca-affected  hα7 receptor are consistent between 
all the 5 interfaces; for example, all five loops C were closed in the presence of Ca2+ ; this was 
not observed at the Ca2+ free system. Overall, our results suggest that an increase in Ca2+ ion 
concentration in the environment of the nicotinic receptor is associated with loop C closure, 
observed for both ECD-only and our ‘whole receptor’ simulations. Elevated Ca2+ also caused 
partial channel opening in the absence of an agonist, possibly indirectly by binding to metal 
binding sites. This leads to an attendant increase in Ca2+ permeability. These structural and 
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biophysical changes, combined, suggest that the net effect of elevated Ca2+ is to induce a 
partially activated receptor state that is distinct from both the resting, and the agonist-activated, 
states. We propose that the structure identified from this chapter is related to a partially-active 
state, one that is primed and more prone to subsequent activation by agonist. The presence of 
Ca2+ thus, as expected, serves as a potentiator that could cause a higher rate of receptor 
activation- and therefore, abnormally high rates of desensitization. Over-desensitization of the 
nAChRs has been shown to be associated with neurological disease states, including muscular 
tremors associated with Parkinson’s disease. Although some of the allosteric changes that do 
occur due to agonist binding are known and are similar to those described in this chapter, the 
changes and structural dynamics related to potentiation of the receptor via excess Ca2+ ion 
concentrations could differ from ‘normal’ activation by agonist, leading to ‘abnormal’ receptor 
behavior due to, what might be described, as ‘damage’ induced by the presence of high Ca2+ 
levels.
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6.1. Introduction 
With our observations of the structural changes that took place in the receptor transmembrane 
domain, due to the presence of a strong concentration of Ca2+ ions in its environment, it seems 
profitable to obtain some understanding of the influences this will have on interactions of the α-
conotoxin GID at the receptor binding pocket in the presence of Ca2+ ions. Here, we describe 
preliminary simulation studies to understand the influence of Ca2+ ions on [γ4E]-GID’s structure 
(Fig 6.1), and also on the hα7 receptor pocket. 
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6.2 Methods 
 
Figure 6.1: Illustration of the MD simulation system containing 35 Ca2+ ions with an approximate 
ionic concentration of ~5mM. Blue spheres indicate the Ca2+ ions, hα7 ECD and GID represented 
as ribbons. hα7 is colour coded according to subunit, while GID is represented according to its 
secondary structure at the ligand binding site that is at the junction of the receptor subunits. 
 
For this study the extracellular domain of the hα7-[γ4E]-GID complex was placed in cubic 
simulation boxes with edge lengths of 111 x 111 x 111Ǻ for the Ca2+-free and Ca2+-affected 
simulations, respectively. The boxes were solvated with 39,111 SPC water molecules. To 
neutralize charge and maintain an ionic concentration of ~250 mM to affect the receptor, 25 Ca2+ 
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ions alone were added to the system. However, in the Ca2+ free simulation box, 15 Na+ ions were 
added, only to neutralise the system.  All simulations were performed using GROMACS version 
4.5.5(349, 350), with the Amber 99SB-ILDN force-field (Lindorff-Larsen et al., 2010). Six 
independent simulations were performed for the two systems, which were run for 40 ns each. 
The final 10 ns were analysed, and were combined into a single ‘super-trajectory’ of 60 ns 
duration, for ease of presentation. Other simulation procedures and parameters are the same as 
those described in Chapter 3. 
 
6.3. Results and Discussions 
6.3.1. Changes in [γ4E]-GID structure 
Observation of the Ca2+-affected trajectory showed that the system remained stable for the whole 
40ns of all the 6 seed simulations. Moreover, [γ4E]-GID also remained intact within the receptor 
pocket. In order to take a closer look at the changes in toxin structure, we analysed the change in 
secondary structure the toxin alone at receptor pockets 1, 3, and 5 respectively (labelled as 
hα7α7-1, 2 and 3 respectively). Figure 6.2 shows the transition of [γ4E]-GID’s secondary 
structure across the 60ns trajectory. During the simulation, only subtle differences in secondary 
structure could be noticed at residues closer to the IRDE-tail, when compared to the structure 
simulated in a Ca2+ free system (Fig 3.9). 
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Figure 6.2: STRIDE secondary structure plots of each [γ4E]-GID residue (y-axes) with respect to 
simulation time (x-axes) for three nominally equivalent hα7 interfaces (A-C respectively), under 
high [Ca2+] conditions. 
 
We also analysed the changes in conformation of [γ4E]-GID at the 3 respective binding pockets 
studied earlier, via cluster analysis (Fig. 6.3). Cluster analysis of the various structures showed a 
general decrease in conformational changes of [γ4E]-GID, compared to that in a neutralised 
system. This was evident by the smaller RMSD cut-off values (0.48-0.52Å) used to analyse 
[γ4E]-GID at the Ca2+ affected system in comparison to the control (~0.6Å). The number of 
clusters displayed by [γ4E]-GID at a low RMSD cut-off value of ~0.5Å (compared to [γ4E]-GID 
in a Ca2+ free system), suggests that [γ4E]-GID is more conformationally constrained in a Ca2+ -
rich environment. Also, most structures identified by the clusters show that [γ4E]-GID remained 
compact within the binding pocket with the N-terminal tail closer to the rest of the toxin body. 
This was not the appearance of [γ4E]-GID in the Ca2+-free system, where the N-terminal was 
distended and stood further apart from the remaining toxin. From the cluster analysis, therefore, 
[γ4E]-GID seems to interact with the hα7 binding in a similar manner to its behaviour at the 
α4β2 receptor binding pocket.     
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Figure 6.3: Conformational cluster identification number with respect to simulation time for [γ4E]-
GID at the three nominally equivalent hα7 interfaces (A-C respectively).  
 
The structures that represented some of the clusters were then extracted from the trajectory and 
superimposed on each other (Fig 6.4). This allowed a clearer visualisation of [γ4E]-GID’s 
structural transition better, and also to enable identification of the major conformations that 
[γ4E]-GID took up throughout the simulations. As observed from the cluster analysis, it is clear 
that the toxin tends to ‘shrink’ within itself, as it did at the α4β2 receptor binding pocket. In fact 
a strong resemblance in structure to that at the α4β2 receptor pocket can be seen in Fig 6.4, with 
the N-terminal tail standing at a more perpendicular axis to the rest of the toxin body (as seen 
also in Fig 3.16). Comparison of the data obtained from the cluster analysis of [γ4E]-GID at the 
α4β2 receptor (Figures 3.9 and 3.16) (in a Ca2+-free system), to that of Figures 6.2 and 6.3, 
suggests that the presence of Ca2+ ions could cause structural changes to [γ4E]-GID that  might  
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have implications on its ability to inhibit α4β2. However, further analysis is required to test the 
validity of this assumption. 
 
Figure 6.4: Superimposition of the [γ4E]-GID structures, identified by conformational cluster 
analysis to populate the majority of the respective trajectories for three hα7 interfaces.  
 
6.3.2 Changes in the hα7 receptor binding pocket 
We also ran 6 independent MD simulations of the extracellular domain of the hα7 receptor with 
the toxin bound at the respective binding pocket, in the presence of ~3-4mM concentration of 
Ca2+ ions for 40ns each, and extracted the last 10ns of each simulation and concatenated them. 
The number of contacts that were made between the receptor and the toxin at the Ca2+ affected 
system (averaged over the concatenated trajectory of 60ns) were found to be comparatively 
higher than that at the Ca2+ free simulation system (Figures 6.5 and 6.6). 
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Figure 6.5: Average number of contacts that each [γ4E]-GID residue made with the hα7 receptor at 
a Ca2+ free and Ca2+ affected systems respectively. Panel (A) shows [γ4E]-GID’s interaction at the 
principal hα7 subunit, while panel (B) shows GID interactions at the complementary hα7 subunit 
respectively. More number of interactions are formed for the Ca2+ affected system compared to 
that at the Ca2+ free simulation system. 
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Figure 6.6: Difference in average number of contacts that each [γ4E]-GID residue made with the 
hα7 receptor at a Ca2+ free and Ca2+ affected systems, calculated by subtracting the values from 
Ca2+-free from Ca2+-affected simulations . Panel (A) shows [γ4E]-GID’s interaction at the principal 
hα7 subunit, while panel (B) shows [γ4E]-GID interactions at the complementary hα7 subunit 
respectively. Generally, more number of interactions are formed for the Ca2+ affected system 
compared to that at the Ca2+ free simulation system. 
 
This difference in receptor-toxin interaction between the two simulation systems is significant at 
certain [γ4E]-GID residues. Figure 6.5 shows the difference in number of contacts at each [γ4E]-
GID residue taken by subtracting the values from Ca2+-free from Ca2+-affected simulations. The 
bar charts indicate that generally, more number of interactions are formed for the Ca2+ affected 
system compared to that at the Ca2+ free simulation system (with a few exceptions, such as R12 
and O16 in Fig. 6.5A or I1 at Fig. 6.5B). Specifically, at the hα7(+) face, GID[N8, P9, A10 and 
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V18] show a higher number of contacts compared to that at the Ca2+-free system. Similarly at the 
hα7(-) face, [γ4E]-GID[S7, P9, R12 and V13] show more number of contacts at the Ca2+-
affected system compared to that at the Ca2+-free simulation system. Also, the comparatively 
higher number of contacts close to the Cys-Cys pair residues and [γ4E]-GID at the Ca2+-affected 
system compared to that at the Ca2+-free system could also suggest that   at the Ca2+ affected 
system, the loop C that forms the ligand binding pocket moves in closer to the complementary 
face compared to that at the Ca2+ free system, thus the loop more effectively encloses around the 
toxin. 
When the average loop C tip distance between the hα7(+)-C191-sulphur and hα7(-)Y-Cϒ were 
taken into account from the respective trajectories, it was found that the loop C at the Ca2+ 
affected system closed into the adjacent subunit by ~1Å more than that at the Ca2+ free system on 
average (Fig. 6.7). This can be compared to results from Chapter 5, which also shows that the 
loops C closed into the adjacent complementary subunit in the absence of an agonist. The 
comparatively tight ligand binding pocket at the Ca2+ affected system could result in an increase 
in the i) opening of the channel pore and hence ii) reduction of GID’s efficacy towards blocking 
channel opening. The presence of Ca2+ (or other) ions clearly affect the interaction between GID 
and hα7, suggesting that these divalent ions may tend to reduce the inhibitory efficacy of 
conotoxins. Further work is needed to study the influence of other physiologically-relevant ions 
and species on conotoxins interactions with nAChRs. The impact of divalent ions may be 
significant, and are likely to have a major influence on the design of novel toxins aimed at 
enhancing their potency and selectivity.  
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Figure 6.7: Average  C-loop distance (between the hα7(+) loop C Cys212-sulphur and Y54-Cϒ of 
the hα7(-) subunit) at the Ca2+ affected and Ca2+ free  simulation systems over the 60ns trajectory 
at all 5 α7 subunit interfaces (panels A-E) are shown. The Ca2+ affected simulation system at 2/5 
interfaces (panels C and E) show closer distance between the above mentioned residues than at the 
other interfaces when compared to the Ca2+ free simulation system. 
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6.4 Conclusions 
The effect of Ca2+ on the hα7 receptor, with regards to the closure of the C-loops into the adjacent 
subunit and the opening of the channel as observed in Chapter-5, are interesting. It was thus 
intriguing to also study the effect of Ca2+ ions on [γ4E]-GID as well as the human α7 receptor 
binding site to see how Ca2+ ions influenced [γ4E]-GID binding. STRIDE analysis of [γ4E]-GID 
in the Ca2+ affected system showed that the toxin did not differ significantly compared to that in a 
Ca2+ free simulation system (Fig. 3.9). Cluster-analysis suggested that the [γ4E]-GID could be 
more restrained at the hα7-Ca2+ affected system. In addition, superimposition of the [γ4E]-GID 
structures that were most prevalent in the trajectory suggested resemblance to [γ4E]-GID bound to 
the α4β2 receptor pocket. These results must be validated by further experimentation. However, 
based on the structural changes that occur to [γ4E]-GID, we suggest that the presence of Ca2+ ions 
could further diminish the ability of [γ4E]-GID to inhibit the hα7 receptor. 
At the hα7 receptor binding pocket, [γ4E]-GID exhibited more contacts with the receptor in the 
simulation system affected by Ca2+ ions. When the [γ4E]-GID contacts were compared, [γ4E]-
GID[N8, P9, A10 and V18] show a higher number of contacts at the Ca2+ affected system 
compared to that at the Ca2+-free system. Similarly at the hα7(-) face, [γ4E]-GID[S7, P9, R12 
and V13] was seen to show more number of contacts at the Ca2+ affected receptor pocket. The 
increase in the number of contacts in the Ca2+ affected system, in comparison to that at the Ca2+ 
free system, is suggested to be also due to the closure of the C-loops in the presence of Ca2+ (as 
also observed in section 5.3.1). Although more experimental evidence is required, these 
preliminary results make evident that the presence of Ca2+ ions could certainly influence 
conotoxin-receptor binding. 
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7.1. Conotoxin-nAChR Interactions  
Neuronal nicotinic receptors are important ion channels in the brain and are located at strategic 
locations to fulfil their particular task of relaying nerve impulses through the brain and causing 
the release of neurotransmitters such as dopamine, serotonin, etc. On the other hand, it is also 
these receptors, specifically the α7 and the α4β2 nicotinic receptor subtypes that are implicated 
in neuropathic pain and various neurodegenerative disorders such as Alzheimer’s and 
Parkinson’s diseases. Although medication is currently available to address the symptoms of 
these diseases, their limited effectiveness necessitates the continued search for novel 
therapeutics. While drugs (e.g. Mecamylamine and cytisine-based compounds) have been 
developed which do target these receptors, they lack in specificity, hence there is a good chance 
that other receptors and protein structures are affected. Thus there is a need for a target specific 
drug which will in principle, exhibit fewer off-target effects. Conotoxins, extracted from the 
venom of Conus snails have been studied to specifically target nicotinic receptors. While many 
cocktails of conotoxins have been discovered to date, each toxin targets specific or specific 
groups of receptors (Table 1.1), while many others are yet to be characterised. However, there 
are no conotoxins that have a strong potency towards the human α4β2. Only the α-conotoxin 
[γ4E]-GID shows μ-molar potency towards the human α4β2 receptor and a comparatively 
stronger potency towards the human α7 receptor. Amongst the central aims of this thesis were to 
understand [γ4E]-GID-nAChR interactions with the α7 and α4β2 subtypes, and to propose 
possible [γ4E]-GID mutants which could enhance selectivity for α4β2 over α7. In the following 
sections, we summarise the main conclusions from this thesis, describe preliminary studies of 
[γ4E]-GID-nAChRs under elevated Ca2+ concentration, and briefly consider some future 
directions. 
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In an attempt to propose mutants which could increase the potency of [γ4E]-GID towards the 
hα4β2 receptor by comparing its interactions with hα7 receptor (Chapter 3), we found that the 
conotoxin N-terminal tail end residues govern the interaction. There are marked differences in 
[γ4E]-GID N-terminal tail structures between hα7 and the interfaces present in rα4β2  and hα4β2 
, leading us to propose that the difference in conotoxin structure could be one factor related to the 
difference in potency between the two subtypes. Additionally, analysis of [γ4E]-GID-nAChR 
pairwise inter-residue contacts, together with mutational free energy analysis using an empirical 
forcefield, lead us to propose specific mutants which could enhance selectivity. A number of 
these mutants (or at least [γ4E]-GID positions) were probed by experimental collaborators, and 
while these experiments indicate that mutants such as [γ4E]-GID[R2D, S7T, V13N and V18N] 
did show an increase in potency towards the human α4β2 receptor, more work is needed to 
understand the cooperative contribution of [γ4E]-GID residues that are causative for increased 
potency, rather than understanding the contribution from individual residues alone. Also, it 
would be beneficial to further understand interactions if high resolution structures of conotoxins 
bound to neuronal nAChRs were available.  
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 7.2. Importance of the Unbinding Pathway of the α-Conotoxin 
[γ4E]-GID 
In Chapter 4, umbrella sampling simulations were instrumental in sampling the conformational 
space and thus validating experimental binding energy results obtained by previous studies. 
More interestingly, we were also able to differentiate the curvilinear path taken by [ϒ4E]-GID as 
it exited the hα7 receptor binding pocket, which is in contrast to that at the human and rat 
α4β2/α4α4 receptor binding pockets. This observation pointed to the importance of the toxin-
receptor interactions with the complementary subunit that contributed to the binding pocket. The 
unbinding pathways examined also suggest that certain regions, far from the canonical binding 
pocket, might be targetable by conotoxins. In silico mutagenesis calculations could be performed 
on structures in which the toxin is bound to receptor sites that have been identified to form a high 
number of inter-atomic contacts, thereby proposing mutants which simultaneously stabilise 
[ϒ4E]-GID binding at such alternative sites at hα4β2, while destabilising the same interaction at 
hα7. Future experiments could be performed on these novel mutants to ascertain whether 
targeting alternative sites is a viable strategy for designing high potency, high selectivity 
conotoxins, not only for α7 and α4β2 , but for other receptor pairs for which it is important to 
differentiate between subtype interfaces.  
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7.3. Possible Effects of Ca2+ Ion Concentration on nAChRs and in 
Neurodegenerative Diseases 
The maintenance of the concentration of intracellular Ca2+ ions in the brain is important for its 
proper functioning. However, a dysregulation of these ions are often noticed in patients affected 
by neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Hence we aimed 
to understand how Ca2+ affects the hα7 receptor in the extracellular domain (ECD) as well as 
transmembrane (TM) domains (Chapter 5). In addition, if the structure or function of the receptor 
did alter, the receptor conotoxin interactions would also certainly vary from that in a Ca2+-free 
solution. Hence, it would be vital to look at conotoxin structure and interaction studies from a 
different angle altogether, i.e., in the presence of an increased Ca2+ ion concentration. Previous 
studies on nicotinic receptor have shown Ca2+ ions to potentiate heteromeric 2-, α3-, and α4- 
containing neuronal receptors(213, 496). 
Our studies, involving the simulation of the extracellular domain of the human α7 receptor 
showed that Ca2+ ions made persistent contacts with specific metal binding sites that are known 
to resist hydrolysis and potentiated the receptor. These sites were also identified by Galzi and 
colleagues in previous mutation studies. Further, loops C, which are important in ligand binding, 
were observed to close into the adjacent subunit in the absence of a ligand. Such motion is 
associated with receptor activation. We were also interested in the influence of Ca2+ ions on the 
transmembrane domain, especially given our observation of loop C closure at the ECD. Analysis 
of our MD simulations of a Ca2+ ion containing extracellular-transmembrane domain system, and 
comparison of the same to that in a Ca2+ ion free system revealed significant differences in the 
structure especially of the pore lining M2 helices as well as the M4 helices. In comparison, the 
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M1 and M3 helices did not show significant changes in structure. Likewise, substantial 
conformational shifts in the M2-M3 loops were also observed. In addition, when the density of 
the DOPC layer surrounding the transmembrane was analysed and compared to the density in 
DOPC density in the Ca2+-free system (control), it was found that the density of DOPC in the 
Ca2+ affected system was much lower at the regions that were closest to the transmembrane 
domain, while the density was highest at the edges of the box. These results indicate that there 
could be a positive disturbance or shift in the DOPC bilayer from the centre of the box towards 
its edges, possibly due to the structural changes occurring at the M2 helices. Examining the size 
of the pore with respect to simulation time suggested that the Ca2+ affected receptor showed a 
fluctuation in pore diameter of ~6-10Å during the course of the simulation, while the receptor in 
the control system showed no fluctuation in pore diameter, which remained at about 2-3Å units. 
A potential of mean force (PMF) analysis was also conducted on a Ca2+ ion permeating through 
a Ca2+ free and Ca2+ affected channel. The results suggest that the pore lining M2 helix residues 
of the Ca2+ free receptor structure (D123, S271, V274 and E281), posed a strong impediment to 
the passage of the Ca2+ ion by serving as strong binding sites, marked by the deep energy well of 
the PMF curve. However, the Ca2+ ion permeating through the Ca2+ affected receptor pore 
received comparatively less resistance by residues that guarded the pore (H127, T267 and E281). 
This was marked by a shallower well compared to that of the Ca2+ free receptor at the respective 
distance along the x-axis. In addition to this, comparison of the interactions made by the passing 
Ca2+ ion with previous simulation studies regarding channel opening (497) also reinforced our 
observations. These results were a sure indication that the Ca2+ ions surrounding the receptor 
were responsible for structural changes leading to channel-pore opening.  These data thus 
suggest that elevated Ca2+ ion concentration in the environment of neuronal nicotinic receptors 
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cause many structural changes to the receptor that resemble those induced by agonist binding, 
and may be related to an ‘excited’ state of the receptor that would be more readily activatable by 
agonist binding. 
 
7.4. Possible Effects of Ca2+ Ion Concentration on [γ4E]-GID at the 
human-α7 receptor 
A short simulation study was also done to study the effect of Ca2+ ions on the structure of [γ4E]-
GID and also understand how it can influence the interaction of the same with the ligand binding 
domain (Chapter 6).  STRIDE analysis showed that the secondary structure of [γ4E]-GID’s 
IRDE-tail (Fig. 6.2) differed slightly from that from the [γ4E]-GID-nAChR simulation in a 
neutral solution (Fig. 3.9). Further, cluster analysis of the [γ4E]-GID toxin showed that the latter 
was comparatively less flexible within the ligand binding pocket and its dynamics within the 
Ca2+ affected hα7 receptor binding pocket were similar to that at the α4β2 receptor. 
Superimposition of the [γ4E]-GID from the respective clusters identified also suggested a 
difference in activity compared to [γ4E]-GID’s activity in a neutral solution. However analysis 
of the trajectory suggested that on average, the number of interactions between [γ4E]-GID and 
the receptor pocket were more than that in a neutral solution. The c-loop was also found to move 
closer to the adjacent subunit of the hα7 receptor pocket, during the course of the simulation. 
This is not surprising, as a similar observation was also noticed when the hα7 receptor was 
simulated in a Ca2+ ion rich environment in the absence of [γ4E]-GID in its binding pocket. 
Overall, these results seem to suggest that [γ4E]-GID loses its inhibitory characteristics towards 
the hα7 receptor in the presence of Ca2+ ions. 
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7.5. Closing Thoughts and Future Directions 
The study of [γ4E]-GID and understanding the behaviour of [γ4E]-GID at the neuronal nicotinic 
receptors is indeed an interesting one, especially with the use of MD simulation. However, there 
is a need for this study to be enhanced by the use of more precise experimental evidences. Our 
simulation study was partly supported by single-point mutation studies on the [γ4E]-GID toxin 
(Chapter 3). But this does not rule out the combined effect more than one [γ4E]-GID residue to 
influence the binding of [γ4E]-GID to the respective receptor binding site, which also needs to be 
examined in future studies. 
Similar to understanding the effect of multiple mutations at the [γ4E]-GID toxin, it is also 
important that we understand the importance of various receptor residues. Chapter 4 of this thesis 
identified a substantial number of receptor residues at the complementary subunit interface of the 
ligand binding pocket to which [γ4E]-GID interacted differently amongst the different receptors. 
By confirming and understanding the significance of these receptor residues using experimental 
studies, we can deepen our understanding of the difference in behaviour of [γ4E]-GID towards 
the hα7 receptor and the α4β2 receptor subtypes. This would certainly be of importance while 
designing [γ4E]-GID to differentiate between targeting the α7 and the α4β2 receptor subtypes 
Chapters 5 of this thesis helped in shedding light into the effect of Ca2+ ions on the hα7 receptor 
alone. This study was conducted to understand if a high concentration of Ca2+ ions might 
influence [γ4E]-GID binding as well. The results from chapter 6 showed that the structure of 
[γ4E]-GID and hence its binding was different in the presence of Ca2+ ions. However, more 
experiments involving electrophysiology studies would be suitable to get a clear picture into the 
influence of Ca2+ ions on the receptor and hence it’s binding properties.  
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Supplementary Figures 
Supplementary figure 3.1: shows figures comparing the binding modes of all the binding sites 
at the hα7 receptor (Panels A-E), Hα4β2 receptor (Panels F-H) and the Rα4β2 receptor (Panels I-
K) 
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Supplementary figure 3.2: Shows the evolution of the minimum distance between [γ4E]-GID-
S7 and Y128 at the rα4(+) receptor and Y210 on the hα7 receptor. 
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Supplementary Figure 5.1: Porcupine plot of normal mode 4 predicted using the anisotropic 
network model 2.0 server (http://anm.csb.pitt.edu/). Arrows indicate direction of concerted 
motion of each residue, each represented by a single sphere.  
 
 
